{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Research_Articles"],"not_rendered":{"defined_names":1},"read":"whole","date_system":"1900"}

{"sheet":"Research_Articles","index":0,"n_rows":36598,"n_cols":6,"rows_kept":4500,"cut":true,"bounds":{"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0}}
["Article_ID","PMID","Source","DOI","Title","Update"]
[1,"35259705","Diabetes Metab Syndr","10.1016/j.dsx.2022.102446","Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis.","2022-03-10"]
[2,"35259493","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2022.02.018","Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia.","2022-03-10"]
[3,"35259337","Chem Phys Lipids","10.1016/j.chemphyslip.2022.105192","New insights into NAFLD based on preclinical MRI studies.","2022-03-10"]
[4,"35258780","Chin J Integr Med","10.1007/s11655-022-3307-3","Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[5,"35258483","Endocr Connect","10.1530/EC-21-0537","Menopause-associated risk of cardiovascular disease.","2022-03-10"]
[6,"35256934","Acta Pharm Sin B","10.1016/j.apsb.2021.09.019","Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.","2022-03-10"]
[7,"35256601","Cell Death Discov","10.1038/s41420-022-00889-7","LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease.","2022-03-10"]
[8,"35256204","Transplant Proc","10.1016/j.transproceed.2021.10.032","Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors.","2022-03-10"]
[9,"35256195","Thromb Res","10.1016/j.thromres.2022.02.023","Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease.","2022-03-10"]
[10,"35255811","BMC Gastroenterol","10.1186/s12876-022-02176-2","The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.","2022-03-10"]
[11,"35255600","Endocrinol Metab (Seoul)","10.3803/EnM.2022.102","State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis.","2022-03-10"]
[12,"35255597","Endocrinol Metab (Seoul)","10.3803/EnM.2022.101","The Influence of Obesity and Metabolic Health on Vascular Health.","2022-03-10"]
[13,"35255263","Lancet Oncol","10.1016/S1470-2045(22)00078-X","Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.","2022-03-10"]
[14,"35254877","Arch Physiol Biochem","10.1080/13813455.2022.2046106","Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis.","2022-03-10"]
[15,"35254642","Hepatol Int","10.1007/s12072-022-10300-3","MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[16,"35252828","JHEP Rep","10.1016/j.jhepr.2022.100444","Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators.","2022-03-10"]
[17,"35252807","iScience","10.1016/j.isci.2022.103890","A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease.","2022-03-10"]
[18,"35252260","Front Med (Lausanne)","10.3389/fmed.2022.829979","Intermittent Hypoxia Rewires the Liver Transcriptome and Fires up Fatty Acids Usage for Mitochondrial Respiration.","2022-03-10"]
[19,"35252196","Front Cell Dev Biol","10.3389/fcell.2022.836021","ULK1 Signaling in the Liver: Autophagy Dependent and Independent Actions.","2022-03-10"]
[20,"35251901","Australas J Ultrasound Med","10.1002/ajum.12286","Portal Venous Pulsatility Index as a predictor of fibrosis in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[21,"35251583","J Healthc Eng","10.1155/2022/9331284","Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population.","2022-03-10"]
[22,"35251469","Oxid Med Cell Longev","10.1155/2022/3589525","Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.","2022-03-10"]
[23,"35251371","Dis Markers","10.1155/2022/4930355","Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.","2022-03-10"]
[24,"35251356","EFSA J","10.2903/j.efsa.2022.7074","Tolerable upper intake level for dietary sugars.","2022-03-10"]
[25,"35251100","Front Plant Sci","10.3389/fpls.2022.829118","Raffinose Family Oligosaccharides: Friend or Foe for Human and Plant Health?","2022-03-10"]
[26,"35251036","Front Immunol","10.3389/fimmu.2022.840106","Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies.","2022-03-10"]
[27,"35250889","Front Endocrinol (Lausanne)","10.3389/fendo.2022.840299","Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis.","2022-03-10"]
[28,"35250880","Front Endocrinol (Lausanne)","10.3389/fendo.2022.821689","A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease.","2022-03-10"]
[29,"35250856","Front Endocrinol (Lausanne)","10.3389/fendo.2022.785819","Not Enough Fat: Mouse Models of Inherited Lipodystrophy.","2022-03-10"]
[30,"35250593","Front Pharmacol","10.3389/fphar.2022.843872","Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[31,"35250588","Front Pharmacol","10.3389/fphar.2022.842636","Platelets in Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[32,"35250014","Ultrasound Q","10.1097/RUQ.0000000000000599","Clinical Feasibility of Shear Wave Dispersion Slope for Noninvasive Diagnosis of Nonalcoholic Steatohepatitis in Patients With Morbid Obesity: Preliminary Results Using US Shear Wave Elastography.","2022-03-10"]
[34,"35249505","Curr Drug Saf","10.2174/1574886317666220304124756","Pioglitazone, Bladder Cancer and the Presumption of Innocence.","2022-03-10"]
[35,"35249343","Ann Palliat Med","10.21037/apm-21-3890","Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people.","2022-03-10"]
[36,"35249342","Ann Palliat Med","10.21037/apm-21-3943","Risk factors and correlation of colorectal polyps with type 2 diabetes mellitus.","2022-03-10"]
[37,"35248654","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109819","Metabolic determinants of NAFLD in adults with type 1 diabetes.","2022-03-10"]
[38,"35248539","Gastroenterology","10.1053/j.gastro.2022.01.058","NAFLD and the Gut-Liver Axis: Exploring an Undernutrition Perspective.","2022-03-10"]
[39,"35247883","Cancer Epidemiol Biomarkers Prev","10.1158/1055-9965.EPI-21-1303","Cancer epidemiology in Hispanic populations: what have we learned and where do we need to make progress?","2022-03-10"]
[40,"35247631","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2022.02.019","The critical and diverse roles of CD4-CD8- double negative T cells in nonalcoholic fatty liver disease.","2022-03-10"]
[41,"35247611","Mol Metab","10.1016/j.molmet.2022.101462","Serum Amyloid A1 Exacerbates Hepatic Steatosis via TLR4 Mediated NF-&#954;B Signaling Pathway.","2022-03-10"]
[44,"35246007","Bioengineered","10.1080/21655979.2022.2045837","Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.","2022-03-10"]
[45,"35245436","Mol Cell","10.1016/j.molcel.2022.01.021","Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination.","2022-03-10"]
[46,"35244697","J Clin Endocrinol Metab","10.1210/clinem/dgac122","Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Non-Alcoholic Fatty Liver Disease in Middle Age.","2022-03-10"]
[47,"35244676","Am J Clin Nutr","10.1093/ajcn/nqac059","Sex-related association of NAFLD and liver fibrosis with body fat distribution in the general US population.","2022-03-10"]
[48,"35243281","JHEP Rep","10.1016/j.jhepr.2022.100443","Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.","2022-03-10"]
[49,"35243280","JHEP Rep","10.1016/j.jhepr.2021.100416","Cellular origins of regenerating liver and hepatocellular carcinoma.","2022-03-10"]
[50,"35243111","Transl Gastroenterol Hepatol","10.21037/tgh.2020.02.20","Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice.","2022-03-10"]
[51,"35242578","Mol Genet Metab Rep","10.1016/j.ymgmr.2022.100847","Expression signature of the Leigh syndrome French-Canadian type.","2022-03-10"]
[52,"35242173","PPAR Res","10.1155/2022/4709300","Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[53,"35242045","Front Physiol","10.3389/fphys.2021.817152","Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease.","2022-03-10"]
[54,"35241921","J Inflamm Res","10.2147/JIR.S354878","Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach.","2022-03-10"]
[55,"35240510","Biochem Biophys Res Commun","10.1016/j.bbrc.2022.02.033","Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice.","2022-03-10"]
[56,"35240344","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2022.02.015","Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.","2022-03-10"]
[57,"35238939","J Clin Endocrinol Metab","10.1210/clinem/dgac068","Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[58,"35238782","Turk J Gastroenterol","10.5152/tjg.2022.21705","Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant Setting.","2022-03-10"]
[59,"35238641","Proc Natl Acad Sci U S A","10.1073/pnas.2200083119","Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.","2022-03-10"]
[60,"35237077","Hepat Med","10.2147/HMER.S350703","Evaluation of the Effect of Hydromethanolic Seed Extract of Lepidium sativum L. (Fetto) on Deep-fried Palm Oil Diet Induced Nonalcoholic Fatty Liver Disease on Male Swiss Albino Mice.","2022-03-10"]
[61,"35236351","Lipids Health Dis","10.1186/s12944-022-01637-7","Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.","2022-03-10"]
[62,"35235789","Cell Rep","10.1016/j.celrep.2022.110454","Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.","2022-03-10"]
[63,"35235219","Aliment Pharmacol Ther","10.1111/apt.16831","Review article: current and emerging therapies for the management of cirrhosis and its complications.","2022-03-10"]
[64,"35234251","Clin Sci (Lond)","10.1042/CS20211177","MicroRNAs as messengers of liver diseases: has the message finally been decrypted?","2022-03-10"]
[65,"35233386","J Clin Transl Hepatol","10.14218/JCTH.2021.00171","Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease.","2022-03-10"]
[66,"35233381","J Clin Transl Hepatol","10.14218/JCTH.2021.00200","Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis.","2022-03-10"]
[67,"35233368","J Clin Transl Hepatol","10.14218/JCTH.2021.00089","Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study.","2022-03-10"]
[69,"35232986","Sci Rep","10.1038/s41598-022-06614-9","Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.","2022-03-10"]
[70,"35232007","Clin Mol Hepatol","10.3350/cmh.2021.0406","NAFLD increases Risk of Carotid Atherosclerosis and Ischemic Stroke. An Updated Meta-Analysis with 135,602 Individuals.","2022-03-10"]
[71,"35231745","Surg Oncol","10.1016/j.suronc.2022.101730","Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma.","2022-03-10"]
[72,"35230646","Neurochem Res","10.1007/s11064-022-03551-x","Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence.","2022-03-10"]
[73,"35230526","Langenbecks Arch Surg","10.1007/s00423-022-02484-x","Is there a role for preoperative liver reducing diet in hepatectomy? A systematic review.","2022-03-10"]
[74,"35230042","Swiss Med Wkly","10.4414/smw.2022.w30138","Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.","2022-03-10"]
[75,"35229847","Food Funct","10.1039/d1fo03952k","N-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury via regulating the intestinal microecology in mice.","2022-03-10"]
[76,"35229334","Aliment Pharmacol Ther","10.1111/apt.16844","Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.","2022-03-10"]
[77,"35229329","Hepatology","10.1002/hep.32434","Risk Factors for Hepatocellular Cancer in Contemporary Cohorts of Patients with Cirrhosis.","2022-03-10"]
[78,"35229183","Pediatr Radiol","10.1007/s00247-022-05313-x","Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.","2022-03-10"]
[79,"35229049","Health Sci Rep","10.1002/hsr2.495","Associations between aflatoxin B1-albumin adduct levels with metabolic conditions in Guatemala: A cross-sectional study.","2022-03-10"]
[80,"35227957","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2022.101896","The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience.","2022-03-10"]
[81,"35227956","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2022.101894","Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with Covid-19.","2022-03-10"]
[82,"35227772","Life Sci","10.1016/j.lfs.2022.120438","sSTEAP4 regulates cellular homeostasis and improves high-fat-diet-caused oxidative stress in hepatocytes.","2022-03-10"]
[83,"35226932","Ultraschall Med","10.1055/a-1724-7289","Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography.","2022-03-10"]
[84,"35226292","Indian J Gastroenterol","10.1007/s12664-021-01209-0","Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.","2022-03-10"]
[85,"35226250","Cell Biol Toxicol","10.1007/s10565-022-09703-7","AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance.","2022-03-10"]
[86,"35225189","Br J Nutr","10.1017/S0007114522000629","Organ meat consumption and risk of nonalcoholic fatty liver disease: the TCLSIH study.","2022-03-10"]
[87,"35224757","Histopathology","10.1111/his.14631","Utility of sonic hedgehog and keratin 8/18 immunohistochemistry for detecting ballooned hepatocytes.","2022-03-10"]
[88,"35223941","Front Nutr","10.3389/fnut.2022.765206","Cumulative Betel Quid Chewing and the Risk of Significant Liver Fibrosis in Subjects With and Without Metabolic Syndrome.","2022-03-10"]
[89,"35223701","Front Pediatr","10.3389/fped.2022.825141","Association Between Non-invasive Diagnostic Methods of Liver Fibrosis and Type 2 Diabetes in Pediatric Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[90,"35223680","Clin Nutr Res","10.7762/cnr.2022.11.1.42","Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study.","2022-03-10"]
[91,"35222903","Ther Adv Chronic Dis","10.1177/20406223221077958","Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial.","2022-03-10"]
[92,"35222799","Oxid Med Cell Longev","10.1155/2022/5180242","4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes.","2022-03-10"]
[93,"35222075","Front Physiol","10.3389/fphys.2022.803445","MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3.","2022-03-10"]
[94,"35222044","Front Pharmacol","10.3389/fphar.2022.829686","Antibiotic Disruption of the Gut Microbiota Enhances the Murine Hepatic Dysfunction Associated With a High-Salt Diet.","2022-03-10"]
[95,"35221291","J Pharmacol Exp Ther","10.1124/jpet.121.001018","Resveratrol attenuates HFD-induced hepatic lipotoxicity by up-regulating Bmi-1 expression.","2022-03-10"]
[96,"35220997","Discov Med",null,"Farnesoid X Receptor as a Promising Therapeutic Target for Nonalcoholic Fatty Liver Disease (NAFLD) and the Current Development of Its Agonists.","2022-03-10"]
[97,"35220673","Liver Int","10.1111/liv.15209","Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes.","2022-03-10"]
[99,"35220605","Hepatology","10.1002/hep.32427","Metabolic subtypes of nonalcoholic fatty liver disease patients exhibit distinctive cardiovascular risk profiles.","2022-03-10"]
[100,"35220131","Phytomedicine","10.1016/j.phymed.2022.153994","2,3,5,4'-tetrahydroxy-stilbene-2-O-&#946;-D-glucoside ameliorates NAFLD via attenuating hepatic steatosis through inhibiting mitochondrial dysfunction dependent on SIRT5.","2022-03-10"]
[101,"35219732","Eur J Pharmacol","10.1016/j.ejphar.2022.174857","mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis.","2022-03-10"]
[102,"35218767","Life Sci","10.1016/j.lfs.2022.120428","Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation.","2022-03-10"]
[103,"35218234","Hepatology","10.1002/hep.32428","Dual roles of B lymphocytes in murine models of diet-induced non-alcoholic fatty liver disease.","2022-03-10"]
[105,"35218194","J Nutr","10.1093/jn/nxac046","Clinical Intervention to Reduce Dietary Sugar does not Impact Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.","2022-03-10"]
[106,"35217953","Environ Sci Pollut Res Int","10.1007/s11356-022-19369-7","Environmental exposure to low-dose perfluorohexanesulfonate promotes obesity and non-alcoholic fatty liver disease in mice fed a high-fat diet.","2022-03-10"]
[107,"35217817","Acta Pharmacol Sin","10.1038/s41401-022-00880-z","Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease.","2022-03-10"]
[108,"35217669","Nat Commun","10.1038/s41467-022-28641-w","The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.","2022-03-10"]
[109,"35217283","Clin Imaging","10.1016/j.clinimag.2022.02.010","Ultrasound attenuation coefficient of the liver and spleen in adults: A preliminary observation.","2022-03-10"]
[110,"35217259","J Pharm Biomed Anal","10.1016/j.jpba.2022.114663","CE with Cu2+ ions and 2-hydroxypropyl-&#946;-cyclodextrin additives for the investigation of amino acids composition of the culture medium in a cellular model of non-alcoholic fatty liver disease.","2022-03-10"]
[111,"35216753","Lancet Digit Health","10.1016/S2589-7500(21)00270-3","Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.","2022-03-10"]
[112,"35216556","BMC Endocr Disord","10.1186/s12902-022-00967-y","Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease.","2022-03-10"]
[113,"35216439","Int J Mol Sci","10.3390/ijms23042325","Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr-/-.Leiden Mice.","2022-03-10"]
[114,"35216326","Int J Mol Sci","10.3390/ijms23042209","New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.","2022-03-10"]
[115,"35216174","Int J Mol Sci","10.3390/ijms23042059","Whole Body Ip6k1 Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction.","2022-03-10"]
[116,"35216100","Int J Mol Sci","10.3390/ijms23041986","Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.","2022-03-10"]
[117,"35215517","Nutrients","10.3390/nu14040867","Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases.","2022-03-10"]
[118,"35215504","Nutrients","10.3390/nu14040854","Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study.","2022-03-10"]
[119,"35213373","J Alzheimers Dis","10.3233/JAD-215409","Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-&#946; and Tau Pathology in Middle-Aged Adults: The Framingham Study.","2022-03-10"]
[120,"35213006","Methods Mol Biol","10.1007/978-1-0716-2128-8_26","Generation of Adenovirus for In Vitro and In Vivo Studies of Hepatocytes.","2022-03-10"]
[121,"35213002","Methods Mol Biol","10.1007/978-1-0716-2128-8_22","Analysis of the Sphingolipidome in NAFLD.","2022-03-10"]
[122,"35213001","Methods Mol Biol","10.1007/978-1-0716-2128-8_21","In Vivo Analysis of Necrosis and Ferroptosis in Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[123,"35213000","Methods Mol Biol","10.1007/978-1-0716-2128-8_20","Ex Vivo Dual-Hit Method for Inflammasome Activation in Liver.","2022-03-10"]
[124,"35212999","Methods Mol Biol","10.1007/978-1-0716-2128-8_19","Assessment of Lipotoxic Endoplasmic Reticulum (ER) Stress in Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[125,"35212998","Methods Mol Biol","10.1007/978-1-0716-2128-8_18","Analysis of Insulin Resistance in Nonalcoholic Steatohepatitis.","2022-03-10"]
[126,"35212997","Methods Mol Biol","10.1007/978-1-0716-2128-8_17","Metabolic Phenotyping in Mice with NASH Using Indirect Calorimetry.","2022-03-10"]
[127,"35212996","Methods Mol Biol","10.1007/978-1-0716-2128-8_16","Computational Pipeline for Next-Generation Sequencing (NGS) Studies in Genetics of NASH.","2022-03-10"]
[128,"35212995","Methods Mol Biol","10.1007/978-1-0716-2128-8_15","Single Cell RNA Sequencing in NASH.","2022-03-10"]
[129,"35212994","Methods Mol Biol","10.1007/978-1-0716-2128-8_14","Analysis of Liver Responses to Non-alcoholic Steatohepatitis by mRNA-Sequencing.","2022-03-10"]
[130,"35212993","Methods Mol Biol","10.1007/978-1-0716-2128-8_13","Chromatin Immunoprecipitation Assay in Primary Mouse Hepatocytes and Mouse Liver.","2022-03-10"]
[131,"35212991","Methods Mol Biol","10.1007/978-1-0716-2128-8_11","Culture of Mouse Liver Ductal Organoids.","2022-03-10"]
[132,"35212989","Methods Mol Biol","10.1007/978-1-0716-2128-8_9","Purification and Isolation of Hepatic Stellate Cells.","2022-03-10"]
[133,"35212987","Methods Mol Biol","10.1007/978-1-0716-2128-8_7","Isolation and Culture of Mouse Hepatocytes and Kupffer Cells (KCs).","2022-03-10"]
[134,"35212986","Methods Mol Biol","10.1007/978-1-0716-2128-8_6","Measurement of In Vivo VLDL and Chylomicron Secretion.","2022-03-10"]
[135,"35212985","Methods Mol Biol","10.1007/978-1-0716-2128-8_5","Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[136,"35212984","Methods Mol Biol","10.1007/978-1-0716-2128-8_4","Measurement of Hepatic Lipids.","2022-03-10"]
[137,"35212983","Methods Mol Biol","10.1007/978-1-0716-2128-8_3","Hydrodynamic Injection for Developing NASH Model.","2022-03-10"]
[138,"35212982","Methods Mol Biol","10.1007/978-1-0716-2128-8_2","Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[139,"35212981","Methods Mol Biol","10.1007/978-1-0716-2128-8_1","Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[140,"35212643","Eur J Endocrinol","10.1530/EJE-21-1221","Increased liver fat associates with severe metabolic perturbations in low birth weight men.","2022-03-10"]
[141,"35212227","J Agric Food Chem","10.1021/acs.jafc.1c07538","Targeted Lipidomics Reveal the Effects of Different Phospholipids on the Phospholipid Profiles of Hepatic Mitochondria and Endoplasmic Reticulum in High-Fat/High-Fructose-Diet-Induced Nonalcoholic Fatty Liver Disease Mice.","2022-03-10"]
[142,"35212074","J Magn Reson Imaging","10.1002/jmri.28131","Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine-Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[143,"35211584","World J Clin Cases","10.12998/wjcc.v10.i5.1457","Nonalcoholic fatty liver disease shows significant sex dimorphism.","2022-03-10"]
[144,"35209867","BMC Gastroenterol","10.1186/s12876-022-02148-6","Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China.","2022-03-10"]
[145,"35208613","Medicina (Kaunas)","10.3390/medicina58020290","Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.","2022-03-10"]
[146,"35208576","Medicina (Kaunas)","10.3390/medicina58020252","The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.","2022-03-10"]
[147,"35208513","Medicina (Kaunas)","10.3390/medicina58020189","Evaluation of Dose-Dependent Obesity and Diabetes-Related Complications of Water Chestnut (Fruit of Trapa japonica) Extracts in Type II Obese Diabetic Mice Induced by 45% Kcal High-Fat Diet.","2022-03-10"]
[148,"35208265","Metabolites","10.3390/metabo12020192","Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis.","2022-03-10"]
[149,"35208241","Metabolites","10.3390/metabo12020167","Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases.","2022-03-10"]
[150,"35208229","Metabolites","10.3390/metabo12020155","The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents.","2022-03-10"]
[151,"35208205","Metabolites","10.3390/metabo12020130","A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver.","2022-03-10"]
[152,"35207770","J Pers Med","10.3390/jpm12020282","Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients.","2022-03-10"]
[153,"35207239","J Clin Med","10.3390/jcm11040968","Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes.","2022-03-10"]
[154,"35207209","J Clin Med","10.3390/jcm11040935","Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults.","2022-03-10"]
[155,"35206988","Healthcare (Basel)","10.3390/healthcare10020374","Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis.","2022-03-10"]
[156,"35206539","Int J Environ Res Public Health","10.3390/ijerph19042350","Protective Effect of Leisure-Time Physical Activity and Resistance Training on Nonalcoholic Fatty Liver Disease: A Nationwide Cross-Sectional Study.","2022-03-10"]
[157,"35204710","Biomolecules","10.3390/biom12020208","Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.","2022-03-10"]
[158,"35204522","Diagnostics (Basel)","10.3390/diagnostics12020431","A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer.","2022-03-10"]
[159,"35204498","Diagnostics (Basel)","10.3390/diagnostics12020407","Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.","2022-03-10"]
[160,"35204232","Antioxidants (Basel)","10.3390/antiox11020349","Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway.","2022-03-10"]
[161,"35204113","Antioxidants (Basel)","10.3390/antiox11020230","Effects of Colchicine in a Rat Model of Diet-Induced Hyperlipidemia.","2022-03-10"]
[162,"35203687","Biomedicines","10.3390/biomedicines10020479","A Novel 2-Hit Zebrafish Model to Study Early Pathogenesis of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[163,"35203662","Biomedicines","10.3390/biomedicines10020453","The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features.","2022-03-10"]
[164,"35203659","Biomedicines","10.3390/biomedicines10020451","Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[165,"35203610","Biomedicines","10.3390/biomedicines10020401","Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor &#945; Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study.","2022-03-10"]
[166,"35203502","Biomedicines","10.3390/biomedicines10020294","Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model.","2022-03-10"]
[167,"35203484","Biomedicines","10.3390/biomedicines10020274","Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates.","2022-03-10"]
[168,"35203457","Biomedicines","10.3390/biomedicines10020249","Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences.","2022-03-10"]
[170,"35202771","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109791","Dapagliflozin for nonalcoholic fatty liver disease: A systematic review and meta-analysis.","2022-03-10"]
[172,"35201574","Hepatol Int","10.1007/s12072-021-10265-9","Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis.","2022-03-10"]
[173,"35199429","HIV Med","10.1111/hiv.13274","\"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV\".","2022-03-10"]
[174,"35198905","iScience","10.1016/j.isci.2022.103859","Deletion of RNF186 expression suppresses diet-induced hepatic steatosis by regulating insulin activity.","2022-03-10"]
[175,"35198900","iScience","10.1016/j.isci.2022.103847","NAFLD indirectly impairs antigen-specific CD8+ T&#160;cell immunity against liver cancer in mice.","2022-03-10"]
[176,"35197660","Acta Inform Med","10.5455/aim.2021.29.260-265","Biochemical Parameters as Predictors of Underlying Liver Disease in Patients with Chronic Kidney Disorders.","2022-03-10"]
[177,"35197460","Nat Commun","10.1038/s41467-022-28692-z","Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.","2022-03-10"]
[178,"35196551","Ann Hepatol","10.1016/j.aohep.2022.100690","Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease.","2022-03-10"]
[179,"35196511","Am J Med Sci","10.1016/j.amjms.2021.10.029","Deciphering the Role of Aquaporins in Metabolic Diseases: A Mini Review.","2022-03-10"]
[180,"35196341","PLoS One","10.1371/journal.pone.0264075","The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.","2022-03-10"]
[181,"35195774","Arch Microbiol","10.1007/s00203-022-02802-3","A review on the effect of gut microbiota on metabolic diseases.","2022-03-10"]
[182,"35195697","JAMA Netw Open","10.1001/jamanetworkopen.2022.0262","Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[183,"35195377","Minerva Endocrinol (Torino)","10.23736/S2724-6507.20.03257-5","Inflammation is associated with impairment of oxidative status, carbohydrate and lipid metabolism in type 2 diabetes complicated by non-alcoholic fatty liver disease.","2022-03-10"]
[185,"35194014","Nutr Diabetes","10.1038/s41387-022-00187-2","Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity.","2022-03-10"]
[186,"35193993","Gut Liver","10.5009/gnl210391","Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","2022-03-10"]
[187,"35193889","BMJ Open Gastroenterol","10.1136/bmjgast-2021-000831","Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in Rajarata Pregnancy Cohort (RaPCo).","2022-03-10"]
[188,"35192934","Mol Ther","10.1016/j.ymthe.2022.02.021","Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma.","2022-03-10"]
[189,"35192912","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109789","Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis.","2022-03-10"]
[190,"35192675","PLoS One","10.1371/journal.pone.0264348","Itemization difference of patient-reported outcome in patients with chronic liver disease.","2022-03-10"]
[191,"35192111","Clin Exp Med","10.1007/s10238-022-00799-z","Liver biopsy for assessment of chronic liver diseases: a synopsis.","2022-03-10"]
[192,"35191422","Chin Med J (Engl)","10.1097/CM9.0000000000002092","Hepatocyte nuclear factor 4&#945; in the pathogenesis of non-alcoholic fatty liver disease.","2022-03-10"]
[193,"35191421","Chin Med J (Engl)","10.1097/CM9.0000000000002089","From MAFLD to hepatocellular carcinoma and everything in between.","2022-03-10"]
[194,"35190927","Mol Biol Rep","10.1007/s11033-022-07174-x","Atheroprotective and hepatoprotective effects of trans-chalcone through modification of eNOS/AMPK/KLF-2 pathway and regulation of COX-2, Ang-II, and PDGF mRNA expression in NMRI mice fed HCD.","2022-03-10"]
[195,"35190696","Acta Pharmacol Sin","10.1038/s41401-022-00860-3","Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis.","2022-03-10"]
[196,"35190444","BMJ Open","10.1136/bmjopen-2021-057820","Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study.","2022-03-10"]
[197,"35190357","Anatol J Cardiol","10.5152/AnatolJCardiol.2021.433","Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men.","2022-03-10"]
[198,"35189786","Scand J Gastroenterol","10.1080/00365521.2022.2041085","Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease.","2022-03-10"]
[199,"35189388","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.02.028","Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium.","2022-03-10"]
[201,"35188871","Epigenetics","10.1080/15592294.2022.2039850","Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children.","2022-03-10"]
[202,"35188038","Scand J Gastroenterol","10.1080/00365521.2022.2032320","Non-alcoholic fatty liver disease and intestinal immune status: a narrative review.","2022-03-10"]
[203,"35187967","Exp Biol Med (Maywood)","10.1177/15353702221077218","Iron-accumulating splenocytes may exacerbate non-alcoholic steatohepatitis through the production of proinflammatory cytokines and reactive oxygen species.","2022-03-10"]
[204,"35187942","Rev Esp Enferm Dig","10.17235/reed.2022.8718/2022","Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease.","2022-03-10"]
[205,"35187676","J Food Biochem","10.1111/jfbc.14045","Chitosan oligosaccharide attenuates hepatic steatosis in HepG2 cells via the activation of AMP-activated protein kinase.","2022-03-10"]
[206,"35187020","Front Nutr","10.3389/fnut.2021.795391","Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States.","2022-03-10"]
[207,"35186807","Can J Gastroenterol Hepatol","10.1155/2022/2868904","Therapeutic Effects of Milk Thistle (Silybum marianum L.) and Artichoke (Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats.","2022-03-10"]
[208,"35185803","Front Endocrinol (Lausanne)","10.3389/fendo.2022.830012","Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[209,"35185113","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000003418","Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study.","2022-03-10"]
[210,"35184490","Zhonghua Liu Xing Bing Xue Za Zhi","10.3760/cma.j.cn112338-20210809-00621","[A cohort study on the correlation between alanine aminotransferase trajectories and new-onset metabolic fatty liver disease].","2022-03-10"]
[212,"35183303","Lancet Diabetes Endocrinol","10.1016/S2213-8587(22)00003-1","A global view of the interplay between non-alcoholic fatty liver disease and diabetes.","2022-03-10"]
[213,"35182670","J Ethnopharmacol","10.1016/j.jep.2022.115117","Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells.","2022-03-10"]
[214,"35182330","Mol Cell Biochem","10.1007/s11010-022-04392-6","Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1.","2022-03-10"]
[215,"35182007","Liver Int","10.1111/liv.15197","The NAFLD-MAFLD debate: Is there a Consensus-on-Consensus methodology?","2022-03-10"]
[216,"35181565","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.02.018","UNOS Down-staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies.","2022-03-10"]
[217,"35181350","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109781","Metabolic Changes Induced by Dapagliflozin, an SGLT2 Inhibitor, in Japanese Patients with Type 2 Diabetes Treated by Oral Anti-diabetic Agents: A Randomized, Clinical Trial.","2022-03-10"]
[218,"35180651","Pathol Res Pract","10.1016/j.prp.2022.153798","Stage-dependent expression of fibrogenic markers in alcohol-related liver disease.","2022-03-10"]
[219,"35178989","Zhongguo Zhong Yao Za Zhi","10.19540/j.cnki.cjcmm.20211008.402","[Mechanism of Zexie Decoction in improvement of nonalcoholic fatty liver disease based on LKB1/AMPK/PGC-1&#945; pathway].","2022-03-10"]
[220,"35178663","Hepatol Int","10.1007/s12072-022-10304-z","Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.","2022-03-10"]
[221,"35178496","APL Bioeng","10.1063/5.0081695","Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD).","2022-03-10"]
[222,"35178204","Caspian J Intern Med","10.22088/cjim.13.1.23","Effect of Oral and parenteral routes of vitamin D supplementation on serum 25(OH) vitamin D levels in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[223,"35178098","Evid Based Complement Alternat Med","10.1155/2022/1638740","A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[224,"35178085","Gastroenterol Res Pract","10.1155/2022/5980390","The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran.","2022-03-10"]
[225,"35176709","Biomed Pharmacother","10.1016/j.biopha.2022.112697","Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.","2022-03-10"]
[226,"35176096","PLoS One","10.1371/journal.pone.0263931","Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.","2022-03-10"]
[227,"35176047","PLoS One","10.1371/journal.pone.0263826","Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand.","2022-03-10"]
[228,"35174539","J Gastroenterol Hepatol","10.1111/jgh.15799","Validation of five hepatic steatosis algorithms in metabolic- associated fatty liver disease: a population based study.","2022-03-10"]
[229,"35174500","J Sci Food Agric","10.1002/jsfa.11820","Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial community.","2022-03-10"]
[230,"35174209","Front Mol Biosci","10.3389/fmolb.2021.804097","ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets.","2022-03-10"]
[231,"35174195","Front Nutr","10.3389/fnut.2021.779912","Dietary Vitamin C Intake Is Associated With Improved Liver Function and Glucose Metabolism in Chinese Adults.","2022-03-10"]
[232,"35173677","Front Endocrinol (Lausanne)","10.3389/fendo.2021.739875","Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.","2022-03-10"]
[233,"35173541","Int J Biol Sci","10.7150/ijbs.67533","The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.","2022-03-10"]
[234,"35173224","Sci Rep","10.1038/s41598-022-06512-0","A robust gene expression signature for NASH in liver expression data.","2022-03-10"]
[235,"35172845","Nutr Metab (Lond)","10.1186/s12986-022-00644-w","Effects of exercise on high-fat diet-induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice.","2022-03-10"]
[236,"35172328","J Clin Endocrinol Metab","10.1210/clinem/dgac088","Growth hormone and insulin-like growth factor I regulation of nonalcoholic fatty liver disease.","2022-03-10"]
[237,"35171499","Ther Innov Regul Sci","10.1007/s43441-022-00380-6","Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey.","2022-03-10"]
[238,"35171411","Med Biol Eng Comput","10.1007/s11517-022-02505-3","Exploring diet associations with Covid-19 and other diseases: a Network Analysis-based approach.","2022-03-10"]
[239,"35171314","Pathologe","10.1007/s00292-022-01052-w","[Histopathological evaluation of nonalcoholic fatty liver disease : Automated evaluation of liver biopsies].","2022-03-10"]
[240,"35171164","Food Funct","10.1039/d1fo02989d","Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice.","2022-03-10"]
[241,"35170435","Saudi J Gastroenterol","10.4103/sjg.sjg_512_21","Correlation between serum total bile acid and nonalcoholic fatty liver disease: A cross-sectional study.","2022-03-10"]
[242,"35170434","Saudi J Gastroenterol","10.4103/sjg.sjg_576_21","Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia.","2022-03-10"]
[243,"35170400","Bioengineered","10.1080/21655979.2022.2037374","Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification.","2022-03-10"]
[244,"35169195","Sci Rep","10.1038/s41598-022-06205-8","Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus.","2022-03-10"]
[245,"35168828","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2022.01.009","Visceral adipose tissue quality was associated with nonalcoholic fatty liver disease, independent of its quantity.","2022-03-10"]
[246,"35167495","JCI Insight","10.1172/jci.insight.157906","Ethnic and gender differences in hepatic lipid content and related cardiometabolic parameters in lean individuals.","2022-03-10"]
[247,"35167194","J Diabetes Investig","10.1111/jdi.13772","Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus.","2022-03-10"]
[248,"35166723","Clin Transl Gastroenterol","10.14309/ctg.0000000000000466","Relationship between hepatic gene expression, intestinal microbiota and inferred functional metagenomic analysis in NAFLD.","2022-03-10"]
[249,"35166009","Diabetes Obes Metab","10.1111/dom.14670","Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes.","2022-03-10"]
[250,"35165568","Cureus","10.7759/cureus.21110","Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[251,"35164657","Bioengineered","10.1080/21655979.2022.2036902","Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro.","2022-03-10"]
[252,"35164326","Molecules","10.3390/molecules27031062","Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells.","2022-03-10"]
[253,"35164140","Molecules","10.3390/molecules27030858","A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.","2022-03-10"]
[254,"35164079","Molecules","10.3390/molecules27030815","Genistein-Opportunities Related to an Interesting Molecule of Natural Origin.","2022-03-10"]
[255,"35163991","Molecules","10.3390/molecules27030727","Sitagliptin Is More Effective Than Gliclazide in Preventing &nbsp;Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[256,"35163881","Molecules","10.3390/molecules27030607","The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.","2022-03-10"]
[257,"35163821","Int J Mol Sci","10.3390/ijms23031899","Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.","2022-03-10"]
[258,"35163521","Int J Mol Sci","10.3390/ijms23031600","The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases.","2022-03-10"]
[259,"35163026","Int J Mol Sci","10.3390/ijms23031102","Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[260,"35162992","Int J Mol Sci","10.3390/ijms23031070","Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond.","2022-03-10"]
[261,"35162967","Int J Mol Sci","10.3390/ijms23031044","Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis.","2022-03-10"]
[262,"35162956","Int J Mol Sci","10.3390/ijms23031032","Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders.","2022-03-10"]
[263,"35162699","Int J Environ Res Public Health","10.3390/ijerph19031675","Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults.","2022-03-10"]
[264,"35162067","Int J Environ Res Public Health","10.3390/ijerph19031042","The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients.","2022-03-10"]
[265,"35160340","J Clin Med","10.3390/jcm11030890","Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[266,"35160329","J Clin Med","10.3390/jcm11030878","Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors.","2022-03-10"]
[267,"35160204","J Clin Med","10.3390/jcm11030753","Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements.","2022-03-10"]
[268,"35160087","J Clin Med","10.3390/jcm11030635","Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[269,"35159371","Cells","10.3390/cells11030562","The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period.","2022-03-10"]
[270,"35159342","Cells","10.3390/cells11030533","The Translational Bridge between Inflammation and Hepatocarcinogenesis.","2022-03-10"]
[271,"35159219","Cells","10.3390/cells11030409","S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.","2022-03-10"]
[272,"35158328","J Physiol Pharmacol","10.26402/jpp.2021.5.01","Current approach to hepatobiliary manifestations in inflammatory bowel disease.","2022-03-10"]
[273,"35158055","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.057","Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[274,"35157960","J Hepatol","10.1016/j.jhep.2022.01.025","Hepatic lymphatic vascular system in health and disease.","2022-03-10"]
[275,"35154670","Food Sci Nutr","10.1002/fsn3.2368","The effect of Spirulina sauce, as a functional food, on cardiometabolic risk factors, oxidative stress biomarkers, glycemic profile, and liver enzymes in nonalcoholic fatty liver disease patients: A randomized double-blinded clinical trial.","2022-03-10"]
[276,"35154609","Gastroenterol Hepatol Bed Bench",null,"Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran.","2022-03-10"]
[277,"35154608","Gastroenterol Hepatol Bed Bench",null,"Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis.","2022-03-10"]
[278,"35154523","Arch Med Sci","10.5114/aoms/98948","Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss.","2022-03-10"]
[279,"35154005","Front Endocrinol (Lausanne)","10.3389/fendo.2021.802114","Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study.","2022-03-10"]
[280,"35153490","Int J Tryptophan Res","10.1177/11786469211070533","Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis.","2022-03-10"]
[281,"35153138","Hepatobiliary Pancreat Dis Int","10.1016/j.hbpd.2022.01.006","Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.","2022-03-10"]
[282,"35152974","Adv Clin Chem","10.1016/bs.acc.2021.09.003","Advances in fibrosis biomarkers in nonalcoholic fatty liver disease.","2022-03-10"]
[283,"35152674","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20210105-00007","[Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease].","2022-03-10"]
[284,"35152673","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200507-00234","[Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway].","2022-03-10"]
[285,"35152669","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20191227-00482","[Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection].","2022-03-10"]
[286,"35152526","Liver Int","10.1111/liv.15195","Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study.","2022-03-10"]
[287,"35152446","Hepatology","10.1002/hep.32404","FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis.","2022-03-10"]
[288,"35152443","J Food Sci","10.1111/1750-3841.16076","Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota&#160;in mouse with nonalcoholic fatty liver disease induced by high-fat diet.","2022-03-10"]
[290,"35151246","Folia Biol (Praha)",null,"Luteoloside Ameliorates Palmitic Acid-Induced in Vitro Model of Non-alcoholic Fatty Liver Disease via Activating STAT3-Triggered Hepatocyte Regeneration.","2022-03-10"]
[291,"35150905","Mol Metab","10.1016/j.molmet.2022.101454","ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acids.","2022-03-10"]
[292,"35150314","Abdom Radiol (NY)","10.1007/s00261-022-03434-3","Clinical evaluation of grayscale and linear scale hepatorenal indices for fatty liver quantification: a prospective study of a native Chinese population.","2022-03-10"]
[293,"35148806","Nutr Metab (Lond)","10.1186/s12986-022-00641-z","Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage.","2022-03-10"]
[294,"35148334","PLoS One","10.1371/journal.pone.0263828","Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression.","2022-03-10"]
[295,"35147926","J Endocrinol Invest","10.1007/s40618-022-01755-0","Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.","2022-03-10"]
[296,"35147302","Hepatol Commun","10.1002/hep4.1906","Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD.","2022-03-10"]
[297,"35147274","Eur J Neurol","10.1111/ene.15277","Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study.","2022-03-10"]
[298,"35146945","Hepatol Commun","10.1002/hep4.1877","A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[300,"35145074","Nat Commun","10.1038/s41467-022-28435-0","Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes.","2022-03-10"]
[301,"35144542","BMC Gastroenterol","10.1186/s12876-022-02137-9","Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD.","2022-03-10"]
[302,"35144365","Minerva Gastroenterol (Torino)","10.23736/S2724-5985.22.03139-4","Non-invasive biomarkers of non-alcoholic fatty liver disease in patients with Metabolic Syndrome: insights from the RESOLVE study.","2022-03-10"]
[303,"35144334","Endocrinol Metab (Seoul)","10.3803/EnM.2021.1293","Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.","2022-03-10"]
[304,"35144052","Redox Biol","10.1016/j.redox.2022.102236","The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities.","2022-03-10"]
[305,"35143711","Clin Transl Sci","10.1111/cts.13235","Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH.","2022-03-10"]
[306,"35143562","PLoS One","10.1371/journal.pone.0263768","Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.","2022-03-10"]
[307,"35143431","Curr Opin Gastroenterol","10.1097/MOG.0000000000000823","Metabolic dysfunction-associated fatty liver disease: a year in review.","2022-03-10"]
[308,"35143415","Aging (Albany NY)","10.18632/aging.203817","Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.","2022-03-10"]
[310,"35142988","Curr Gastroenterol Rep","10.1007/s11894-022-00835-8","Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis.","2022-03-10"]
[311,"35142615","Diagn Interv Radiol","10.5152/dir.2021.21845","Proton density fat fraction: magnetic resonance imaging applications beyond the liver.","2022-03-10"]
[314,"35141790","Mamm Genome","10.1007/s00335-022-09945-0","RMRP inhibition prevents NAFLD progression in rats via regulating miR-206/PTPN1 axis.","2022-03-10"]
[315,"35141703","Front Oral Health","10.3389/froh.2021.784448","Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection.","2022-03-10"]
[316,"35140621","Front Pharmacol","10.3389/fphar.2022.833705","Limonin, an AMPK Activator, Inhibits Hepatic Lipid Accumulation in High Fat Diet Fed Mice.","2022-03-10"]
[317,"35140487","Diabetes Metab Syndr Obes","10.2147/DMSO.S348870","The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study.","2022-03-10"]
[318,"35140289","Sci Rep","10.1038/s41598-022-06143-5","Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.","2022-03-10"]
[319,"35138995","Pharm Biol","10.1080/13880209.2022.2029501","Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis.","2022-03-10"]
[320,"35138548","Intern Emerg Med","10.1007/s11739-022-02933-x","NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study.","2022-03-10"]
[321,"35137416","J Cell Physiol","10.1002/jcp.30699","The role of exosomal miRNA in nonalcoholic fatty liver disease.","2022-03-10"]
[322,"35136128","Sci Rep","10.1038/s41598-022-06035-8","Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS).","2022-03-10"]
[323,"35135742","Dig Liver Dis","10.1016/j.dld.2022.01.130","Intrahepatic lipid content is independently associated with soluble E-selectin levels: The Maastricht study.","2022-03-10"]
[324,"35134508","J Nutr Biochem","10.1016/j.jnutbio.2022.108955","Mechanisms of autophagic responses to altered nutritional status.","2022-03-10"]
[325,"35134507","J Nutr Biochem","10.1016/j.jnutbio.2022.108957","Green tea extract increases adiponectin and PPAR &#945; levels to improve hepatic steatosis.","2022-03-10"]
[326,"35134438","Life Sci","10.1016/j.lfs.2022.120379","Fluorene-9-bisphenol exposure decreases locomotor activity and induces lipid-metabolism disorders by impairing fatty acid oxidation in zebrafish.","2022-03-10"]
[327,"35134388","Anal Biochem","10.1016/j.ab.2022.114581","Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies.","2022-03-10"]
[329,"35133671","Hepatology","10.1002/hep.32403","Randomized placebo-controlled trial of losartan for pediatric NAFLD.","2022-03-10"]
[330,"35133148","J Agric Food Chem","10.1021/acs.jafc.1c06681","Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation.","2022-03-10"]
[331,"35133139","Environ Sci Technol","10.1021/acs.est.1c07182","3-tert-Butyl-4-hydroxyanisole Impairs Hepatic Lipid Metabolism in Male Mice Fed with a High-Fat Diet.","2022-03-10"]
[332,"35133032","FASEB J","10.1096/fj.202101607R","TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.","2022-03-10"]
[333,"35132345","Oxid Med Cell Longev","10.1155/2022/2315575","Differentially Expressed Hepatic Genes Revealed by Transcriptomics in Pigs with Different Liver Lipid Contents.","2022-03-10"]
[334,"35131122","Clin Investig Arterioscler","10.1016/j.arteri.2021.10.001","Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!","2022-03-10"]
[335,"35130757","Biol Res Nurs","10.1177/10998004211068026","Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[336,"35130181","Aging (Albany NY)","10.18632/aging.203880","Cholesterol metabolism in aging simultaneously altered in liver and nervous system.","2022-03-10"]
[337,"35129841","Hepatol Res","10.1111/hepr.13757","The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.","2022-03-10"]
[338,"35129307","Liver Int","10.1111/liv.15182","Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models.","2022-03-10"]
[339,"35129295","Liver Int","10.1111/liv.15178","Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease.","2022-03-10"]
[340,"35129258","Liver Int","10.1111/liv.15188","The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint.","2022-03-10"]
[341,"35127789","Front Nutr","10.3389/fnut.2021.803691","Lentinan Supplementation Protects the Gut-Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved.","2022-03-10"]
[342,"35127372","Acta Pharm Sin B","10.1016/j.apsb.2021.05.011","The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.","2022-03-10"]
[343,"35127371","Acta Pharm Sin B","10.1016/j.apsb.2021.07.021","Therapeutic regulation of autophagy in hepatic metabolism.","2022-03-10"]
[344,"35126846","World J Hepatol","10.4254/wjh.v14.i1.168","Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence.","2022-03-10"]
[345,"35126845","World J Hepatol","10.4254/wjh.v14.i1.158","Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?","2022-03-10"]
[346,"35126843","World J Hepatol","10.4254/wjh.v14.i1.119","Is there a role of lipid-lowering therapies in the management of fatty liver disease?","2022-03-10"]
[347,"35126317","Front Endocrinol (Lausanne)","10.3389/fendo.2021.825448","Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014.","2022-03-10"]
[348,"35126113","Front Pharmacol","10.3389/fphar.2021.770652","Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice.","2022-03-10"]
[350,"35124887","Mol Nutr Food Res","10.1002/mnfr.202101115","ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model.","2022-03-10"]
[352,"35124446","J Pharm Biomed Anal","10.1016/j.jpba.2022.114620","Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.","2022-03-10"]
[353,"35124270","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.046","Influence of Nonalcoholic Fatty Liver Disease With Elevated Liver Enzyme Levels on Risk of Cirrhosis and Hepatocellular Carcinoma.","2022-03-10"]
[354,"35124268","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.045","Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19.","2022-03-10"]
[355,"35123096","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.023","Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.","2022-03-10"]
[356,"35122619","J Physiol Biochem","10.1007/s13105-022-00876-7","Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis : Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis.","2022-03-10"]
[357,"35122420","Pediatr Obes","10.1111/ijpo.12902","Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: The healthy start study.","2022-03-10"]
[358,"35122118","Semin Immunopathol","10.1007/s00281-022-00910-2","TNF in the liver: targeting a central player in inflammation.","2022-03-10"]
[359,"35121786","Sci Rep","10.1038/s41598-022-06030-z","Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype.","2022-03-10"]
[360,"35120767","Med Clin (Barc)","10.1016/j.medcli.2021.12.003","Bariatric surgery and non-alcoholic fatty liver disease.","2022-03-10"]
[361,"35120381","Semin Liver Dis","10.1055/s-0041-1742279","The Role of Liver Zonation in Physiology, Regeneration, and Disease.","2022-03-10"]
[362,"35120274","Hepatol Res","10.1111/hepr.13754","Perturbation of Wnt/&#946;-catenin signaling and sexual dimorphism in non-alcoholic fatty liver disease.","2022-03-10"]
[363,"35119232","J Basic Clin Physiol Pharmacol","10.1515/jbcpp-2021-0285","Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data.","2022-03-10"]
[364,"35118444","touchREV Endocrinol","10.17925/EE.2021.17.1.33","Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls.","2022-03-10"]
[365,"35116640","Transl Cancer Res","10.21037/tcr-21-707","Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease.","2022-03-10"]
[366,"35116505","Transl Cancer Res","10.21037/tcr-20-3158","Low expression of AQP9 and its value in hepatocellular carcinoma.","2022-03-10"]
[367,"35115947","Front Pharmacol","10.3389/fphar.2021.816032","Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[368,"35115798","Diabetes Metab Syndr Obes","10.2147/DMSO.S349153","Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus.","2022-03-10"]
[369,"35115689","Nat Genet","10.1038/s41588-021-00991-z","Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort.","2022-03-10"]
[370,"35115498","Cell Death Discov","10.1038/s41420-022-00840-w","Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model.","2022-03-10"]
[371,"35114889","Organogenesis","10.1080/15476278.2021.1994273","Therapeutic Potential of HNF4&#945; in End-stage Liver Disease.","2022-03-10"]
[372,"35114586","Biochem Biophys Res Commun","10.1016/j.bbrc.2022.01.085","Estrogen receptor &#945; mediated M1/M2 macrophages polarization plays a critical role in NASH of female mice.","2022-03-10"]
[373,"35113098","Food Funct","10.1039/d1fo03752h","Curcumin alleviates hepatic steatosis by improving mitochondrial function in postnatal overfed rats and fatty L02 cells through the SIRT3 pathway.","2022-03-10"]
[374,"35112237","Handb Exp Pharmacol","10.1007/164_2021_579","The Circadian Clock and Obesity.","2022-03-10"]
[375,"35111794","Front Nutr","10.3389/fnut.2021.774030","Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[376,"35111769","Front Med (Lausanne)","10.3389/fmed.2021.738835","Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults.","2022-03-10"]
[377,"35111690","Front Cell Infect Microbiol","10.3389/fcimb.2021.733348","Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.","2022-03-10"]
[378,"35111461","Cureus","10.7759/cureus.20776","Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD).","2022-03-10"]
[379,"35110952","World J Gastroenterol","10.3748/wjg.v28.i3.310","Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.","2022-03-10"]
[380,"35109946","Nutr Res Rev","10.1017/S095442242100038X","NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways.","2022-03-10"]
[381,"35109888","Trials","10.1186/s13063-022-06031-3","Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial.","2022-03-10"]
[382,"35108509","Cell Metab","10.1016/j.cmet.2022.01.001","New avenues for NASH therapy by targeting ACC.","2022-03-10"]
[383,"35108454","FEBS Open Bio","10.1002/2211-5463.13376","Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation.","2022-03-10"]
[384,"35108315","PLoS One","10.1371/journal.pone.0262855","Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.","2022-03-10"]
[385,"35107763","Curr Atheroscler Rep","10.1007/s11883-022-01000-2","Childhood Hypertriglyceridemia: Is It Time for a New Approach?","2022-03-10"]
[386,"35107741","Mol Biol Rep","10.1007/s11033-022-07142-5","Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPAR&#945;/Fgf21 signaling.","2022-03-10"]
[387,"35107488","Arq Bras Cir Dig","10.1590/0102-672020210002e1626","OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES.","2022-03-10"]
[388,"35106510","Cell Rep Med","10.1016/j.xcrm.2021.100498","Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism.","2022-03-10"]
[389,"35104782","Ecotoxicol Environ Saf","10.1016/j.ecoenv.2022.113257","Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota.","2022-03-10"]
[390,"35104757","Phytomedicine","10.1016/j.phymed.2021.153919","Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPAR&#945;/PGC-1&#945;-mediated mitochondrial oxidative metabolism.","2022-03-10"]
[391,"35104330","Diabetes Care","10.2337/dc21-1953","Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes.","2022-03-10"]
[392,"35103461","Minerva Endocrinol (Torino)","10.23736/S2724-6507.22.03752-6","Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders.","2022-03-10"]
[393,"35102341","Nat Metab","10.1038/s42255-021-00518-0","PSD3 downregulation confers protection against fatty liver disease.","2022-03-10"]
[394,"35102183","Sci Rep","10.1038/s41598-022-05528-w","Intergenerational effects of preconception opioids on glucose homeostasis and hepatic transcription in adult male rats.","2022-03-10"]
[395,"35102146","Nat Commun","10.1038/s41467-022-28138-6","Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.","2022-03-10"]
[396,"35102112","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002347","Clinical implications of hepatic structure and function evaluation based on vibration-controlled transient elastography and liver maximum function capacity test in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[397,"35101634","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.020","Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression.","2022-03-10"]
[398,"35101633","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.021","Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[399,"35101037","BMC Med","10.1186/s12916-022-02239-x","Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations.","2022-03-10"]
[400,"35100965","Mol Med","10.1186/s10020-021-00428-7","Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1.","2022-03-10"]
[401,"35100585","Ann Nutr Metab","10.1159/000522193","Influences of vitamin D levels and vitamin D binding protein polymorphisms on non-alcoholic fatty liver disease risk in a Chinese population.","2022-03-10"]
[402,"35100462","Diabet Med","10.1111/dme.14799","An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.","2022-03-10"]
[403,"35100057","Metab Syndr Relat Disord","10.1089/met.2021.0106","Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.","2022-03-10"]
[404,"35100024","Circulation","10.1161/CIRCULATIONAHA.121.055600","Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3.","2022-03-10"]
[405,"35098442","Hepatol Int","10.1007/s12072-021-10286-4","Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review.","2022-03-10"]
[406,"35097198","AACE Clin Case Rep","10.1016/j.aace.2021.07.001","Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism.","2022-03-10"]
[407,"35096933","Front Nutr","10.3389/fnut.2021.787430","Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation.","2022-03-10"]
[408,"35096879","Front Med (Lausanne)","10.3389/fmed.2021.788881","Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter.","2022-03-10"]
[409,"35096868","Front Med (Lausanne)","10.3389/fmed.2021.774079","MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.","2022-03-10"]
[410,"35096103","Evid Based Complement Alternat Med","10.1155/2022/1670014","Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking.","2022-03-10"]
[411,"35094409","Med Phys","10.1002/mp.15484","Vibration-controlled transient elastography for noninvasive evaluation of liver steatosis.","2022-03-10"]
[412,"35093608","Mol Cell Proteomics","10.1016/j.mcpro.2022.100207","Integrated liver and plasma proteomics in obese mice reveals complex metabolic regulation.","2022-03-10"]
[413,"35093393","Biochem Pharmacol","10.1016/j.bcp.2022.114933","Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease.","2022-03-10"]
[414,"35093339","Life Sci","10.1016/j.lfs.2022.120355","Endothelial group IVA phospholipase A2 promotes hepatic fibrosis with sinusoidal capillarization in the early stage of non-alcoholic steatohepatitis in mice.","2022-03-10"]
[415,"35093101","J Transl Med","10.1186/s12967-022-03263-4","Single-cell transcriptomic analysis reveals a novel cell state&#160;and switching genes during hepatic stellate cell activation in vitro.","2022-03-10"]
[416,"35092912","EBioMedicine","10.1016/j.ebiom.2022.103858","The influence of host genetics on liver microbiome composition in patients with NAFLD.","2022-03-10"]
[418,"35092183","Pediatr Obes","10.1111/ijpo.12893","Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity.","2022-03-10"]
[419,"35091842","Dig Dis Sci","10.1007/s10620-021-07363-x","Validation and Performance of FibroScan&#174;-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[420,"35091821","Diabetologia","10.1007/s00125-021-05649-3","Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice.","2022-03-10"]
[421,"35091747","J Nutr","10.1093/jn/nxab404","Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults.","2022-03-10"]
[422,"35090960","J Hepatol","10.1016/j.jhep.2022.01.011","Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.","2022-03-10"]
[423,"35089884","Chin Med J (Engl)","10.1097/CM9.0000000000002027","Non-invasive tests of non-alcoholic fatty liver disease.","2022-03-10"]
[425,"35089208","Medicine (Baltimore)","10.1097/MD.0000000000028658","Association between liver stiffness measurement by transient elastography and chronic kidney disease.","2022-03-10"]
[426,"35089193","Medicine (Baltimore)","10.1097/MD.0000000000028559","Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII.","2022-03-10"]
[428,"35087774","Front Pediatr","10.3389/fped.2021.784221","Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.","2022-03-10"]
[429,"35087411","Front Pharmacol","10.3389/fphar.2021.826628","Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.","2022-03-10"]
[430,"35087037","Cell Death Dis","10.1038/s41419-022-04521-5","Long-term oral administration of an HNF4&#945; agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function.","2022-03-10"]
[431,"35086794","Prim Care Diabetes","10.1016/j.pcd.2022.01.005","Metabolic dysfunction-associated fatty liver disease - How relevant is this to primary care physicians and diabetologists?","2022-03-10"]
[432,"35086000","Food Chem","10.1016/j.foodchem.2022.132087","Amelioration action of gastrodigenin rhamno-pyranoside from Moringa seeds on non-alcoholic fatty liver disease.","2022-03-10"]
[434,"35085594","J Hepatol","10.1016/j.jhep.2022.01.010","Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants.","2022-03-10"]
[435,"35085294","PLoS One","10.1371/journal.pone.0262291","Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease.","2022-03-10"]
[436,"35085026","Metab Syndr Relat Disord","10.1089/met.2021.0104","Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[438,"35084136","Rev Med Suisse","10.53738/REVMED.2022.18.766.111","[New approaches to risk and the use of electronic tools in primary care medicine in 2021].","2022-03-10"]
[439,"35083765","Hepatology","10.1002/hep.32363","Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome.","2022-03-10"]
[440,"35083304","Front Cardiovasc Med","10.3389/fcvm.2021.824481","Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis.","2022-03-10"]
[441,"35083257","Front Med (Lausanne)","10.3389/fmed.2021.814951","Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[442,"35082753","Front Endocrinol (Lausanne)","10.3389/fendo.2021.775677","Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease.","2022-03-10"]
[443,"35081304","Diabetes Metab J","10.4093/dmj.2021.0130","Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[444,"35080508","Clin Transl Gastroenterol","10.14309/ctg.0000000000000435","Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study.","2022-03-10"]
[445,"35080136","J Diabetes Investig","10.1111/jdi.13756","Non-alcoholic fatty liver disease and type&#8201;2 diabetes: An update.","2022-03-10"]
[446,"35080048","J Gastroenterol Hepatol","10.1111/jgh.15787","Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.","2022-03-10"]
[447,"35079935","Mol Biol Rep","10.1007/s11033-022-07175-w","Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network.","2022-03-10"]
[448,"35079162","Eur J Clin Nutr","10.1038/s41430-022-01069-7","Inflammatory potential of diet and risk of nonalcoholic fatty liver disease: a prospective cohort study.","2022-03-10"]
[449,"35078487","Chin Med","10.1186/s13020-022-00573-z","Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-&#954;B/NLRP3 inflammasome-mediated hepatic inflammation in mice.","2022-03-10"]
[450,"35077907","Environ Toxicol Pharmacol","10.1016/j.etap.2022.103819","Enterobacter cloacae aggravates metabolic disease by inducing inflammation and lipid accumulation.","2022-03-10"]
[451,"35077243","J Cardiovasc Pharmacol Ther","10.1177/10742484221074585","The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity.","2022-03-10"]
[452,"35076304","Radiology","10.1148/radiol.210736","US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.","2022-03-10"]
[453,"35076162","Hepatol Commun","10.1002/hep4.1896","Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults.","2022-03-10"]
[455,"35075592","Hepatol Int","10.1007/s12072-022-10296-w","Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice.","2022-03-10"]
[456,"35075477","Lab Med","10.1093/labmed/lmab118","Serum Metabolomics in Patients with Coexisting NAFLD and T2DM Using Liquid Chromatography-Mass Spectrometry.","2022-03-10"]
[457,"35075185","Sci Rep","10.1038/s41598-022-05228-5","MAFLD progression contributes to altered thalamus metabolism and brain structure.","2022-03-10"]
[458,"35074921","Proc Natl Acad Sci U S A","10.1073/pnas.2107742119","Myeloid cell TBK1 restricts inflammatory responses.","2022-03-10"]
[459,"35072848","Inflammopharmacology","10.1007/s10787-021-00916-6","The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules.","2022-03-10"]
[460,"35072542","Antioxid Redox Signal","10.1089/ars.2021.0156","SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS.","2022-03-10"]
[461,"35072021","JHEP Rep","10.1016/j.jhepr.2021.100409","Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.","2022-03-10"]
[462,"35071330","Front Mol Biosci","10.3389/fmolb.2021.824776","HSD17B13: A Potential Therapeutic Target for NAFLD.","2022-03-10"]
[463,"35071254","Front Med (Lausanne)","10.3389/fmed.2021.736109","Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19.","2022-03-10"]
[464,"35070304","Mol Clin Oncol","10.3892/mco.2021.2488","Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD.","2022-03-10"]
[465,"35070018","World J Hepatol","10.4254/wjh.v13.i12.2179","Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study.","2022-03-10"]
[466,"35070015","World J Hepatol","10.4254/wjh.v13.i12.2150","Determination of \"indeterminate score\" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia.","2022-03-10"]
[467,"35070009","World J Hepatol","10.4254/wjh.v13.i12.2071","Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis.","2022-03-10"]
[468,"35070000","World J Hepatol","10.4254/wjh.v13.i12.1956","Liver manifestations and complications in inflammatory bowel disease: A review.","2022-03-10"]
[469,"35069993","World J Hepatol","10.4254/wjh.v13.i12.1828","Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.","2022-03-10"]
[470,"35069992","World J Hepatol","10.4254/wjh.v13.i12.1816","Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?","2022-03-10"]
[471,"35069014","Genet Res (Camb)","10.1155/2022/8560831","Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills.","2022-03-10"]
[472,"35068798","J Clin Exp Hepatol","10.1016/j.jceh.2021.08.016","Diagnosis and Management of Cirrhotic Cardiomyopathy.","2022-03-10"]
[473,"35068797","J Clin Exp Hepatol","10.1016/j.jceh.2021.08.002","Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD.","2022-03-10"]
[474,"35068796","J Clin Exp Hepatol","10.1016/j.jceh.2021.08.017","A Current Understanding of Bile Acids in Chronic Liver Disease.","2022-03-10"]
[475,"35068786","J Clin Exp Hepatol","10.1016/j.jceh.2021.03.012","Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study.","2022-03-10"]
[476,"35068681","J Clin Biochem Nutr","10.3164/jcbn.21-40","A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial.","2022-03-10"]
[477,"35068225","Exp Biol Med (Maywood)","10.1177/15353702211072443","Impact of spexin on metabolic diseases and inflammation: An updated minireview.","2022-03-10"]
[478,"35067753","Eur J Nutr","10.1007/s00394-021-02772-0","The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial.","2022-03-10"]
[479,"35067233","Nutr Res Rev","10.1017/S0954422422000038","MITOCHONDRIAL DYSFUNCTION AND EPIGENETICS UNDERLYING THE LINK BETWEEN EARLY-LIFE NUTRITION AND NON-ALCOHOLIC FATTY LIVER DISEASE.","2022-03-10"]
[480,"35067116","Ethn Health","10.1080/13557858.2022.2027883","Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.","2022-03-10"]
[481,"35066992","Liver Int","10.1111/liv.15171","The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).","2022-03-10"]
[482,"35066087","J Hepatol","10.1016/j.jhep.2021.12.039","Is it time for chronopharmacology in NASH?","2022-03-10"]
[484,"35065293","Biochem Biophys Res Commun","10.1016/j.bbrc.2022.01.060","Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.","2022-03-10"]
[485,"35065166","Life Sci","10.1016/j.lfs.2022.120336","Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription.","2022-03-10"]
[486,"35064579","J Pathol","10.1002/path.5871","Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.","2022-03-10"]
[487,"35064545","Hepatol Int","10.1007/s12072-021-10281-9","The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.","2022-03-10"]
[488,"35064452","Indian J Gastroenterol","10.1007/s12664-021-01198-0","Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.","2022-03-10"]
[489,"35064417","Qual Life Res","10.1007/s11136-022-03090-6","The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States.","2022-03-10"]
[490,"35063810","Nutrition","10.1016/j.nut.2021.111570","Satellite cell content and muscle regeneration in a mouse model of NAFLD.","2022-03-10"]
[491,"35063601","J Hepatol","10.1016/j.jhep.2021.12.031","Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.","2022-03-10"]
[492,"35063496","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109208","Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study.","2022-03-10"]
[493,"35063242","Clin Nutr ESPEN","10.1016/j.clnesp.2021.11.023","Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial.","2022-03-10"]
[494,"35062050","Biomed Pharmacother","10.1016/j.biopha.2021.112377","CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver.","2022-03-10"]
[495,"35061826","PLoS One","10.1371/journal.pone.0262715","A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.","2022-03-10"]
[496,"35061665","PLoS Biol","10.1371/journal.pbio.3001522","Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPAR&#947;.","2022-03-10"]
[497,"35061559","Arch Physiol Biochem","10.1080/13813455.2021.2024578","Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPAR&#945; in the liver and muscles of high fat diet-fed rats.","2022-03-10"]
[498,"35061189","Curr Oncol Rep","10.1007/s11912-021-01160-5","Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications.","2022-03-10"]
[499,"35060922","Endocr Connect","10.1530/EC-21-0566","Association between thyroid function and assessment of hepatic fat and iron contents by magnetic resonance imaging.","2022-03-10"]
[500,"35060815","Expert Opin Investig Drugs","10.1080/13543784.2022.2032640","Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials.","2022-03-10"]
[501,"35060744","J Med Chem","10.1021/acs.jmedchem.1c02002","Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPAR&#945;/&#948; Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis.","2022-03-10"]
[502,"35060066","Hepatol Int","10.1007/s12072-022-10298-8","Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.","2022-03-10"]
[503,"35059041","Dis Markers","10.1155/2021/8833287","Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children.","2022-03-10"]
[504,"35058782","Front Pharmacol","10.3389/fphar.2021.798735","TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/&#946;-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[505,"35058605","Eur J Clin Nutr","10.1038/s41430-022-01081-x","Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial.","2022-03-10"]
[506,"35058529","Sci Rep","10.1038/s41598-022-05140-y","Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine.","2022-03-10"]
[507,"35058515","Sci Rep","10.1038/s41598-022-05037-w","Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease.","2022-03-10"]
[508,"35058147","Eur J Intern Med","10.1016/j.ejim.2021.12.011","Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis.","2022-03-10"]
[509,"35057689","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2022.2032661","Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease.","2022-03-10"]
[510,"35057565","Nutrients","10.3390/nu14020386","Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice.","2022-03-10"]
[511,"35057439","Nutrients","10.3390/nu14020258","Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study.","2022-03-10"]
[512,"35056346","Medicina (Kaunas)","10.3390/medicina58010038","Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection?","2022-03-10"]
[513,"35055797","Int J Environ Res Public Health","10.3390/ijerph19020971","Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study.","2022-03-10"]
[514,"35055407","J Pers Med","10.3390/jpm12010092","Decrease in Sleep Duration and Poor Sleep Quality over Time Is Associated with an Increased Risk of Incident Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[515,"35055177","Int J Mol Sci","10.3390/ijms23020991","Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level.","2022-03-10"]
[516,"35054924","Int J Mol Sci","10.3390/ijms23020739","GLP-1a: Going beyond Traditional Use.","2022-03-10"]
[517,"35054847","Int J Mol Sci","10.3390/ijms23020662","The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[518,"35054837","Int J Mol Sci","10.3390/ijms23020652","The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[519,"35054478","Life (Basel)","10.3390/life12010082","Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters.","2022-03-10"]
[520,"35054428","Life (Basel)","10.3390/life12010035","The Possible Association of Non-Alcoholic Fatty Liver Disease with Acute Cholangitis: A Retrospective Multicenter Cohort Study.","2022-03-10"]
[521,"35053962","Foods","10.3390/foods11020231","Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice.","2022-03-10"]
[522,"35053629","Children (Basel)","10.3390/children9010004","Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index.","2022-03-10"]
[523,"35053625","Cancers (Basel)","10.3390/cancers14020372","Correction: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-&#946;, and STAT3 Signaling. Cancers 2021, 13, 940.","2022-03-10"]
[524,"35053404","Cells","10.3390/cells11020288","Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.","2022-03-10"]
[525,"35053253","Biomolecules","10.3390/biom12010105","Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis.","2022-03-10"]
[526,"35053205","Biomolecules","10.3390/biom12010056","Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.","2022-03-10"]
[527,"35053008","Biology (Basel)","10.3390/biology11010010","The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome.","2022-03-10"]
[528,"35052873","Biomedicines","10.3390/biomedicines10010195","Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[529,"35052872","Biomedicines","10.3390/biomedicines10010194","Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update.","2022-03-10"]
[530,"35052859","Biomedicines","10.3390/biomedicines10010182","Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies.","2022-03-10"]
[531,"35052840","Biomedicines","10.3390/biomedicines10010161","From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.","2022-03-10"]
[532,"35052811","Biomedicines","10.3390/biomedicines10010131","Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS).","2022-03-10"]
[533,"35052765","Biomedicines","10.3390/biomedicines10010084","Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis.","2022-03-10"]
[534,"35052763","Biomedicines","10.3390/biomedicines10010083","Intestinal Barrier and Permeability in Health, Obesity and NAFLD.","2022-03-10"]
[535,"35052736","Biomedicines","10.3390/biomedicines10010055","Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury.","2022-03-10"]
[536,"35052726","Biomedicines","10.3390/biomedicines10010046","Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets.","2022-03-10"]
[537,"35052690","Biomedicines","10.3390/biomedicines10010015","Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.","2022-03-10"]
[538,"35052685","Biomedicines","10.3390/biomedicines10010005","Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model.","2022-03-10"]
[539,"35052640","Antioxidants (Basel)","10.3390/antiox11010136","Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways.","2022-03-10"]
[540,"35052597","Antioxidants (Basel)","10.3390/antiox11010092","Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice.","2022-03-10"]
[541,"35052595","Antioxidants (Basel)","10.3390/antiox11010091","Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[542,"35052590","Antioxidants (Basel)","10.3390/antiox11010086","Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models.","2022-03-10"]
[543,"35052573","Antioxidants (Basel)","10.3390/antiox11010069","Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig.","2022-03-10"]
[544,"35052547","Antioxidants (Basel)","10.3390/antiox11010043","Preventive Effects of &#946;-Cryptoxanthin, a Potent Antioxidant and Provitamin A Carotenoid, on Lifestyle-Related Diseases-A Central Focus on Its Effects on Non-Alcoholic Fatty Liver Disease (NAFLD).","2022-03-10"]
[545,"35051649","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.002","Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.","2022-03-10"]
[546,"35051605","J Ethnopharmacol","10.1016/j.jep.2022.114999","Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.","2022-03-10"]
[547,"35051553","Mol Cell Endocrinol","10.1016/j.mce.2022.111562","Pdcd4 promotes lipid deposition by attenuating PPAR&#945;-mediated fatty acid oxidation in hepatocytes.","2022-03-10"]
[548,"35050189","Metabolites","10.3390/metabo12010067","The Role of Fructose as a Cardiovascular Risk Factor: An Update.","2022-03-10"]
[549,"35050187","Metabolites","10.3390/metabo12010065","The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases.","2022-03-10"]
[550,"35050176","Metabolites","10.3390/metabo12010055","Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPAR&#945; Pathway.","2022-03-10"]
[551,"35048923","Food Funct","10.1039/d1fo03920b","Feeding of cuticles from Tenebrio molitor larvae modulates the gut microbiota and attenuates hepatic steatosis in obese Zucker rats.","2022-03-10"]
[552,"35048297","J Gen Intern Med","10.1007/s11606-021-07341-z","The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care.","2022-03-10"]
[553,"35048271","Mol Biol Rep","10.1007/s11033-021-07072-8","Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice.","2022-03-10"]
[554,"35048107","Eur Heart J","10.1093/eurheartj/ehab919","Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial.","2022-03-10"]
[555,"35047847","HGG Adv","10.1016/j.xhgg.2021.100056","Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease.","2022-03-10"]
[556,"35047580","Front Cardiovasc Med","10.3389/fcvm.2021.805812","Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes.","2022-03-10"]
[557,"35047125","World J Diabetes","10.4239/wjd.v12.i12.2119","Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease.","2022-03-10"]
[558,"35047114","World J Diabetes","10.4239/wjd.v12.i12.1979","Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response.","2022-03-10"]
[559,"35046901","Front Endocrinol (Lausanne)","10.3389/fendo.2021.802541","The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model.","2022-03-10"]
[560,"35046824","Front Pharmacol","10.3389/fphar.2021.801730","Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress.","2022-03-10"]
[562,"35046474","Sci Rep","10.1038/s41598-022-04971-z","Hepatic galectin-3 is associated with lipid droplet area in non-alcoholic steatohepatitis in a new swine model.","2022-03-10"]
[563,"35046340","Gan To Kagaku Ryoho",null,"[A Case of Nonalcoholic Fatty Liver Disease after Pancreatoduodenectomy Which Reduced Tolerability of Chemotherapy for Postoperative Recurrence].","2022-03-10"]
[564,"35045647","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20201113-00614","[Research progress of sodium butyrate in metabolic-associated fatty liver disease].","2022-03-10"]
[565,"35045634","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20210106-00009","[Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].","2022-03-10"]
[566,"35045633","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200527-00279","[Role and mechanism of miRNA-181a in nonalcoholic fatty liver disease].","2022-03-10"]
[567,"35045632","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200422-00204","[Study on plasma Golgi protein 73 and related models in the diagnosis of nonalcoholic fatty liver disease].","2022-03-10"]
[568,"35045557","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000003384","Trends and Disparities in Pediatric Nonalcoholic Fatty Liver Disease-Associated Hospitalizations in the United States.","2022-03-10"]
[574,"35044230","Antioxid Redox Signal","10.1089/ars.2021.0157","Inhibition of fatty acid translocase (FAT/CD36) palmitoylation enhances hepatic fatty acid &#946;-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-CoA synthetase 1.","2022-03-10"]
[575,"35043830","Sao Paulo Med J","10.1590/1516-3180.2021.0095.R2.22062021","Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil.","2022-03-10"]
[576,"35043829","Sao Paulo Med J","10.1590/1516-3180.2021.0015.R1.14062021","High prevalence of functional dyspepsia in nonalcoholic fatty liver disease: a cross-sectional study.","2022-03-10"]
[577,"35042213","Pathobiology","10.1159/000521034","Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism.","2022-03-10"]
[578,"35041626","Am J Gastroenterol","10.14309/ajg.0000000000001606","Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[579,"35041255","Phytother Res","10.1002/ptr.7334","Activation of PGC-1&#945; via isoliquiritigenin-induced downregulation of miR-138-5p alleviates nonalcoholic fatty liver disease.","2022-03-10"]
[580,"35040788","Turk J Gastroenterol","10.5152/tjg.2022.20715","Association Between Neutrophil-to-Lymphocyte Ratio with Inflammatory Activity and Fibrosis in Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[581,"35040549","Hepatol Res","10.1111/hepr.13745","2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[582,"35040495","Eur J Clin Invest","10.1111/eci.13750","Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.","2022-03-10"]
[583,"35040254","Chem Biol Drug Des","10.1111/cbdd.14021","SU5, a new Auraptene analog with improved metabolic stability, ameliorates nonalcoholic fatty liver disease in methionine- and choline-deficient diet-fed db/db mice.","2022-03-10"]
[584,"35040119","Eur J Clin Invest","10.1111/eci.13748","Fatty kidney: A possible future for chronic kidney disease research.","2022-03-10"]
[585,"35040007","Mol Biol Rep","10.1007/s11033-021-07012-6","High-fat diet intake ameliorates the expression of hedgehog signaling pathway in adult rat liver.","2022-03-10"]
[586,"35039476","Cell Death Dis","10.1038/s41419-022-04504-6","Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective.","2022-03-10"]
[587,"35038997","BMC Public Health","10.1186/s12889-021-12486-x","Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study.","2022-03-10"]
[588,"35038955","Bioengineered","10.1080/21655979.2021.2017698","MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice.","2022-03-10"]
[589,"35038311","Eur J Endocrinol","10.1530/EJE-21-0850","Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.","2022-03-10"]
[590,"35038159","J Cell Commun Signal","10.1007/s12079-022-00667-1","Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetes.","2022-03-10"]
[591,"35036892","Metabol Open","10.1016/j.metop.2021.100158","Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD].","2022-03-10"]
[592,"35036886","JHEP Rep","10.1016/j.jhepr.2021.100412","Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD.","2022-03-10"]
[593,"35036572","Biol Methods Protoc","10.1093/biomethods/bpab023","Preparation of fatty acid solutions exerts significant impact on experimental outcomes in cell culture models of lipotoxicity.","2022-03-10"]
[594,"35035690","Am J Transl Res",null,"Bile acid metabolism and liver fibrosis following treatment with bifid triple viable capsules in nonalcoholic fatty liver disease.","2022-03-10"]
[595,"35035496","Evid Based Complement Alternat Med","10.1155/2022/1124901","Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR&#945; Signaling Pathway.","2022-03-10"]
[596,"35035396","Pak J Med Sci","10.12669/pjms.38.1.4968","Frequency of non-alcoholic fatty liver disease (NAFLD) and its associated risk factors among Type-2 diabetics.","2022-03-10"]
[597,"35035378","Front Endocrinol (Lausanne)","10.3389/fendo.2021.773340","Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity.","2022-03-10"]
[598,"35035359","Front Physiol","10.3389/fphys.2021.783341","Exercise Alleviates the Apolipoprotein A5-Toll-Like Receptor 4 Axis Impairment in Mice With High-Fat Diet-Induced Non-alcoholic Steatohepatitis.","2022-03-10"]
[599,"35034938","Endocr J","10.1507/endocrj.EJ21-0536","Associations among FT4 level, FT3/FT4 ratio, and non-alcoholic fatty liver disease in Chinese patients with hypopituitarism.","2022-03-10"]
[600,"35034930","Biol Pharm Bull","10.1248/bpb.b21-00716","Vitexin Attenuates Non-alcoholic Fatty Liver Disease Lipid Accumulation in High Fat-Diet Fed Mice by Activating Autophagy and Reducing Endoplasmic Reticulum Stress in Liver.","2022-03-10"]
[601,"35034646","Lipids Health Dis","10.1186/s12944-022-01622-0","The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery.","2022-03-10"]
[602,"35034553","J Med Econ","10.1080/13696998.2022.2026702","Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease.","2022-03-10"]
[603,"35033597","Diabetes Res Clin Pract","10.1016/j.diabres.2022.109195","Association between bedtime at night and nonalcoholic fatty liver disease diagnosed by liver ultrasound transient elastography.","2022-03-10"]
[604,"35033554","Eur J Pharmacol","10.1016/j.ejphar.2022.174760","Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling.","2022-03-10"]
[605,"35032633","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.01.007","Spleen Size Does Not Correlate With Histological Stage of Liver Disease in People With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[606,"35032545","Metabolism","10.1016/j.metabol.2022.155136","The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials.","2022-03-10"]
[607,"35032488","Eur J Pharmacol","10.1016/j.ejphar.2022.174750","Dichloroacetate reactivates pyruvate-supported peroxide removal by liver mitochondria and prevents NAFLD aggravation in NAD(P)+ transhydrogenase-null mice consuming a high-fat diet.","2022-03-10"]
[609,"35030323","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00261-2","Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.","2022-03-10"]
[610,"35030194","PLoS One","10.1371/journal.pone.0261789","Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1.","2022-03-10"]
[611,"35029891","Medicine (Baltimore)","10.1097/MD.0000000000028443","Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases.","2022-03-10"]
[612,"35029027","J Cell Mol Med","10.1111/jcmm.17175","Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.","2022-03-10"]
[613,"35028685","Calcif Tissue Int","10.1007/s00223-021-00939-9","Fatty Liver Index and Skeletal Muscle Density.","2022-03-10"]
[614,"35028615","Cell Rep Med","10.1016/j.xcrm.2021.100474","Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b study.","2022-03-10"]
[615,"35028346","Data Brief","10.1016/j.dib.2021.107773","Dataset for liver metabolomic profile of highland barley Monascus purpureus went extract-treated golden hamsters with nonalcoholic fatty liver disease.","2022-03-10"]
[616,"35027111","J Am Coll Cardiol","10.1016/j.jacc.2021.11.007","Risk of Heart&#160;Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC&#160;Review&#160;Topic&#160;of&#160;the&#160;Week.","2022-03-10"]
[617,"35027066","Lipids Health Dis","10.1186/s12944-021-01617-3","Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults.","2022-03-10"]
[620,"35024739","Rom J Morphol Embryol","10.47162/RJME.62.2.17","Systemic and adipose tissue inflammation in NASH: correlations with histopathological aspects.","2022-03-10"]
[621,"35024735","Rom J Morphol Embryol","10.47162/RJME.62.2.13","Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?","2022-03-10"]
[622,"35024313","Acta Pharm Sin B","10.1016/j.apsb.2021.05.030","Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.","2022-03-10"]
[623,"35024308","Acta Pharm Sin B","10.1016/j.apsb.2021.10.014","Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liver.","2022-03-10"]
[624,"35024184","J Adv Res","10.1016/j.jare.2021.06.001","Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.","2022-03-10"]
[625,"35024053","Cardiovasc Ther","10.1155/2021/7956161","Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.","2022-03-10"]
[626,"35023936","Diabetes Metab Syndr Obes","10.2147/DMSO.S330526","Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP).","2022-03-10"]
[627,"35023202","Hepatology","10.1002/hep.32336","T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis.","2022-03-10"]
[628,"35023183","Aliment Pharmacol Ther","10.1111/apt.16772","NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study.","2022-03-10"]
[631,"35021995","BMC Gastroenterol","10.1186/s12876-022-02099-y","Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population.","2022-03-10"]
[632,"35021598","Clin Mol Hepatol","10.3350/cmh.2021.0371","Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study.","2022-03-10"]
[633,"35021063","Cell","10.1016/j.cell.2021.12.018","Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches.","2022-03-10"]
[634,"35021057","Immunity","10.1016/j.immuni.2021.12.013","Inflammation in obesity, diabetes, and related disorders.","2022-03-10"]
[635,"35020496","Metab Syndr Relat Disord","10.1089/met.2020.0104","Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients.","2022-03-10"]
[636,"35020479","Metab Syndr Relat Disord","10.1089/met.2021.0105","Age- and Sex-Specific Differences in Distribution of Cardiometabolic Diseases and Associations of Hand-Grip Strength Indices with Type 2 Diabetes in Korean Adults.","2022-03-10"]
[637,"35019905","Biomater Sci","10.1039/d1bm01637g","Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice.","2022-03-10"]
[638,"35018944","Food Funct","10.1039/d1fo03026d","Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo.","2022-03-10"]
[639,"35018737","Hepatol Commun","10.1002/hep4.1892","Hepatocyte TGF-&#946; Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p.","2022-03-10"]
[640,"35018684","Phytother Res","10.1002/ptr.7366","Banana green peels extract protects against nonalcoholic fatty liver disease in high-fat-fed mice through modulation of lipid metabolism and inflammation.","2022-03-10"]
[642,"35016999","J Nutr Biochem","10.1016/j.jnutbio.2022.108945","Gestational hypercholesterolemia programs hepatic steatosis in a sex-specific manner in ApoE-deficient mice.","2022-03-10"]
[643,"35016856","Obes Res Clin Pract","10.1016/j.orcp.2022.01.001","High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up.","2022-03-10"]
[644,"35016686","Nutr Metab (Lond)","10.1186/s12986-021-00634-4","The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease.","2022-03-10"]
[645,"35016619","BMC Geriatr","10.1186/s12877-021-02721-w","Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review.","2022-03-10"]
[647,"35015019","Food Funct","10.1039/d1fo03541j","Preventive effects of black soybean polyphenols on non-alcoholic fatty liver disease in three different mouse models.","2022-03-10"]
[648,"35015002","Food Funct","10.1039/d1fo03119h","Higher serum vitamin A is associated with a worsened progression of non-alcoholic fatty liver disease in adults: a prospective study.","2022-03-10"]
[649,"35014850","Nutr Hosp","10.20960/nh.03856","[ESPEN Practical Guideline: Clinical nutrition in liver disease].","2022-03-10"]
[650,"35014168","Basic Clin Pharmacol Toxicol","10.1111/bcpt.13705","Efficacy of fibroblast growth factor 21 in non-alcoholic fatty liver disease in guinea pigs.","2022-03-10"]
[651,"35014161","Diabetes Obes Metab","10.1111/dom.14651","The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment.","2022-03-10"]
[652,"35014156","Diabetes Obes Metab","10.1111/dom.14646","Inhibition of 11&#946;-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.","2022-03-10"]
[653,"35014145","Diabetes Obes Metab","10.1111/dom.14650","Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).","2022-03-10"]
[654,"35013596","Nat Rev Nephrol","10.1038/s41581-021-00519-y","Association of metabolic dysfunction-associated fatty liver disease with kidney disease.","2022-03-10"]
[655,"35013582","Sci Rep","10.1038/s41598-021-04524-w","PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice.","2022-03-10"]
[656,"35013417","Sci Rep","10.1038/s41598-021-04036-7","Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver.","2022-03-10"]
[657,"35013082","AIDS","10.1097/QAD.0000000000003170","Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV.","2022-03-10"]
[658,"35013040","J Oleo Sci","10.5650/jos.ess21228","Pink Lotus Essential Oil and Alleviates on Free Fatty Acid Induced Steatosis in HepG2 Cells via PI3K/Akt and NF-&#954;B Pathways.","2022-03-10"]
[659,"35011784","J Clin Med","10.3390/jcm11010041","Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects.","2022-03-10"]
[660,"35011746","J Clin Med","10.3390/jcm11010004","Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles.","2022-03-10"]
[661,"35011625","Cells","10.3390/cells11010061","The Nuclear Receptor PXR in Chronic Liver Disease.","2022-03-10"]
[662,"35011585","Cells","10.3390/cells11010023","Cynanchum atratum Alleviates Non-Alcoholic Fatty Liver by Balancing Lipogenesis and Fatty Acid Oxidation in a High-Fat, High-Fructose Diet Mice Model.","2022-03-10"]
[663,"35010976","Nutrients","10.3390/nu14010103","Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota.","2022-03-10"]
[664,"35010966","Nutrients","10.3390/nu14010091","Effect of Different Types of Intermittent Fasting on Biochemical and Anthropometric Parameters among Patients with Metabolic-Associated Fatty Liver Disease (MAFLD)-A Systematic Review.","2022-03-10"]
[665,"35010950","Nutrients","10.3390/nu14010076","Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.","2022-03-10"]
[666,"35010924","Nutrients","10.3390/nu14010042","Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-&#954;B Signaling in a Rat Non-Alcoholic Steatohepatitis Model.","2022-03-10"]
[667,"35010923","Nutrients","10.3390/nu14010049","Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.","2022-03-10"]
[668,"35009003","Int J Mol Sci","10.3390/ijms23010577","Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[669,"35008925","Int J Mol Sci","10.3390/ijms23010498","Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.","2022-03-10"]
[670,"35008852","Int J Mol Sci","10.3390/ijms23010426","Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.","2022-03-10"]
[671,"35008682","Int J Mol Sci","10.3390/ijms23010256","Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[673,"35007752","J Biomed Inform","10.1016/j.jbi.2022.103986","Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models.","2022-03-10"]
[674,"35007392","Liver Int","10.1111/liv.15163","Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?","2022-03-10"]
[675,"35006629","Hepatology","10.1002/hep.32326","Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans.","2022-03-10"]
[676,"35005800","Aliment Pharmacol Ther","10.1111/apt.16766","A sequential approach using the age-adjusted fibrosis-4 index and vibration-controlled transient elastography to detect advanced fibrosis in Korean patients with non-alcoholic fatty liver disease.","2022-03-10"]
[677,"35005749","Food Funct","10.1039/d1fo03793e","Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet.","2022-03-10"]
[678,"35005119","Genes Dis","10.1016/j.gendis.2021.02.008","Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[679,"35005107","Genes Dis","10.1016/j.gendis.2021.01.005","Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders.","2022-03-10"]
[682,"35004947","Hepatobiliary Surg Nutr","10.21037/hbsn-20-263","The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study.","2022-03-10"]
[683,"35004861","Front Mol Biosci","10.3389/fmolb.2021.823277","Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects.","2022-03-10"]
[684,"35004736","Front Med (Lausanne)","10.3389/fmed.2021.764472","Association Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China.","2022-03-10"]
[685,"35004133","Anal Cell Pathol (Amst)","10.1155/2021/4853355","MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPK&#945;.","2022-03-10"]
[686,"35003876","Biomed Opt Express","10.1364/BOE.442608","Intravital two-photon imaging and quantification of hepatic steatosis and fibrosis in a live small animal model.","2022-03-10"]
[687,"35003513","Oxid Med Cell Longev","10.1155/2021/3877617","TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization.","2022-03-10"]
[688,"35003024","Front Microbiol","10.3389/fmicb.2021.793854","Effect of Chinese Herbal Medicine Mixture 919 Syrup on Regulation of the Ghrelin Pathway and Intestinal Microbiota in Rats With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[690,"35002979","Front Endocrinol (Lausanne)","10.3389/fendo.2021.808526","Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options.","2022-03-10"]
[691,"35002729","Front Pharmacol","10.3389/fphar.2021.796207","Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[692,"35001468","Pediatr Diabetes","10.1111/pedi.13311","Organ fat in Latino youth at risk for type 2 diabetes.","2022-03-10"]
[693,"35001345","J Physiol Biochem","10.1007/s13105-021-00852-7","Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway.","2022-03-10"]
[694,"35000203","Hepatology","10.1002/hep.32324","Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.","2022-03-10"]
[695,"35000120","Clin J Gastroenterol","10.1007/s12328-021-01585-2","The impact of emricasan on chronic liver diseases: current data.","2022-03-10"]
[696,"34999396","Int Immunopharmacol","10.1016/j.intimp.2021.108306","Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.","2022-03-10"]
[697,"34999330","Clin Nutr","10.1016/j.clnu.2021.12.014","Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis.","2022-03-10"]
[698,"34998993","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.12.043","Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[699,"34998898","Mol Cell Endocrinol","10.1016/j.mce.2022.111554","Ceramide signaling in the gut.","2022-03-10"]
[700,"34998040","Eur J Med Chem","10.1016/j.ejmech.2021.114089","Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis.","2022-03-10"]
[701,"34998036","Int Immunopharmacol","10.1016/j.intimp.2021.108503","Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.","2022-03-10"]
[702,"34997649","J Clin Lab Anal","10.1002/jcla.24225","The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.","2022-03-10"]
[703,"34997159","Sci Rep","10.1038/s41598-021-04361-x","Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease.","2022-03-10"]
[704,"34996457","Lipids Health Dis","10.1186/s12944-021-01610-w","NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study.","2022-03-10"]
[705,"34995410","Liver Int","10.1111/liv.15160","Roles for the mycobiome in liver disease.","2022-03-10"]
[706,"34994824","Naunyn Schmiedebergs Arch Pharmacol","10.1007/s00210-021-02177-0","The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics.","2022-03-10"]
[707,"34993581","J Mol Med (Berl)","10.1007/s00109-021-02170-3","A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?","2022-03-10"]
[708,"34993571","Diabetologia","10.1007/s00125-021-05628-8","Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.","2022-03-10"]
[709,"34993389","Curr Dev Nutr","10.1093/cdn/nzab138","Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models.","2022-03-10"]
[710,"34993216","Front Med (Lausanne)","10.3389/fmed.2021.805029","Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus.","2022-03-10"]
[711,"34992694","Dis Markers","10.1155/2021/6591784","Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation.","2022-03-10"]
[712,"34992579","Front Endocrinol (Lausanne)","10.3389/fendo.2021.773342","Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[713,"34992541","Front Pharmacol","10.3389/fphar.2021.796590","Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling.","2022-03-10"]
[714,"34992540","Front Pharmacol","10.3389/fphar.2021.793586","Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[716,"34992072","BMJ Open Gastroenterol","10.1136/bmjgast-2021-000798","Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD.","2022-03-10"]
[717,"34990887","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.12.018","Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis.","2022-03-10"]
[718,"34990729","Toxicol Appl Pharmacol","10.1016/j.taap.2021.115855","Whole life exposure to low dose cadmium alters diet-induced NAFLD.","2022-03-10"]
[719,"34990473","PLoS One","10.1371/journal.pone.0261555","Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.","2022-03-10"]
[720,"34990079","Liver Int","10.1111/liv.15156","Adherence to the dietary approaches to stop hypertension diet and non-alcoholic fatty liver disease.","2022-03-10"]
[721,"34990037","Hepatology","10.1002/hep.32315","Placebo effect on progression and regression in NASH: Evidence from a meta-analysis.","2022-03-10"]
[722,"34988994","Aliment Pharmacol Ther","10.1111/apt.16763","Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.","2022-03-10"]
[723,"34988895","Obes Surg","10.1007/s11695-021-05885-x","Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States.","2022-03-10"]
[724,"34988690","Acta Diabetol","10.1007/s00592-021-01830-7","Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.","2022-03-10"]
[725,"34988225","Biomed Res Int","10.1155/2021/3654660","Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis.","2022-03-10"]
[726,"34988202","Ann Transl Med","10.21037/atm-21-5767","Y-box binding protein 1 regulates liver lipid metabolism by regulating the Wnt/&#946;-catenin signaling pathway.","2022-03-10"]
[727,"34987607","Therap Adv Gastroenterol","10.1177/17562848211062807","Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis.","2022-03-10"]
[728,"34986838","Cancer Cell Int","10.1186/s12935-021-02421-w","STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway.","2022-03-10"]
[729,"34986792","BMC Gastroenterol","10.1186/s12876-021-02088-7","Relationship of circulating total bilirubin, UDP-glucuronosyltransferases 1A1 and the development of non-alcoholic fatty liver disease: a cross-sectional study.","2022-03-10"]
[730,"34986375","J Affect Disord","10.1016/j.jad.2021.12.128","Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies.","2022-03-10"]
[731,"34986301","Endocrinol Metab (Seoul)","10.3803/EnM.2021.1100","The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice.","2022-03-10"]
[736,"34983755","BMJ Open","10.1136/bmjopen-2021-049767","Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis.","2022-03-10"]
[737,"34983637","Diabetol Metab Syndr","10.1186/s13098-021-00759-9","Overweight/obesity in adolescents with type 1 diabetes belonging to an admixed population. A Brazilian multicenter study.","2022-03-10"]
[738,"34983596","Chin Med","10.1186/s13020-021-00559-3","Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages.","2022-03-10"]
[739,"34983354","Endocr Metab Immune Disord Drug Targets","10.2174/1871530322666220104095534","Increasing risk factors of non-alcoholic fatty liver disease, a look into chronic periodontitis and insulin resistance.","2022-03-10"]
[740,"34983091","Korean J Radiol","10.3348/kjr.2021.0112","Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.","2022-03-10"]
[741,"34982494","J Intern Med","10.1111/joim.13450","Soat2 ties cholesterol metabolism to &#946;-oxidation and glucose tolerance in male mice.","2022-03-10"]
[742,"34982430","Eur Rev Med Pharmacol Sci","10.26355/eurrev_202112_27615","Intervention effects of four exercise modalities on nonalcoholic fatty liver disease: a systematic review and Bayesian network meta-analysis.","2022-03-10"]
[744,"34981470","Adv Exp Med Biol","10.1007/978-3-030-73234-9_4","The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review.","2022-03-10"]
[745,"34981468","Adv Exp Med Biol","10.1007/978-3-030-73234-9_2","Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial.","2022-03-10"]
[746,"34981443","Clin J Gastroenterol","10.1007/s12328-021-01567-4","Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM.","2022-03-10"]
[747,"34981313","Dig Dis Sci","10.1007/s10620-021-07317-3","Bariatric Surgery in NAFLD.","2022-03-10"]
[748,"34981123","Biosci Rep","10.1042/BSR20212248","Tandem mass tag-based proteomics analysis of type 2 diabetes mellitus with non-alcoholic fatty liver disease in mice treated with acupuncture.","2022-03-10"]
[749,"34981106","Food Funct","10.1039/d1fo03108b","Supplementation with cyanidin and delphinidin mitigates high fat diet-induced endotoxemia and associated liver inflammation in mice.","2022-03-10"]
[750,"34980714","J Nutr Sci Vitaminol (Tokyo)","10.3177/jnsv.67.366","Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[751,"34980375","Food Res Int","10.1016/j.foodres.2021.110824","Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling.","2022-03-10"]
[752,"34980174","J Transl Med","10.1186/s12967-021-03210-9","Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.","2022-03-10"]
[753,"34979169","Toxicology","10.1016/j.tox.2021.153088","Elemicin exposure induced aberrant lipid metabolism via modulation of gut microbiota in mice.","2022-03-10"]
[754,"34979142","Toxicol Appl Pharmacol","10.1016/j.taap.2021.115858","Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress.","2022-03-10"]
[756,"34978351","Aliment Pharmacol Ther","10.1111/apt.16760","Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.","2022-03-10"]
[757,"34978298","J Vis Exp","10.3791/63062","Isolation and Characterization of Mouse Primary Liver Sinusoidal Endothelial Cells.","2022-03-10"]
[758,"34978141","Obes Rev","10.1111/obr.13409","Human microbiome and metabolic health: An overview of systematic reviews.","2022-03-10"]
[759,"34977520","JHEP Rep","10.1016/j.jhepr.2021.100411","Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions.","2022-03-10"]
[760,"34977519","JHEP Rep","10.1016/j.jhepr.2021.100392","Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[761,"34977518","JHEP Rep","10.1016/j.jhepr.2021.100390","Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.","2022-03-10"]
[762,"34977507","iScience","10.1016/j.isci.2021.103549","In&#160;vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications.","2022-03-10"]
[763,"34977130","Front Nutr","10.3389/fnut.2021.791861","Sirt1 Promotes the Restoration of Hepatic Progenitor Cell (HPC)-Mediated Liver Fatty Injury in NAFLD Through Activating the Wnt/&#946;-Catenin Signal Pathway.","2022-03-10"]
[764,"34977118","Front Nutr","10.3389/fnut.2021.759690","Lactational High Fat Diet in Mice Causes Insulin Resistance and NAFLD in Male Offspring Which Is Partially Rescued by Maternal Metformin Treatment.","2022-03-10"]
[765,"34975333","Int J Biol Sci","10.7150/ijbs.66834","Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.","2022-03-10"]
[766,"34975241","J Clin Exp Hepatol","10.1016/j.jceh.2021.12.003","Vaccination in Chronic Liver Disease: An Update.","2022-03-10"]
[767,"34974285","Nutrition","10.1016/j.nut.2021.111539","Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis.","2022-03-10"]
[768,"34974284","Nutrition","10.1016/j.nut.2021.111541","Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease.","2022-03-10"]
[769,"34974159","Mol Metab","10.1016/j.molmet.2021.101428","CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.","2022-03-10"]
[770,"34974078","Metabolism","10.1016/j.metabol.2021.155115","Cytoskeleton alterations in non-alcoholic fatty liver disease.","2022-03-10"]
[771,"34973842","Transplant Proc","10.1016/j.transproceed.2021.11.008","Bariatric Surgery and Solid-Organ Transplantation.","2022-03-10"]
[772,"34973642","Food Chem","10.1016/j.foodchem.2021.131941","Metabolomic profiling of M. speciosa champ at different growth stages.","2022-03-10"]
[773,"34973184","Clin Chim Acta","10.1016/j.cca.2021.12.026","The ALT upper reference interval debate: Blame it on the alcohol.","2022-03-10"]
[774,"34972203","J Crohns Colitis","10.1093/ecco-jcc/jjab212","Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.","2022-03-10"]
[775,"34971904","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.12.065","Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.","2022-03-10"]
[776,"34971806","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.12.034","Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.","2022-03-10"]
[777,"34971370","J Clin Endocrinol Metab","10.1210/clinem/dgab933","Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[778,"34970870","Hepatol Commun","10.1002/hep4.1841","Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD.","2022-03-10"]
[779,"34970143","Front Pharmacol","10.3389/fphar.2021.771976","Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice.","2022-03-10"]
[780,"34969770","Anticancer Res","10.21873/anticanres.15518","Development of Non-alcoholic Steatohepatitis and Nodular Regenerative Hyperplasia in C57BL/6J Mice Fed a Fructose-containing Western Diet.","2022-03-10"]
[781,"34967286","Mini Rev Med Chem","10.2174/1389557522666211229112223","Dietary Intake of Hydrolyzable Tannins and Condensed Tannins to Regulate Lipid Metabolism.","2022-03-10"]
[782,"34967199","Asia Pac J Clin Nutr","10.6133/apjcn.202112_30(4).0017","Dietary iron and zinc intakes and nonalcoholic fatty liver disease: A meta-analysis.","2022-03-10"]
[783,"34966854","Hepatoma Res","10.20517/2394-5079.2021.74","Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes.","2022-03-10"]
[784,"34966657","J Clin Transl Hepatol","10.14218/JCTH.2021.00189","Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).","2022-03-10"]
[785,"34966656","J Clin Transl Hepatol","10.14218/JCTH.2021.00174","Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?","2022-03-10"]
[787,"34966475","Oxid Med Cell Longev","10.1155/2021/2234695","Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[788,"34966296","Front Psychiatry","10.3389/fpsyt.2021.711835","Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[789,"34966292","Front Physiol","10.3389/fphys.2021.781789","Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk.","2022-03-10"]
[790,"34966282","Front Pharmacol","10.3389/fphar.2021.786596","Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.","2022-03-10"]
[791,"34966134","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002340","Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease.","2022-03-10"]
[792,"34966133","Curr Opin Lipidol","10.1097/MOL.0000000000000814","Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications.","2022-03-10"]
[793,"34965565","Probl Radiac Med Radiobiol","10.33145/2304-8336-2021-26-437-448","SUBCLINICAL INFLAMMATION IN NON/ALCOHOLIC FATTY LIVER DISEASE AT THE REMOTE PERIOD AFTER THE CHORNOBYL ACCIDENT.","2022-03-10"]
[794,"34965016","Clin Transl Med","10.1002/ctm2.634","Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease.","2022-03-10"]
[795,"34964604","Biomacromolecules","10.1021/acs.biomac.1c01360","Construction of Glycogen-Based Nanoparticles Loaded with Resveratrol for the Alleviation of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[796,"34964438","Elife","10.7554/eLife.70472","Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA.","2022-03-10"]
[797,"34964117","Compr Physiol","10.1002/cphy.c210024","Bile Acids, Gut Microbiome and the Road to Fatty Liver Disease.","2022-03-10"]
[798,"34962148","Metab Syndr Relat Disord","10.1089/met.2021.0098","PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus.","2022-03-10"]
[799,"34962146","Metab Syndr Relat Disord","10.1089/met.2021.0111","Prevalence of Hepatic Steatosis and Fibrosis in the United States.","2022-03-10"]
[800,"34962132","Rev Esp Enferm Dig","10.17235/reed.2021.8524/2021","Can NAFLD overwhelm the Spanish healthcare system in the years to come?","2022-03-10"]
[801,"34960036","Nutrients","10.3390/nu13124484","Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis.","2022-03-10"]
[802,"34960005","Nutrients","10.3390/nu13124453","Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial.","2022-03-10"]
[803,"34959992","Nutrients","10.3390/nu13124440","Curcumin in Metabolic Health and Disease.","2022-03-10"]
[804,"34959990","Nutrients","10.3390/nu13124438","Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance.","2022-03-10"]
[805,"34959901","Nutrients","10.3390/nu13124349","Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review.","2022-03-10"]
[806,"34959760","Nutrients","10.3390/nu13124208","Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study.","2022-03-10"]
[807,"34959755","Nutrients","10.3390/nu13124203","The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices.","2022-03-10"]
[808,"34959747","Nutrients","10.3390/nu13124195","High-Fructose, High-Fat Diet Alters Muscle Composition and Fuel Utilization in a Juvenile Iberian Pig Model of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[809,"34959291","Pharmaceutics","10.3390/pharmaceutics13122009","Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed 'Aging Cascade'.","2022-03-10"]
[810,"34959259","FASEB J","10.1096/fj.202101570R","High-fat diet-induced increases in glucocorticoids contribute to the development of non-alcoholic fatty liver disease in mice.","2022-03-10"]
[811,"34959119","Biomed Pharmacother","10.1016/j.biopha.2021.112582","GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.","2022-03-10"]
[812,"34959080","J Neurol Sci","10.1016/j.jns.2021.120117","Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations.","2022-03-10"]
[814,"34958922","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.12.029","Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017-2018.","2022-03-10"]
[815,"34958817","Metabolism","10.1016/j.metabol.2021.154958","Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.","2022-03-10"]
[816,"34958747","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.029","Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis.","2022-03-10"]
[817,"34957917","Adipocyte","10.1080/21623945.2021.2015864","Adipose tissue plays a major role in retinoic acid-mediated metabolic homoeostasis.","2022-03-10"]
[818,"34957498","Diabetes","10.2337/db21-0363","Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice.","2022-03-10"]
[819,"34957487","Diabetes","10.2337/db21-0475","Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity.","2022-03-10"]
[820,"34957434","Cell Genom","10.1016/j.xgen.2021.100066","Machine learning enables new insights into genetic contributions to liver fat accumulation.","2022-03-10"]
[821,"34957156","Front Med (Lausanne)","10.3389/fmed.2021.781567","Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.","2022-03-10"]
[822,"34957088","Front Cell Dev Biol","10.3389/fcell.2021.702414","Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer.","2022-03-10"]
[823,"34956485","Am J Transl Res",null,"A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method.","2022-03-10"]
[824,"34956386","Evid Based Complement Alternat Med","10.1155/2021/8920757","Procyanidin B2 Alleviates Palmitic Acid-Induced Injury in HepG2 Cells via Endoplasmic Reticulum Stress Pathway.","2022-03-10"]
[825,"34956171","Front Immunol","10.3389/fimmu.2021.708978","Hepatic Macrophage as a Key Player in Fatty Liver Disease.","2022-03-10"]
[826,"34956080","Front Endocrinol (Lausanne)","10.3389/fendo.2021.769069","Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","2022-03-10"]
[827,"34955810","Front Aging Neurosci","10.3389/fnagi.2021.748888","Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study.","2022-03-10"]
[829,"34954946","Zhonghua Wai Ke Za Zhi","10.3760/cma.j.cn112139-20210803-00350","[Risk factors of newly developed nonalcoholic fatty liver disease after pancreaticoduodenectomy].","2022-03-10"]
[830,"34954945","Zhonghua Wai Ke Za Zhi","10.3760/cma.j.cn112139-20211104-00516","[Clinical effect of minimally invasive duodenum preserving pancreatic head resection for benign and pre-malignant lesions of pancreatic head].","2022-03-10"]
[831,"34954593","Eur J Med Chem","10.1016/j.ejmech.2021.114061","Discovery of new and highly effective quadruple FFA1 and PPAR&#945;/&#947;/&#948; agonists as potential anti-fatty liver agents.","2022-03-10"]
[832,"34954499","Redox Biol","10.1016/j.redox.2021.102224","Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation.","2022-03-10"]
[833,"34954342","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2021.166319","Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse.","2022-03-10"]
[834,"34954022","Free Radic Biol Med","10.1016/j.freeradbiomed.2021.12.304","Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage.","2022-03-10"]
[835,"34953171","J Magn Reson Imaging","10.1002/jmri.28040","The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.","2022-03-10"]
[836,"34953098","Liver Int","10.1111/liv.15139","Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups.","2022-03-10"]
[837,"34952219","Endocr Pract","10.1016/j.eprac.2021.12.010","Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis.","2022-03-10"]
[838,"34951993","Gastroenterology","10.1053/j.gastro.2021.12.250","Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.","2022-03-10"]
[839,"34951726","Hepatology","10.1002/hep.32302","Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[840,"34951153","Hepatol Commun","10.1002/hep4.1884","Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver.","2022-03-10"]
[841,"34951036","J Med Virol","10.1002/jmv.27545","Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase.","2022-03-10"]
[842,"34950996","Indian J Gastroenterol","10.1007/s12664-021-01176-6","Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease.","2022-03-10"]
[844,"34950780","JGH Open","10.1002/jgh3.12682","Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.","2022-03-10"]
[845,"34950560","Cureus","10.7759/cureus.20515","Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[846,"34950107","Front Endocrinol (Lausanne)","10.3389/fendo.2021.780617","Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[847,"34950105","Front Endocrinol (Lausanne)","10.3389/fendo.2021.777075","Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities.","2022-03-10"]
[848,"34950104","Front Endocrinol (Lausanne)","10.3389/fendo.2021.768850","Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence.","2022-03-10"]
[849,"34950103","Front Endocrinol (Lausanne)","10.3389/fendo.2021.760981","Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[850,"34948230","Int J Mol Sci","10.3390/ijms222413424","It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?","2022-03-10"]
[851,"34948020","Int J Mol Sci","10.3390/ijms222413219","The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[852,"34946801","Genes (Basel)","10.3390/genes12121852","SESN3 Inhibited SMAD3 to Relieve Its Suppression for MiR-124, Thus Regulating Pre-Adipocyte Adipogenesis.","2022-03-10"]
[853,"34946689","Molecules","10.3390/molecules26247615","Mechanochemical-Assisted Extraction and Hepatoprotective Activity Research of Flavonoids from Sea Buckthorn (Hippopha&#235; rhamnoides L.) Pomaces.","2022-03-10"]
[854,"34945677","Foods","10.3390/foods10123126","Lactobacillus plantarum MA2 Ameliorates Methionine and Choline-Deficient Diet Induced Non-Alcoholic Fatty Liver Disease in Rats by Improving the Intestinal Microecology and Mucosal Barrier.","2022-03-10"]
[855,"34945573","Foods","10.3390/foods10123022","The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD).","2022-03-10"]
[856,"34945051","J Clin Med","10.3390/jcm10245755","Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care.","2022-03-10"]
[857,"34945016","J Clin Med","10.3390/jcm10245721","Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.","2022-03-10"]
[858,"34944736","Biomedicines","10.3390/biomedicines9121920","Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[859,"34944732","Biomedicines","10.3390/biomedicines9121912","Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.","2022-03-10"]
[860,"34944730","Biomedicines","10.3390/biomedicines9121915","Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem.","2022-03-10"]
[861,"34944728","Biomedicines","10.3390/biomedicines9121903","Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.","2022-03-10"]
[862,"34944726","Biomedicines","10.3390/biomedicines9121913","NASH and Systemic Complications: From Basic to Clinical Research.","2022-03-10"]
[863,"34944709","Biomedicines","10.3390/biomedicines9121893","Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment.","2022-03-10"]
[864,"34944706","Biomedicines","10.3390/biomedicines9121890","The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.","2022-03-10"]
[865,"34944682","Biomedicines","10.3390/biomedicines9121866","Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic.","2022-03-10"]
[866,"34944668","Biomedicines","10.3390/biomedicines9121853","The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.","2022-03-10"]
[867,"34944593","Biomedicines","10.3390/biomedicines9121776","Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[868,"34944567","Biomedicines","10.3390/biomedicines9121751","Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients.","2022-03-10"]
[869,"34944525","Biomolecules","10.3390/biom11121881","A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach.","2022-03-10"]
[870,"34944452","Biomolecules","10.3390/biom11121808","Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.","2022-03-10"]
[871,"34944021","Cells","10.3390/cells10123513","IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.","2022-03-10"]
[872,"34943946","Cells","10.3390/cells10123440","Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese Ay Mice.","2022-03-10"]
[873,"34943942","Cells","10.3390/cells10123434","MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis.","2022-03-10"]
[874,"34943908","Cells","10.3390/cells10123401","Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[875,"34943814","Cells","10.3390/cells10123306","Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2.","2022-03-10"]
[876,"34943809","Cells","10.3390/cells10123300","Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[877,"34943553","Diagnostics (Basel)","10.3390/diagnostics11122316","Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up.","2022-03-10"]
[878,"34943469","Diagnostics (Basel)","10.3390/diagnostics11122233","Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population.","2022-03-10"]
[879,"34943221","Biology (Basel)","10.3390/biology10121306","Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPAR&#945;.","2022-03-10"]
[880,"34943134","Antioxidants (Basel)","10.3390/antiox10122031","Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation.","2022-03-10"]
[881,"34943104","Antioxidants (Basel)","10.3390/antiox10122001","The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation.","2022-03-10"]
[882,"34943103","Antioxidants (Basel)","10.3390/antiox10122000","Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[883,"34942625","Dig Dis","10.1159/000521662","Clinical profiles of Asians with NAFLD: A systematic review and meta-analysis.","2022-03-10"]
[884,"34942286","J Hepatol","10.1016/j.jhep.2021.12.012","Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.","2022-03-10"]
[885,"34941988","J Gastrointestin Liver Dis","10.15403/jgld-3758","The Role of Psychotherapy in the Treatment of Patients with Non- alcoholic Fatty Liver Disease and Obstructive Sleep Apnea.","2022-03-10"]
[886,"34941156","Medicine (Baltimore)","10.1097/MD.0000000000028366","Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials.","2022-03-10"]
[887,"34941049","Medicine (Baltimore)","10.1097/MD.0000000000028083","Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease: A protocol for systematic review and meta-analysis.","2022-03-10"]
[888,"34940698","Mar Drugs","10.3390/md19120699","Soluble Polysaccharide Derived from Laminaria japonica Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation.","2022-03-10"]
[889,"34939204","Hepatology","10.1002/hep.32294","Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease.","2022-03-10"]
[890,"34939092","Eur J Prev Cardiol","10.1093/eurjpc/zwab212","Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.","2022-03-10"]
[891,"34939051","J Mass Spectrom Adv Clin Lab","10.1016/j.jmsacl.2021.10.001","A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease.","2022-03-10"]
[892,"34938809","Biomed Res Int","10.1155/2021/5633211","WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[893,"34938631","Cureus","10.7759/cureus.19755","Glycogenic Hepatopathy as the Etiology of Abnormal Liver Chemistries in an Uncontrolled Type I Diabetic Patient.","2022-03-10"]
[894,"34938271","Front Endocrinol (Lausanne)","10.3389/fendo.2021.773432","Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[895,"34938205","Front Physiol","10.3389/fphys.2021.788411","Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases.","2022-03-10"]
[896,"34938193","Front Pharmacol","10.3389/fphar.2021.788558","Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model.","2022-03-10"]
[897,"34938090","Diabetes Metab Syndr Obes","10.2147/DMSO.S335364","The Predictive Ability of Hepatic Steatosis Index for Gestational Diabetes Mellitus and Large for Gestational Age Infant Compared with Other Noninvasive Indices Among Chinese Pregnancies: A Preliminary Double-center Cohort Study.","2022-03-10"]
[898,"34935645","JCI Insight","10.1172/jci.insight.154093","Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring.","2022-03-10"]
[900,"34935140","Br J Pharmacol","10.1111/bph.15784","Mineralocorticoid receptors in non-alcoholic fatty liver disease.","2022-03-10"]
[901,"34934197","Acta Pharmacol Sin","10.1038/s41401-021-00836-9","GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis.","2022-03-10"]
[902,"34934162","Sci Rep","10.1038/s41598-021-03870-z","Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes.","2022-03-10"]
[903,"34933963","Open Heart","10.1136/openhrt-2021-001850","Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.","2022-03-10"]
[904,"34933429","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20210106-00008","[AGT rs5051 gene polymorphism increases the risk of coronary heart disease in patients with non-alcoholic fatty liver disease in the Han Chinese population].","2022-03-10"]
[905,"34933428","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200720-00402","[Studying the correlation between ferritin and non-alcoholic fatty liver disease].","2022-03-10"]
[906,"34933427","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20210713-00338","[Abnormal expression of CD44 aggravates liver disease progression in patients with non-alcoholic fatty liver disease accompanied with hepatitis B virus replication].","2022-03-10"]
[907,"34933426","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20201110-00607","[Quantitative analysis of non-alcoholic fatty liver disease based on MRI proton density fat fraction in the coastal region of Qingdao].","2022-03-10"]
[908,"34933425","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200826-00478","[Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].","2022-03-10"]
[909,"34933319","Ultrasonography","10.14366/usg.21167","Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.","2022-03-10"]
[910,"34933288","Phys Med Biol","10.1088/1361-6560/ac4562","Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver.","2022-03-10"]
[912,"34932603","PLoS One","10.1371/journal.pone.0261690","Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.","2022-03-10"]
[913,"34932136","Diabetologia","10.1007/s00125-021-05627-9","Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease.","2022-03-10"]
[914,"34931979","Curr Mol Med","10.2174/1573405617666210712141600","Endogenous liver protections against lipotoxicity and oxidative stress to avoid the progression of non-alcoholic fatty liver to more serious disease.","2022-03-10"]
[915,"34931492","Hepatol Commun","10.1002/hep4.1828","Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.","2022-03-10"]
[916,"34931080","Nat Metab","10.1038/s42255-021-00501-9","Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.","2022-03-10"]
[917,"34930143","BMC Gastroenterol","10.1186/s12876-021-02067-y","Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis.","2022-03-10"]
[918,"34929996","Minerva Gastroenterol (Torino)","10.23736/S2724-5985.21.02982-X","Evaluation of MACK-3 parameters, metabolic and fibrotic characteristics of non-alcoholic fatty liver disease patients with hypertension.","2022-03-10"]
[919,"34929490","EBioMedicine","10.1016/j.ebiom.2021.103768","Peripheral immune cells in NAFLD patients: A spyhole to disease progression.","2022-03-10"]
[920,"34929391","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.12.015","Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.","2022-03-10"]
[921,"34929318","Gastroenterol Hepatol","10.1016/j.gastrohep.2021.12.004","Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease.","2022-03-10"]
[922,"34928469","Adv Ther","10.1007/s12325-021-02008-x","Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data.","2022-03-10"]
[923,"34928415","Eur Radiol","10.1007/s00330-021-08381-z","MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.","2022-03-10"]
[924,"34928287","Food Funct","10.1039/d1fo02610k","Identification of mitochondria-related hub genes in sarcopenia and functional regulation of MFG-E8 on ROS-mediated mitochondrial dysfunction and cell cycle arrest.","2022-03-10"]
[925,"34927450","J Am Heart Assoc","10.1161/JAHA.121.022576","Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.","2022-03-10"]
[926,"34927282","Drug Dev Res","10.1002/ddr.21905","Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice.","2022-03-10"]
[927,"34927277","Aliment Pharmacol Ther","10.1111/apt.16745","Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality.","2022-03-10"]
[928,"34927251","Eur J Clin Invest","10.1111/eci.13733","De novo lipogenesis in non-alcoholic fatty liver disease: Quantification with stable isotope tracers.","2022-03-10"]
[929,"34927020","iScience","10.1016/j.isci.2021.103449","Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation.","2022-03-10"]
[930,"34926735","Regen Ther","10.1016/j.reth.2021.11.005","Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair.","2022-03-10"]
[931,"34926533","Front Med (Lausanne)","10.3389/fmed.2021.795421","Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population.","2022-03-10"]
[932,"34925237","Front Endocrinol (Lausanne)","10.3389/fendo.2021.767314","Current and Potential Therapies Targeting Inflammation in NASH.","2022-03-10"]
[933,"34925033","Front Pharmacol","10.3389/fphar.2021.775528","Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[934,"34924365","J Obes Metab Syndr","10.7570/jomes21063","Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment.","2022-03-10"]
[935,"34924319","Dig Liver Dis","10.1016/j.dld.2021.04.029","Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO).","2022-03-10"]
[936,"34924246","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2021.04.028","Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO).","2022-03-10"]
[937,"34923965","BMC Gastroenterol","10.1186/s12876-021-02072-1","Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China.","2022-03-10"]
[938,"34923950","Curr Mol Pharmacol","10.2174/1874467215666211217120448","Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular Mechanisms.","2022-03-10"]
[939,"34923473","Wiad Lek",null,"FEASIBILITY OF CYSTATIN C DETERMINATION FOR EARLY DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH TYPE 2 DIABETES COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY EXPOSED TO COVID-19 INFECTION IN THE PAST.","2022-03-10"]
[940,"34923463","Wiad Lek",null,"INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE.","2022-03-10"]
[941,"34923459","Wiad Lek",null,"THE EFFECTIVENESS OF COMPLEX THERAPY WITH THE INCLUSION OF THE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE.","2022-03-10"]
[942,"34923456","Wiad Lek",null,"INTESTINAL LESIONS OCCURRING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AFTER SUFFERING THE COVID-19 INFECTION.","2022-03-10"]
[943,"34923087","J Ethnopharmacol","10.1016/j.jep.2021.114922","Highland barley Monascus purpureus Went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters.","2022-03-10"]
[944,"34922811","J Diabetes Complications","10.1016/j.jdiacomp.2021.108101","DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.","2022-03-10"]
[945,"34922644","Lancet Diabetes Endocrinol","10.1016/S2213-8587(21)00284-9","Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia.","2022-03-10"]
[946,"34922604","Trials","10.1186/s13063-021-05702-x","Omega-3 mechanism of action&#160;in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the \"Brazilian Omega Study\" (BROS)-a randomized controlled trial.","2022-03-10"]
[947,"34922572","Nutr Metab (Lond)","10.1186/s12986-021-00631-7","Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats.","2022-03-10"]
[948,"34922062","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101848","Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners.","2022-03-10"]
[949,"34922061","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101843","Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study.","2022-03-10"]
[950,"34921696","Biofactors","10.1002/biof.1811","High-fat-induced nonalcoholic fatty liver potentiates vulnerability to and the severity of viral hepatitis in a C3H/HeN mouse model.","2022-03-10"]
[951,"34921208","Sci Rep","10.1038/s41598-021-03679-w","Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis.","2022-03-10"]
[952,"34921174","Sci Rep","10.1038/s41598-021-03279-8","Elevated serum S14 levels are associated with more severe liver steatosis by ultrasonography.","2022-03-10"]
[955,"34920070","Int J Biol Macromol","10.1016/j.ijbiomac.2021.12.036","MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.","2022-03-10"]
[956,"34919684","J Nutr","10.1093/jn/nxab392","A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery.","2022-03-10"]
[957,"34919585","PLoS One","10.1371/journal.pone.0261377","Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action.","2022-03-10"]
[958,"34919135","JAMA Netw Open","10.1001/jamanetworkopen.2021.39558","Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials.","2022-03-10"]
[959,"34918671","Medicine (Baltimore)","10.1097/MD.0000000000028165","Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States.","2022-03-10"]
[960,"34918493","Pediatr Obes","10.1111/ijpo.12880","MicroRNAs as the promising markers of comorbidities in childhood obesity-A systematic review.","2022-03-10"]
[963,"34917917","Metabol Open","10.1016/j.metop.2021.100153","Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development.","2022-03-10"]
[964,"34917640","Front Med (Lausanne)","10.3389/fmed.2021.787777","Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study.","2022-03-10"]
[965,"34917315","Frontline Gastroenterol","10.1136/flgastro-2020-101480","Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease.","2022-03-10"]
[966,"34917312","Frontline Gastroenterol","10.1136/flgastro-2020-101669","Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[967,"34916874","Mediators Inflamm","10.1155/2021/6642246","Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.","2022-03-10"]
[968,"34916558","Sci Rep","10.1038/s41598-021-03583-3","A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight.","2022-03-10"]
[969,"34915801","Pharm Biol","10.1080/13880209.2021.1979594","Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis.","2022-03-10"]
[971,"34915054","J Hepatol","10.1016/j.jhep.2021.12.004","A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH.","2022-03-10"]
[972,"34915036","Metabolism","10.1016/j.metabol.2021.154955","Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.","2022-03-10"]
[973,"34914973","Exp Mol Pathol","10.1016/j.yexmp.2021.104733","TGF-&#946;1 signaling can worsen NAFLD with liver fibrosis backdrop.","2022-03-10"]
[974,"34914849","J Intern Med","10.1111/joim.13434","Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100.","2022-03-10"]
[975,"34914079","Eat Weight Disord","10.1007/s40519-021-01287-1","Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO).","2022-03-10"]
[976,"34914039","Indian J Gastroenterol","10.1007/s12664-021-01202-7","Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity.","2022-03-10"]
[977,"34912244","Front Physiol","10.3389/fphys.2021.795298","Translational Control in Liver Disease.","2022-03-10"]
[978,"34911725","BMJ Open","10.1136/bmjopen-2021-056260","Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study.","2022-03-10"]
[979,"34911587","BMC Nutr","10.1186/s40795-021-00490-8","Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial.","2022-03-10"]
[980,"34911556","BMC Biol","10.1186/s12915-021-01192-0","Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress.","2022-03-10"]
[981,"34911172","Endocrinol Metab (Seoul)","10.3803/EnM.2021.1331","Serotonergic Regulation of Hepatic Energy Metabolism.","2022-03-10"]
[982,"34910548","Sci Transl Med","10.1126/scitranslmed.abg8116","A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques.","2022-03-10"]
[983,"34910546","Sci Transl Med","10.1126/scitranslmed.abg8117","Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis.","2022-03-10"]
[984,"34909896","Rev Assoc Med Bras (1992)","10.1590/1806-9282.20210718","Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis.","2022-03-10"]
[985,"34909876","Rev Assoc Med Bras (1992)","10.1590/1806-9282.20210316","Anthropometric clinical indicators of visceral adiposity as predictors of nonalcoholic fatty liver disease.","2022-03-10"]
[986,"34909847","Arq Gastroenterol","10.1590/S0004-2803.202100000-80","MONOCYTE/HDL RATIO IN NON-ALCOHOLIC HEPATIC STEATOSIS.","2022-03-10"]
[987,"34909677","Curr Res Pharmacol Drug Discov","10.1016/j.crphar.2021.100051","ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score.","2022-03-10"]
[988,"34909410","Psoriasis (Auckl)","10.2147/PTT.S342911","Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.","2022-03-10"]
[989,"34908012","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000003371","Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[990,"34907983","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002324","The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations.","2022-03-10"]
[991,"34907907","J Clin Invest","10.1172/JCI150996","Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.","2022-03-10"]
[992,"34907906","J Clin Invest","10.1172/JCI154645","Dietary sugar restriction reduces hepatic de novo lipogenesis in boys with fatty liver disease.","2022-03-10"]
[993,"34907642","J Cell Mol Med","10.1111/jcmm.17126","Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.","2022-03-10"]
[998,"34906902","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.12.017","Obesity induced Ext1 reduction mediates the occurrence of NAFLD.","2022-03-10"]
[999,"34906552","Chem Phys Lipids","10.1016/j.chemphyslip.2021.105164","Study of lipid proton difference evaluation via 9.4T MRI analysis of fatty liver induced by exposure to methionine and choline-deficient (MCD) diet and high-fat diet (HFD) in an animal model.","2022-03-10"]
[1000,"34906049","Biochemistry (Mosc)","10.1134/S0006297921110055","AMPK/PGC-1&#945;/GLUT4-Mediated Effect of Icariin on Hyperlipidemia-Induced Non-Alcoholic Fatty Liver Disease and Lipid Metabolism Disorder in Mice.","2022-03-10"]
[1001,"34905800","Z Gastroenterol","10.1055/a-1695-3637","Focal fatty sparing as an indicator of higher-grade fatty liver assessed by attenuation imaging: a prospective clinical study in NAFLD population.","2022-03-10"]
[1002,"34905320","Rev Med Inst Mex Seguro Soc",null,"[Detecting non-alcoholic fatty liver in children with owerweight and obesity.]","2022-03-10"]
[1003,"34905051","J Clin Endocrinol Metab","10.1210/clinem/dgab897","Fibrogenesis marker PRO-C3 is higher in advanced liver fibrosis and improves in patients undergoing bariatric surgery.","2022-03-10"]
[1004,"34904966","Am J Gastroenterol","10.14309/ajg.0000000000001584","Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.","2022-03-10"]
[1005,"34904923","Expert Opin Ther Targets","10.1080/14728222.2021.2018418","PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date.","2022-03-10"]
[1006,"34904613","Food Funct","10.1039/d1fo02481g","Steatosis induced by nonylphenol in HepG2 cells and the intervention effect of curcumin.","2022-03-10"]
[1007,"34904045","World J Hepatol","10.4254/wjh.v13.i11.1777","Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection.","2022-03-10"]
[1008,"34904038","World J Hepatol","10.4254/wjh.v13.i11.1688","Abnormal liver enzymes: A review for clinicians.","2022-03-10"]
[1009,"34904031","World J Hepatol","10.4254/wjh.v13.i11.1584","Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity.","2022-03-10"]
[1010,"34904028","World J Hepatol","10.4254/wjh.v13.i11.1534","Liver involvement in inflammatory bowel disease: What should the clinician know?","2022-03-10"]
[1011,"34904026","World J Hepatol","10.4254/wjh.v13.i11.1494","Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome.","2022-03-10"]
[1012,"34903973","Iran J Pharm Res","10.22037/ijpr.2020.114477.14872","Benefits and Risks of Melatonin in Hepatic and Pancreatic Disorders; A Review of Clinical Evidences.","2022-03-10"]
[1014,"34903883","Nat Metab","10.1038/s42255-021-00489-2","Peroxisomal &#946;-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis.","2022-03-10"]
[1015,"34903499","Dig Liver Dis","10.1016/j.dld.2021.11.015","Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate.","2022-03-10"]
[1016,"34902629","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.12.003","Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487.","2022-03-10"]
[1017,"34902220","J Dig Dis","10.1111/1751-2980.13071","The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C.","2022-03-10"]
[1018,"34902008","Am J Clin Nutr","10.1093/ajcn/nqab392","Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study.","2022-03-10"]
[1019,"34901909","Lancet Reg Health Eur","10.1016/j.lanepe.2021.100240","Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018).","2022-03-10"]
[1020,"34901236","Front Cardiovasc Med","10.3389/fcvm.2021.777131","Statins in Non-alcoholic Steatohepatitis.","2022-03-10"]
[1021,"34901163","Front Mol Biosci","10.3389/fmolb.2021.792667","The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1022,"34900816","J Diabetes Metab Disord","10.1007/s40200-021-00916-x","The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease.","2022-03-10"]
[1023,"34900782","J Diabetes Metab Disord","10.1007/s40200-021-00857-5","Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease.","2022-03-10"]
[1024,"34900534","Acta Pharm Sin B","10.1016/j.apsb.2021.03.018","Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease.","2022-03-10"]
[1025,"34899679","Front Immunol","10.3389/fimmu.2021.667354","Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases.","2022-03-10"]
[1026,"34899591","Front Endocrinol (Lausanne)","10.3389/fendo.2021.691556","Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.","2022-03-10"]
[1027,"34899351","Front Pharmacol","10.3389/fphar.2021.789430","Network Pharmacology-Based Analysis of Pogostemon cablin (Blanco) Benth Beneficial Effects to Alleviate Nonalcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[1028,"34898613","PLoS One","10.1371/journal.pone.0260994","The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.","2022-03-10"]
[1029,"34897744","J Appl Toxicol","10.1002/jat.4272","Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-&#916;12,14 PGJ2.","2022-03-10"]
[1030,"34896638","Ann Hepatol","10.1016/j.aohep.2021.100651","Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis.","2022-03-10"]
[1031,"34896404","J Hepatol","10.1016/j.jhep.2021.11.029","The fecal mycobiome in non-alcoholic fatty liver disease.","2022-03-10"]
[1032,"34895743","J Hepatol","10.1016/j.jhep.2021.10.025","The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?","2022-03-10"]
[1034,"34895322","Stem Cell Res Ther","10.1186/s13287-021-02663-5","Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice.","2022-03-10"]
[1035,"34895316","Skelet Muscle","10.1186/s13395-021-00282-5","Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study.","2022-03-10"]
[1036,"34894782","J Cutan Med Surg","10.1177/12034754211066906","Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.","2022-03-10"]
[1037,"34894722","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00309.2021","ROR&#945; contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.","2022-03-10"]
[1038,"34894060","Liver Int","10.1111/liv.15129","Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease.","2022-03-10"]
[1039,"34894052","Liver Int","10.1111/liv.15133","Associations of liver volume and other markers of hepatic steatosis with all-cause mortality in the general population.","2022-03-10"]
[1040,"34893685","Acta Pharmacol Sin","10.1038/s41401-021-00819-w","The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis.","2022-03-10"]
[1041,"34893641","Nat Commun","10.1038/s41467-021-27539-3","The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression.","2022-03-10"]
[1042,"34893351","Trends Pharmacol Sci","10.1016/j.tips.2021.11.011","ER stress in obesity pathogenesis and management.","2022-03-10"]
[1043,"34891753","Annu Int Conf IEEE Eng Med Biol Soc","10.1109/EMBC46164.2021.9629507","A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis).","2022-03-10"]
[1044,"34890795","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.12.002","2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis.","2022-03-10"]
[1045,"34890093","Liver Int","10.1111/liv.15127","Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.","2022-03-10"]
[1046,"34890063","Hepatology","10.1002/hep.32274","NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH.","2022-03-10"]
[1047,"34890043","Eur J Clin Invest","10.1111/eci.13731","The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women.","2022-03-10"]
[1048,"34889100","J Med Chem","10.1021/acs.jmedchem.1c01017","Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor.","2022-03-10"]
[1049,"34888546","Aging Pathobiol Ther","10.31491/apt.2021.03.052","Hepatic steatosis, a lesion reported in captive aged common marmosets.","2022-03-10"]
[1050,"34887931","Evid Based Complement Alternat Med","10.1155/2021/3364579","Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation.","2022-03-10"]
[1051,"34887672","Diabetes Metab Syndr Obes","10.2147/DMSO.S333431","Upregulated lncRNA HCG18 in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance.","2022-03-10"]
[1052,"34887649","World J Gastroenterol","10.3748/wjg.v27.i43.7563","Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study.","2022-03-10"]
[1053,"34887631","World J Gastroenterol","10.3748/wjg.v27.i41.7113","Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach.","2022-03-10"]
[1054,"34886991","J Comp Pathol","10.1016/j.jcpa.2021.10.002","Role of Plin5 Deficiency in Progression of Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.","2022-03-10"]
[1055,"34886772","Curr Alzheimer Res","10.2174/1567205018666211209095652","Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation.","2022-03-10"]
[1056,"34884968","Int J Mol Sci","10.3390/ijms222313163","Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro.","2022-03-10"]
[1057,"34884910","Int J Mol Sci","10.3390/ijms222313105","TG68, a Novel Thyroid Hormone Receptor-&#946; Agonist for the Treatment of NAFLD.","2022-03-10"]
[1058,"34884762","Int J Mol Sci","10.3390/ijms222312947","Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story.","2022-03-10"]
[1059,"34884755","Int J Mol Sci","10.3390/ijms222312945","Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.","2022-03-10"]
[1060,"34884650","Int J Mol Sci","10.3390/ijms222312844","Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model.","2022-03-10"]
[1061,"34884625","Int J Mol Sci","10.3390/ijms222312797","Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD.","2022-03-10"]
[1062,"34884447","Int J Mol Sci","10.3390/ijms222312643","Intracellular Exposure Dose-Associated Susceptibility of Steatotic Hepatocytes to Metallic Nanoparticles.","2022-03-10"]
[1063,"34883157","J Hepatol","10.1016/j.jhep.2021.10.016","Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease.","2022-03-10"]
[1064,"34883038","J Med Food","10.1089/jmf.2021.0088","Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding.","2022-03-10"]
[1065,"34882949","Diabetes Obes Metab","10.1111/dom.14616","Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow-up (DPV) database.","2022-03-10"]
[1066,"34882306","FEBS J","10.1111/febs.16317","p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.","2022-03-10"]
[1067,"34881510","Pediatr Obes","10.1111/ijpo.12872","The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial.","2022-03-10"]
[1068,"34881283","Front Nutr","10.3389/fnut.2021.784354","Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity.","2022-03-10"]
[1069,"34880774","Front Physiol","10.3389/fphys.2021.748517","Effect of Long-Term Exercise on Liver Lipid Metabolism in Chinese Patients With NAFLD: A Systematic Review and Meta-Analysis.","2022-03-10"]
[1071,"34879108","PLoS One","10.1371/journal.pone.0260721","PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.","2022-03-10"]
[1072,"34878523","Endocrinology","10.1210/endocr/bqab249","Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet.","2022-03-10"]
[1073,"34878418","Curr Opin Anaesthesiol","10.1097/ACO.0000000000001084","Preoperative evaluation of geriatric patients undergoing liver transplantation.","2022-03-10"]
[1074,"34877910","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2022.2016391","Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.","2022-03-10"]
[1075,"34877270","World J Clin Cases","10.12998/wjcc.v9.i31.9333","Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids.","2022-03-10"]
[1076,"34876392","Turk J Gastroenterol","10.5152/tjg.2021.201171","Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.","2022-03-10"]
[1077,"34876018","BMC Gastroenterol","10.1186/s12876-021-02041-8","Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study.","2022-03-10"]
[1078,"34875824","J Prev Med Public Health","10.3961/jpmph.21.387","Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea.","2022-03-10"]
[1079,"34875531","Public Health","10.1016/j.puhe.2021.10.012","NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population.","2022-03-10"]
[1081,"34875127","J Intern Med","10.1111/joim.13428","Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study.","2022-03-10"]
[1082,"34874519","Chin J Integr Med","10.1007/s11655-021-3309-6","Lycium barbarum Polysaccharides Promotes Mitochondrial Biogenesis and Energy Balance in a NAFLD Cell Model.","2022-03-10"]
[1083,"34873855","Clin Obes","10.1111/cob.12502","Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study.","2022-03-10"]
[1084,"34873633","Eur Radiol Exp","10.1186/s41747-021-00250-0","Advances in liver US, CT, and MRI: moving toward the future.","2022-03-10"]
[1085,"34873092","AIDS","10.1097/QAD.0000000000003084","A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil.","2022-03-10"]
[1086,"34872787","Ultrasound Med Biol","10.1016/j.ultrasmedbio.2021.11.002","Superb Microvascular Imaging-Based Vascular Index to Assess Adult Hepatic Steatosis: A Feasibility Study.","2022-03-10"]
[1087,"34872379","Am J Mens Health","10.1177/15579883211063335","A Qualitative Analysis of Mexican-Origin Men's Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk Reduction.","2022-03-10"]
[1088,"34872045","Clin Nutr","10.1016/j.clnu.2021.11.016","&#932;he anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis.","2022-03-10"]
[1089,"34871813","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.038","An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.","2022-03-10"]
[1090,"34871812","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.039","Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1091,"34871361","Arch Pathol Lab Med","10.5858/arpa.2021-0339-RA","Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1092,"34871234","Medicine (Baltimore)","10.1097/MD.0000000000027640","Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.","2022-03-10"]
[1093,"34871105","Crit Rev Food Sci Nutr","10.1080/10408398.2021.2006137","Phytosterols as bioactive food components against nonalcoholic fatty liver disease.","2022-03-10"]
[1094,"34870783","J Gastrointest Cancer","10.1007/s12029-021-00748-1","The Gut Microbiome and Hepatocellular Carcinoma.","2022-03-10"]
[1095,"34870551","Pharm Biol","10.1080/13880209.2021.1990969","Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK.","2022-03-10"]
[1096,"34870139","Metabol Open","10.1016/j.metop.2021.100151","Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver.","2022-03-10"]
[1097,"34870138","Metabol Open","10.1016/j.metop.2021.100149","Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD).","2022-03-10"]
[1098,"34869957","JACC Basic Transl Sci","10.1016/j.jacbts.2021.07.010","Relationship of Nonalcoholic Fatty Liver Disease and Heart&#160;Failure With Preserved Ejection Fraction.","2022-03-10"]
[1099,"34869587","Front Mol Biosci","10.3389/fmolb.2021.751938","Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis.","2022-03-10"]
[1100,"34869532","Front Nutr","10.3389/fnut.2021.760985","Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults.","2022-03-10"]
[1101,"34869521","Front Nutr","10.3389/fnut.2021.744825","Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1104,"34869352","Front Cell Dev Biol","10.3389/fcell.2021.762828","Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma.","2022-03-10"]
[1105,"34868307","Gastroenterol Res Pract","10.1155/2021/6696473","Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study.","2022-03-10"]
[1106,"34867414","Front Pharmacol","10.3389/fphar.2021.783393","The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1107,"34867384","Front Pharmacol","10.3389/fphar.2021.762182","Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review.","2022-03-10"]
[1108,"34867358","Front Pharmacol","10.3389/fphar.2021.750147","(+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPAR&#945;-FGF21 Pathway.","2022-03-10"]
[1109,"34867343","Front Pharmacol","10.3389/fphar.2021.734670","Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids.","2022-03-10"]
[1110,"34866939","Cancer Manag Res","10.2147/CMAR.S338783","Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study.","2022-03-10"]
[1111,"34866849","J Clin Exp Hepatol","10.1016/j.jceh.2021.07.016","Tobacco, Cigarettes, and the Liver: The Smoking Gun.","2022-03-10"]
[1112,"34866847","J Clin Exp Hepatol","10.1016/j.jceh.2021.02.002","Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.","2022-03-10"]
[1113,"34866843","J Clin Exp Hepatol","10.1016/j.jceh.2021.02.008","Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance Spectroscopy.","2022-03-10"]
[1114,"34866842","J Clin Exp Hepatol","10.1016/j.jceh.2021.03.002","Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children.","2022-03-10"]
[1115,"34866201","Aliment Pharmacol Ther","10.1111/apt.16720","A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach.","2022-03-10"]
[1116,"34865353","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20190712-00244","[Study on the state of macrophage infiltration in the progression of non-alcoholic fatty liver disease induced by high-fat diet in mice].","2022-03-10"]
[1117,"34864598","Int J Hyg Environ Health","10.1016/j.ijheh.2021.113886","Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds is associated with a risk of obesity and diabetes mellitus among Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017.","2022-03-10"]
[1118,"34863942","Mol Metab","10.1016/j.molmet.2021.101409","The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease.","2022-03-10"]
[1119,"34863940","Mol Metab","10.1016/j.molmet.2021.101411","URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.","2022-03-10"]
[1121,"34863034","J Hepatobiliary Pancreat Sci","10.1002/jhbp.1093","Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan.","2022-03-10"]
[1124,"34862975","FASEB J","10.1096/fj.202101397R","Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.","2022-03-10"]
[1125,"34862599","Br J Pharmacol","10.1111/bph.15768","Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota.","2022-03-10"]
[1126,"34862596","Br J Pharmacol","10.1111/bph.15767","Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high-fat diet.","2022-03-10"]
[1127,"34862475","Commun Biol","10.1038/s42003-021-02883-8","Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota.","2022-03-10"]
[1128,"34861841","BMC Gastroenterol","10.1186/s12876-021-02038-3","FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.","2022-03-10"]
[1129,"34861339","Prev Med","10.1016/j.ypmed.2021.106903","Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.","2022-03-10"]
[1130,"34861229","Environ Res","10.1016/j.envres.2021.112427","CRISPR screen identified that UGT1A9 was required for bisphenols-induced mitochondria dyshomeostasis.","2022-03-10"]
[1131,"34860705","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002323","Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.","2022-03-10"]
[1132,"34860704","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002325","Serum copper, ceruloplasmin, and their relations to metabolic factors in nonalcoholic fatty liver disease: a cross-sectional study.","2022-03-10"]
[1133,"34860208","J Occup Environ Med","10.1097/JOM.0000000000002402","Determination of Cardiovascular Risk in 56,262 Spanish Construction Workers: Cardiovascular Risk in Construction Workers.","2022-03-10"]
[1134,"34859513","Phytother Res","10.1002/ptr.7344","Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1&#945;/XBP1 pathway.","2022-03-10"]
[1135,"34859497","J Gastroenterol Hepatol","10.1111/jgh.15748","Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers.","2022-03-10"]
[1136,"34859106","J Immunol Res","10.1155/2021/3928323","Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD.","2022-03-10"]
[1137,"34858740","Cureus","10.7759/cureus.19046","Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.","2022-03-10"]
[1138,"34858322","Front Endocrinol (Lausanne)","10.3389/fendo.2021.716533","The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review.","2022-03-10"]
[1139,"34857248","Clin Nutr ESPEN","10.1016/j.clnesp.2021.08.005","Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial.","2022-03-10"]
[1140,"34857244","Clin Nutr ESPEN","10.1016/j.clnesp.2021.08.028","High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus.","2022-03-10"]
[1141,"34857059","J Dev Orig Health Dis","10.1017/S2040174421000659","Maternal high-fat diet consumption programs male offspring to mitigate complications in liver regeneration.","2022-03-10"]
[1142,"34856978","BMC Pulm Med","10.1186/s12890-021-01759-1","Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography.","2022-03-10"]
[1143,"34856895","Curr Protein Pept Sci","10.2174/1389203722666211202151557","Soybean &#946;-Conglycinin: Structure Characteristic, Allergenicity, Plasma Lipid-Controlling, Prevention of Obesity and Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1144,"34856688","Zhonghua Nei Ke Za Zhi","10.3760/cma.j.cn112138-20210308-00191","[Correlation between intrahepatic triglyceride content quantified by proton magnetic resonance spectroscopy and glucose metabolism].","2022-03-10"]
[1145,"34855819","PLoS One","10.1371/journal.pone.0260479","Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.","2022-03-10"]
[1146,"34855640","Chin Med J (Engl)","10.1097/CM9.0000000000001888","Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma.","2022-03-10"]
[1147,"34855339","FP Essent",null,"Liver Disease: Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1148,"34854929","Eur Radiol","10.1007/s00330-021-08369-9","Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.","2022-03-10"]
[1149,"34854066","Hormones (Athens)","10.1007/s42000-021-00339-6","Nonalcoholic fatty liver disease: lifestyle and quality of life.","2022-03-10"]
[1150,"34853966","Bull Exp Biol Med","10.1007/s10517-021-05359-1","Knockdown of Sirt1 Gene in Mice Results in Lipid Accumulation in the Liver Mediated via PGC-1&#945;-Induced Mitochondrial Dysfunction and Oxidative Stress.","2022-03-10"]
[1151,"34853949","Handb Exp Pharmacol","10.1007/164_2021_564","Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance.","2022-03-10"]
[1152,"34853313","Nat Commun","10.1038/s41467-021-27309-1","GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity.","2022-03-10"]
[1153,"34851748","Can J Physiol Pharmacol","10.1139/cjpp-2021-0559","The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes.","2022-03-10"]
[1154,"34850865","Dis Model Mech","10.1242/dmm.049173","Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice.","2022-03-10"]
[1155,"34850615","Clin Chem Lab Med","10.1515/cclm-2021-0837","Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.","2022-03-10"]
[1156,"34850445","J Gastroenterol Hepatol","10.1111/jgh.15746","The microbial metabolome in metabolic-associated fatty liver disease.","2022-03-10"]
[1157,"34849373","Front Phys","10.3389/fphy.2021.665562","Feasibility of Hepatic Fat Quantification Using Proton Density Fat Fraction by Multi-Echo Chemical-Shift-Encoded MRI at 7T.","2022-03-10"]
[1158,"34849196","Comput Struct Biotechnol J","10.1016/j.csbj.2021.10.032","Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease.","2022-03-10"]
[1159,"34848984","Diabetes Metab Syndr Obes","10.2147/DMSO.S338097","Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD.","2022-03-10"]
[1160,"34848839","Exp Mol Med","10.1038/s12276-021-00712-w","Roles of I&#954;B kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease.","2022-03-10"]
[1161,"34848360","J Ethnopharmacol","10.1016/j.jep.2021.114873","Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02&#160;cells and zebrafish model.","2022-03-10"]
[1162,"34848359","J Ethnopharmacol","10.1016/j.jep.2021.114870","Systematic characterization of the metabolites of defatted walnut powder extract in vivo and screening of the mechanisms against NAFLD by UPLC-Q-Exactive Orbitrap MS combined with network pharmacology.","2022-03-10"]
[1164,"34847883","BMC Gastroenterol","10.1186/s12876-021-02039-2","Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study.","2022-03-10"]
[1167,"34847213","Food Funct","10.1039/d1fo02696h","Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence.","2022-03-10"]
[1168,"34847156","PLoS One","10.1371/journal.pone.0260320","Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).","2022-03-10"]
[1169,"34845832","Liver Int","10.1111/liv.15120","Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3).","2022-03-10"]
[1170,"34843158","Liver Int","10.1111/liv.15118","Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.","2022-03-10"]
[1171,"34842411","Anal Chem","10.1021/acs.analchem.1c04246","Highly Selective Fluorescent Probe Design for Visualizing Hepatic Hydrogen Sulfide in the Pathological Progression of Nonalcoholic Fatty Liver.","2022-03-10"]
[1172,"34841632","Hepatol Res","10.1111/hepr.13737","Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era.","2022-03-10"]
[1173,"34841290","Cell Rep Med","10.1016/j.xcrm.2021.100437","Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease.","2022-03-10"]
[1174,"34840719","Ther Adv Endocrinol Metab","10.1177/20420188211055557","NAFLD in type 1 diabetes: overrated or underappreciated?","2022-03-10"]
[1175,"34840484","J Clin Exp Hepatol","10.1016/j.jceh.2021.11.009","The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis.","2022-03-10"]
[1176,"34840086","J Diabetes Complications","10.1016/j.jdiacomp.2021.108083","First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status.","2022-03-10"]
[1177,"34839623","Clin Mol Hepatol","10.3350/cmh.2021.0301","Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients.","2022-03-10"]
[1178,"34838723","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.026","Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1179,"34838715","Mol Metab","10.1016/j.molmet.2021.101402","A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.","2022-03-10"]
[1180,"34838052","J Nanobiotechnology","10.1186/s12951-021-01137-3","Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7.","2022-03-10"]
[1181,"34837012","Sci Rep","10.1038/s41598-021-02455-0","Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model.","2022-03-10"]
[1182,"34836382","Nutrients","10.3390/nu13114127","The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities.","2022-03-10"]
[1183,"34836332","Nutrients","10.3390/nu13114077","Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1184,"34836318","Nutrients","10.3390/nu13114063","Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults.","2022-03-10"]
[1185,"34836315","Nutrients","10.3390/nu13114060","Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols.","2022-03-10"]
[1186,"34836021","Nutrients","10.3390/nu13113765","Euphausia pacifica (North Pacific Krill): Review of Chemical Features and Potential Benefits of 8-HEPE against Metabolic Syndrome, Dyslipidemia, NAFLD, and Atherosclerosis.","2022-03-10"]
[1187,"34835981","Nutrients","10.3390/nu13113725","Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice.","2022-03-10"]
[1188,"34835949","Nutrients","10.3390/nu13113693","Effects of Lingonberry (Vaccinium vitis-idaea L.) Supplementation on Hepatic Gene Expression in High-Fat Diet Fed Mice.","2022-03-10"]
[1189,"34835937","Nutrients","10.3390/nu13113679","Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study.","2022-03-10"]
[1190,"34835476","Microorganisms","10.3390/microorganisms9112351","Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension.","2022-03-10"]
[1191,"34835410","Microorganisms","10.3390/microorganisms9112284","Polyclonal Aptamers for Specific Fluorescence Labeling and Quantification of the Health Relevant Human Gut Bacterium Parabacteroides distasonis.","2022-03-10"]
[1192,"34833467","Medicina (Kaunas)","10.3390/medicina57111249","Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.","2022-03-10"]
[1193,"34831479","Cells","10.3390/cells10113257","Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1194,"34831201","Cells","10.3390/cells10112978","Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.","2022-03-10"]
[1195,"34831031","Cells","10.3390/cells10112806","Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1196,"34830997","Cancers (Basel)","10.3390/cancers13225844","Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach.","2022-03-10"]
[1197,"34830641","J Clin Med","10.3390/jcm10225359","Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease-A Single Center Experience.","2022-03-10"]
[1198,"34830360","Int J Mol Sci","10.3390/ijms222212478","Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.","2022-03-10"]
[1199,"34830313","Int J Mol Sci","10.3390/ijms222212431","Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1200,"34830072","Int J Mol Sci","10.3390/ijms222212190","T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1201,"34829968","Biomedicines","10.3390/biomedicines9111739","The Role of Neuropeptide Y in Adipocyte-Macrophage Crosstalk during High Fat Diet-Induced Adipose Inflammation and Liver Steatosis.","2022-03-10"]
[1202,"34829926","Biomedicines","10.3390/biomedicines9111697","Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress.","2022-03-10"]
[1203,"34829889","Biomedicines","10.3390/biomedicines9111660","Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.","2022-03-10"]
[1204,"34829876","Biomedicines","10.3390/biomedicines9111647","Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers.","2022-03-10"]
[1205,"34829865","Biomedicines","10.3390/biomedicines9111636","Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers.","2022-03-10"]
[1206,"34829779","Biomedicines","10.3390/biomedicines9111549","Sex-Dependent Effects of Eicosapentaenoic Acid on Hepatic Steatosis in UCP1 Knockout Mice.","2022-03-10"]
[1207,"34829753","Biomedicines","10.3390/biomedicines9111524","Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC.","2022-03-10"]
[1208,"34829565","Antioxidants (Basel)","10.3390/antiox10111694","Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity.","2022-03-10"]
[1209,"34829402","Diagnostics (Basel)","10.3390/diagnostics11112053","Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets.","2022-03-10"]
[1210,"34829394","Diagnostics (Basel)","10.3390/diagnostics11112047","A Step Closer to the \"Fourth 90\": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV.","2022-03-10"]
[1211,"34828697","Children (Basel)","10.3390/children8110984","Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity.","2022-03-10"]
[1212,"34828420","Genes (Basel)","10.3390/genes12111813","Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study.","2022-03-10"]
[1213,"34828259","Genes (Basel)","10.3390/genes12111653","Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition.","2022-03-10"]
[1214,"34827721","Biomolecules","10.3390/biom11111723","The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1215,"34827579","Biomolecules","10.3390/biom11111582","Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms.","2022-03-10"]
[1216,"34826603","Pharmacol Res","10.1016/j.phrs.2021.106004","Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-&#946;1 pathway: therapeutic role of roflumilast.","2022-03-10"]
[1217,"34826302","Am J Case Rep","10.12659/AJCR.932961","A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH).","2022-03-10"]
[1218,"34825156","JHEP Rep","10.1016/j.jhepr.2021.100387","Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.","2022-03-10"]
[1219,"34825068","Biochem Biophys Rep","10.1016/j.bbrep.2021.101168","Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.","2022-03-10"]
[1220,"34823548","J Transl Med","10.1186/s12967-021-03150-4","CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype.","2022-03-10"]
[1221,"34823063","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.11.007","TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In&#160;Vitro Models.","2022-03-10"]
[1224,"34822647","Vet Sci","10.3390/vetsci8110274","Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation.","2022-03-10"]
[1225,"34822586","Toxins (Basel)","10.3390/toxins13110802","Ochratoxin A Induces Steatosis via PPAR&#947;-CD36 Axis.","2022-03-10"]
[1226,"34822420","Metabolites","10.3390/metabo11110762","Hepatic Response of Magnesium-Restricted Wild Type Mice.","2022-03-10"]
[1227,"34822395","Metabolites","10.3390/metabo11110737","Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics.","2022-03-10"]
[1228,"34822057","Hepatol Int","10.1007/s12072-021-10266-8","Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure.","2022-03-10"]
[1229,"34821899","Food Funct","10.1039/d1fo02921e","Maternal sucralose exposure induces Paneth cell defects and exacerbates gut dysbiosis of progeny mice.","2022-03-10"]
[1230,"34821093","Zhongguo Ying Yong Sheng Li Xue Za Zhi","10.12047/j.cjap.6058.2021.082","[Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism].","2022-03-10"]
[1231,"34821035","Liver Int","10.1111/liv.15116","Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.","2022-03-10"]
[1232,"34819920","Front Endocrinol (Lausanne)","10.3389/fendo.2021.752944","Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1233,"34819792","Saudi Pharm J","10.1016/j.jsps.2021.09.014","Cold-pressed raspberry seeds oil ameliorates high-fat diet triggered non-alcoholic fatty liver disease.","2022-03-10"]
[1234,"34819740","Clin Exp Gastroenterol","10.2147/CEG.S226130","Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks.","2022-03-10"]
[1235,"34819013","Endocr Metab Immune Disord Drug Targets","10.2174/1871530321666211124102837","Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases.","2022-03-10"]
[1236,"34818372","PLoS One","10.1371/journal.pone.0260477","Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study.","2022-03-10"]
[1237,"34818080","Metab Syndr Relat Disord","10.1089/met.2021.0086","Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1238,"34817929","Liver Int","10.1111/liv.15108","Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health.","2022-03-10"]
[1239,"34817071","FEBS Lett","10.1002/1873-3468.14242","Comparative proteomic profiling reveals a pathogenic role&#160;for the O-GlcNAcylated AIMP2-PARP1 complex in aging-related hepatic steatosis in mice.","2022-03-10"]
[1240,"34816913","Rev Assoc Med Bras (1992)","10.1590/1806-9282.20201016","Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[1242,"34816355","Obes Surg","10.1007/s11695-021-05797-w","Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH.","2022-03-10"]
[1243,"34816009","JGH Open","10.1002/jgh3.12658","Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis.","2022-03-10"]
[1244,"34815553","Nat Rev Endocrinol","10.1038/s41574-021-00584-0","Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.","2022-03-10"]
[1245,"34815444","Sci Rep","10.1038/s41598-021-01951-7","A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates.","2022-03-10"]
[1246,"34815180","Trends Mol Med","10.1016/j.molmed.2021.10.005","Linking liver metabolic and vascular disease via bile acid signaling.","2022-03-10"]
[1247,"34814851","BMC Gastroenterol","10.1186/s12876-021-02017-8","Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.","2022-03-10"]
[1248,"34814419","Zhonghua Liu Xing Bing Xue Za Zhi","10.3760/cma.j.cn112338-20200428-00668","[Analysis on influencing factors for nonalcoholic fatty liver disease in Jinchang cohort].","2022-03-10"]
[1249,"34814397","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200416-00189","[Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].","2022-03-10"]
[1250,"34814394","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20201017-00558","[Serum exosomal miRNAs profiling and functional study in patients with non-alcoholic fatty liver disease].","2022-03-10"]
[1251,"34814392","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20201018-00560","[Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].","2022-03-10"]
[1252,"34814152","Ann Nutr Metab","10.1159/000520368","Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study.","2022-03-10"]
[1253,"34813997","Biomed Pharmacother","10.1016/j.biopha.2021.112441","SP-1154, a novel synthetic TGF-&#946; inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice.","2022-03-10"]
[1255,"34813621","PLoS One","10.1371/journal.pone.0260313","Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.","2022-03-10"]
[1256,"34813496","Physiol Int","10.1556/2060.2021.00188","Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy.","2022-03-10"]
[1257,"34813379","Metab Syndr Relat Disord","10.1089/met.2021.0107","The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers.","2022-03-10"]
[1258,"34813249","Arch Argent Pediatr","10.5546/aap.2021.427","[Obesity-fatty liver: the role of the pediatrician].","2022-03-10"]
[1259,"34811857","Aging Cell","10.1111/acel.13523","Cisd2 slows down liver aging and attenuates age-related metabolic dysfunction in male mice.","2022-03-10"]
[1260,"34811578","Handb Exp Pharmacol","10.1007/164_2021_561","NAFLD and NASH: The Metabolically Diseased Liver.","2022-03-10"]
[1261,"34810377","Saudi J Gastroenterol","10.4103/sjg.sjg_260_21","Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.","2022-03-10"]
[1262,"34810376","Saudi J Gastroenterol","10.4103/sjg.sjg_249_21","Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications.","2022-03-10"]
[1263,"34809436","Annu Rev Med","10.1146/annurev-med-042220-020407","Fatty Liver Disease: Diagnosis and Stratification.","2022-03-10"]
[1264,"34809412","Endocrinol Metab (Seoul)","10.3803/EnM.2021.1087","The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011).","2022-03-10"]
[1265,"34808701","Phytother Res","10.1002/ptr.7311","Esculetin: A review of its pharmacology and pharmacokinetics.","2022-03-10"]
[1266,"34808618","Dig Dis","10.1159/000521062","The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.","2022-03-10"]
[1267,"34808500","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.11.038","Endoplasmic reticulum stress increases LECT2 expression via ATF4.","2022-03-10"]
[1268,"34808393","Ann Hepatol","10.1016/j.aohep.2021.100584","Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.","2022-03-10"]
[1269,"34808388","Bioorg Med Chem Lett","10.1016/j.bmcl.2021.128464","Design, synthesis and activity evaluation of prodrug form JBP485 and Vitamin E for alleviation of NASH.","2022-03-10"]
[1270,"34808224","J Pediatr","10.1016/j.jpeds.2021.11.042","Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.","2022-03-10"]
[1271,"34806071","Lancet Reg Health Eur","10.1016/j.lanepe.2021.100222","Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding.","2022-03-10"]
[1272,"34806068","Lancet Reg Health Eur","10.1016/j.lanepe.2021.100206","Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study.","2022-03-10"]
[1273,"34805816","JHEP Rep","10.1016/j.jhepr.2021.100370","Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.","2022-03-10"]
[1274,"34805582","Transl Gastroenterol Hepatol","10.21037/tgh-20-247","Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis.","2022-03-10"]
[1275,"34805412","J Diabetes Res","10.1155/2021/7692447","Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus.","2022-03-10"]
[1277,"34805029","Can J Gastroenterol Hepatol","10.1155/2021/8936865","GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.","2022-03-10"]
[1278,"34803928","Front Endocrinol (Lausanne)","10.3389/fendo.2021.766419","Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD.","2022-03-10"]
[1279,"34803916","Front Endocrinol (Lausanne)","10.3389/fendo.2021.751020","Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases.","2022-03-10"]
[1280,"34803681","Front Pharmacol","10.3389/fphar.2021.732496","The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.","2022-03-10"]
[1281,"34803499","Int J Biol Sci","10.7150/ijbs.65588","CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD+/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes.","2022-03-10"]
[1282,"34803493","Int J Biol Sci","10.7150/ijbs.64714","Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.","2022-03-10"]
[1283,"34803490","Int J Biol Sci","10.7150/ijbs.63889","SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-&#954;B Activation in Macrophages.","2022-03-10"]
[1284,"34803389","Clin Exp Gastroenterol","10.2147/CEG.S329424","Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis.","2022-03-10"]
[1285,"34803123","Endocr J","10.1507/endocrj.EJ21-0563","Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population.","2022-03-10"]
[1286,"34802660","Clin Liver Dis","10.1016/j.cld.2021.08.005","Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease.","2022-03-10"]
[1288,"34801522","Biochem Pharmacol","10.1016/j.bcp.2021.114845","Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma.","2022-03-10"]
[1291,"34800721","Ann Hepatol","10.1016/j.aohep.2021.100556","Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.","2022-03-10"]
[1292,"34799510","Curr Opin Infect Dis","10.1097/QCO.0000000000000798","Frailty in people living with HIV: an update.","2022-03-10"]
[1293,"34799486","Curr Opin Lipidol","10.1097/MOL.0000000000000799","Fatty liver and cerebrovascular disease: plausible association and possible mechanisms.","2022-03-10"]
[1294,"34798892","BMC Complement Med Ther","10.1186/s12906-021-03436-6","Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial.","2022-03-10"]
[1295,"34798835","BMC Gastroenterol","10.1186/s12876-021-02020-z","PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD.","2022-03-10"]
[1296,"34798335","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.007","Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes.","2022-03-10"]
[1297,"34798176","J Hepatol","10.1016/j.jhep.2021.11.012","MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis.","2022-03-10"]
[1298,"34798124","Biochem Pharmacol","10.1016/j.bcp.2021.114841","CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD).","2022-03-10"]
[1299,"34797530","Rheumatol Ther","10.1007/s40744-021-00397-7","Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.","2022-03-10"]
[1300,"34796193","Front Nutr","10.3389/fnut.2021.727785","Translatomics Probes Into the Role of Lycopene on Improving Hepatic Steatosis Induced by High-Fat Diet.","2022-03-10"]
[1301,"34796096","Pediatr Gastroenterol Hepatol Nutr","10.5223/pghn.2021.24.6.518","Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism?","2022-03-10"]
[1302,"34795655","Front Microbiol","10.3389/fmicb.2021.761836","Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1303,"34795650","Front Microbiol","10.3389/fmicb.2021.756299","Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis.","2022-03-10"]
[1304,"34795391","Commun Biol","10.1038/s42003-021-02839-y","Precancerous liver diseases do not cause increased mutagenesis in liver stem cells.","2022-03-10"]
[1305,"34795230","Cell Death Dis","10.1038/s41419-021-04382-4","Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.","2022-03-10"]
[1306,"34794397","BMC Endocr Disord","10.1186/s12902-021-00899-z","Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.","2022-03-10"]
[1307,"34794237","Biomed Pharmacother","10.1016/j.biopha.2021.112372","Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease.","2022-03-10"]
[1308,"34794234","Biomed Pharmacother","10.1016/j.biopha.2021.112357","Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.","2022-03-10"]
[1309,"34794182","Semin Liver Dis","10.1055/s-0041-1739455","The Neglected Role of Bile Duct Epithelial Cells in NASH.","2022-03-10"]
[1310,"34794021","Ecotoxicol Environ Saf","10.1016/j.ecoenv.2021.112986","Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease.","2022-03-10"]
[1311,"34793868","J Hepatol","10.1016/j.jhep.2021.10.029","Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.","2022-03-10"]
[1312,"34793866","J Hepatol","10.1016/j.jhep.2021.11.009","A new perspective on NAFLD: Focusing on lipid droplets.","2022-03-10"]
[1313,"34791524","Int J Colorectal Dis","10.1007/s00384-021-04065-8","Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up.","2022-03-10"]
[1314,"34791370","J Nutr","10.1093/jn/nxab391","Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study.","2022-03-10"]
[1315,"34790034","Int J Med Sci","10.7150/ijms.64458","Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study.","2022-03-10"]
[1316,"34789275","J Nanobiotechnology","10.1186/s12951-021-01108-8","A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis.","2022-03-10"]
[1317,"34789244","Lipids Health Dis","10.1186/s12944-021-01590-x","Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats.","2022-03-10"]
[1318,"34789138","Curr Med Imaging","10.2174/1573405617666211117141640","Evaluation of Aortic Distensibility in Patients with Nonalcoholic Fatty Liver using CT.","2022-03-10"]
[1320,"34788749","Oncology","10.1159/000519995","Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage.","2022-03-10"]
[1321,"34788612","Cell Rep","10.1016/j.celrep.2021.110018","TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment.","2022-03-10"]
[1322,"34787864","Eur Rev Med Pharmacol Sci","10.26355/eurrev_202111_27104","The role of gluten-free diet in nonalcoholic fatty liver disease development.","2022-03-10"]
[1323,"34787756","Biochem Genet","10.1007/s10528-021-10144-w","Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis.","2022-03-10"]
[1324,"34786857","Mol Nutr Food Res","10.1002/mnfr.202100602","Oxidized Pork Induces Hepatic Steatosis by Impairing Thyroid Hormone Function in Mice.","2022-03-10"]
[1325,"34786828","Kaohsiung J Med Sci","10.1002/kjm2.12474","Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.","2022-03-10"]
[1326,"34786549","JHEP Rep","10.1016/j.jhepr.2021.100381","Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.","2022-03-10"]
[1327,"34786546","Chronic Dis Transl Med","10.1016/j.cdtm.2021.08.002","Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis.","2022-03-10"]
[1328,"34786524","Hepatoma Res","10.20517/2394-5079.2021.82","The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD.","2022-03-10"]
[1329,"34786236","Cureus","10.7759/cureus.18641","Non-alcoholic Fatty Liver Disease and Carbohydrate Restricted Diets: A Case Report and Literature Review.","2022-03-10"]
[1330,"34786215","IEEE J Transl Eng Health Med","10.1109/JTEHM.2021.3124937","Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis.","2022-03-10"]
[1331,"34786176","World J Hepatol","10.4254/wjh.v13.i10.1417","Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database.","2022-03-10"]
[1332,"34786174","World J Hepatol","10.4254/wjh.v13.i10.1394","Serum zonulin levels in patients with liver cirrhosis: Prognostic implications.","2022-03-10"]
[1333,"34786172","World J Hepatol","10.4254/wjh.v13.i10.1367","Liver and COVID-19: From care of patients with liver diseases to liver injury.","2022-03-10"]
[1334,"34786161","World J Hepatol","10.4254/wjh.v13.i10.1203","Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.","2022-03-10"]
[1335,"34785918","Diabetes Metab Syndr Obes","10.2147/DMSO.S337416","Association Between Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Incidence of Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study.","2022-03-10"]
[1336,"34785385","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101833","Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-&#946;-mediated fibrosis.","2022-03-10"]
[1337,"34784620","Exp Clin Endocrinol Diabetes","10.1055/a-1666-0431","Shear Wave Elastography Reveals a High Prevalence of NAFLD-related Fibrosis Even in Type 1 Diabetes.","2022-03-10"]
[1338,"34783592","Radiology","10.1148/radiol.2021211027","Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.","2022-03-10"]
[1339,"34783554","J Agric Food Chem","10.1021/acs.jafc.1c05596","Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition.","2022-03-10"]
[1340,"34783191","Hepatol Commun","10.1002/hep4.1852","Predicting Liver-Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests.","2022-03-10"]
[1341,"34783091","J Hum Nutr Diet","10.1111/jhn.12962","The Dietary Inflammatory Index and hepatic health in the US adult population.","2022-03-10"]
[1342,"34783017","Br J Pharmacol","10.1111/bph.15727","A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation.","2022-03-10"]
[1343,"34781143","Biomed Pharmacother","10.1016/j.biopha.2021.112404","Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction.","2022-03-10"]
[1344,"34780785","Exp Cell Res","10.1016/j.yexcr.2021.112922","MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5.","2022-03-10"]
[1345,"34780166","Chem Res Toxicol","10.1021/acs.chemrestox.1c00199","Differential Roles of Water-Insoluble and Water-Soluble Fractions of Diesel Exhaust Particles in the Development of Adverse Health Effects Due to Chronic Instillation of Diesel Exhaust Particles.","2022-03-10"]
[1346,"34780030","Hepatol Int","10.1007/s12072-021-10258-8","Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.","2022-03-10"]
[1347,"34779535","Hepatology","10.1002/hep.32244","Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[1348,"34779464","Food Funct","10.1039/d1fo00979f","MUFA in metabolic syndrome and associated risk factors: is MUFA the opposite side of the PUFA coin?","2022-03-10"]
[1349,"34779413","J Clin Invest","10.1172/JCI154147","Controversies surrounding peripheral cannabinoid receptor 1 in fatty liver disease.","2022-03-10"]
[1350,"34778544","Transplant Direct","10.1097/TXD.0000000000001227","Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.","2022-03-10"]
[1351,"34778314","Front Med (Lausanne)","10.3389/fmed.2021.752999","Longitudinal Associations Between Hand Grip Strength and Non-Alcoholic Fatty Liver Disease in Adults: A Prospective Cohort Study.","2022-03-10"]
[1352,"34778099","Front Cell Infect Microbiol","10.3389/fcimb.2021.683743","Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1353,"34777740","Ther Adv Chronic Dis","10.1177/20406223211048649","The association between NAFLD and risk of chronic kidney disease: a cross-sectional study.","2022-03-10"]
[1354,"34777484","Front Genet","10.3389/fgene.2021.772487","Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1355,"34777261","Front Endocrinol (Lausanne)","10.3389/fendo.2021.770986","Endotoxins and Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1356,"34777255","Front Endocrinol (Lausanne)","10.3389/fendo.2021.760860","Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.","2022-03-10"]
[1357,"34776827","Food Nutr Res","10.29219/fnr.v65.8087","Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL/6J obese mice.","2022-03-10"]
[1358,"34775841","Exp Biol Med (Maywood)","10.1177/15353702211055099","Bioinformatics analysis of an animal model of diet-induced nonalcoholic fatty liver disease with rapid progression.","2022-03-10"]
[1359,"34774989","Cell Signal","10.1016/j.cellsig.2021.110190","LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.","2022-03-10"]
[1360,"34774753","Mol Ther","10.1016/j.ymthe.2021.11.007","An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis.","2022-03-10"]
[1362,"34774623","Life Sci","10.1016/j.lfs.2021.120133","Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weight.","2022-03-10"]
[1365,"34774104","Trials","10.1186/s13063-021-05784-7","Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.","2022-03-10"]
[1366,"34773939","Clin Exp Pediatr","10.3345/cep.2021.00787","Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with NASH/NAFLD: a randomized clinical trial.","2022-03-10"]
[1367,"34773291","Transpl Int","10.1111/tri.14158","A meta-analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes.","2022-03-10"]
[1368,"34773257","Hepatology","10.1002/hep.32235","A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome.","2022-03-10"]
[1369,"34773093","Eur J Clin Nutr","10.1038/s41430-021-01044-8","Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence.","2022-03-10"]
[1371,"34772312","J Int Med Res","10.1177/03000605211055378","Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis.","2022-03-10"]
[1372,"34771745","Cancers (Basel)","10.3390/cancers13215583","In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.","2022-03-10"]
[1373,"34771023","Molecules","10.3390/molecules26216614","Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.","2022-03-10"]
[1374,"34769488","Int J Mol Sci","10.3390/ijms222112058","The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.","2022-03-10"]
[1375,"34769333","Int J Mol Sci","10.3390/ijms222111905","Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD.","2022-03-10"]
[1376,"34769332","Int J Mol Sci","10.3390/ijms222111904","Association between Equol Production Status and Nonalcoholic Steatohepatitis.","2022-03-10"]
[1377,"34769060","Int J Mol Sci","10.3390/ijms222111629","Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.","2022-03-10"]
[1378,"34768942","Int J Mol Sci","10.3390/ijms222111513","In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.","2022-03-10"]
[1379,"34768813","Int J Mol Sci","10.3390/ijms222111383","The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[1380,"34768539","J Clin Med","10.3390/jcm10215019","What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review.","2022-03-10"]
[1381,"34768440","J Clin Med","10.3390/jcm10214906","Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study.","2022-03-10"]
[1382,"34768009","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.004","Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.","2022-03-10"]
[1383,"34765514","J Tradit Complement Med","10.1016/j.jtcme.2021.04.004","Genistein and exercise treatment reduced NASH related HDAC3, IL-13 and MMP-12 expressions in ovariectomized rats fed with high fat high fructose diet.","2022-03-10"]
[1384,"34765249","Curr Health Sci J","10.12865/CHSJ.47.02.19","Contribution of Modern Echocardiographic Techniques in the Detection of Subclinical Heart Dysfunction in Young Adults with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1385,"34765085","Oxid Med Cell Longev","10.1155/2021/8790369","Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function.","2022-03-10"]
[1386,"34764881","Front Physiol","10.3389/fphys.2021.739174","Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice.","2022-03-10"]
[1387,"34764398","Sci Rep","10.1038/s41598-021-01663-y","A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D).","2022-03-10"]
[1388,"34764005","J Formos Med Assoc","10.1016/j.jfma.2021.10.014","Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.","2022-03-10"]
[1389,"34763561","J Int Med Res","10.1177/03000605211056841","Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?","2022-03-10"]
[1390,"34763304","Parkinsonism Relat Disord","10.1016/j.parkreldis.2021.10.030","Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease.","2022-03-10"]
[1391,"34762911","J Biol Chem","10.1016/j.jbc.2021.101388","Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes.","2022-03-10"]
[1392,"34762779","Arch Endocrinol Metab","10.20945/2359-3997000000397","Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity.","2022-03-10"]
[1393,"34762761","FASEB J","10.1096/fj.202100856R","Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion.","2022-03-10"]
[1395,"34762106","JAMA","10.1001/jama.2021.19569","Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.","2022-03-10"]
[1396,"34761883","Minerva Med","10.23736/S0026-4806.21.07665-5","Inflammatory-nutritional scores in the diagnosis of NASH and liver fibrosis.","2022-03-10"]
[1397,"34761514","J Cell Mol Med","10.1111/jcmm.17042","Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective study.","2022-03-10"]
[1399,"34760965","Hepatobiliary Surg Nutr","10.21037/hbsn-20-787","Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity.","2022-03-10"]
[1400,"34759828","Front Pharmacol","10.3389/fphar.2021.768576","Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy.","2022-03-10"]
[1401,"34759311","Nat Commun","10.1038/s41467-021-26536-w","Elevated circulating follistatin associates with an increased risk of type 2 diabetes.","2022-03-10"]
[1402,"34759011","Drug Metab Dispos","10.1124/dmd.121.000388","Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling.","2022-03-10"]
[1403,"34758930","Arch Pediatr","10.1016/j.arcped.2021.09.009","The role of nutrition in non-alcoholic fatty liver disease treatment in obese children.","2022-03-10"]
[1404,"34758848","Chin Med","10.1186/s13020-021-00528-w","Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy.","2022-03-10"]
[1405,"34758532","Zhonghua Yi Xue Za Zhi","10.3760/cma.j.cn112137-20210416-00913","[Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].","2022-03-10"]
[1406,"34758326","Cell Rep","10.1016/j.celrep.2021.109968","m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity.","2022-03-10"]
[1407,"34757877","Pediatr Ann","10.3928/19382359-20211019-02","Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1408,"34757352","Mol Omics","10.1039/d1mo00274k","Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis.","2022-03-10"]
[1409,"34757199","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.10.040","Disease Progression Modeling for Economic Evaluation in Nonalcoholic Fatty Liver Disease-A Systematic Review.","2022-03-10"]
[1410,"34757198","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.10.033","Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery.","2022-03-10"]
[1411,"34757160","Toxicology","10.1016/j.tox.2021.153015","The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro.","2022-03-10"]
[1413,"34757046","Mol Metab","10.1016/j.molmet.2021.101364","Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.","2022-03-10"]
[1414,"34756982","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.10.007","A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET.","2022-03-10"]
[1415,"34756030","ACS Appl Mater Interfaces","10.1021/acsami.1c14674","Fluorescent Egg White-Based Carbon Dots as a High-Sensitivity Iron Chelator for the Therapy of Nonalcoholic Fatty Liver Disease by Iron Overload in Zebrafish.","2022-03-10"]
[1416,"34755918","Environ Toxicol","10.1002/tox.23404","Polystyrene nanoplastics potentiate the development of hepatic fibrosis in high fat diet fed mice.","2022-03-10"]
[1417,"34755544","J Am Heart Assoc","10.1161/JAHA.121.021654","Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.","2022-03-10"]
[1419,"34755088","iScience","10.1016/j.isci.2021.103233","Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver.","2022-03-10"]
[1420,"34755002","J Endocr Soc","10.1210/jendso/bvab155","Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care.","2022-03-10"]
[1421,"34754380","World J Diabetes","10.4239/wjd.v12.i10.1809","Non-alcoholic fatty liver disease, diabetes medications and blood pressure.","2022-03-10"]
[1422,"34754150","World J Gastroenterol","10.3748/wjg.v27.i39.6522","Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?","2022-03-10"]
[1424,"34753279","Clin Mol Hepatol","10.3350/cmh.2021.0310","MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region.","2022-03-10"]
[1425,"34753223","Liver Transpl","10.1002/lt.26365","Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm.","2022-03-10"]
[1426,"34752964","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.001","Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study.","2022-03-10"]
[1428,"34752711","Annu Rev Pathol","10.1146/annurev-pathmechdis-032521-102529","Role of the Inflammasome in Liver Disease.","2022-03-10"]
[1429,"34750345","Sci Rep","10.1038/s41598-021-00501-5","Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility.","2022-03-10"]
[1430,"34749893","Nurs Clin North Am","10.1016/j.cnur.2021.07.009","Obesity and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1432,"34749473","Zhonghua Yu Fang Yi Xue Za Zhi","10.3760/cma.j.cn112150-20201102-01264","[Effects of (+)-catechin and epigallocatechin gallate on alcoholic fatty liver in mice models].","2022-03-10"]
[1433,"34749354","Hum Hered","10.1159/000520734","Association of PNPLA3 I148M with Liver Disease Biomarkers in Latinos.","2022-03-10"]
[1435,"34746842","Curr Res Physiol","10.1016/j.crphys.2021.09.004","High-fat diet-associated cognitive decline: Is zinc finger protein 1 (ZPR1) the molecular connection?","2022-03-10"]
[1436,"34746691","iScience","10.1016/j.isci.2021.103196","Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2.","2022-03-10"]
[1437,"34746195","Front Med (Lausanne)","10.3389/fmed.2021.761538","Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies.","2022-03-10"]
[1438,"34746184","Front Med (Lausanne)","10.3389/fmed.2021.750044","Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases.","2022-03-10"]
[1439,"34746177","Front Med (Lausanne)","10.3389/fmed.2021.737759","Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy.","2022-03-10"]
[1440,"34745924","Avicenna J Phytomed","10.22038/AJP.2021.17835","Gallic acid protects the liver against NAFLD induced by dust exposure and high-fat diet through inhibiting oxidative stress and repressing the inflammatory signaling pathways NF-k&#946;/TNF-&#945;/IL-6 in Wistar rats.","2022-03-10"]
[1441,"34745420","Oxid Med Cell Longev","10.1155/2021/6889533","The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD.","2022-03-10"]
[1442,"34745017","Front Endocrinol (Lausanne)","10.3389/fendo.2021.770740","The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.","2022-03-10"]
[1443,"34743980","Eur J Pharmacol","10.1016/j.ejphar.2021.174604","Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms.","2022-03-10"]
[1444,"34743657","Adipocyte","10.1080/21623945.2021.1982164","Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD.","2022-03-10"]
[1445,"34743485","Ultrasonography","10.14366/usg.21099","Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications.","2022-03-10"]
[1446,"34742934","Arch Biochem Biophys","10.1016/j.abb.2021.109080","The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids.","2022-03-10"]
[1447,"34742814","Gastroenterol Hepatol","10.1016/j.gastrohep.2021.10.003","Body composition and phase angle by bioimpedance in patients with MAFLD.","2022-03-10"]
[1448,"34741649","Eur J Nutr","10.1007/s00394-021-02732-8","Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults.","2022-03-10"]
[1449,"34741554","Hepatology","10.1002/hep.32228","Global burden of NAFLD and chronic liver disease among adolescents and young adults.","2022-03-10"]
[1455,"34741169","Nat Rev Immunol","10.1038/s41577-021-00639-3","Immune cell-mediated features of non-alcoholic steatohepatitis.","2022-03-10"]
[1456,"34740705","J Hepatol","10.1016/j.jhep.2021.10.018","EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.","2022-03-10"]
[1457,"34740672","Toxicology","10.1016/j.tox.2021.153021","MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period.","2022-03-10"]
[1459,"34740573","Metabolism","10.1016/j.metabol.2021.154925","Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.","2022-03-10"]
[1460,"34740314","Mol Med","10.1186/s10020-021-00407-y","Nuclear receptors: a bridge linking the gut microbiome and the host.","2022-03-10"]
[1461,"34740106","EBioMedicine","10.1016/j.ebiom.2021.103661","The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.","2022-03-10"]
[1462,"34739937","Nutrition","10.1016/j.nut.2021.111491","Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis.","2022-03-10"]
[1463,"34738990","J Hypertens","10.1097/HJH.0000000000002954","Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus.","2022-03-10"]
[1464,"34738917","Endocr Connect","10.1530/EC-21-0367","Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes.","2022-03-10"]
[1465,"34737604","J Inflamm Res","10.2147/JIR.S330499","Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota.","2022-03-10"]
[1466,"34737121","J Mol Cell Cardiol","10.1016/j.yjmcc.2021.10.007","NAFLD as a continuous driver in the whole spectrum of vascular disease.","2022-03-10"]
[1467,"34736960","Cancer Lett","10.1016/j.canlet.2021.10.039","Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis.","2022-03-10"]
[1468,"34736591","Pediatr Clin North Am","10.1016/j.pcl.2021.07.013","Pediatric Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1469,"34736535","Cell Biosci","10.1186/s13578-021-00701-6","Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation.","2022-03-10"]
[1470,"34736334","Ceska Gynekol","10.48095/cccg2021343","Conservative possibilities influencing PCOS syndrome - the importance of nutrition.","2022-03-10"]
[1471,"34736312","Clin Mol Hepatol","10.3350/cmh.2021.0188","U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases.","2022-03-10"]
[1472,"34734674","Pediatr Obes","10.1111/ijpo.12869","Exercise dose on hepatic fat and cardiovascular health in adolescents with excess of adiposity.","2022-03-10"]
[1473,"34734480","J Cell Mol Med","10.1111/jcmm.16994","Exercise ameliorates insulin resistance and improves ASK1-mediated insulin signalling in obese rats.","2022-03-10"]
[1474,"34734433","J Gastroenterol Hepatol","10.1111/jgh.15729","New perspective on fecal microbiota transplantation in liver diseases.","2022-03-10"]
[1475,"34734369","J Gastrointest Surg","10.1007/s11605-021-05188-7","The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.","2022-03-10"]
[1476,"34734090","J Immunol Res","10.1155/2021/4084566","Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways.","2022-03-10"]
[1477,"34733981","Ann Transl Med","10.21037/atm-21-4012","TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells.","2022-03-10"]
[1478,"34733762","J Lasers Med Sci","10.34172/jlms.2021.39","The Effect of Laser Therapy Along With Mediterranean Diet Versus Mediterranean Diet Only on Older Adults With Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial.","2022-03-10"]
[1479,"34732369","Pharmacol Res","10.1016/j.phrs.2021.105964","Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.","2022-03-10"]
[1480,"34731006","Sci Adv","10.1126/sciadv.abh1541","Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD.","2022-03-10"]
[1481,"34730847","J Ultrasound Med","10.1002/jum.15870","A Pre-Release Algorithm With a Confidence Map for Estimating the Attenuation Coefficient for Liver Fat Quantification.","2022-03-10"]
[1482,"34730559","Clin Transl Gastroenterol","10.14309/ctg.0000000000000420","Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents.","2022-03-10"]
[1483,"34729904","Obes Rev","10.1111/obr.13367","Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery.","2022-03-10"]
[1484,"34729306","Acta Pharm Sin B","10.1016/j.apsb.2021.03.022","3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing.","2022-03-10"]
[1485,"34728268","Presse Med","10.1016/j.lpm.2021.104085","Complications of lipodystrophy syndromes.","2022-03-10"]
[1486,"34728047","Zhongguo Yi Xue Ke Xue Yuan Xue Bao","10.3881/j.issn.1000-503X.12688","[Research Progress of Quantitative Ultrasound Assessment of Liver Steatosis in Non-alcoholic Fatty Liver Disease].","2022-03-10"]
[1487,"34727818","Expert Opin Ther Targets","10.1080/14728222.2021.1999416","A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH).","2022-03-10"]
[1488,"34727379","Biomed Chromatogr","10.1002/bmc.5271","Lipidomic-based investigation into the therapeutic effects of polyene phosphatidylcholine and Babao Dan on rats with non-alcoholic fatty liver disease.","2022-03-10"]
[1489,"34726820","Intern Med J","10.1111/imj.15603","Clinical relevance of Shear Wave Elastography compared with Transient Elastography and other markers of liver fibrosis - a cross-sectional study.","2022-03-10"]
[1490,"34726357","J Pediatr Endocrinol Metab","10.1515/jpem-2021-0070","Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements.","2022-03-10"]
[1491,"34726318","Diabetes Obes Metab","10.1111/dom.14597","Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke.","2022-03-10"]
[1492,"34726148","Proc Nutr Soc","10.1017/S0029665121003761","Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism.","2022-03-10"]
[1496,"34724062","J Clin Endocrinol Metab","10.1210/clinem/dgab795","The Effect of High-intensity Interval Training vs Moderate-intensity Continuous Training on Liver Fat: A Systematic Review and Meta-Analysis.","2022-03-10"]
[1497,"34723254","JPGN Rep","10.1097/PG9.0000000000000077","Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints.","2022-03-10"]
[1498,"34722615","Front Nutr","10.3389/fnut.2021.756565","Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice.","2022-03-10"]
[1499,"34722411","Can J Gastroenterol Hepatol","10.1155/2021/8873652","Anatomical Brain Changes and Cognitive Abilities in Patients with Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1500,"34722175","J Clin Transl Hepatol","10.14218/JCTH.2021.00058","Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1501,"34722019","Cureus","10.7759/cureus.18201","Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review.","2022-03-10"]
[1502,"34721326","Front Microbiol","10.3389/fmicb.2021.728823","Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota.","2022-03-10"]
[1503,"34719928","J Agric Food Chem","10.1021/acs.jafc.1c05213","Erythritol Improves Nonalcoholic Fatty Liver Disease by Activating Nrf2 Antioxidant Capacity.","2022-03-10"]
[1504,"34719614","J Nutr Sci Vitaminol (Tokyo)","10.3177/jnsv.67.292","Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome.","2022-03-10"]
[1505,"34718898","Egypt Heart J","10.1186/s43044-021-00222-0","The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography.","2022-03-10"]
[1506,"34718870","J Gastroenterol","10.1007/s00535-021-01833-9","Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review.","2022-03-10"]
[1507,"34717726","Trials","10.1186/s13063-021-05695-7","Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).","2022-03-10"]
[1508,"34717194","Int Immunopharmacol","10.1016/j.intimp.2021.108290","Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-&#954;B.","2022-03-10"]
[1509,"34717002","Hepatology","10.1002/hep.32221","Breviscapine alleviates NASH by inhibiting TGF-&#946;-activated kinase 1-dependent signaling.","2022-03-10"]
[1510,"34716911","Hormones (Athens)","10.1007/s42000-021-00334-x","Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease.","2022-03-10"]
[1511,"34715296","Free Radic Biol Med","10.1016/j.freeradbiomed.2021.10.017","Role of vitamin E in the treatment of non-alcoholic steatohepatitis.","2022-03-10"]
[1512,"34712920","iScience","10.1016/j.isci.2021.103222","A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease.","2022-03-10"]
[1513,"34712528","Cureus","10.7759/cureus.18245","An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders.","2022-03-10"]
[1514,"34712448","Middle East J Dig Dis","10.34172/mejdd.2021.213","Melatonin Levels in Patients with Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals according to Fibrosis Level.","2022-03-10"]
[1515,"34712447","Middle East J Dig Dis","10.34172/mejdd.2021.212","Evaluating Pancreatic index in Patients with and without Metabolic Syndrome.","2022-03-10"]
[1516,"34712025","World J Gastroenterol","10.3748/wjg.v27.i37.6161","Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases.","2022-03-10"]
[1517,"34711912","Sci Rep","10.1038/s41598-021-99958-7","Loss of hepatic&#160;Flcn protects against fibrosis and inflammation by activating autophagy pathways.","2022-03-10"]
[1518,"34711595","BMJ Open","10.1136/bmjopen-2021-051218","Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.","2022-03-10"]
[1519,"34710938","Z Gastroenterol","10.1055/a-1482-9236","Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures.","2022-03-10"]
[1520,"34710482","J Hepatol","10.1016/j.jhep.2021.10.013","Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.","2022-03-10"]
[1521,"34710382","Am J Pathol","10.1016/j.ajpath.2021.10.002","A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages.","2022-03-10"]
[1523,"34708234","Sheng Li Xue Bao",null,"[KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].","2022-03-10"]
[1524,"34708231","Sheng Li Xue Bao",null,"[The role of SIRT6 in nonalcoholic steatohepatitis].","2022-03-10"]
[1525,"34708066","Front Nutr","10.3389/fnut.2021.751436","Integrated Transcriptomic and Translatomic Inquiry of the Role of Betaine on Lipid Metabolic Dysregulation Induced by a High-Fat Diet.","2022-03-10"]
[1526,"34707711","Exp Ther Med","10.3892/etm.2021.10865","MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis.","2022-03-10"]
[1527,"34707687","Therap Adv Gastroenterol","10.1177/17562848211037094","Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study.","2022-03-10"]
[1528,"34707622","Front Immunol","10.3389/fimmu.2021.766170","Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[1529,"34707573","Front Endocrinol (Lausanne)","10.3389/fendo.2021.751802","Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis.","2022-03-10"]
[1530,"34707570","Front Endocrinol (Lausanne)","10.3389/fendo.2021.733625","Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk.","2022-03-10"]
[1532,"34707258","Nat Rev Gastroenterol Hepatol","10.1038/s41575-021-00523-4","Advancing the global public health agenda for NAFLD: a consensus statement.","2022-03-10"]
[1533,"34707201","Sci Rep","10.1038/s41598-021-00676-x","Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II.","2022-03-10"]
[1535,"34706716","Lipids Health Dis","10.1186/s12944-021-01568-9","Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.","2022-03-10"]
[1536,"34706656","BMC Gastroenterol","10.1186/s12876-021-01958-4","Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors.","2022-03-10"]
[1537,"34706542","J Agric Food Chem","10.1021/acs.jafc.1c04933","Sulforaphane Regulates Glucose and Lipid Metabolisms in Obese Mice by Restraining JNK and Activating Insulin and FGF21 Signal Pathways.","2022-03-10"]
[1538,"34706243","Cell Rep","10.1016/j.celrep.2021.109897","Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease.","2022-03-10"]
[1539,"34705426","ACS Nano","10.1021/acsnano.1c02158","Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1540,"34704339","Trop Med Int Health","10.1111/tmi.13696","Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans.","2022-03-10"]
[1541,"34704009","Metabol Open","10.1016/j.metop.2021.100140","Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models.","2022-03-10"]
[1542,"34704008","Metabol Open","10.1016/j.metop.2021.100138","Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis.","2022-03-10"]
[1543,"34704005","JHEP Rep","10.1016/j.jhepr.2021.100359","PI3K&#947; promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation.","2022-03-10"]
[1544,"34703257","Diabetes Metab Syndr Obes","10.2147/DMSO.S332659","QSHY Granules Promote White Adipose Tissue Browning and Correct BCAAs Metabolic Disorder in NAFLD Mice.","2022-03-10"]
[1545,"34702329","Diabetol Metab Syndr","10.1186/s13098-021-00741-5","Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease.","2022-03-10"]
[1546,"34699301","Adipocyte","10.1080/21623945.2021.1983241","Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice.","2022-03-10"]
[1547,"34697932","J Korean Med Sci","10.3346/jkms.2021.36.e291","Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.","2022-03-10"]
[1548,"34697917","Hepatol Commun","10.1002/hep4.1808","Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based Study.","2022-03-10"]
[1550,"34697666","Handb Exp Pharmacol","10.1007/164_2021_558","Obesity and Obstructive Sleep Apnea.","2022-03-10"]
[1552,"34697380","Sci Rep","10.1038/s41598-021-00454-9","Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS.","2022-03-10"]
[1553,"34696656","Xenobiotica","10.1080/00498254.2020.1858207","Transcription profiling of cadmium-exposed livers reveals alteration of lipid metabolism and predisposition to hepatic steatosis.","2022-03-10"]
[1554,"34695558","J Nutr Biochem","10.1016/j.jnutbio.2021.108888","Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.","2022-03-10"]
[1555,"34695228","Eur J Clin Invest","10.1111/eci.13695","Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis.","2022-03-10"]
[1556,"34694070","Mol Syst Biol","10.15252/msb.202110459","Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.","2022-03-10"]
[1557,"34694029","FASEB J","10.1096/fj.202002656RRR","BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model.","2022-03-10"]
[1558,"34694013","Aliment Pharmacol Ther","10.1111/apt.16674","Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.","2022-03-10"]
[1559,"34693661","Cancer Med","10.1002/cam4.4367","First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.","2022-03-10"]
[1560,"34693553","J Gastroenterol Hepatol","10.1111/jgh.15723","Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.","2022-03-10"]
[1561,"34693238","JHEP Rep","10.1016/j.jhepr.2021.100362","Non-invasive biomarkers of Fontan-associated liver disease.","2022-03-10"]
[1562,"34693236","JHEP Rep","10.1016/j.jhepr.2021.100322","Non-alcoholic fatty liver disease: A patient guideline.","2022-03-10"]
[1563,"34692739","Front Med (Lausanne)","10.3389/fmed.2021.753268","Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.","2022-03-10"]
[1564,"34692725","Front Med (Lausanne)","10.3389/fmed.2021.734847","PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial.","2022-03-10"]
[1565,"34691178","J Oncol","10.1155/2021/7764817","Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.","2022-03-10"]
[1566,"34690666","Int J Public Health","10.3389/ijph.2021.1604371","Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.","2022-03-10"]
[1567,"34690658","J Taibah Univ Med Sci","10.1016/j.jtumed.2021.03.010","Impact of standard treatment on the quality of life of non-alcoholic fatty liver disease patients.","2022-03-10"]
[1568,"34690105","Rev Gastroenterol Mex (Engl Ed)","10.1016/j.rgmxen.2021.09.002","Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them.","2022-03-10"]
[1569,"34689770","Lipids Health Dis","10.1186/s12944-021-01577-8","Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study.","2022-03-10"]
[1570,"34689689","J Obstet Gynaecol","10.1080/01443615.2021.1969346","Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women.","2022-03-10"]
[1571,"34689362","Hepatology","10.1002/hep.32213","Switch-associated protein 70 protects against nonalcoholic fatty liver disease&#160;via suppression of TAK1.","2022-03-10"]
[1572,"34689159","Cell Death Discov","10.1038/s41420-021-00707-6","HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes.","2022-03-10"]
[1573,"34688952","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.10.023","Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.","2022-03-10"]
[1574,"34688661","J Biol Chem","10.1016/j.jbc.2021.101331","A retinoic acid receptor &#946;2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.","2022-03-10"]
[1575,"34688168","Curr Opin Pharmacol","10.1016/j.coph.2021.09.007","Non-alcoholic fatty liver disease: Current therapeutic options.","2022-03-10"]
[1576,"34687281","Liver Int","10.1111/liv.15087","Risk factors for bleeding hepatocellular adenoma in a United States cohort.","2022-03-10"]
[1577,"34687092","Biofactors","10.1002/biof.1797","Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action.","2022-03-10"]
[1578,"34686753","Sci Rep","10.1038/s41598-021-00425-0","Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant.","2022-03-10"]
[1579,"34686466","J Integr Med","10.1016/j.joim.2021.09.003","Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis.","2022-03-10"]
[1580,"34686147","BMC Gastroenterol","10.1186/s12876-021-01974-4","The liver steatosis severity and lipid characteristics in primary biliary cholangitis.","2022-03-10"]
[1581,"34685636","Cells","10.3390/cells10102656","Oxysterol 7-&#945; Hydroxylase (CYP7B1) Attenuates Metabolic-Associated Fatty Liver Disease in Mice at Thermoneutrality.","2022-03-10"]
[1582,"34685614","Cells","10.3390/cells10102634","Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1583,"34685496","Cells","10.3390/cells10102516","Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression.","2022-03-10"]
[1584,"34684698","Molecules","10.3390/molecules26206117","Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.","2022-03-10"]
[1585,"34684653","Nutrients","10.3390/nu13103652","Coffeeberry Activates the CaMKII/CREB/BDNF Pathway, Normalizes Autophagy and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model.","2022-03-10"]
[1586,"34684586","Nutrients","10.3390/nu13103579","Time-Restricted Feeding during Puberty Ameliorates Adiposity and Prevents Hepatic Steatosis in a Mouse Model of Childhood Obesity.","2022-03-10"]
[1587,"34684533","Nutrients","10.3390/nu13103532","Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice.","2022-03-10"]
[1588,"34684510","Nutrients","10.3390/nu13103509","Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis.","2022-03-10"]
[1589,"34684463","Nutrients","10.3390/nu13103462","Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV.","2022-03-10"]
[1590,"34684455","Nutrients","10.3390/nu13103455","Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model.","2022-03-10"]
[1591,"34684404","Nutrients","10.3390/nu13103400","Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus.","2022-03-10"]
[1592,"34684371","Nutrients","10.3390/nu13103370","Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis.","2022-03-10"]
[1593,"34684339","Nutrients","10.3390/nu13103338","Ethanol Extract of Liriope platyphylla Root Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice via Regulation of Lipogenesis and Lipid Uptake.","2022-03-10"]
[1594,"34684335","Nutrients","10.3390/nu13103334","Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.","2022-03-10"]
[1595,"34684094","Medicina (Kaunas)","10.3390/medicina57101057","Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time.","2022-03-10"]
[1596,"34683439","Microorganisms","10.3390/microorganisms9102118","Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults.","2022-03-10"]
[1597,"34682795","J Clin Med","10.3390/jcm10204673","Defining NASH from a Multi-Omics Systems Biology Perspective.","2022-03-10"]
[1598,"34682759","J Clin Med","10.3390/jcm10204638","Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma.","2022-03-10"]
[1599,"34681787","Int J Mol Sci","10.3390/ijms222011128","The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1600,"34681759","Int J Mol Sci","10.3390/ijms222011085","Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2.","2022-03-10"]
[1601,"34681695","Int J Mol Sci","10.3390/ijms222011037","Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.","2022-03-10"]
[1602,"34681600","Int J Mol Sci","10.3390/ijms222010940","Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling.","2022-03-10"]
[1603,"34681291","Foods","10.3390/foods10102242","Tebuconazole Fungicide Induces Lipid Accumulation and Oxidative Stress in HepG2 Cells.","2022-03-10"]
[1604,"34681228","Pharmaceuticals (Basel)","10.3390/ph14101004","Lipid-Lowering Bioactivity of Microalga Nitzschia laevis Extract Containing Fucoxanthin in Murine Model and Carcinomic Hepatocytes.","2022-03-10"]
[1605,"34681219","Pharmaceuticals (Basel)","10.3390/ph14100995","Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach.","2022-03-10"]
[1606,"34681193","Pharmaceuticals (Basel)","10.3390/ph14100969","Posidonia oceanica (L.) Delile Extract Reduces Lipid Accumulation through Autophagy Activation in HepG2 Cells.","2022-03-10"]
[1607,"34680608","Biomedicines","10.3390/biomedicines9101491","The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments.","2022-03-10"]
[1608,"34680557","Biomedicines","10.3390/biomedicines9101440","Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet.","2022-03-10"]
[1609,"34680522","Biomedicines","10.3390/biomedicines9101405","Lipid Disorders in NAFLD and Chronic Kidney Disease.","2022-03-10"]
[1610,"34680518","Biomedicines","10.3390/biomedicines9101401","The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.","2022-03-10"]
[1611,"34680486","Biomedicines","10.3390/biomedicines9101370","Nonalcoholic Fatty Liver Disease and the Kidney: A Review.","2022-03-10"]
[1612,"34680476","Biomedicines","10.3390/biomedicines9101359","Genetics Is of the Essence to Face NAFLD.","2022-03-10"]
[1613,"34680463","Biomedicines","10.3390/biomedicines9101346","Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges.","2022-03-10"]
[1614,"34679681","Antioxidants (Basel)","10.3390/antiox10101546","Ameliorative Effect of Annona muricata (Graviola) Extract on Hyperglycemia Induced Hepatic Damage in Type 2 Diabetic Mice.","2022-03-10"]
[1615,"34679664","Antioxidants (Basel)","10.3390/antiox10101529","Dimeric Histidine as a Novel Free Radical Scavenger Alleviates Non-Alcoholic Liver Injury.","2022-03-10"]
[1616,"34679651","Antioxidants (Basel)","10.3390/antiox10101516","Association of Urinary and Dietary Selenium and of Serum Selenium Species with Serum Alanine Aminotransferase in a Healthy Italian Population.","2022-03-10"]
[1617,"34679515","Diagnostics (Basel)","10.3390/diagnostics11101817","The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography.","2022-03-10"]
[1618,"34679242","Liver Int","10.1111/liv.15081","Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.","2022-03-10"]
[1619,"34679051","Vet Sci","10.3390/vetsci8100221","Changes in Serum Lipid Profiles among Canine Patients Suffering from Chronic Hepatitis.","2022-03-10"]
[1620,"34678858","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002299","Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.","2022-03-10"]
[1622,"34678374","Toxicol Appl Pharmacol","10.1016/j.taap.2021.115758","Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3.","2022-03-10"]
[1623,"34678296","Clin Chim Acta","10.1016/j.cca.2021.10.018","The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases.","2022-03-10"]
[1624,"34677420","Metabolites","10.3390/metabo11100706","Molecular Mechanisms of the SLC13A5 Gene Transcription.","2022-03-10"]
[1625,"34677409","Metabolites","10.3390/metabo11100694","Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review.","2022-03-10"]
[1626,"34677372","Metabolites","10.3390/metabo11100657","In Utero Exposure to Persistent Organic Pollutants and Childhood Lipid Levels.","2022-03-10"]
[1627,"34677008","Hepatol Commun","10.1002/hep4.1830","Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1628,"34676692","Hepatol Commun","10.1002/hep4.1833","Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus.","2022-03-10"]
[1629,"34676233","Front Nutr","10.3389/fnut.2021.734859","NAFLD and Physical Exercise: Ready, Steady, Go!","2022-03-10"]
[1630,"34675940","Front Immunol","10.3389/fimmu.2021.762564","Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases.","2022-03-10"]
[1631,"34675931","Front Immunol","10.3389/fimmu.2021.747794","Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice.","2022-03-10"]
[1634,"34675338","Sci Rep","10.1038/s41598-021-99008-2","Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis.","2022-03-10"]
[1635,"34675003","Diabetes","10.2337/db21-0363","Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice.","2022-03-10"]
[1636,"34674650","BMC Gastroenterol","10.1186/s12876-021-01978-0","Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study.","2022-03-10"]
[1637,"34674510","Endocrinol Metab (Seoul)","10.3803/EnM.2021.1110","Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study.","2022-03-10"]
[1638,"34674097","Inflammation","10.1007/s10753-021-01573-1","Deoxycholic Acid Promotes Pyroptosis in Free Fatty Acid-Induced Steatotic Hepatocytes by Inhibiting PINK1-Mediated Mitophagy.","2022-03-10"]
[1639,"34671996","Aliment Pharmacol Ther","10.1111/apt.16664","Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis.","2022-03-10"]
[1640,"34671210","Int J Biol Sci","10.7150/ijbs.63732","Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/&#946;-catenin-Cyp2e1 Signaling.","2022-03-10"]
[1641,"34671102","Nat Rev Endocrinol","10.1038/s41574-021-00573-3","Metabolic implications of pancreatic fat accumulation.","2022-03-10"]
[1642,"34670068","Ann Pediatr Endocrinol Metab","10.6065/apem.2142042.021","Wilson disease diagnosed incidentally by targeted gene panel sequencing in a Korean boy with severe obesity.","2022-03-10"]
[1644,"34670043","N Engl J Med","10.1056/NEJMoa2029349","Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1645,"34670042","N Engl J Med","10.1056/NEJMoa2036205","A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.","2022-03-10"]
[1646,"34669440","Sci Transl Med","10.1126/scitranslmed.abe8939","Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.","2022-03-10"]
[1647,"34669319","Minerva Endocrinol (Torino)","10.23736/S2724-6507.21.03564-8","Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease.","2022-03-10"]
[1648,"34669068","J Med Ultrason (2001)","10.1007/s10396-021-01135-w","MRI-derived proton density fat fraction.","2022-03-10"]
[1649,"34668765","J Med Food","10.1089/jmf.2021.K.0090","Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice.","2022-03-10"]
[1650,"34668658","Hepatol Commun","10.1002/hep4.1831","Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis.","2022-03-10"]
[1651,"34668597","Hepatology","10.1002/hep.32207","High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population.","2022-03-10"]
[1652,"34667947","JHEP Rep","10.1016/j.jhepr.2021.100346","New targets for NAFLD.","2022-03-10"]
[1653,"34666156","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.10.018","The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States.","2022-03-10"]
[1654,"34666041","J Biol Chem","10.1016/j.jbc.2021.101311","Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36.","2022-03-10"]
[1655,"34666025","Clin Chim Acta","10.1016/j.cca.2021.10.014","Gut microbiome and metabolic response in non-alcoholic fatty liver disease.","2022-03-10"]
[1656,"34665792","Clin Transl Gastroenterol","10.14309/ctg.0000000000000417","Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study.","2022-03-10"]
[1657,"34665236","J Mol Cell Biol","10.1093/jmcb/mjab066","cGAS&#8210;STING signaling and function in metabolism and kidney diseases.","2022-03-10"]
[1658,"34664321","J Clin Lab Anal","10.1002/jcla.24061","Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case-control study.","2022-03-10"]
[1659,"34664301","J Gastroenterol Hepatol","10.1111/jgh.15713","Diet and gut microbiome in fatty liver and its associated liver cancer.","2022-03-10"]
[1660,"34664288","J Food Biochem","10.1111/jfbc.13976","Sesamol ameliorates hepatic lipid accumulation and oxidative stress in steatosis HepG2 cells via the PPAR signaling pathway.","2022-03-10"]
[1661,"34663793","Nutr Diabetes","10.1038/s41387-021-00170-3","Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.","2022-03-10"]
[1662,"34663576","Diabetes","10.2337/db21-0475","Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity.","2022-03-10"]
[1663,"34663438","Diabetol Metab Syndr","10.1186/s13098-021-00731-7","The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial.","2022-03-10"]
[1664,"34662928","Pediatr Obes","10.1111/ijpo.12862","Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction.","2022-03-10"]
[1665,"34662732","Environ Toxicol Pharmacol","10.1016/j.etap.2021.103755","Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases.","2022-03-10"]
[1666,"34662449","Hepatology","10.1002/hep.32204","Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[1667,"34661762","J Genet Eng Biotechnol","10.1186/s43141-021-00257-5","NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients.","2022-03-10"]
[1668,"34660809","J Diabetes Res","10.1155/2021/3715026","Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1669,"34660604","Front Cell Dev Biol","10.3389/fcell.2021.745985","Dual Regulation of Tank Binding Kinase 1 by BRG1 in Hepatocytes Contributes to Reactive Oxygen Species Production.","2022-03-10"]
[1670,"34660454","J Family Med Prim Care","10.4103/jfmpc.jfmpc_412_21","Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data.","2022-03-10"]
[1671,"34660070","Cureus","10.7759/cureus.17869","A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population.","2022-03-10"]
[1672,"34659501","Exp Ther Med","10.3892/etm.2021.10790","Non-alcoholic fatty liver disease and hematologic manifestations (Review).","2022-03-10"]
[1673,"34659439","Evid Based Complement Alternat Med","10.1155/2021/9003603","Ginsenoside Re Improves Inflammation and Fibrosis in Hepatic Tissue by Upregulating PPAR&#947; Expression and Inhibiting Oxidative Stress in db/db Mice.","2022-03-10"]
[1674,"34659388","Bioinorg Chem Appl","10.1155/2021/4041415","The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review.","2022-03-10"]
[1675,"34659125","Front Endocrinol (Lausanne)","10.3389/fendo.2021.743202","Predictive Modeling of MAFLD Based on Hsp90&#945; and the Therapeutic Application of Teprenone in a Diet-Induced Mouse Model.","2022-03-10"]
[1676,"34658353","Nan Fang Yi Ke Da Xue Xue Bao","10.12122/j.issn.1673-4254.2021.09.13","[Quantitative analysis of differential proteins in liver tissues of patients with non-alcoholic steatohepatitis using iTRAQ technology].","2022-03-10"]
[1677,"34658280","Hisp Health Care Int","10.1177/15404153211043885","Perceived Barriers to Weight Loss among Hispanic Patients with Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1678,"34657611","Lipids Health Dis","10.1186/s12944-021-01573-y","Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.","2022-03-10"]
[1679,"34657040","Cytogenet Genome Res","10.1159/000518284","PinX1 Depletion Improves Liver Injury in a Mouse Model of Nonalcoholic Fatty Liver Disease via Increasing Telomerase Activity and Inhibiting Apoptosis.","2022-03-10"]
[1680,"34656650","J Hepatol","10.1016/j.jhep.2021.09.040","Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.","2022-03-10"]
[1681,"34656648","Metabolism","10.1016/j.metabol.2021.154914","CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.","2022-03-10"]
[1682,"34655812","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.10.002","Hepatocyte-Specific Deletion of HIF2&#945; Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.","2022-03-10"]
[1683,"34655465","J Gastroenterol Hepatol","10.1111/jgh.15709","Altered bile acid glycine&#160;:&#160;taurine ratio in the progression of chronic liver disease.","2022-03-10"]
[1684,"34654976","Curr Gastroenterol Rep","10.1007/s11894-021-00827-0","Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide.","2022-03-10"]
[1685,"34654875","Acta Pharmacol Sin","10.1038/s41401-021-00786-2","Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.","2022-03-10"]
[1687,"34653759","Biomed Pharmacother","10.1016/j.biopha.2021.112329","Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL/6J wild-type mice.","2022-03-10"]
[1688,"34653686","Ann Hepatol","10.1016/j.aohep.2021.100562","Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.","2022-03-10"]
[1689,"34653601","J Nutr Biochem","10.1016/j.jnutbio.2021.108883","Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPAR&#947; pathways.","2022-03-10"]
[1690,"34653272","Aliment Pharmacol Ther","10.1111/apt.16646","Trends in statin utilisation in US adults with non-alcoholic fatty liver disease.","2022-03-10"]
[1691,"34653177","PLoS One","10.1371/journal.pone.0254892","Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.","2022-03-10"]
[1692,"34652813","FEBS Lett","10.1002/1873-3468.14207","Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy.","2022-03-10"]
[1693,"34652536","Mol Cell Biochem","10.1007/s11010-021-04269-0","Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.","2022-03-10"]
[1694,"34652089","J Sports Med Phys Fitness","10.23736/S0022-4707.20.11693-1","Changes in mitochondrial biogenesis and fatty liver indicators in rat following continuous and high intensity interval training.","2022-03-10"]
[1695,"34652078","J Breast Cancer","10.4048/jbc.2021.24.e41","Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival.","2022-03-10"]
[1696,"34651580","J Clin Invest","10.1172/JCI144801","Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2.","2022-03-10"]
[1697,"34651578","J Clin Invest","10.1172/JCI153640","Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player.","2022-03-10"]
[1698,"34651285","J Physiol Biochem","10.1007/s13105-021-00850-9","Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2.","2022-03-10"]
[1699,"34651015","Front Mol Biosci","10.3389/fmolb.2021.725308","RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases.","2022-03-10"]
[1700,"34650994","Front Med (Lausanne)","10.3389/fmed.2021.725390","Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases.","2022-03-10"]
[1702,"34650394","Food Nutr Res","10.29219/fnr.v65.7670","Chronic liquid fructose supplementation does not cause liver tumorigenesis but elicits clear sex differences in the metabolic response in Sprague-Dawley rats.","2022-03-10"]
[1703,"34649958","Cancer Epidemiol Biomarkers Prev","10.1158/1055-9965.EPI-21-0754","Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1704,"34649337","Biomed Pharmacother","10.1016/j.biopha.2021.112181","Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NF&#954;B signaling pathway-a study based on network pharmacology.","2022-03-10"]
[1705,"34649307","Clin Mol Hepatol","10.3350/cmh.2021.0174","Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods.","2022-03-10"]
[1706,"34649219","Biomed Pharmacother","10.1016/j.biopha.2021.112298","Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment.","2022-03-10"]
[1707,"34648896","J Hepatol","10.1016/j.jhep.2021.09.032","Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis.","2022-03-10"]
[1708,"34648769","Metabolism","10.1016/j.metabol.2021.154911","Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.","2022-03-10"]
[1709,"34647407","Chembiochem","10.1002/cbic.202100463","Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.","2022-03-10"]
[1710,"34646997","EClinicalMedicine","10.1016/j.eclinm.2021.101145","acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study.","2022-03-10"]
[1711,"34646672","Cureus","10.7759/cureus.17622","Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1712,"34646529","Food Sci Nutr","10.1002/fsn3.2521","Sargassum fusiforme polysaccharide attenuates high-sugar-induced lipid accumulation in HepG2 cells and Drosophila melanogaster larvae.","2022-03-10"]
[1713,"34646360","Therap Adv Gastroenterol","10.1177/17562848211050436","Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease.","2022-03-10"]
[1714,"34646233","Front Endocrinol (Lausanne)","10.3389/fendo.2021.729828","Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders.","2022-03-10"]
[1715,"34646017","Nature","10.1038/s41586-021-03974-6","Convergent somatic mutations in metabolism genes in chronic liver disease.","2022-03-10"]
[1716,"34642957","J Food Sci","10.1111/1750-3841.15929","Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster.","2022-03-10"]
[1717,"34642390","Sci Rep","10.1038/s41598-021-99400-y","Development and validation of a neural network for NAFLD diagnosis.","2022-03-10"]
[1718,"34641807","BMC Geriatr","10.1186/s12877-021-02490-6","A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80.","2022-03-10"]
[1719,"34640643","J Clin Med","10.3390/jcm10194625","Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver.","2022-03-10"]
[1720,"34640482","J Clin Med","10.3390/jcm10194466","Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis.","2022-03-10"]
[1721,"34639207","Int J Mol Sci","10.3390/ijms221910858","Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.","2022-03-10"]
[1722,"34639029","Int J Mol Sci","10.3390/ijms221910688","Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio.","2022-03-10"]
[1723,"34638941","Int J Mol Sci","10.3390/ijms221910604","MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1724,"34638880","Int J Mol Sci","10.3390/ijms221910541","A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity.","2022-03-10"]
[1725,"34638640","Int J Mol Sci","10.3390/ijms221910303","Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies.","2022-03-10"]
[1726,"34638217","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20191204-00446","[Advances in the study of the role of adenosine 2A receptor in liver injury].","2022-03-10"]
[1727,"34638206","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20200429-00223","[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].","2022-03-10"]
[1728,"34635855","Nat Med","10.1038/s41591-021-01489-1","ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.","2022-03-10"]
[1729,"34635626","Gut Liver","10.5009/gnl210167","Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.","2022-03-10"]
[1731,"34634561","Biomed Pharmacother","10.1016/j.biopha.2021.112314","Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice.","2022-03-10"]
[1732,"34634521","Mol Metab","10.1016/j.molmet.2021.101353","STE20-type kinase TAOK3 regulates hepatic lipid partitioning.","2022-03-10"]
[1733,"34633706","Hepatology","10.1002/hep.32197","Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease.","2022-03-10"]
[1734,"34633105","Aliment Pharmacol Ther","10.1111/apt.16631","Dose-response relationships of accelerometer-measured sedentary behaviour and physical activity with non-alcoholic fatty liver disease.","2022-03-10"]
[1735,"34632902","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2021.1991312","Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis.","2022-03-10"]
[1736,"34632700","Mol Nutr Food Res","10.1002/mnfr.202100381","Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet.","2022-03-10"]
[1737,"34632357","J Transl Autoimmun","10.1016/j.jtauto.2021.100126","Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis.","2022-03-10"]
[1738,"34631329","Biosci Microbiota Food Health","10.12938/bmfh.2020-061","Effects of a high-&#947;-polyglutamic acid-containing natto diet on liver lipids and cecal microbiota of adult female mice.","2022-03-10"]
[1739,"34631140","Obes Sci Pract","10.1002/osp4.509","\"Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD\".","2022-03-10"]
[1740,"34631129","Obes Sci Pract","10.1002/osp4.484","Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study.","2022-03-10"]
[1741,"34630909","World J Diabetes","10.4239/wjd.v12.i9.1576","Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis.","2022-03-10"]
[1742,"34630901","World J Diabetes","10.4239/wjd.v12.i9.1479","Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?","2022-03-10"]
[1743,"34630878","World J Hepatol","10.4254/wjh.v13.i9.1107","Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge.","2022-03-10"]
[1744,"34630869","World J Hepatol","10.4254/wjh.v13.i9.969","Coronavirus disease 2019 and non-alcoholic fatty liver disease.","2022-03-10"]
[1745,"34630157","Front Physiol","10.3389/fphys.2021.737709","Effect of Exercise Training on Fat Loss-Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution.","2022-03-10"]
[1746,"34630100","Front Pharmacol","10.3389/fphar.2021.724747","CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway.","2022-03-10"]
[1747,"34629804","World J Gastroenterol","10.3748/wjg.v27.i35.5803","Screening for nonalcoholic fatty liver disease-when, who and how?","2022-03-10"]
[1748,"34629802","World J Gastroenterol","10.3748/wjg.v27.i34.5793","Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood.","2022-03-10"]
[1749,"34629799","World J Gastroenterol","10.3748/wjg.v27.i34.5753","Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.","2022-03-10"]
[1750,"34629256","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2021.08.032","Extent and features of liver steatosis in&#160;vitro pave the way to endothelial dysfunction without physical cell-to-cell contact.","2022-03-10"]
[1751,"34629064","Lipids Health Dis","10.1186/s12944-021-01570-1","Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan.","2022-03-10"]
[1752,"34629059","Lipids Health Dis","10.1186/s12944-021-01561-2","The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.","2022-03-10"]
[1753,"34629056","Lipids Health Dis","10.1186/s12944-021-01560-3","Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China.","2022-03-10"]
[1754,"34629052","Lipids Health Dis","10.1186/s12944-021-01526-5","Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.","2022-03-10"]
[1755,"34628896","Ann Palliat Med","10.21037/apm-21-2339","Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus.","2022-03-10"]
[1756,"34628383","Georgian Med News",null,"THE INFLUENCE OF HYPERCHOLESTEROLEMIA AND CONCOMITANT STATIN THERAPY ON THE STATE OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE.","2022-03-10"]
[1757,"34628102","Atherosclerosis","10.1016/j.atherosclerosis.2021.09.018","IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study.","2022-03-10"]
[1758,"34627976","J Hepatol","10.1016/j.jhep.2021.09.039","Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.","2022-03-10"]
[1759,"34627751","Am J Pathol","10.1016/j.ajpath.2021.09.010","Hepatic Steatosis in the Mouse Model of Wilson Disease Coincides with a Muted Inflammatory Response.","2022-03-10"]
[1760,"34627696","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2021.08.037","Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.","2022-03-10"]
[1761,"34627692","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2021.08.039","Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society.","2022-03-10"]
[1762,"34626855","Mol Metab","10.1016/j.molmet.2021.101349","The hepatocyte IKK:NF-&#954;B axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.","2022-03-10"]
[1763,"34626841","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.09.013","Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.","2022-03-10"]
[1764,"34626833","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.09.041","Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis.","2022-03-10"]
[1765,"34626589","J Lipid Res","10.1016/j.jlr.2021.100134","Low production of 12&#945;-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70-/- mice by reducing fat absorption.","2022-03-10"]
[1766,"34626331","Hepatol Int","10.1007/s12072-021-10252-0","Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study.","2022-03-10"]
[1767,"34624564","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.09.040","Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary Care.","2022-03-10"]
[1768,"34624333","J Lipid Res","10.1016/j.jlr.2021.100133","Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet.","2022-03-10"]
[1769,"34624198","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2021.1991792","Current epidemiology in hepatocellular carcinoma.","2022-03-10"]
[1770,"34622555","Diabetes Obes Metab","10.1111/dom.14569","Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes.","2022-03-10"]
[1771,"34622234","Cell Rep Med","10.1016/j.xcrm.2021.100397","Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota.","2022-03-10"]
[1772,"34622192","Metabol Open","10.1016/j.metop.2021.100130","Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults.","2022-03-10"]
[1773,"34622006","JGH Open","10.1002/jgh3.12650","Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score.","2022-03-10"]
[1774,"34621822","World J Clin Cases","10.12998/wjcc.v9.i26.7717","Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus.","2022-03-10"]
[1775,"34621326","Evid Based Complement Alternat Med","10.1155/2021/8386848","A Novel Identified Peptide Hormone \"Metabolitin\" Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway.","2022-03-10"]
[1776,"34621170","Front Pharmacol","10.3389/fphar.2021.736655","Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy via ANT-AMPK-mTORC1 Signaling Pathway.","2022-03-10"]
[1777,"34621168","Front Pharmacol","10.3389/fphar.2021.727636","Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics.","2022-03-10"]
[1778,"34621052","Nat Med","10.1038/s41591-021-01495-3","Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.","2022-03-10"]
[1779,"34620897","Sci Rep","10.1038/s41598-021-99036-y","A weight regain of 1.5&#160;kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men.","2022-03-10"]
[1780,"34620653","BMJ Open","10.1136/bmjopen-2020-045802","Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation.","2022-03-10"]
[1781,"34619251","J Hepatol","10.1016/j.jhep.2021.09.024","Asian perspective on NAFLD-associated HCC.","2022-03-10"]
[1782,"34619105","Lancet Diabetes Endocrinol","10.1016/S2213-8587(21)00244-8","COVID-19 and metabolic disease: mechanisms and clinical management.","2022-03-10"]
[1783,"34619074","Cell Metab","10.1016/j.cmet.2021.09.010","Molecular aspects of fructose metabolism and metabolic disease.","2022-03-10"]
[1784,"34619026","Liver Int","10.1111/liv.15080","The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta-analysis.","2022-03-10"]
[1785,"34618982","FASEB J","10.1096/fj.202100380RRR","Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[1786,"34618619","Scand J Gastroenterol","10.1080/00365521.2021.1984572","Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care.","2022-03-10"]
[1787,"34618611","Immunopharmacol Immunotoxicol","10.1080/08923973.2021.1984520","Capillin protects against non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation and oxidative stress.","2022-03-10"]
[1788,"34617537","Food Funct","10.1039/d1fo02106k","Kombuchas from green and black teas reduce oxidative stress, liver steatosis and inflammation, and improve glucose metabolism in Wistar rats fed a high-fat high-fructose diet.","2022-03-10"]
[1789,"34617207","Obes Surg","10.1007/s11695-021-05724-z","Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus.","2022-03-10"]
[1790,"34617180","Bull Exp Biol Med","10.1007/s10517-021-05285-2","Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-&#946;.","2022-03-10"]
[1791,"34616724","Front Cell Dev Biol","10.3389/fcell.2021.704704","Comprehensive Analysis of NAFLD and the Therapeutic Target Identified.","2022-03-10"]
[1792,"34615918","Sci Rep","10.1038/s41598-021-99132-z","Electrical impedance tomography for non-invasive identification of fatty liver infiltrate in overweight individuals.","2022-03-10"]
[1793,"34615727","Gut","10.1136/gutjnl-2021-324305","Novel therapeutic targets for cholestatic and fatty liver disease.","2022-03-10"]
[1794,"34614409","Cell Metab","10.1016/j.cmet.2021.09.008","DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing.","2022-03-10"]
[1795,"34613814","Sci Transl Med","10.1126/scitranslmed.abd1206","Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis.","2022-03-10"]
[1796,"34611618","JHEP Rep","10.1016/j.jhepr.2021.100343","External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population.","2022-03-10"]
[1797,"34611524","J Hepatocell Carcinoma","10.2147/JHC.S284430","An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma.","2022-03-10"]
[1798,"34611144","Cell Death Discov","10.1038/s41420-021-00660-4","Ferroptosis in liver disease: new insights into disease mechanisms.","2022-03-10"]
[1799,"34610926","BMJ Open Gastroenterol","10.1136/bmjgast-2021-000780","Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt.","2022-03-10"]
[1800,"34610720","Diabetes Metab J","10.4093/dmj.2021.0197","Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases.","2022-03-10"]
[1801,"34610207","Liver Int","10.1111/liv.15078","Association of genetic variations with NAFLD in lean individuals.","2022-03-10"]
[1802,"34609305","Turk J Gastroenterol","10.5152/tjg.2021.20522","Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.","2022-03-10"]
[1803,"34609304","Turk J Gastroenterol","10.5152/tjg.2021.20294","Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis.","2022-03-10"]
[1804,"34609237","Health Informatics J","10.1177/14604582211043158","Trend research of vitamin D receptor: Bibliometric analysis.","2022-03-10"]
[1805,"34609086","United European Gastroenterol J","10.1002/ueg2.12150","Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.","2022-03-10"]
[1806,"34608587","Hepatol Int","10.1007/s12072-021-10254-y","Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease.","2022-03-10"]
[1807,"34607492","Angiology","10.1177/00033197211038334","Pancretic Fat Accummulation is Associated with Subclinical Atherosclerosis.","2022-03-10"]
[1808,"34607257","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.09.060","The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver.","2022-03-10"]
[1809,"34607067","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101816","Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.","2022-03-10"]
[1810,"34607007","Fish Shellfish Immunol","10.1016/j.fsi.2021.09.034","Polysaccharide extract from pomelo fruitlet ameliorates diet-induced nonalcoholic fatty liver disease in hybrid grouper (Epinephelus lanceolatus&#9794; &#215; Epinephelus fuscoguttatus&#9792;).","2022-03-10"]
[1811,"34606980","Endocr Pract","10.1016/j.eprac.2021.09.013","Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials.","2022-03-10"]
[1812,"34606913","J Hepatol","10.1016/j.jhep.2021.09.030","Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus.","2022-03-10"]
[1813,"34606912","J Hepatol","10.1016/j.jhep.2021.09.029","Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?","2022-03-10"]
[1815,"34606548","Food Funct","10.1039/d1fo01517f","Sesamol supplementation alleviates nonalcoholic steatohepatitis and atherosclerosis in high-fat, high carbohydrate and high-cholesterol diet-fed rats.","2022-03-10"]
[1816,"34606532","Food Funct","10.1039/d1fo00560j","Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice.","2022-03-10"]
[1818,"34604973","Eur Rev Med Pharmacol Sci","10.26355/eurrev_202109_26800","Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.","2022-03-10"]
[1819,"34604287","Front Nutr","10.3389/fnut.2021.751388","Transcriptomic Analysis Reveals a Sex-Dimorphic Influence of GAT-2 on Murine Liver Function.","2022-03-10"]
[1820,"34604283","Front Nutr","10.3389/fnut.2021.733197","Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats.","2022-03-10"]
[1821,"34604271","Front Nutr","10.3389/fnut.2021.677659","Mechanism of Paeoniae Radix Alba in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement.","2022-03-10"]
[1822,"34604270","Front Nutr","10.3389/fnut.2021.642509","Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants.","2022-03-10"]
[1823,"34603404","Front Genet","10.3389/fgene.2021.762978","Corrigendum: Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study.","2022-03-10"]
[1825,"34603215","Front Endocrinol (Lausanne)","10.3389/fendo.2021.744710","The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease.","2022-03-10"]
[1826,"34603198","Front Endocrinol (Lausanne)","10.3389/fendo.2021.695750","Association of ANGPTL8 and Resistin With Diabetic Nephropathy&#160;in Type 2 Diabetes Mellitus.","2022-03-10"]
[1827,"34603083","Front Physiol","10.3389/fphys.2021.728407","Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases.","2022-03-10"]
[1828,"34602548","Biol Pharm Bull","10.1248/bpb.b21-00520","Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.","2022-03-10"]
[1829,"34602251","Gastroenterology","10.1053/j.gastro.2021.07.049","Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1830,"34602072","Lipids Health Dis","10.1186/s12944-021-01564-z","Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.","2022-03-10"]
[1831,"34601620","J Gastroenterol","10.1007/s00535-021-01828-6","Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.","2022-03-10"]
[1832,"34601385","Stem Cell Res","10.1016/j.scr.2021.102523","In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules.","2022-03-10"]
[1833,"34601002","Mol Cell Endocrinol","10.1016/j.mce.2021.111464","Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.","2022-03-10"]
[1834,"34600974","J Hepatol","10.1016/j.jhep.2021.09.021","TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion.","2022-03-10"]
[1835,"34600973","J Hepatol","10.1016/j.jhep.2021.09.026","ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD.","2022-03-10"]
[1836,"34600906","Metabolism","10.1016/j.metabol.2021.154893","The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.","2022-03-10"]
[1837,"34599938","Life Sci","10.1016/j.lfs.2021.119983","Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH).","2022-03-10"]
[1838,"34598315","Immun Inflamm Dis","10.1002/iid3.538","Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation.","2022-03-10"]
[1839,"34597608","Life Sci","10.1016/j.lfs.2021.119997","The role of Sirtuin 2 in sustaining functional integrity of the liver.","2022-03-10"]
[1840,"34595203","Front Nutr","10.3389/fnut.2021.745609","Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.","2022-03-10"]
[1843,"34593018","BMC Pharmacol Toxicol","10.1186/s40360-021-00524-8","Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis.","2022-03-10"]
[1844,"34592488","Phytomedicine","10.1016/j.phymed.2021.153739","Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.","2022-03-10"]
[1845,"34592210","Chemosphere","10.1016/j.chemosphere.2021.132316","Blood manganese and nonalcoholic fatty liver disease: A cohort-based case-control study.","2022-03-10"]
[1846,"34591986","Hepatology","10.1002/hep.32179","OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways.","2022-03-10"]
[1847,"34591699","J Med Food","10.1089/jmf.2021.K.0069","Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1848,"34590877","J Int Med Res","10.1177/03000605211047074","Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis.","2022-03-10"]
[1849,"34590386","Pediatr Transplant","10.1111/petr.14155","Hepatic macrosteatosis in the US pediatric deceased liver donor population.","2022-03-10"]
[1850,"34590082","Aust J Gen Pract","10.31128/AJGP-05-21-5974","Updates in fatty liver disease: Pathophysiology, diagnosis and management.","2022-03-10"]
[1851,"34589520","Front Mol Biosci","10.3389/fmolb.2021.742002","Saliva and Plasma Reflect Metabolism Altered by Diabetes and Periodontitis.","2022-03-10"]
[1852,"34588976","Front Pharmacol","10.3389/fphar.2021.636204","N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function.","2022-03-10"]
[1853,"34588764","Drug Des Devel Ther","10.2147/DDDT.S315724","Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease.","2022-03-10"]
[1854,"34588551","Sci Rep","10.1038/s41598-021-98806-y","Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis.","2022-03-10"]
[1855,"34588540","Sci Rep","10.1038/s41598-021-98776-1","Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease.","2022-03-10"]
[1856,"34587729","Zhonghua Yi Xue Za Zhi","10.3760/cma.j.cn112137-20210107-00044","[Clinical features and risk factors of metabolic syndrome in adult hypopituitary patients].","2022-03-10"]
[1857,"34587704","Asia Pac J Clin Nutr","10.6133/apjcn.202109_30(3).0011","Skeletal muscle mass indexes and nonalcoholic fatty liver disease in Chinese elders.","2022-03-10"]
[1859,"34586531","Invest New Drugs","10.1007/s10637-021-01185-4","Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.","2022-03-10"]
[1860,"34585892","J Assoc Physicians India",null,"Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.","2022-03-10"]
[1861,"34585409","J Food Biochem","10.1111/jfbc.13945","Crataegus aronia prevents high-fat diet-induced hepatic steatosis in rats by activating AMPK-induced suppression of SREBP1 and activation of PPAR&#945;.","2022-03-10"]
[1862,"34585128","EClinicalMedicine","10.1016/j.eclinm.2021.101137","The influence of equitable access policies and socioeconomic factors on post-liver transplant survival.","2022-03-10"]
[1863,"34584580","Prz Gastroenterol","10.5114/pg.2021.109063","Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis.","2022-03-10"]
[1864,"34583706","Cardiovasc Diabetol","10.1186/s12933-021-01374-8","The association of hepatic steatosis and fibrosis with heart failure and mortality.","2022-03-10"]
[1865,"34583137","Nutrition","10.1016/j.nut.2021.111447","Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease.","2022-03-10"]
[1866,"34580427","Pediatr Res","10.1038/s41390-021-01754-6","Predictors of non-alcoholic fatty liver disease in children.","2022-03-10"]
[1867,"34579641","Endocr Metab Immune Disord Drug Targets","10.2174/1871530321666210927153831","Adiponectin is Inversely Associated with Insulin Resistance in Adolescents with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1868,"34579068","Nutrients","10.3390/nu13093192","The Effect of Probiotics (MCP&#174; BCMC&#174; Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1869,"34579016","Nutrients","10.3390/nu13093139","Pancreatic &#946;-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1870,"34579012","Nutrients","10.3390/nu13093135","Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis.","2022-03-10"]
[1871,"34578919","Nutrients","10.3390/nu13093042","Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.","2022-03-10"]
[1872,"34578867","Nutrients","10.3390/nu13092989","Amelioration of Hepatic Steatosis in Mice through Bacteroides uniformis CBA7346-Mediated Regulation of High-Fat Diet-Induced Insulin Resistance and Lipogenesis.","2022-03-10"]
[1873,"34578828","Nutrients","10.3390/nu13092952","Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD.","2022-03-10"]
[1874,"34578806","Nutrients","10.3390/nu13092928","Independent Dose-Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1875,"34576229","Int J Mol Sci","10.3390/ijms221810062","Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-&#954;B Signaling Pathway.","2022-03-10"]
[1876,"34576136","Int J Mol Sci","10.3390/ijms22189969","Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in Pparg-Null Mice.","2022-03-10"]
[1877,"34576091","Int J Mol Sci","10.3390/ijms22189931","Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose.","2022-03-10"]
[1878,"34576053","Int J Mol Sci","10.3390/ijms22189889","Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism.","2022-03-10"]
[1879,"34575934","Int J Mol Sci","10.3390/ijms22189772","The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype.","2022-03-10"]
[1880,"34575933","Int J Mol Sci","10.3390/ijms22189758","Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line.","2022-03-10"]
[1881,"34574647","Int J Environ Res Public Health","10.3390/ijerph18189724","Bone Mineral Density in Congenital Generalized Lipodystrophy: The Role of Bone Marrow Tissue, Adipokines, and Insulin Resistance.","2022-03-10"]
[1882,"34574082","Foods","10.3390/foods10091973","AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling.","2022-03-10"]
[1883,"34573947","Diagnostics (Basel)","10.3390/diagnostics11091605","Determining the Target Population That Would Most Benefit from Screening for Hepatic Fibrosis in a Primary Care Setting.","2022-03-10"]
[1884,"34573421","Genes (Basel)","10.3390/genes12091439","The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1885,"34572959","Cancers (Basel)","10.3390/cancers13184732","Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective.","2022-03-10"]
[1886,"34572795","Cancers (Basel)","10.3390/cancers13184567","Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1887,"34572442","Biomedicines","10.3390/biomedicines9091256","Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1888,"34572434","Biomedicines","10.3390/biomedicines9091248","Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study.","2022-03-10"]
[1889,"34572415","Biomedicines","10.3390/biomedicines9091229","Cisd2 Preserves the Youthful Pattern of the Liver Proteome during Natural Aging of Mice.","2022-03-10"]
[1890,"34572279","Biomedicines","10.3390/biomedicines9091093","Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States.","2022-03-10"]
[1891,"34572151","Cells","10.3390/cells10092502","Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology.","2022-03-10"]
[1892,"34571924","Cells","10.3390/cells10092273","Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism.","2022-03-10"]
[1893,"34571189","J Nutr Biochem","10.1016/j.jnutbio.2021.108867","Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.","2022-03-10"]
[1894,"34570916","Aliment Pharmacol Ther","10.1111/apt.16608","Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging.","2022-03-10"]
[1895,"34570568","Bratisl Lek Listy","10.4149/BLL_2021_110","Serum butyrylcholinesterase activities in patients with non-alcoholic fatty liver disease. Comparison with liver proteosynthetic function and liver fibrosis.","2022-03-10"]
[1896,"34568346","Front Cell Dev Biol","10.3389/fcell.2021.736677","Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis.","2022-03-10"]
[1897,"34568090","Front Cell Infect Microbiol","10.3389/fcimb.2021.698852","Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1898,"34567490","J Healthc Eng","10.1155/2021/9928160","Study on Syndrome Intervention of Nonalcoholic Fatty Liver Disease from the Perspective of Deficiency and Excess.","2022-03-10"]
[1899,"34567270","Therap Adv Gastroenterol","10.1177/17562848211042200","Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey.","2022-03-10"]
[1900,"34566696","Front Physiol","10.3389/fphys.2021.732929","Liver Zonation - Revisiting Old Questions With New Technologies.","2022-03-10"]
[1901,"34566670","Front Physiol","10.3389/fphys.2021.669202","Gardenoside Hinders Caspase-1-Mediated Hepatocyte Pyroptosis Through the CTCF/DPP4 Signaling Pathway.","2022-03-10"]
[1902,"34566663","Front Pharmacol","10.3389/fphar.2021.742465","Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies.","2022-03-10"]
[1903,"34566646","Front Pharmacol","10.3389/fphar.2021.722016","Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[1904,"34565785","Korean J Gastroenterol","10.4166/kjg.2021.040","Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1905,"34565765","J Atheroscler Thromb","10.5551/jat.63159","Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.","2022-03-10"]
[1906,"34565720","Zhong Nan Da Xue Xue Bao Yi Xue Ban","10.11817/j.issn.1672-7347.2021.210264","Abnormal m6A modification in non-alcoholic fatty liver disease.","2022-03-10"]
[1907,"34565410","Malar J","10.1186/s12936-021-03918-5","Transcriptome-based analysis of blood samples reveals elevation of DNA damage response, neutrophil degranulation, cancer and neurodegenerative pathways in Plasmodium falciparum patients.","2022-03-10"]
[1908,"34565261","Int J Food Sci Nutr","10.1080/09637486.2021.1979478","The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial.","2022-03-10"]
[1909,"34565074","Rev Cardiovasc Med","10.31083/j.rcm2203082","Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease.","2022-03-10"]
[1910,"34564946","Liver Int","10.1111/liv.15064","A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis.","2022-03-10"]
[1911,"34564931","Liver Transpl","10.1002/lt.26313","Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.","2022-03-10"]
[1912,"34564899","J Intern Med","10.1111/joim.13380","Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies.","2022-03-10"]
[1913,"34564441","Metabolites","10.3390/metabo11090625","Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver Transplantation.","2022-03-10"]
[1914,"34564380","Metabolites","10.3390/metabo11090564","Identification of a Variant in APOB Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese Families.","2022-03-10"]
[1915,"34564157","Mar Drugs","10.3390/md19090495","Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice.","2022-03-10"]
[1917,"34563665","J Nutr Biochem","10.1016/j.jnutbio.2021.108869","Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.","2022-03-10"]
[1918,"34563519","J Lipid Res","10.1016/j.jlr.2021.100123","Inhibition of chylomicron assembly leads to dissociation of hepatic steatosis from inflammation and fibrosis.","2022-03-10"]
[1919,"34562443","J Pediatr","10.1016/j.jpeds.2021.09.033","The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice.","2022-03-10"]
[1920,"34561962","J Diabetes Investig","10.1111/jdi.13678","Metabolic associated fatty liver disease is a risk factor for chronic kidney disease.","2022-03-10"]
[1921,"34561722","Eur J Nutr","10.1007/s00394-021-02668-z","Effects of &#946;-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice.","2022-03-10"]
[1922,"34560854","Cardiovasc Diabetol","10.1186/s12933-021-01388-2","Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.","2022-03-10"]
[1923,"34560694","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000002288","Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey.","2022-03-10"]
[1924,"34560608","Clin Nutr","10.1016/j.clnu.2021.08.021","Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study.","2022-03-10"]
[1925,"34560554","Biomed Pharmacother","10.1016/j.biopha.2021.112166","Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis.","2022-03-10"]
[1926,"34560278","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.09.021","A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1927,"34560015","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00300-9","Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study.","2022-03-10"]
[1928,"34559251","Arch Toxicol","10.1007/s00204-021-03134-9","Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD+-dependent metabolic adaptation.","2022-03-10"]
[1929,"34559098","Medicine (Baltimore)","10.1097/MD.0000000000027050","The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.","2022-03-10"]
[1930,"34558862","Hepatol Commun","10.1002/hep4.1818","Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[1931,"34558856","Hepatol Commun","10.1002/hep4.1801","Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.","2022-03-10"]
[1932,"34558854","Hepatol Commun","10.1002/hep4.1785","ROR&#945; Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.","2022-03-10"]
[1933,"34558853","Hepatol Commun","10.1002/hep4.1802","Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection.","2022-03-10"]
[1934,"34558849","Hepatol Commun","10.1002/hep4.1789","Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity.","2022-03-10"]
[1935,"34558842","Hepatol Commun","10.1002/hep4.1751","Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.","2022-03-10"]
[1936,"34558838","Hepatol Commun","10.1002/hep4.1707","Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data.","2022-03-10"]
[1937,"34558835","Hepatol Commun","10.1002/hep4.1696","Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.","2022-03-10"]
[1938,"34558829","Hepatol Commun","10.1002/hep4.1765","Poor Awareness of Liver Disease Among Adults With NAFLD in the United States.","2022-03-10"]
[1939,"34558828","Hepatol Commun","10.1002/hep4.1766","PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.","2022-03-10"]
[1940,"34558817","Hepatol Commun","10.1002/hep4.1760","Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016.","2022-03-10"]
[1941,"34558644","Mol Med Rep","10.3892/mmr.2021.12463","PPAR&#947; attenuates hepatic inflammation and oxidative stress of non&#8209;alcoholic steatohepatitis via modulating the miR&#8209;21&#8209;5p/SFRP5 pathway.","2022-03-10"]
[1942,"34558178","J Cell Mol Med","10.1111/jcmm.16933","Five-in-One: Simultaneous isolation of multiple major liver cell types from livers of normal and NASH mice.","2022-03-10"]
[1943,"34557660","JHEP Rep","10.1016/j.jhepr.2021.100350","Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.","2022-03-10"]
[1944,"34557535","Front Cardiovasc Med","10.3389/fcvm.2021.742382","Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment.","2022-03-10"]
[1945,"34557498","Front Med (Lausanne)","10.3389/fmed.2021.665520","Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders.","2022-03-10"]
[1946,"34557398","Pediatr Gastroenterol Hepatol Nutr","10.5223/pghn.2021.24.5.455","The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.","2022-03-10"]
[1947,"34557397","Pediatr Gastroenterol Hepatol Nutr","10.5223/pghn.2021.24.5.443","Investigation of Thiol/Disulfide Balance in Obese Rats with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[1948,"34557367","Cureus","10.7759/cureus.17321","Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus.","2022-03-10"]
[1949,"34557366","Cureus","10.7759/cureus.17320","The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC).","2022-03-10"]
[1950,"34556715","Sci Rep","10.1038/s41598-021-98248-6","Ruminant fat intake improves gut microbiota, serum inflammatory parameter and fatty acid profile in tissues of Wistar rats.","2022-03-10"]
[1951,"34555423","J Hepatol","10.1016/j.jhep.2021.09.008","Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.","2022-03-10"]
[1952,"34555422","J Hepatol","10.1016/j.jhep.2021.09.007","NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options.","2022-03-10"]
[1953,"34555346","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00308-3","Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.","2022-03-10"]
[1955,"34555255","Liver Int","10.1111/liv.15061","COVID-19, adaptative immune response and metabolic-associated liver disease.","2022-03-10"]
[1956,"34554611","J Paediatr Child Health","10.1111/jpc.15751","Liver stiffness measurement as a quantitative method for liver fibrosis in children with non-alcoholic fatty liver disease: A meta-analysis.","2022-03-10"]
[1957,"34553836","Obesity (Silver Spring)","10.1002/oby.23263","Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease.","2022-03-10"]
[1958,"34552988","Biomed Res Int","10.1155/2021/7561645","Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis.","2022-03-10"]
[1959,"34552789","Arab J Urol","10.1080/2090598X.2021.1959261","Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study.","2022-03-10"]
[1960,"34552698","World J Hepatol","10.4254/wjh.v13.i8.916","Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence.","2022-03-10"]
[1961,"34552561","Front Endocrinol (Lausanne)","10.3389/fendo.2021.721198","GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH.","2022-03-10"]
[1962,"34551612","Future Med Chem","10.4155/fmc-2021-0241","Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2/RAGE/NF-&#954;B signaling pathway.","2022-03-10"]
[1963,"34551462","J Complement Integr Med","10.1515/jcim-2021-0296","Non-alcoholic fatty liver disease&#160;- discussed under the light of Unani medicine.","2022-03-10"]
[1964,"34550043","Adipocyte","10.1080/21623945.2021.1979277","Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice.","2022-03-10"]
[1965,"34549824","FASEB J","10.1096/fj.202002713RR","Creld2 function during unfolded protein response is essential for liver metabolism homeostasis.","2022-03-10"]
[1966,"34549558","Adv Clin Exp Med","10.17219/acem/140506","A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice.","2022-03-10"]
[1967,"34549325","Eur Radiol","10.1007/s00330-021-08269-y","Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.","2022-03-10"]
[1968,"34548787","Clin Interv Aging","10.2147/CIA.S295524","NAFLD in the Elderly.","2022-03-10"]
[1969,"34548598","Sci Rep","10.1038/s41598-021-98254-8","Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis.","2022-03-10"]
[1970,"34547477","Ann Hepatol","10.1016/j.aohep.2021.100534","Alternative splicing and liver disease.","2022-03-10"]
[1971,"34547464","Mol Ther","10.1016/j.ymthe.2021.09.016","METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.","2022-03-10"]
[1972,"34547171","Liver Int","10.1111/liv.15059","The role of hepatic lipid composition in obesity-related metabolic disease.","2022-03-10"]
[1973,"34546515","Obes Surg","10.1007/s11695-021-05701-6","Changes in Total Homocysteine and Glutathione Levels After Laparoscopic Sleeve Gastrectomy in Children with Metabolic-Associated Fatty Liver Disease.","2022-03-10"]
[1974,"34546514","Obes Surg","10.1007/s11695-021-05642-0","Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score-Matched Analysis.","2022-03-10"]
[1975,"34546125","Radiology","10.1148/radiol.2021204288","Quantification of Liver Fat Content with CT and MRI: State of the Art.","2022-03-10"]
[1976,"34544714","BMJ Case Rep","10.1136/bcr-2021-244805","Hepatopulmonary syndrome as the first and only manifestation of cirrhosis in a patient with hypopituitarism.","2022-03-10"]
[1977,"34543756","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101807","Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.","2022-03-10"]
[1978,"34543735","Diabetes Metab","10.1016/j.diabet.2021.101281","Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design.","2022-03-10"]
[1979,"34543610","Lancet","10.1016/S0140-6736(21)01374-X","Liver cirrhosis.","2022-03-10"]
[1980,"34543583","Arch Physiol Biochem","10.1080/13813455.2021.1975758","Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF-&#954;B signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease.","2022-03-10"]
[1981,"34543448","Clin Pharmacol Ther","10.1002/cpt.2423","Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study.","2022-03-10"]
[1982,"34543321","PLoS One","10.1371/journal.pone.0257352","Fatty liver index as a predictive marker for the development of diabetes: A retrospective cohort study using Japanese health check-up data.","2022-03-10"]
[1983,"34542962","Clin Lab","10.7754/Clin.Lab.2021.210109","Association between Serum Free Fatty Acids to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study.","2022-03-10"]
[1985,"34541964","Expert Opin Pharmacother","10.1080/14656566.2021.1978978","Management of non-alcoholic fatty liver disease in patients with sarcopenia.","2022-03-10"]
[1986,"34540943","Visc Med","10.1159/000515445","Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD).","2022-03-10"]
[1987,"34540134","Kans J Med","10.17161/kjm.vol1414984","Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease.","2022-03-10"]
[1988,"34537988","Hepatology","10.1002/hep.32163","Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.","2022-03-10"]
[1989,"34537584","Curr Opin Pharmacol","10.1016/j.coph.2021.08.014","Genetic risk scores and personalization of care in fatty liver disease.","2022-03-10"]
[1990,"34537182","Anal Biochem","10.1016/j.ab.2021.114387","Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?","2022-03-10"]
[1991,"34536973","FEBS Lett","10.1002/1873-3468.14193","Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.","2022-03-10"]
[1992,"34536498","Life Sci","10.1016/j.lfs.2021.119963","Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NF&#954;B signaling pathway.","2022-03-10"]
[1993,"34536264","Anat Rec (Hoboken)","10.1002/ar.24770","Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.","2022-03-10"]
[1994,"34536163","J Med Ultrason (2001)","10.1007/s10396-021-01136-9","Quantitative assessment of liver steatosis using ultrasound: dual-energy CT.","2022-03-10"]
[1995,"34535985","Hepatol Commun","10.1002/hep4.1805","Genome-Wide Association Study of NAFLD Using Electronic Health Records.","2022-03-10"]
[1996,"34535644","Nat Commun","10.1038/s41467-021-25701-5","A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.","2022-03-10"]
[1997,"34535562","J Pharmacol Exp Ther","10.1124/jpet.121.000786","Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.","2022-03-10"]
[1998,"34534913","Redox Biol","10.1016/j.redox.2021.102105","Hepatic Regulator of G Protein Signaling 6 (RGS6) drives non-alcoholic fatty liver disease by promoting oxidative stress and ATM-dependent cell death.","2022-03-10"]
[1999,"34534894","Clin Nutr","10.1016/j.clnu.2021.08.012","Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease.","2022-03-10"]
[2000,"34533904","Am J Manag Care","10.37765/ajmc.2021.88671","Baffled by NAFLD: the horse might be out of the barn but should not take us for a ride.","2022-03-10"]
[2001,"34533882","Cancer Sci","10.1111/cas.15142","Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.","2022-03-10"]
[2002,"34533632","J Gastroenterol","10.1007/s00535-021-01796-x","Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.","2022-03-10"]
[2003,"34533606","Eur Radiol","10.1007/s00330-021-08261-6","Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.","2022-03-10"]
[2004,"34533266","Hepatol Res","10.1111/hepr.13688","Evidence-based clinical&#160;practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.","2022-03-10"]
[2005,"34533252","J Biochem Mol Toxicol","10.1002/jbt.22914","Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation.","2022-03-10"]
[2006,"34533249","Phytother Res","10.1002/ptr.7279","The effects of co-administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial.","2022-03-10"]
[2007,"34532996","Hepatol Commun","10.1002/hep4.1822","TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease.","2022-03-10"]
[2008,"34532981","Hepatol Commun","10.1002/hep4.1807","The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis.","2022-03-10"]
[2009,"34532024","Food Sci Nutr","10.1002/fsn3.2482","&#969;3PUFAs improve hepatic steatosis in postnatal overfed rats and HepG2 cells by inhibiting acetyl-CoA carboxylase.","2022-03-10"]
[2010,"34531465","Sci Rep","10.1038/s41598-021-97686-6","Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[2011,"34531312","Drug Metab Dispos","10.1124/dmd.121.000413","Strategies to Diagnose Non-Alcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.","2022-03-10"]
[2012,"34531129","Dig Liver Dis","10.1016/j.dld.2021.08.018","Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation.","2022-03-10"]
[2013,"34530928","Microbiome","10.1186/s40168-021-01125-7","Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice.","2022-03-10"]
[2014,"34530818","BMC Med","10.1186/s12916-021-02079-1","Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.","2022-03-10"]
[2015,"34530527","Clin Mol Hepatol","10.3350/cmh.2021.0205","Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes.","2022-03-10"]
[2017,"34529948","Biochem Pharmacol","10.1016/j.bcp.2021.114764","Ubiquitin pathways regulate the pathogenesis of chronic liver disease.","2022-03-10"]
[2018,"34529585","Physiol Int","10.1556/2060.2021.00183","The \"GG\" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.","2022-03-10"]
[2020,"34529067","JAMA Netw Open","10.1001/jamanetworkopen.2021.23923","Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[2021,"34528882","Turk J Gastroenterol","10.5152/tjg.2021.20677","Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.","2022-03-10"]
[2022,"34528723","Aliment Pharmacol Ther","10.1111/apt.16596","Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor &#945; modulator (SPPARM&#945;), versus placebo in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[2023,"34528679","Int J Epidemiol","10.1093/ije/dyab174","Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study.","2022-03-10"]
[2025,"34528223","Horm Metab Res","10.1055/a-1587-9211","Clinical Value and Role of miR-129-5p in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[2026,"34527673","Front Cell Dev Biol","10.3389/fcell.2021.720900","Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice.","2022-03-10"]
[2027,"34527094","Gastroenterology Res","10.14740/gr1445","Non-Invasive Assessment of Liver Fibrosis and Steatosis in End-Stage Renal Disease Patients Undergoing Renal Transplant Evaluation.","2022-03-10"]
[2028,"34526911","Front Physiol","10.3389/fphys.2021.710420","Metabolic Changes of Hepatocytes in NAFLD.","2022-03-10"]
[2029,"34526786","Infect Drug Resist","10.2147/IDR.S326386","Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury.","2022-03-10"]
[2030,"34526653","Commun Biol","10.1038/s42003-021-02616-x","Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system.","2022-03-10"]
[2031,"34525916","Curr Med Chem","10.2174/0929867328666210825111350","Beneficial Effects of Dietary Polyphenols in the Prevention and Treatment of NAFLD: Cell-Signaling Pathways Underlying Health Effects.","2022-03-10"]
[2032,"34525124","PLoS One","10.1371/journal.pone.0251665","Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[2033,"34524971","Endocr Connect","10.1530/EC-21-0353","IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study.","2022-03-10"]
[2034,"34524919","AIDS Patient Care STDS","10.1089/apc.2021.0106","Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir.","2022-03-10"]
[2035,"34524608","Hepatol Int","10.1007/s12072-021-10253-z","Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke.","2022-03-10"]
[2036,"34524512","Histochem Cell Biol","10.1007/s00418-021-02030-8","Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver.","2022-03-10"]
[2037,"34524028","J Med Food","10.1089/jmf.2021.K.0048","Black Mulberry Extract Elicits Hepatoprotective Effects in Nonalcoholic Fatty Liver Disease Models by Inhibition of Histone Acetylation.","2022-03-10"]
[2038,"34523235","Liver Int","10.1111/liv.15055","Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019.","2022-03-10"]
[2039,"34523053","Inflammation","10.1007/s10753-021-01550-8","Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis.","2022-03-10"]
[2040,"34522969","J Nutr","10.1093/jn/nxab253","Intake of Nuts and Seeds Is Associated with a Lower Prevalence of Nonalcoholic Fatty Liver Disease in US Adults: Findings from 2005-2018 NHANES.","2022-03-10"]
[2041,"34522873","EClinicalMedicine","10.1016/j.eclinm.2021.101116","Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).","2022-03-10"]
[2042,"34522493","Cureus","10.7759/cureus.16855","The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review.","2022-03-10"]
[2043,"34521905","Sci Rep","10.1038/s41598-021-97439-5","Development of a highly sensitive chemiluminescent enzyme immunoassay for fragmented cytokeratin 18 using new antibodies.","2022-03-10"]
[2045,"34521466","Trials","10.1186/s13063-021-05529-6","Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial.","2022-03-10"]
[2046,"34521354","Environ Health Prev Med","10.1186/s12199-021-01010-7","The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017.","2022-03-10"]
[2047,"34521152","Liver Int","10.1111/liv.15057","Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis.","2022-03-10"]
[2050,"34520731","Arch Biochem Biophys","10.1016/j.abb.2021.109032","Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease.","2022-03-10"]
[2052,"34519576","Radiology","10.1148/radiol.2021210046","Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.","2022-03-10"]
[2054,"34519101","Hepatology","10.1002/hep.32153","The RNA binding protein human antigen R is a gatekeeper of liver homeostasis.","2022-03-10"]
[2055,"34519030","Eur J Clin Invest","10.1111/eci.13680","Hydrogen sulphide in liver glucose/lipid metabolism and non-alcoholic fatty liver disease.","2022-03-10"]
[2056,"34517467","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20191209-00452","[Research progress on non-alcoholic fatty liver disease animal models].","2022-03-10"]
[2057,"34517466","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20190520-00178","[New development for targeted therapy of non-alcoholic fatty liver disease with thyroid hormone receptor beta].","2022-03-10"]
[2058,"34517451","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20210708-00328","[Emphasizing the mutual effects of metabolic-associated fatty liver disease with infectious disease].","2022-03-10"]
[2059,"34517014","Metabolism","10.1016/j.metabol.2021.154874","Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.","2022-03-10"]
[2060,"34516703","Int J Clin Pract","10.1111/ijcp.14852","Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.","2022-03-10"]
[2061,"34516586","PLoS One","10.1371/journal.pone.0257391","The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.","2022-03-10"]
[2062,"34516075","ACS Appl Mater Interfaces","10.1021/acsami.1c13157","Quantitative Structure-Activity Relationship Enables the Rational Design of Lipid Droplet-Targeting Carbon Dots for Visualizing Bisphenol A-Induced Nonalcoholic Fatty Liver Disease-like Changes.","2022-03-10"]
[2063,"34515137","J Innate Immun","10.1159/000518407","The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[2064,"34513923","Front Mol Biosci","10.3389/fmolb.2021.715765","The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.","2022-03-10"]
[2065,"34513896","Front Med (Lausanne)","10.3389/fmed.2021.744713","The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","2022-03-10"]
[2066,"34513769","Front Pediatr","10.3389/fped.2021.724426","Comparison of Body Mass Index and Fat Indices in Predicting the Severity of Nonalcoholic Fatty Liver Disease Among Children Who Are Overweight and Obese.","2022-03-10"]
[2067,"34512784","Evid Based Complement Alternat Med","10.1155/2021/9561613","Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation.","2022-03-10"]
[2068,"34512330","Front Pharmacol","10.3389/fphar.2021.693701","Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[2069,"34511825","J Clin Exp Hepatol","10.1016/j.jceh.2020.10.004","Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis-A Case Report.","2022-03-10"]
[2070,"34511823","J Clin Exp Hepatol","10.1016/j.jceh.2020.12.008","Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!","2022-03-10"]
[2071,"34511822","J Clin Exp Hepatol","10.1016/j.jceh.2021.04.012","Hepatogenous Diabetes: A Primer.","2022-03-10"]
[2072,"34511820","J Clin Exp Hepatol","10.1016/j.jceh.2020.11.004","Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.","2022-03-10"]
[2073,"34511816","J Clin Exp Hepatol","10.1016/j.jceh.2020.12.009","Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.","2022-03-10"]
[2074,"34511814","J Clin Exp Hepatol","10.1016/j.jceh.2021.01.004","Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.","2022-03-10"]
[2080,"34511460","Georgian Med News",null,"[METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)].","2022-03-10"]
[2081,"34511367","Obes Res Clin Pract","10.1016/j.orcp.2021.09.002","Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study.","2022-03-10"]
[2082,"34511051","Benef Microbes","10.3920/BM2020.0183","Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.","2022-03-10"]
[2083,"34511037","Bioengineered","10.1080/21655979.2021.1960463","Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.","2022-03-10"]
[2084,"34511035","Bioengineered","10.1080/21655979.2021.1954134","Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair.","2022-03-10"]
[2085,"34510514","Hepatology","10.1002/hep.32148","Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice.","2022-03-10"]
[2087,"34509791","Diabetes Metab Syndr","10.1016/j.dsx.2021.102258","Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver.","2022-03-10"]
[2088,"34509679","World Neurosurg","10.1016/j.wneu.2021.09.012","Thrombocytopenia Associated with Unrecognized Non-Alcoholic Fatty Liver Disease Is an Independent Predictor of Perioperative Significant Blood Loss in Cervical Laminoplasty.","2022-03-10"]
[2090,"34509375","Surg Obes Relat Dis","10.1016/j.soard.2021.07.021","Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years.","2022-03-10"]
[2094,"34508810","Pharmacol Res","10.1016/j.phrs.2021.105879","GADD45&#946; stabilized by direct interaction with HSP72 ameliorates insulin resistance and lipid accumulation.","2022-03-10"]
[2095,"34508791","J Hepatol","10.1016/j.jhep.2021.08.028","Rational HCC screening approaches for patients with NAFLD.","2022-03-10"]
[2096,"34508671","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00275-2","Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa.","2022-03-10"]
[2097,"34508669","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00296-X","Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa.","2022-03-10"]
[2098,"34508601","J Clin Endocrinol Metab","10.1210/clinem/dgab641","Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.","2022-03-10"]
[2099,"34508436","JNMA J Nepal Med Assoc","10.31729/jnma.5719","Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study.","2022-03-10"]
[2100,"34508238","Nat Rev Gastroenterol Hepatol","10.1038/s41575-021-00502-9","Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.","2022-03-10"]
[2101,"34508113","Sci Rep","10.1038/s41598-021-96966-5","Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD.","2022-03-10"]
[2102,"34507895","Dig Liver Dis","10.1016/j.dld.2021.08.017","The safety and efficacy evaluation of Sodium-Glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty Liver disease: An updated meta-analysis.","2022-03-10"]
[2103,"34506332","Clin Transl Gastroenterol","10.14309/ctg.0000000000000400","The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD.","2022-03-10"]
[2104,"34506234","Adipocyte","10.1080/21623945.2021.1970341","A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease.","2022-03-10"]
[2105,"34505899","Nephrol Dial Transplant","10.1093/ndt/gfab266","Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a case-control study.","2022-03-10"]
[2106,"34505434","Se Pu","10.3724/SP.J.1123.2021.06006","[Identification of LAMTOR1-regulated metabolites using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry in malignant transformation of liver inflammation].","2022-03-10"]
[2107,"34505423","Endocrinol Diabetes Metab","10.1002/edm2.296","Oxy210, a novel inhibitor of hedgehog and TGF-&#946; signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice.","2022-03-10"]
[2108,"34504563","Exp Ther Med","10.3892/etm.2021.10543","Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.","2022-03-10"]
[2109,"34504179","Sci Rep","10.1038/s41598-021-97385-2","Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.","2022-03-10"]
[2110,"34503976","Mol Pharmacol","10.1124/molpharm.121.000357","Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene.","2022-03-10"]
[2111,"34503201","Cancers (Basel)","10.3390/cancers13174391","Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer.","2022-03-10"]
[2112,"34503151","Cancers (Basel)","10.3390/cancers13174342","Host-Microbiota Interactions in Liver Inflammation and Cancer.","2022-03-10"]
[2113,"34502347","Int J Mol Sci","10.3390/ijms22179436","Molecular Imaging of Brown Adipose Tissue Mass.","2022-03-10"]
[2114,"34502047","Int J Mol Sci","10.3390/ijms22179139","Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases.","2022-03-10"]
[2115,"34501590","Int J Environ Res Public Health","10.3390/ijerph18178993","Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.","2022-03-10"]
[2116,"34501508","Int J Environ Res Public Health","10.3390/ijerph18178918","Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis.","2022-03-10"]
[2117,"34501231","J Clin Med","10.3390/jcm10173783","Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.","2022-03-10"]
[2118,"34500407","Curr Opin Pharmacol","10.1016/j.coph.2021.07.021","A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease.","2022-03-10"]
[2119,"34499619","J Clin Invest","10.1172/JCI152242","Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD.","2022-03-10"]
[2120,"34499435","Hepatol Commun","10.1002/hep4.1814","What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?","2022-03-10"]
[2121,"34498502","Ann Med","10.1080/07853890.2021.1974081","High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.","2022-03-10"]
[2122,"34498413","Pediatr Obes","10.1111/ijpo.12849","Recent advances in the epidemiology of nonalcoholic fatty liver disease in children.","2022-03-10"]
[2123,"34498307","Phytother Res","10.1002/ptr.7249","The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.","2022-03-10"]
[2124,"34497708","Ther Adv Endocrinol Metab","10.1177/20420188211034300","Therapeutic approaches for non-alcoholic steatohepatitis.","2022-03-10"]
[2125,"34497507","Front Aging Neurosci","10.3389/fnagi.2021.721858","Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology.","2022-03-10"]
[2126,"34497431","World J Gastroenterol","10.3748/wjg.v27.i30.4999","Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease.","2022-03-10"]
[2127,"34497333","Sci Rep","10.1038/s41598-021-97346-9","Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease.","2022-03-10"]
[2128,"34496884","Lipids Health Dis","10.1186/s12944-021-01521-w","Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.","2022-03-10"]
[2129,"34496264","J Ethnopharmacol","10.1016/j.jep.2021.114603","Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology.","2022-03-10"]
[2130,"34496054","Hepatology","10.1002/hep.32145","Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.","2022-03-10"]
[2131,"34495059","Rev Assoc Med Bras (1992)","10.1590/1806-9282.20201005","The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study.","2022-03-10"]
[2132,"34494551","JCI Insight","10.1172/jci.insight.144762","Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation.","2022-03-10"]
[2133,"34494384","Hepatol Commun","10.1002/hep4.1799","Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis.","2022-03-10"]
[2134,"34493216","BMC Nephrol","10.1186/s12882-021-02483-y","Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos.","2022-03-10"]
[2135,"34493137","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2021.1974295","Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.","2022-03-10"]
[2136,"34492534","Int Immunopharmacol","10.1016/j.intimp.2021.108126","Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.","2022-03-10"]
[2137,"34491886","Gut Microbes","10.1080/19490976.2021.1965463","Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study.","2022-03-10"]
[2138,"34491336","J Clin Endocrinol Metab","10.1210/clinem/dgab658","Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome.","2022-03-10"]
[2139,"34490745","Pediatr Obes","10.1111/ijpo.12852","Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.","2022-03-10"]
[2140,"34490362","Front Cardiovasc Med","10.3389/fcvm.2021.680664","The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study.","2022-03-10"]
[2141,"34490309","Front Med (Lausanne)","10.3389/fmed.2021.723790","Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","2022-03-10"]
[2142,"34489524","Int J Obes (Lond)","10.1038/s41366-021-00941-z","Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages.","2022-03-10"]
[2143,"34489307","Gut","10.1136/gutjnl-2021-325724","Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.","2022-03-10"]
[2144,"34488621","Mol Med","10.1186/s10020-021-00364-6","MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice.","2022-03-10"]
[2145,"34487087","Acta Biomed","10.23750/abm.v92i4.11116","The Prevalence of the Different Components of the Metabolic Syndrome (MetS) in Obese Nondiabetic Children and Young Adolescents and their Anthropometric Data in Relation to Parents.","2022-03-10"]
[2149,"34486129","Alcohol Clin Exp Res","10.1111/acer.14699","Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.","2022-03-10"]
[2168,"34476138","Cureus","10.7759/cureus.16765","Chronic Liver Disease: A Mimic of Systemic Lupus Erythematosus.","2022-03-10"]
[2185,"34469884","Dig Dis","10.1159/000519317","Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.","2022-03-10"]
[2204,"34461220","Pharmacol Res","10.1016/j.phrs.2021.105860","Identification of the anti-fungal drug fenticonazole nitrate as a novel PPAR&#947;-modulating ligand with good therapeutic index: Structure-based screening and biological validation.","2022-03-10"]
[2224,"34453963","J Hepatol","10.1016/j.jhep.2021.08.012","Epidemiology and risk-stratification of NAFLD-associated HCC.","2022-03-10"]
[2241,"34449139","Turk J Pediatr","10.24953/turkjped.2021.04.004","The performance of shear wave elastography on evaluating liver changes in obese and overweight children.","2022-03-10"]
[2259,"34444932","Nutrients","10.3390/nu13082772","The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[2276,"34440495","Life (Basel)","10.3390/life11080751","Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study.","2022-03-10"]
[2294,"34433546","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2021-002362","Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults.","2022-03-10"]
[2311,"34423721","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2021.1946393","Metabolic disorders and the risk of cholangiocarcinoma.","2022-03-10"]
[2328,"34416976","Gastroenterology","10.1053/j.gastro.2021.04.074","Preparing for the NASH Epidemic: A Call to Action.","2022-03-10"]
[2347,"34407600","Diabetes Metab J","10.4093/dmj.2020.0223","Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway.","2022-03-10"]
[2366,"34401141","Ann Med Surg (Lond)","10.1016/j.amsu.2021.102677","Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study.","2022-03-10"]
[2384,"34395461","Front Med (Lausanne)","10.3389/fmed.2021.653293","Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[2403,"34385447","Nat Commun","10.1038/s41467-021-25195-1","Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.","2022-03-10"]
[2422,"34377148","Therap Adv Gastroenterol","10.1177/17562848211031394","Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation.","2022-03-10"]
[2441,"34371126","J Nutr Biochem","10.1016/j.jnutbio.2021.108834","Dietary citrate acutely induces insulin resistance and markers of liver inflammation in mice.","2022-03-10"]
[2460,"34364544","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(21)00183-7","Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.","2022-03-10"]
[2477,"34359857","Cells","10.3390/cells10071687","NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved.","2022-03-10"]
[2497,"34352133","J Viral Hepat","10.1111/jvh.13590","COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.","2022-03-10"]
[2520,"34342231","J Agric Food Chem","10.1021/acs.jafc.1c01645","Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease via Inhibiting the mTORC1/SREBP-1c Pathway.","2022-03-10"]
[2533,"34338703","Food Funct","10.1039/d1fo00448d","Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial.","2022-03-10"]
[2552,"34330514","Clin Nutr ESPEN","10.1016/j.clnesp.2021.05.012","Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.","2022-03-10"]
[2570,"34326695","Int J Biol Sci","10.7150/ijbs.58776","Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.","2022-03-10"]
[2589,"34321839","World J Gastroenterol","10.3748/wjg.v27.i25.3705","Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.","2022-03-10"]
[2608,"34311133","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101759","How will NAFLD change the liver transplant landscape in the 2020s?","2022-03-10"]
[2626,"34304291","Abdom Radiol (NY)","10.1007/s00261-021-03225-2","Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility.","2022-03-10"]
[2644,"34298870","Int J Mol Sci","10.3390/ijms22147249","Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance.","2022-03-10"]
[2661,"34294580","Dig Liver Dis","10.1016/j.dld.2021.06.023","Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.","2022-03-10"]
[2679,"34288010","Hepatology","10.1002/hep.32063","Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells.","2022-03-10"]
[2697,"34279051","Obes Rev","10.1111/obr.13316","Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease.","2022-03-10"]
[2714,"34276153","J Clin Exp Hepatol","10.1016/j.jceh.2020.10.003","Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?","2022-03-10"]
[2733,"34267042","Curr Opin Infect Dis","10.1097/QCO.0000000000000759","The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease.","2022-03-10"]
[2751,"34260003","Neurochem Res","10.1007/s11064-021-03398-8","Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/&#946;-Catenin Signalling Pathway.","2022-03-10"]
[2769,"34250000","Front Nutr","10.3389/fnut.2021.700058","Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.","2022-03-10"]
[2770,"34249975","Front Med (Lausanne)","10.3389/fmed.2021.683250","Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.","2022-03-10"]
[2787,"34240649","Int J Immunopathol Pharmacol","10.1177/20587384211031417","Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2.","2022-03-10"]
[2805,"34234198","Sci Rep","10.1038/s41598-021-93294-6","Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery.","2022-03-10"]
[2828,"34227068","Eur Rev Med Pharmacol Sci","10.26355/eurrev_202106_26142","Liver changes in Wilson's disease: the full spectrum. A report of 127 biopsies from 43 patients.","2022-03-10"]
[2845,"34221404","SAGE Open Med Case Rep","10.1177/2050313X211025145","Ibuprofen-associated minimal change disease and acute interstitial nephritis with possibly linked membranous glomerulonephritis.","2022-03-10"]
[2862,"34213039","J Clin Lab Anal","10.1002/jcla.23880","Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores.","2022-03-10"]
[2881,"34206629","Nutrients","10.3390/nu13072135","Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring.","2022-03-10"]
[2899,"34202667","Biomolecules","10.3390/biom11070937","The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD).","2022-03-10"]
[2916,"34199270","Int J Environ Res Public Health","10.3390/ijerph18126412","Association between Blood Mercury Levels and Non-Alcoholic Fatty Liver Disease in Non-Obese Populations: The Korean National Environmental Health Survey (KoNEHS) 2012-2014.","2022-03-10"]
[2935,"34192367","Hepatology","10.1002/hep.32034","The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.","2022-03-10"]
[2955,"34185201","Inflammopharmacology","10.1007/s10787-021-00837-4","Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD.","2022-03-10"]
[2972,"34178303","J Surg Case Rep","10.1093/jscr/rjab247","Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report.","2022-03-10"]
[2989,"34172319","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2021.05.024","Discovery of analogues of non-&#946; oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism.","2022-03-10"]
[3010,"34164843","Hepatology","10.1002/hep.32027","On the Mechanisms of Biliary Flux.","2022-03-10"]
[3030,"34158256","Dig Liver Dis","10.1016/j.dld.2021.05.002","BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression.","2022-03-10"]
[3054,"34152626","Aliment Pharmacol Ther","10.1111/apt.16487","Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.","2022-03-10"]
[3072,"34141987","Hepatol Commun","10.1002/hep4.1700","A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease.","2022-03-10"]
[3090,"34135558","World J Gastroenterol","10.3748/wjg.v27.i21.2850","Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology.","2022-03-10"]
[3110,"34126247","Endocr Pract","10.1016/j.eprac.2021.06.003","High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.","2022-03-10"]
[3127,"34119629","J Nutr Biochem","10.1016/j.jnutbio.2021.108799","Sugar kelp (Saccharina latissima) inhibits hepatic inflammation and fibrosis in a mouse model of diet-induced nonalcoholic steatohepatitis.","2022-03-10"]
[3148,"34113260","Front Physiol","10.3389/fphys.2021.646491","Effect of &#969;-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders.","2022-03-10"]
[3169,"34105780","Hepatology","10.1002/hep.31995","Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis.","2022-03-10"]
[3188,"34095305","Biomed Res Int","10.1155/2021/6615881","A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation.","2022-03-10"]
[3207,"34089894","J Proteomics","10.1016/j.jprot.2021.104278","Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases.","2022-03-10"]
[3225,"34081362","J Intern Med","10.1111/joim.13337","Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients.","2022-03-10"]
[3247,"34072832","Cells","10.3390/cells10061355","Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[3261,"34067649","Metabolites","10.3390/metabo11050320","Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[3284,"34061469","J Cachexia Sarcopenia Muscle","10.1002/jcsm.12723","Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases.","2022-03-10"]
[3302,"34052187","Biochem Pharmacol","10.1016/j.bcp.2021.114624","Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition.","2022-03-10"]
[3322,"34046014","Front Endocrinol (Lausanne)","10.3389/fendo.2021.668984","Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice.","2022-03-10"]
[3339,"34036255","JHEP Rep","10.1016/j.jhepr.2021.100261","Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.","2022-03-10"]
[3359,"34028830","Med J Aust","10.5694/mja2.51096","Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study.","2022-03-10"]
[3376,"34025577","Front Endocrinol (Lausanne)","10.3389/fendo.2021.647459","Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII.","2022-03-10"]
[3396,"34017059","Exp Mol Med","10.1038/s12276-021-00614-x","The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.","2022-03-10"]
[3416,"34007801","J Clin Transl Hepatol","10.14218/JCTH.2020.00151","Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease.","2022-03-10"]
[3434,"34001645","Gut","10.1136/gutjnl-2021-324243","Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.","2022-03-10"]
[3452,"33994867","Int J Biol Sci","10.7150/ijbs.59588","MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[3469,"33991468","Biomol Concepts","10.1515/bmc-2021-0004","Myosteatosis in NAFLD patients correlates with plasma Cathepsin D.","2022-03-10"]
[3487,"33987020","PeerJ","10.7717/peerj.11346","Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study.","2022-03-10"]
[3506,"33978391","Minerva Gastroenterol (Torino)","10.23736/S2724-5985.21.02910-7","Probiotics and gut health.","2022-03-10"]
[3523,"33970520","J Magn Reson Imaging","10.1002/jmri.27677","In Vivo Magnetic Resonance Spectroscopy of Hyperpolarized [1-13 C]Pyruvate and Proton Density Fat Fraction in a Guinea Pig Model of Non-Alcoholic Fatty Liver Disease Development After Life-Long Western Diet Consumption.","2022-03-10"]
[3541,"33962617","Health Qual Life Outcomes","10.1186/s12955-021-01778-w","Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey.","2022-03-10"]
[3561,"33953700","Front Endocrinol (Lausanne)","10.3389/fendo.2021.663039","Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.","2022-03-10"]
[3579,"33946843","Microorganisms","10.3390/microorganisms9050957","Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.","2022-03-10"]
[3580,"33946377","Medicina (Kaunas)","10.3390/medicina57050434","The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis.","2022-03-10"]
[3598,"33937292","Front Med (Lausanne)","10.3389/fmed.2021.656658","Test-Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients.","2022-03-10"]
[3620,"33928009","Clin Nephrol Case Stud","10.5414/CNCS110123","Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma.","2022-03-10"]
[3635,"33923525","Nutrients","10.3390/nu13041314","The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights.","2022-03-10"]
[3652,"33919190","Antioxidants (Basel)","10.3390/antiox10050633","The Impact of H2S on Obesity-Associated Metabolic Disturbances.","2022-03-10"]
[3671,"33912056","Front Pharmacol","10.3389/fphar.2021.646239","P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway.","2022-03-10"]
[3689,"33901636","Comp Biochem Physiol C Toxicol Pharmacol","10.1016/j.cbpc.2021.109061","Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental model.","2022-03-10"]
[3708,"33896100","Liver Int","10.1111/liv.14898","Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.","2022-03-10"]
[3727,"33889132","Front Endocrinol (Lausanne)","10.3389/fendo.2021.639548","Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.","2022-03-10"]
[3745,"33879970","J Clin Biochem Nutr","10.3164/jcbn.20-129","Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study.","2022-03-10"]
[3762,"33871465","J Vis Exp","10.3791/62457","Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.","2022-03-10"]
[3781,"33865909","J Hepatol","10.1016/j.jhep.2021.02.037","Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity.","2022-03-10"]
[3801,"33860590","Phytother Res","10.1002/ptr.7101","Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis.","2022-03-10"]
[3819,"33857552","Adv Drug Deliv Rev","10.1016/j.addr.2021.04.008","Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis.","2022-03-10"]
[3838,"33852613","PLoS One","10.1371/journal.pone.0249556","Intrahepatic distribution of nerve fibers and alterations due to fibrosis in diseased liver.","2022-03-10"]
[3856,"33844769","Rev Med Chil","10.4067/S0034-98872020001101630","[The impact on metabolic and reproductive diseases of low-carbohydrate and ketogenic diets].","2022-03-10"]
[3874,"33837670","Liver Transpl","10.1002/lt.26069","Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications.","2022-03-10"]
[3893,"33830112","Mymensingh Med J",null,"Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus.","2022-03-10"]
[3915,"33820503","Mini Rev Med Chem","10.2174/1389557521666210405160658","Mechanism of Natural Drugs on Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[3932,"33813462","Wiad Lek",null,"RATIO OF MAIN PHYLOTYPES OF GUT MICROBIOTA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE BODY MASS INDEX.","2022-03-10"]
[3949,"33810079","Biomolecules","10.3390/biom11030473","Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview.","2022-03-10"]
[3967,"33806784","Children (Basel)","10.3390/children8030247","MAFLD in Obese Children: A Challenging Definition.","2022-03-10"]
[3984,"33801289","Biomedicines","10.3390/biomedicines9030248","The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research.","2022-03-10"]
[4003,"33793651","PLoS One","10.1371/journal.pone.0249491","Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.","2022-03-10"]
[4023,"33785637","Pediatrics","10.1542/peds.2020-009829","Alternative Etiologies of Liver Disease in Children With Suspected NAFLD.","2022-03-10"]
[4041,"33779332","Hum Exp Toxicol","10.1177/09603271211002886","Therapeutic effects of myocardin-related transcription factor A (MRTF-A) knockout on experimental mice with nonalcoholic steatohepatitis induced by high-fat diet.","2022-03-10"]
[4059,"33773468","Biomed Pharmacother","10.1016/j.biopha.2021.111504","4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation.","2022-03-10"]
[4077,"33768585","Hepatology","10.1002/hep.31832","Tumor Necrosis Factor &#945;-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.","2022-03-10"]
[4094,"33762733","Nature","10.1038/s41586-021-03362-0","NASH limits anti-tumour surveillance in immunotherapy-treated HCC.","2022-03-10"]
[4114,"33752128","EBioMedicine","10.1016/j.ebiom.2021.103290","Conjugated secondary 12&#945;-hydroxylated bile acids promote liver fibrogenesis.","2022-03-10"]
[4133,"33746083","J Hepatol","10.1016/j.jhep.2021.02.034","Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.","2022-03-10"]
[4152,"33739984","PLoS One","10.1371/journal.pone.0248856","Association between sarcopenia level and metabolic syndrome.","2022-03-10"]
[4170,"33729777","J Agric Food Chem","10.1021/acs.jafc.1c00751","Dietary Polyphenols to Combat Nonalcoholic Fatty Liver Disease via the Gut-Brain-Liver Axis: A Review of Possible Mechanisms.","2022-03-10"]
[4189,"33722690","Mol Metab","10.1016/j.molmet.2021.101210","Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression.","2022-03-10"]
[4207,"33713358","Hepatology","10.1002/hep.31801","TNF-&#945;-Induce Protein 8-Like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal-Regulating Kinase 1.","2022-03-10"]
[4225,"33708180","Front Microbiol","10.3389/fmicb.2021.611323","Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota.","2022-03-10"]
[4242,"33692781","Front Immunol","10.3389/fimmu.2021.603133","Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[4260,"33685086","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.cn501113-20191010-00369","[Role of 1, 25-dihydroxyvitamin D3 in liver lipid metabolism induced by methionine-choline-deficient diet in rats].","2022-03-10"]
[4277,"33679803","Front Immunol","10.3389/fimmu.2021.640869","Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[4298,"33672864","Life (Basel)","10.3390/life11020143","FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic.","2022-03-10"]
[4315,"33668153","Cancers (Basel)","10.3390/cancers13050940","MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-&#946;, and STAT3 Signaling.","2022-03-10"]
[4333,"33662773","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2021.101638","Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.","2022-03-10"]
[4354,"33650781","Physiol Rep","10.14814/phy2.14773","Serum fetuin-A and Ser312 phosphorylated fetuin-A responses and markers of insulin sensitivity after a single bout of moderate intensity exercise.","2022-03-10"]
[4367,"33647205","Chem Res Toxicol","10.1021/acs.chemrestox.0c00445","LXR&#945;/&#946; Antagonism Protects against Lipid Accumulation in the Liver but Increases Plasma Cholesterol in Rhesus Macaques.","2022-03-10"]
[4393,"33636655","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2020.07.024","Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort.","2022-03-10"]
[4394,"33636349","Pharmacol Res","10.1016/j.phrs.2021.105517","Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease.","2022-03-10"]
[4412,"33628758","Can J Gastroenterol Hepatol","10.1155/2021/6649142","Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity.","2022-03-10"]
[4432,"33618508","Clin Mol Hepatol","10.3350/cmh.2020.0162","Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort.","2022-03-10"]
[4453,"33610041","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.02.039","Inhibition of Notch1 signaling reduces hepatocyte injury in nonalcoholic fatty liver disease via autophagy.","2022-03-10"]
[4470,"33603909","Maedica (Bucur)","10.26574/maedica.2020.15.4.513","Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms.","2022-03-10"]
[4491,"33597924","Front Endocrinol (Lausanne)","10.3389/fendo.2020.601627","The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[4511,"33593235","Expert Rev Pharmacoecon Outcomes Res","10.1080/14737167.2021.1890586","Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study.","2022-03-10"]
[4531,"33586025","J Endocrinol Invest","10.1007/s40618-021-01522-7","Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model.","2022-03-10"]
[4548,"33582286","Biochim Biophys Acta Mol Cell Biol Lipids","10.1016/j.bbalip.2021.158905","Chronic systemic exposure to IL6 leads to deregulation of glycolysis and fat accumulation in the zebrafish liver.","2022-03-10"]
[4568,"33578292","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.01.098","Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1.","2022-03-10"]
[4586,"33572544","J Clin Med","10.3390/jcm10030492","Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?","2022-03-10"]
[4604,"33566371","FASEB J","10.1096/fj.202002413RR","NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response.","2022-03-10"]
[4622,"33559403","Pediatr Obes","10.1111/ijpo.12773","Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24&#8201;years.","2022-03-10"]
[4640,"33554350","Hepatology","10.1002/hep.31739","The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis.","2022-03-10"]
[4657,"33549735","Ann Hepatol","10.1016/j.aohep.2021.100320","Hepatic steatosis and respiratory diseases: a new panorama.","2022-03-10"]
[4677,"33545051","Cell Metab","10.1016/j.cmet.2021.01.012","Metabolic stress drives sympathetic neuropathy within the liver.","2022-03-10"]
[4695,"33537324","Front Med (Lausanne)","10.3389/fmed.2020.585618","Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[4712,"33531899","Int J Endocrinol","10.1155/2021/9178616","Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A.","2022-03-10"]
[4739,"33520110","World J Diabetes","10.4239/wjd.v12.i1.84","Novel glucose-lowering drugs for non-alcoholic fatty liver disease.","2022-03-10"]
[4752,"33515562","Life Sci","10.1016/j.lfs.2021.119071","miR-125b promotes the NF-&#954;B-mediated inflammatory response in NAFLD via directly targeting TNFAIP3.","2022-03-10"]
[4770,"33511275","Clin Exp Hepatol","10.5114/ceh.2020.102153","Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression.","2022-03-10"]
[4788,"33505393","Front Immunol","10.3389/fimmu.2020.594150","Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions.","2022-03-10"]
[4805,"33499062","Biomolecules","10.3390/biom11020141","The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.","2022-03-10"]
[4825,"33493235","PLoS One","10.1371/journal.pone.0245921","Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.","2022-03-10"]
[4844,"33486695","Arch Pharm Res","10.1007/s12272-021-01309-7","Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.","2022-03-10"]
[4866,"33476308","J Clin Invest","10.1172/JCI143690","Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis.","2022-03-10"]
[4885,"33467114","Diagnostics (Basel)","10.3390/diagnostics11010132","Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.","2022-03-10"]
[4903,"33458794","Metabolomics","10.1007/s11306-020-01756-1","Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.","2022-03-10"]
[4928,"33446095","BMC Geriatr","10.1186/s12877-020-01910-3","Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.","2022-03-10"]
[4948,"33440159","Cell Rep","10.1016/j.celrep.2020.108626","Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH.","2022-03-10"]
[4967,"33435558","Molecules","10.3390/molecules26020302","Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice.","2022-03-10"]
[4985,"33425804","Can J Gastroenterol Hepatol","10.1155/2020/6638306","Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.","2022-03-10"]
[5004,"33417276","Mol Syst Biol","10.15252/msb.20209684","Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis.","2022-03-10"]
[5021,"33408301","Tohoku J Exp Med","10.1620/tjem.253.11","Eating Fast and Until Full Is Associated with Elevated Alanine Aminotransferase Activity in Japanese Schoolchildren: A Cross-Sectional Study.","2022-03-10"]
[5039,"33397952","Nat Commun","10.1038/s41467-020-20303-z","Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH.","2022-03-10"]
[5056,"33391955","Cureus","10.7759/cureus.11727","Non-alcoholic Fatty Liver Disease Causing Platypnea-Orthodeoxia Syndrome.","2022-03-10"]
[5074,"33387126","Dig Dis Sci","10.1007/s10620-020-06763-9","Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.","2022-03-10"]
[5094,"33378966","Biomed Pharmacother","10.1016/j.biopha.2020.111064","Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.","2022-03-10"]
[5111,"33372064","Biol Open","10.1242/bio.054189","A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference.","2022-03-10"]
[5114,"33371031","BMJ Open","10.1136/bmjopen-2020-040959","Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study.","2022-03-10"]
[5149,"33354557","Can J Gastroenterol Hepatol","10.1155/2020/8820445","Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients.","2022-03-10"]
[5167,"33347986","Free Radic Biol Med","10.1016/j.freeradbiomed.2020.12.010","STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury.","2022-03-10"]
[5188,"33342543","J Hepatol","10.1016/j.jhep.2020.09.037","Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.","2022-03-10"]
[5215,"33336025","Open Med (Wars)","10.1515/med-2020-0212","Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet.","2022-03-10"]
[5216,"33335561","Therap Adv Gastroenterol","10.1177/1756284820974917","The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.","2022-03-10"]
[5233,"33329394","Front Endocrinol (Lausanne)","10.3389/fendo.2020.588502","Aerobic Exercise Training Exerts Beneficial Effects Upon Oxidative Metabolism and Non-Enzymatic Antioxidant Defense in the Liver of Leptin Deficiency Mice.","2022-03-10"]
[5252,"33323025","AIDS Res Hum Retroviruses","10.1089/AID.2020.0177","Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection.","2022-03-10"]
[5272,"33317575","Lipids Health Dis","10.1186/s12944-020-01423-3","A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.","2022-03-10"]
[5290,"33311892","J Clin Exp Hepatol","10.1016/j.jceh.2020.04.017","Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction.","2022-03-10"]
[5310,"33306598","J Chin Med Assoc","10.1097/JCMA.0000000000000469","Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis.","2022-03-10"]
[5327,"33301513","PLoS One","10.1371/journal.pone.0243640","RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.","2022-03-10"]
[5346,"33292701","Biomark Res","10.1186/s40364-020-00239-8","Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function.","2022-03-10"]
[5365,"33281601","Front Pharmacol","10.3389/fphar.2020.529553","The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against-Non-Alcoholic Steatohepatitis.","2022-03-10"]
[5388,"33273997","Oxid Med Cell Longev","10.1155/2019/8294141","Plant Sterol Ester of &#945;-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis.","2022-03-10"]
[5405,"33269229","Quant Imaging Med Surg","10.21037/qims-20-651","Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model.","2022-03-10"]
[5424,"33261113","Biomedicines","10.3390/biomedicines8120546","Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis.","2022-03-10"]
[5443,"33255404","Nutrients","10.3390/nu12123612","POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuates Obesity, Non-Alcoholic Fatty Liver, and Insulin Resistance via Inhibitions of Pancreatic Lipase, cAMP-Dependent PDE Activity, AMPK Activation, and SOCS-3 Suppression.","2022-03-10"]
[5464,"33248170","J Hepatol","10.1016/j.jhep.2020.11.024","Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.","2022-03-10"]
[5485,"33236464","Diabetes Obes Metab","10.1111/dom.14263","Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study.","2022-03-10"]
[5514,"33220492","Mol Metab","10.1016/j.molmet.2020.101122","Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.","2022-03-10"]
[5524,"33219119","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2020-001860","Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans.","2022-03-10"]
[5542,"33214063","Dig Liver Dis","10.1016/j.dld.2020.11.001","Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP).","2022-03-10"]
[5562,"33205261","Curr Gastroenterol Rep","10.1007/s11894-020-00798-8","Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope?","2022-03-10"]
[5580,"33200549","Basic Clin Pharmacol Toxicol","10.1111/bcpt.13535","Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition.","2022-03-10"]
[5598,"33195326","Front Med (Lausanne)","10.3389/fmed.2020.578001","Hypoxia and Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[5617,"33186794","Biomed Pharmacother","10.1016/j.biopha.2020.110984","Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.","2022-03-10"]
[5634,"33181118","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(20)30340-X","The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.","2022-03-10"]
[5654,"33171747","Int J Mol Sci","10.3390/ijms21218351","The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.","2022-03-10"]
[5673,"33164439","Zhongguo Zhong Yao Za Zhi","10.19540/j.cnki.cjcmm.20200427.401","[Effect of Panax japonicus saponin &#8547;a on alleviating nonalcoholic steatohepatitis by regulating miR-17-5p/MFN2 signaling pathway].","2022-03-10"]
[5692,"33153965","Surg Obes Relat Dis","10.1016/j.soard.2020.09.037","Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures.","2022-03-10"]
[5712,"33145423","Clin Exp Hepatol","10.5114/ceh.2020.99506","Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment.","2022-03-10"]
[5729,"33142287","Dig Dis","10.1159/000512746","Natural History of Cirrhosis: Changing Trends in Etiology Over the Years.","2022-03-10"]
[5747,"33134485","Transplant Direct","10.1097/TXD.0000000000001060","Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma.","2022-03-10"]
[5766,"33127749","J Pharmacol Exp Ther","10.1124/jpet.120.000291","Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III.","2022-03-10"]
[5784,"33117662","Psoriasis (Auckl)","10.2147/PTT.S272286","Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter.","2022-03-10"]
[5802,"33114148","Int J Mol Sci","10.3390/ijms21217870","Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases.","2022-03-10"]
[5819,"33106416","Proc Natl Acad Sci U S A","10.1073/pnas.2000466117","Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-&#954;B/NLRP3 inflammasome circuit.","2022-03-10"]
[5839,"33102796","Endocrinol Diabetes Metab","10.1002/edm2.127","The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease.","2022-03-10"]
[5857,"33098868","Arch Biochem Biophys","10.1016/j.abb.2020.108642","miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.","2022-03-10"]
[5876,"33092030","Int J Mol Sci","10.3390/ijms21207746","Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.","2022-03-10"]
[5885,"33089412","J Med Ultrason (2001)","10.1007/s10396-020-01058-y","Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.","2022-03-10"]
[5918,"33076344","Biology (Basel)","10.3390/biology9100338","The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD.","2022-03-10"]
[5935,"33071964","Front Endocrinol (Lausanne)","10.3389/fendo.2020.00654","Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity.","2022-03-10"]
[5954,"33063664","Elife","10.7554/eLife.56573","Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver.","2022-03-10"]
[5972,"33057854","Curr Diab Rep","10.1007/s11892-020-01342-8","Tissue-Specific Fructose Metabolism in Obesity and Diabetes.","2022-03-10"]
[5989,"33050035","Cells","10.3390/cells9102258","Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation.","2022-03-10"]
[6009,"33038502","Contemp Clin Trials","10.1016/j.cct.2020.106170","A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study.","2022-03-10"]
[6026,"33036179","J Clin Med","10.3390/jcm9103213","One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.","2022-03-10"]
[6047,"33029058","J Clin Exp Hepatol","10.1016/j.jceh.2020.04.004","Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?","2022-03-10"]
[6048,"33028928","Sci Rep","10.1038/s41598-020-73653-5","The effects of fructose and metabolic inhibition on hepatocellular carcinoma.","2022-03-10"]
[6065,"33024131","Sci Rep","10.1038/s41598-020-71646-y","Characterization of two types of intranuclear hepatocellular inclusions in NAFLD.","2022-03-10"]
[6086,"33011976","Acta Psychiatr Scand","10.1111/acps.13239","Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort.","2022-03-10"]
[6103,"33007261","Cell","10.1016/j.cell.2020.09.028","One Ring to Rule Them All: Mitochondrial Circular RNAs Control Mitochondrial Function.","2022-03-10"]
[6121,"32998139","Oncology","10.1159/000510366","TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[6141,"32991778","Mol Nutr Food Res","10.1002/mnfr.202000361","Methionine- and Choline-Deficient Diet Enhances Adipose Lipolysis and Leptin Release in aP2-Cre Fatp4-Knockout Mice.","2022-03-10"]
[6159,"32982495","Hepat Med","10.2147/HMER.S265473","Identifying High-Risk NASH Patients: What We Know so Far.","2022-03-10"]
[6179,"32978374","Cell Death Dis","10.1038/s41419-020-03003-w","Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","2022-03-10"]
[6196,"32973715","Front Microbiol","10.3389/fmicb.2020.01975","Constant Light Exposure Alters Gut Microbiota and Promotes the Progression of Steatohepatitis in High Fat Diet Rats.","2022-03-10"]
[6218,"32964054","J Diabetes Res","10.1155/2020/6538208","Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.","2022-03-10"]
[6236,"32959331","Obes Surg","10.1007/s11695-020-04971-w","Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.","2022-03-10"]
[6257,"32951697","Complement Ther Med","10.1016/j.ctim.2020.102398","The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.","2022-03-10"]
[6274,"32945071","Diabetes Obes Metab","10.1111/dom.14196","A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer?","2022-03-10"]
[6294,"32938556","Obes Res Clin Pract","10.1016/j.orcp.2020.08.005","Effects of obesity reduction on transient elastography-based parameters in pediatric non-alcoholic fatty liver disease.","2022-03-10"]
[6313,"32932674","Molecules","10.3390/molecules25184182","Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases.","2022-03-10"]
[6334,"32925017","Clin Hemorheol Microcirc","10.3233/CH-209213","The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.","2022-03-10"]
[6352,"32919135","Bioorg Chem","10.1016/j.bioorg.2020.104262","Design, synthesis and structure-activity relationship studies of novel partial FXR agonists for the treatment of fatty liver.","2022-03-10"]
[6369,"32910646","J Med Chem","10.1021/acs.jmedchem.0c00944","Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose.","2022-03-10"]
[6388,"32899243","J Clin Med","10.3390/jcm9092851","Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting.","2022-03-10"]
[6405,"32891697","Biochimie","10.1016/j.biochi.2020.08.018","Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?","2022-03-10"]
[6430,"32883049","Cells","10.3390/cells9092014","A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.","2022-03-10"]
[6448,"32878529","Pharm Biol","10.1080/13880209.2020.1803365","Cyclocarya paliurus extract attenuates hepatic lipid deposition in HepG2 cells by the lipophagy pathway.","2022-03-10"]
[6468,"32868653","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001845","Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis.","2022-03-10"]
[6487,"32859881","Chin J Physiol","10.4103/CJP.CJP_43_20","Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver disease.","2022-03-10"]
[6507,"32849291","Front Endocrinol (Lausanne)","10.3389/fendo.2020.00505","Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD.","2022-03-10"]
[6524,"32841307","PLoS One","10.1371/journal.pone.0237430","Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.","2022-03-10"]
[6544,"32832391","J Clin Transl Hepatol","10.14218/JCTH.2019.00012","Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise.","2022-03-10"]
[6562,"32824383","Cancers (Basel)","10.3390/cancers12082305","Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.","2022-03-10"]
[6580,"32821336","World J Hepatol","10.4254/wjh.v12.i7.378","Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study.","2022-03-10"]
[6600,"32812775","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00357.2019","Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.","2022-03-10"]
[6618,"32805401","Free Radic Biol Med","10.1016/j.freeradbiomed.2020.08.006","Cyanidin-3-O-&#946;-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-&#954;B signaling pathway.","2022-03-10"]
[6633,"32800550","Biochem Biophys Res Commun","10.1016/j.bbrc.2020.07.136","Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling.","2022-03-10"]
[6659,"32791402","Eur J Med Chem","10.1016/j.ejmech.2020.112649","Synthesis of natural 3'-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome.","2022-03-10"]
[6676,"32784205","BMJ Open Gastroenterol","10.1136/bmjgast-2019-000352","Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome.","2022-03-10"]
[6695,"32777481","Biochim Biophys Acta Mol Cell Biol Lipids","10.1016/j.bbalip.2020.158792","Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis.","2022-03-10"]
[6712,"32773025","Biol Aujourdhui","10.1051/jbio/2020002","[Cell death mechanisms in non-alcoholic steatohepatitis].","2022-03-10"]
[6733,"32766472","Hepatol Commun","10.1002/hep4.1533","Genome-Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study.","2022-03-10"]
[6751,"32759940","Nutr Diabetes","10.1038/s41387-020-00130-3","Neohesperidin enhances PGC-1&#945;-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice.","2022-03-10"]
[6770,"32753923","Diabetes Metab Syndr Obes","10.2147/DMSO.S254555","Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial.","2022-03-10"]
[6789,"32745630","Ann Hepatol","10.1016/j.aohep.2020.07.003","Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.","2022-03-10"]
[6808,"32738331","Toxicol Appl Pharmacol","10.1016/j.taap.2020.115169","A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters.","2022-03-10"]
[6827,"32733017","Sci Rep","10.1038/s41598-020-69820-3","Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice.","2022-03-10"]
[6846,"32725250","Acta Derm Venereol","10.2340/00015555-3597","Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study.","2022-03-10"]
[6863,"32718364","Br J Nutr","10.1017/S0007114520003013","Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice.","2022-03-10"]
[6864,"32718097","Int J Mol Sci","10.3390/ijms21155242","Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?","2022-03-10"]
[6881,"32711755","J Pediatr","10.1016/j.jpeds.2020.04.046","Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic&#160;Fatty Liver Disease.","2022-03-10"]
[6899,"32705262","Mol Med Rep","10.3892/mmr.2020.11249","Expression of Notch family is altered in non&#8209;alcoholic fatty liver disease.","2022-03-10"]
[6919,"32698042","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2020.07.006","Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes.","2022-03-10"]
[6946,"32690265","Bioorg Med Chem","10.1016/j.bmc.2020.115610","Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL).","2022-03-10"]
[6964,"32684985","Diabetol Metab Syndr","10.1186/s13098-020-00570-y","NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.","2022-03-10"]
[6981,"32674529","Clin Mol Hepatol","10.3350/cmh.2020.0067","Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH.","2022-03-10"]
[6998,"32666675","Liver Int","10.1111/liv.14607","Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors.","2022-03-10"]
[7025,"32654390","Liver Int","10.1111/liv.14600","The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.","2022-03-10"]
[7034,"32650222","Nutr Res","10.1016/j.nutres.2020.06.004","Distinct utilization of biotin in and between adipose and brain during aging is associated with a lipogenic shift in Wistar rat brain.","2022-03-10"]
[7054,"32639223","Int J Vitam Nutr Res","10.1024/0300-9831/a000667","Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population.","2022-03-10"]
[7072,"32631678","Rev Neurol (Paris)","10.1016/j.neurol.2020.03.020","Metabolic&#160;alterations in spinal and bulbar muscular atrophy.","2022-03-10"]
[7090,"32626832","Hepatol Commun","10.1002/hep4.1524","Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis-4 Score.","2022-03-10"]
[7109,"32620521","Dig Liver Dis","10.1016/j.dld.2020.04.019","Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration.","2022-03-10"]
[7131,"32608271","Arch Physiol Biochem","10.1080/13813455.2020.1784953","Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone.","2022-03-10"]
[7150,"32599319","Int Immunopharmacol","10.1016/j.intimp.2020.106730","Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-&#945;, IL-1&#946;, and IL-18 in rat liver.","2022-03-10"]
[7168,"32594424","Clin J Gastroenterol","10.1007/s12328-020-01165-w","Monitoring chronological change by liver-to-spleen attenuation ratio for secondary hepatic steatosis for a short term.","2022-03-10"]
[7190,"32588069","Naunyn Schmiedebergs Arch Pharmacol","10.1007/s00210-020-01919-w","In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions.","2022-03-10"]
[7208,"32582754","Front Nutr","10.3389/fnut.2020.00081","PTEN: A Thrifty Gene That Causes Disease in Times of Plenty?","2022-03-10"]
[7227,"32574624","Gastroenterology","10.1053/j.gastro.2020.06.031","IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.","2022-03-10"]
[7244,"32569680","Metabolism","10.1016/j.metabol.2020.154299","Metabolic liver disease in diabetes - From mechanisms to clinical trials.","2022-03-10"]
[7265,"32561908","J Clin Endocrinol Metab","10.1210/clinem/dgaa382","Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth.","2022-03-10"]
[7284,"32555268","Sci Rep","10.1038/s41598-020-66507-7","Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.","2022-03-10"]
[7301,"32550166","J Diabetes Metab Disord","10.1007/s40200-020-00488-2","The landscape of microbiota research in Iran; a bibliometric and network analysis.","2022-03-10"]
[7319,"32540736","Diabetes Metab Syndr","10.1016/j.dsx.2020.06.013","Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19.","2022-03-10"]
[7337,"32531862","Oral Dis","10.1111/odi.13476","Bromelain reduces the non-alcoholic fatty liver disease and periodontal damages caused by ligature-induced periodontitis.","2022-03-10"]
[7357,"32526796","Mol Nutr Food Res","10.1002/mnfr.201900580","Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.","2022-03-10"]
[7374,"32522731","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2020-001311","Regional difference in the susceptibility of non-alcoholic fatty liver disease in China.","2022-03-10"]
[7391,"32516202","Am J Gastroenterol","10.14309/ajg.0000000000000722","Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.","2022-03-10"]
[7411,"32510837","Liver Int","10.1111/liv.14554","Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.","2022-03-10"]
[7430,"32502637","Pharmacol Res","10.1016/j.phrs.2020.104984","Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies.","2022-03-10"]
[7451,"32490750","Physiology (Bethesda)","10.1152/physiol.00005.2020","Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?","2022-03-10"]
[7470,"32483260","Sci Rep","10.1038/s41598-020-65835-y","Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk.","2022-03-10"]
[7487,"32476782","World J Gastroenterol","10.3748/wjg.v26.i18.2155","Natural products that target macrophages in treating non-alcoholic steatohepatitis.","2022-03-10"]
[7507,"32466319","Int J Mol Sci","10.3390/ijms21103732","Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.","2022-03-10"]
[7525,"32455208","ACS Omega","10.1021/acsomega.0c00529","Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats.","2022-03-10"]
[7544,"32448788","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2020-001342","Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial.","2022-03-10"]
[7566,"32440840","J Nephrol","10.1007/s40620-020-00751-y","Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.","2022-03-10"]
[7584,"32435522","World J Gastrointest Pathophysiol","10.4291/wjgp.v11.i3.57","Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics.","2022-03-10"]
[7602,"32428560","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2020.165838","Mitochondrial dysfunction in metabolic syndrome.","2022-03-10"]
[7626,"32415687","Lipids","10.1002/lipd.12244","Relationships between Very Low-Density Lipoproteins-Ceramides, -Diacylglycerols, and -Triacylglycerols in Insulin-Resistant Men.","2022-03-10"]
[7645,"32410320","Hepatol Res","10.1111/hepr.13525","Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[7665,"32403970","Autophagy","10.1080/15548627.2020.1760624","MLKL contributes to Western diet-induced liver injury through inhibiting autophagy.","2022-03-10"]
[7683,"32392051","J Med Chem","10.1021/acs.jmedchem.0c00542","6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic Steatohepatitis.","2022-03-10"]
[7702,"32386450","Liver Int","10.1111/liv.14507","The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue.","2022-03-10"]
[7703,"32385406","Sci Rep","10.1038/s41598-020-64902-8","Pemafibrate, a selective PPAR&#945; modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.","2022-03-10"]
[7720,"32376414","J Hepatol","10.1016/j.jhep.2020.04.037","Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.","2022-03-10"]
[7740,"32369237","J Dig Dis","10.1111/1751-2980.12871","Epidemiology of nonalcoholic fatty liver disease in non-obese populations: Meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles.","2022-03-10"]
[7759,"32362966","Gastroenterology Res","10.14740/gr1273","Benefits of the Therapy With Abexol in Patients With Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[7799,"32352682","Clin Transl Gastroenterol","10.14309/ctg.0000000000000170","The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.","2022-03-10"]
[7805,"32351030","Pediatr Obes","10.1111/ijpo.12653","The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.","2022-03-10"]
[7823,"32344559","Metabolites","10.3390/metabo10040168","Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach.","2022-03-10"]
[7844,"32337059","BMJ Open Gastroenterol","10.1136/bmjgast-2019-000368","Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.","2022-03-10"]
[7864,"32330603","J Hepatol","10.1016/j.jhep.2020.04.009","Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.","2022-03-10"]
[7881,"32324591","Aging (Albany NY)","10.18632/aging.103082","Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.","2022-03-10"]
[7901,"32317079","BMB Rep",null,"GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress.","2022-03-10"]
[7919,"32309672","Contemp Clin Trials Commun","10.1016/j.conctc.2020.100560","Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH.","2022-03-10"]
[7937,"32304992","Int Immunopharmacol","10.1016/j.intimp.2020.106489","Role of pyroptosis in liver diseases.","2022-03-10"]
[7956,"32299509","BMC Res Notes","10.1186/s13104-020-05063-9","Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case-control study in Iran.","2022-03-10"]
[7973,"32293113","J Cell Mol Med","10.1111/jcmm.15139","Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.","2022-03-10"]
[7992,"32285823","Wiad Lek",null,"Changes in the level of &#945;1-antitrypsin in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[8010,"32280772","JGH Open","10.1002/jgh3.12252","Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography.","2022-03-10"]
[8032,"32275114","FASEB J","10.1096/fj.201902687R","Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis.","2022-03-10"]
[8054,"32267559","J Gastroenterol Hepatol","10.1111/jgh.15071","Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?","2022-03-10"]
[8073,"32258142","Biomed Res Int","10.1155/2020/7806860","Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPAR&#948;-AMPK-PGC-1&#945; Pathway in Dyslipidemic Conditions.","2022-03-10"]
[8092,"32250344","J Clin Invest","10.1172/JCI127502","Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice.","2022-03-10"]
[8111,"32243703","Liver Int","10.1111/liv.14453","Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[8129,"32237015","Pediatr Diabetes","10.1111/pedi.13011","Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.","2022-03-10"]
[8149,"32228319","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00528.2019","Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.","2022-03-10"]
[8179,"32217148","Pharmacol Res","10.1016/j.phrs.2020.104770","Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-&#945;, UCP1, and UCP2 genes.","2022-03-10"]
[8189,"32213035","United European Gastroenterol J","10.1177/2050640620909675","Clinical management of type C hepatic encephalopathy.","2022-03-10"]
[8207,"32205261","J Ethnopharmacol","10.1016/j.jep.2020.112776","Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.","2022-03-10"]
[8226,"32192863","Clin Breast Cancer","10.1016/j.clbc.2020.02.004","Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study.","2022-03-10"]
[8246,"32189432","J Cell Mol Med","10.1111/jcmm.15166","A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.","2022-03-10"]
[8263,"32183383","Diagnostics (Basel)","10.3390/diagnostics10030159","Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan.","2022-03-10"]
[8282,"32170127","Sci Rep","10.1038/s41598-020-61473-6","Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice.","2022-03-10"]
[8300,"32161545","Front Pharmacol","10.3389/fphar.2020.00117","Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities.","2022-03-10"]
[8318,"32153507","Front Endocrinol (Lausanne)","10.3389/fendo.2020.00070","Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review.","2022-03-10"]
[8335,"32149276","Food Chem X","10.1016/j.fochx.2020.100081","Current intakes of trans-palmitoleic (trans-C16:1 n-7) and trans-vaccenic (trans-C18:1 n-7) acids in France are exclusively ensured by ruminant milk and ruminant meat: A market basket investigation.","2022-03-10"]
[8354,"32145261","J Hepatol","10.1016/j.jhep.2020.01.029","A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.","2022-03-10"]
[8372,"32139603","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2020-001174","Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.","2022-03-10"]
[8393,"32128893","J Gastroenterol Hepatol","10.1111/jgh.15025","Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-&#954;B signaling pathway.","2022-03-10"]
[8411,"32123238","Sci Rep","10.1038/s41598-020-60797-7","Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey.","2022-03-10"]
[8433,"32112699","Horm Mol Biol Clin Investig","10.1515/hmbci-2019-0044","Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms.","2022-03-10"]
[8456,"32104220","Exp Ther Med","10.3892/etm.2020.8411","Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease.","2022-03-10"]
[8476,"32095444","Clin Nutr Res","10.7762/cnr.2020.9.1.11","Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study.","2022-03-10"]
[8495,"32086988","Liver Int","10.1111/liv.14415","Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.","2022-03-10"]
[8513,"32077785","Metab Syndr Relat Disord","10.1089/met.2019.0120","Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.","2022-03-10"]
[8531,"32070295","BMC Gastroenterol","10.1186/s12876-020-01189-z","Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.","2022-03-10"]
[8534,"32069845","Int J Mol Sci","10.3390/ijms21041241","Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer.","2022-03-10"]
[8553,"32063504","Ann Hepatol","10.1016/j.aohep.2020.01.003","Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?","2022-03-10"]
[8571,"32057700","Ann Hepatol","10.1016/j.aohep.2019.11.011","Role of CD98 in liver disease.","2022-03-10"]
[8589,"32048317","J Gastroenterol Hepatol","10.1111/jgh.15009","Nonalcoholic fatty liver disease burden: Australia, 2019-2030.","2022-03-10"]
[8606,"32043636","FASEB J","10.1096/fj.201901799RR","REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet.","2022-03-10"]
[8627,"32039370","JHEP Rep","10.1016/j.jhepr.2019.05.007","Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity.","2022-03-10"]
[8648,"32033762","Gastroenterol Clin North Am","10.1016/j.gtc.2019.09.005","Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.","2022-03-10"]
[8666,"32028242","Int Immunopharmacol","10.1016/j.intimp.2020.106195","Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis.","2022-03-10"]
[8686,"32022277","Hepatology","10.1002/hep.31157","Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.","2022-03-10"]
[8703,"32017594","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00401.2019","Combined effect of canagliflozin and exercise training on high-fat diet-fed mice.","2022-03-10"]
[8725,"32010935","Biosci Rep","10.1042/BSR20194502","Letter to the Editor: Comments on \"Obesity associated with a novel mitochondrial tRNACys m.5802A>G mutation in a Chinese family\".","2022-03-10"]
[8743,"32003679","Curr Pharm Des","10.2174/1381612826666200131101553","Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?","2022-03-10"]
[8760,"31998283","Front Immunol","10.3389/fimmu.2019.02926","Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.","2022-03-10"]
[8778,"31987257","Complement Ther Med","10.1016/j.ctim.2019.102273","The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.","2022-03-10"]
[8800,"31980746","Eur J Clin Nutr","10.1038/s41430-020-0563-1","Differences in the association of diet quality with body fat distribution between men and women.","2022-03-10"]
[8832,"31973214","Nutrients","10.3390/nu12020287","Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet.","2022-03-10"]
[8852,"31965894","Gut Microbes","10.1080/19490976.2020.1712984","Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome.","2022-03-10"]
[8871,"31955626","Endocr Res","10.1080/07435800.2020.1713802","Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.","2022-03-10"]
[8893,"31950520","Hepatology","10.1002/hep.31118","Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging.","2022-03-10"]
[8910,"31941880","Med Sci Monit","10.12659/MSM.919606","Electrocardiogram-Based R Wave Pulse Wave Index for Assessment of Carotid Atherosclerosis.","2022-03-10"]
[8928,"31935149","Crit Rev Clin Lab Sci","10.1080/10408363.2019.1711360","Fructose and hepatic insulin resistance.","2022-03-10"]
[8950,"31928239","Expert Rev Gastroenterol Hepatol","10.1080/17474124.2020.1715210","Fatty liver in pregnancy: a narrative review of two distinct conditions.","2022-03-10"]
[8972,"31920355","Diabetes Metab Syndr Obes","10.2147/DMSO.S210764","Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation.","2022-03-10"]
[8990,"31913753","J Med Food","10.1089/jmf.2019.4468","Effects of Phytosterol Ester on the Fatty Acid Profiles in Rats with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[9010,"31905444","Ann Pediatr Endocrinol Metab","10.6065/apem.2019.24.4.243","Application of body composition zones in boys with nonalcoholic fatty liver disease.","2022-03-10"]
[9034,"31897769","Acta Diabetol","10.1007/s00592-019-01467-7","Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease.","2022-03-10"]
[9053,"31888241","Nutrients","10.3390/nu11123070","Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial.","2022-03-10"]
[9071,"31885010","Iran J Immunol","10.22034/IJI.2019.80284","Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.","2022-03-10"]
[9088,"31881192","Biochem Pharmacol","10.1016/j.bcp.2019.113780","Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance.","2022-03-10"]
[9108,"31870938","Peptides","10.1016/j.peptides.2019.170231","Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction.","2022-03-10"]
[9126,"31865799","Hypertension","10.1161/HYPERTENSIONAHA.119.13419","Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension.","2022-03-10"]
[9147,"31858390","Endocrine","10.1007/s12020-019-02155-w","Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.","2022-03-10"]
[9171,"31850288","Front Pediatr","10.3389/fped.2019.00491","Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[9190,"31841744","Nutr Res","10.1016/j.nutres.2019.08.009","An energy-restricted high-protein diet supplemented with &#946;-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial.","2022-03-10"]
[9209,"31835352","Cells","10.3390/cells8121597","The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases.","2022-03-10"]
[9227,"31828683","Eur J Clin Microbiol Infect Dis","10.1007/s10096-019-03746-1","Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.","2022-03-10"]
[9246,"31819566","Diabetes Metab Syndr Obes","10.2147/DMSO.S221969","Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications.","2022-03-10"]
[9267,"31811953","Clin Gastroenterol Hepatol","10.1016/j.cgh.2019.11.050","Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis.","2022-03-10"]
[9285,"31805752","Molecules","10.3390/molecules24234394","Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.","2022-03-10"]
[9305,"31797589","Pac Symp Biocomput",null,"Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes.","2022-03-10"]
[9325,"31790429","PLoS One","10.1371/journal.pone.0224921","Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.","2022-03-10"]
[9331,"31788461","Front Pediatr","10.3389/fped.2019.00458","Progressive Liver Disease in Patients With Ataxia Telangiectasia.","2022-03-10"]
[9364,"31777425","J Clin Biochem Nutr","10.3164/jcbn.19-45","Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet.","2022-03-10"]
[9381,"31769484","Clin Sci (Lond)","10.1042/CS20190863","Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.","2022-03-10"]
[9399,"31760308","J Nutr Biochem","10.1016/j.jnutbio.2019.108256","Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.","2022-03-10"]
[9400,"31760070","J Hepatol","10.1016/j.jhep.2019.11.008","Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.","2022-03-10"]
[9420,"31756645","Cytokine","10.1016/j.cyto.2019.154927","Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.","2022-03-10"]
[9441,"31749300","Liver Int","10.1111/liv.14301","Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease.","2022-03-10"]
[9460,"31737175","Oxid Med Cell Longev","10.1155/2019/8742075","Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.","2022-03-10"]
[9478,"31728429","Transl Gastroenterol Hepatol","10.21037/tgh.2019.09.01","Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?","2022-03-10"]
[9497,"31719749","J Toxicol Pathol","10.1293/tox.2018-0045","Proteomics approach to investigate dynamic protein profile involved in high fat diet-induced fatty liver disease in rats.","2022-03-10"]
[9517,"31713012","Diabetologia","10.1007/s00125-019-05024-3","Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality.","2022-03-10"]
[9538,"31703079","PLoS One","10.1371/journal.pone.0224820","Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.","2022-03-10"]
[9557,"31695251","J Clin Exp Hepatol","10.1016/j.jceh.2018.10.004","Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[9575,"31689910","Nutrients","10.3390/nu11112642","The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.","2022-03-10"]
[9594,"31682518","Endocr Pract","10.4158/GL-2019-0406","CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY.","2022-03-10"]
[9618,"31673534","Hepatobiliary Surg Nutr","10.21037/hbsn.2019.04.03","Endogenously increased n-3 PUFA levels in fat-1 transgenic mice do not protect from non-alcoholic steatohepatitis.","2022-03-10"]
[9635,"31668088","Int J Environ Health Res","10.1080/09603123.2019.1680817","Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model.","2022-03-10"]
[9658,"31656991","Rev Endocr Metab Disord","10.1007/s11154-019-09510-2","Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease.","2022-03-10"]
[9677,"31651653","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001573","The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study.","2022-03-10"]
[9697,"31642599","HIV Med","10.1111/hiv.12799","Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients.","2022-03-10"]
[9714,"31635469","Vnitr Lek",null,"Serum markers in diagnostics of steatohepatitis.","2022-03-10"]
[9735,"31631714","Curr Med Res Opin","10.1080/03007995.2019.1683817","Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges.","2022-03-10"]
[9752,"31625373","Clin Lab","10.7754/Clin.Lab.2019.190335","Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[9770,"31616668","Front Med (Lausanne)","10.3389/fmed.2019.00202","Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.","2022-03-10"]
[9792,"31609745","Clin Transl Gastroenterol","10.14309/ctg.0000000000000081","Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.","2022-03-10"]
[9812,"31601203","BMC Endocr Disord","10.1186/s12902-019-0427-7","Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.","2022-03-10"]
[9830,"31595673","EMBO Mol Med","10.15252/emmm.201810124","Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis.","2022-03-10"]
[9850,"31592021","Hepatol Commun","10.1002/hep4.1413","Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation-Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl-Coenzyme A Desaturase As an Enhancer RNA.","2022-03-10"]
[9873,"31581129","Endocr Connect","10.1530/EC-19-0350","Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?","2022-03-10"]
[9891,"31573042","Int J Mol Med","10.3892/ijmm.2019.4350","Fatty liver and alteration of the gut microbiome induced by diallyl disulfide.","2022-03-10"]
[9913,"31563624","Gastroenterology","10.1053/j.gastro.2019.09.008","Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.","2022-03-10"]
[9930,"31555865","Pediatr Surg Int","10.1007/s00383-019-04560-8","Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.","2022-03-10"]
[9948,"31548169","Ann Hepatol","10.1016/j.aohep.2019.07.011","Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review.","2022-03-10"]
[9968,"31541078","Exp Mol Med","10.1038/s12276-019-0309-0","Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis.","2022-03-10"]
[9987,"31535207","J Gastroenterol","10.1007/s00535-019-01628-z","Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.","2022-03-10"]
[10009,"31526528","J Pediatr","10.1016/j.jpeds.2019.07.037","The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy.","2022-03-10"]
[10032,"31519069","Liver Int","10.1111/liv.14251","PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.","2022-03-10"]
[10049,"31514051","Redox Biol","10.1016/j.redox.2019.101314","Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.","2022-03-10"]
[10068,"31503515","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00193.2019","HDL flux is higher in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[10088,"31492960","Sci Rep","10.1038/s41598-019-49262-2","Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.","2022-03-10"]
[10107,"31482482","Obes Surg","10.1007/s11695-019-04161-3","Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting.","2022-03-10"]
[10121,"31474792","Ann Gastroenterol","10.20524/aog.2019.0405","High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy.","2022-03-10"]
[10143,"31470414","Endocr Connect","10.1530/EC-19-0366","Insulin resistance associates with hepatic lobular inflammation in subjects with obesity.","2022-03-10"]
[10163,"31463669","J Nat Med","10.1007/s11418-019-01356-x","Cynandione A from Cynanchum wilfordii inhibits hepatic de novo lipogenesis by activating the LKB1/AMPK pathway in HepG2 cells.","2022-03-10"]
[10183,"31445275","Int J Med Inform","10.1016/j.ijmedinf.2019.06.028","Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.","2022-03-10"]
[10201,"31436362","Liver Int","10.1111/liv.14225","Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.","2022-03-10"]
[10218,"31426291","Int J Mol Sci","10.3390/ijms20163987","Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.","2022-03-10"]
[10235,"31419414","Clin Chim Acta","10.1016/j.cca.2019.08.005","Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease.","2022-03-10"]
[10236,"31419372","Liver Int","10.1111/liv.14213","Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis.","2022-03-10"]
[10255,"31409765","Exp Mol Med","10.1038/s12276-019-0293-4","A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption.","2022-03-10"]
[10274,"31402655","J Agric Food Chem","10.1021/acs.jafc.9b02081","Novel Fluorescence-Based Method To Characterize the Antioxidative Effects of Food Metabolites on Lipid Droplets in Cultured Hepatocytes.","2022-03-10"]
[10293,"31396538","J Diabetes Res","10.1155/2019/4021623","Visfatin Induces Inflammation and Insulin Resistance via the NF-&#954;B and STAT3 Signaling Pathways in Hepatocytes.","2022-03-10"]
[10311,"31390281","J Med Food","10.1089/jmf.2018.4383","Elucidation of the Metabolic and Transcriptional Responses of an Oriental Herbal Medicine, Bangpungtongseong-san, to Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Mice.","2022-03-10"]
[10331,"31386691","PLoS One","10.1371/journal.pone.0220659","Plasma ApoE elevations are associated with NAFLD: The PREVEND Study.","2022-03-10"]
[10350,"31379558","Front Aging Neurosci","10.3389/fnagi.2019.00174","Liver Dysfunction as a Novel Player in Alzheimer's Progression: Looking Outside the Brain.","2022-03-10"]
[10370,"31371265","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2019.06.012","Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.","2022-03-10"]
[10388,"31359543","J Intern Med","10.1111/joim.12964","Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.","2022-03-10"]
[10407,"31349604","Nutrients","10.3390/nu11081712","Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).","2022-03-10"]
[10426,"31341444","Integr Med (Encinitas)",null,"Non-Alcoholic Fatty Liver Disease, an Overview.","2022-03-10"]
[10445,"31334443","Hepatol Commun","10.1002/hep4.1352","Influence of Fat on Differential Receptor Interacting Serine/Threonine Protein Kinase 1 Activity Leading to Apoptotic Cell Death in Murine Liver Ischemia Reperfusion Injury Through Caspase 8.","2022-03-10"]
[10462,"31326093","Am J Med Sci","10.1016/j.amjms.2019.06.008","Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group.","2022-03-10"]
[10494,"31311600","BMC Med","10.1186/s12916-019-1364-z","GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.","2022-03-10"]
[10506,"31309533","FEBS Lett","10.1002/1873-3468.13538","Chronic exposure to Pb2+ perturbs ChREBP transactivation and coerces hepatic dyslipidemia.","2022-03-10"]
[10523,"31301418","Life Sci","10.1016/j.lfs.2019.116644","(5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice.","2022-03-10"]
[10546,"31293341","World J Gastroenterol","10.3748/wjg.v25.i24.3056","Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease.","2022-03-10"]
[10564,"31289229","Proc Natl Acad Sci U S A","10.1073/pnas.1904360116","YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.","2022-03-10"]
[10587,"31279904","J Hepatol","10.1016/j.jhep.2019.06.023","Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.","2022-03-10"]
[10604,"31274482","Asian J Androl","10.4103/aja.aja_68_19","Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity.","2022-03-10"]
[10624,"31266632","Biochem Biophys Res Commun","10.1016/j.bbrc.2019.06.045","Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.","2022-03-10"]
[10643,"31256692","J Diet Suppl","10.1080/19390211.2019.1624671","The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis.","2022-03-10"]
[10662,"31246368","Aliment Pharmacol Ther","10.1111/apt.15316","Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.","2022-03-10"]
[10683,"31237317","J Frailty Aging","10.14283/jfa.2018.37","Relationship between Grip Strength and Nonalcoholic Fatty Liver Disease in Men Living with HIV Referred to a Metabolic Clinic.","2022-03-10"]
[10702,"31230225","Endocrine","10.1007/s12020-019-01977-y","Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities.","2022-03-10"]
[10725,"31220177","PLoS One","10.1371/journal.pone.0218543","Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice.","2022-03-10"]
[10743,"31214028","Front Pharmacol","10.3389/fphar.2019.00582","Prediction of VEGF-C as a Key Target of Pure Total Flavonoids From Citrus Against NAFLD in Mice via Network Pharmacology.","2022-03-10"]
[10761,"31206703","J Physiol","10.1113/JP277270","Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.","2022-03-10"]
[10780,"31197036","J Biol Chem","10.1074/jbc.RA119.008708","Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.","2022-03-10"]
[10798,"31187710","Curr Protein Pept Sci","10.2174/1389203720666190610161535","System Bioinformatic Approach Through Molecular Docking, Network Pharmacology and Microarray Data Analysis to Determine the Molecular Mechanism Underlying the Effects of Rehmanniae Radix Praeparata on Cardiovascular Diseases.","2022-03-10"]
[10816,"31176163","Biomed Pharmacother","10.1016/j.biopha.2019.109047","Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD).","2022-03-10"]
[10833,"31168511","Hepatol Commun","10.1002/hep4.1341","Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.","2022-03-10"]
[10854,"31155687","Dig Dis Sci","10.1007/s10620-019-05687-3","Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.","2022-03-10"]
[10874,"31145699","JCI Insight","10.1172/jci.insight.124819","A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans.","2022-03-10"]
[10879,"31143330","Pan Afr Med J","10.11604/pamj.2019.32.25.16345","Non alcoholic fatty liver disease in a young male with celiac disease.","2022-03-10"]
[10914,"31126802","Hepatobiliary Pancreat Dis Int","10.1016/j.hbpd.2019.05.002","miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.","2022-03-10"]
[10932,"31115065","J Gastroenterol Hepatol","10.1111/jgh.14734","Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.","2022-03-10"]
[10953,"31105018","Ann Hepatol","10.1016/j.aohep.2019.01.011","\"Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?\"","2022-03-10"]
[10974,"31096638","Cells","10.3390/cells8050457","Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro.","2022-03-10"]
[10992,"31089384","Iran J Pharm Res",null,"Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.","2022-03-10"]
[11013,"31081997","Liver Int","10.1111/liv.14135","Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.","2022-03-10"]
[11033,"31076231","Ultrasound Med Biol","10.1016/j.ultrasmedbio.2019.03.021","Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.","2022-03-10"]
[11054,"31064654","Biochem Biophys Res Commun","10.1016/j.bbrc.2019.04.069","IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress.","2022-03-10"]
[11074,"31057294","World J Gastroenterol","10.3748/wjg.v25.i15.1783","Repurposing drugs to target nonalcoholic steatohepatitis.","2022-03-10"]
[11091,"31046138","Clin Endocrinol (Oxf)","10.1111/cen.14001","The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects.","2022-03-10"]
[11092,"31045941","AIDS","10.1097/QAD.0000000000002161","A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.","2022-03-10"]
[11110,"31037218","J Nutr Sci","10.1017/jns.2019.10","Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.","2022-03-10"]
[11129,"31030165","J Nutr Biochem","10.1016/j.jnutbio.2019.03.006","Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.","2022-03-10"]
[11146,"31024089","Nat Rev Gastroenterol Hepatol","10.1038/s41575-019-0144-8","Past, present and future perspectives in nonalcoholic fatty liver disease.","2022-03-10"]
[11167,"31013265","Med Sci Monit","10.12659/MSM.914044","Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance.","2022-03-10"]
[11186,"31007691","J Res Med Sci","10.4103/jrms.JRMS_282_18","A randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[11209,"30998190","Ann Biol Clin (Paris)","10.1684/abc.2019.1436","[Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].","2022-03-10"]
[11229,"30983887","J Inflamm (Lond)","10.1186/s12950-019-0211-5","Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease.","2022-03-10"]
[11247,"30974975","Hum Exp Toxicol","10.1177/0960327119842248","Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet.","2022-03-10"]
[11279,"30961499","Curr Vasc Pharmacol","10.2174/1570161117666190405164313","Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.","2022-03-10"]
[11286,"30957185","Mol Med Rep","10.3892/mmr.2019.10139","Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA&#8209;treated HepG2 cells.","2022-03-10"]
[11307,"30945694","J Genet",null,"Genetics of nonalcoholic fatty liver disease in Asian populations.","2022-03-10"]
[11324,"30937868","Adv Exp Med Biol","10.1007/978-3-030-11093-2_9","Pericytes in the Liver.","2022-03-10"]
[11343,"30929342","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2019.03.012","[Research progress of single-nucleotide polymorphism in theTM6SF2 rs58542926].","2022-03-10"]
[11360,"30922791","Clin Nutr","10.1016/j.clnu.2019.02.024","Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.","2022-03-10"]
[11383,"30917662","Rev Esp Enferm Dig","10.17235/reed.2019.6269/2019","Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype.","2022-03-10"]
[11403,"30909521","Cells","10.3390/cells8030277","A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver.","2022-03-10"]
[11424,"30901028","J Clin Endocrinol Metab","10.1210/jc.2018-02795","Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content.","2022-03-10"]
[11443,"30892882","J Agric Food Chem","10.1021/acs.jafc.8b05032","Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[11463,"30885145","BMC Gastroenterol","10.1186/s12876-019-0958-4","The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.","2022-03-10"]
[11483,"30877020","Pharmacol Ther","10.1016/j.pharmthera.2019.03.006","Intestinal microbiome as a novel therapeutic target for local and systemic inflammation.","2022-03-10"]
[11501,"30868786","J Ayub Med Coll Abbottabad",null,"Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid.","2022-03-10"]
[11521,"30860882","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00474.2018","Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease.","2022-03-10"]
[11541,"30851175","J Gastrointestin Liver Dis","10.15403/jgld.2014.1121.281.alc","Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.","2022-03-10"]
[11560,"30839434","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001385","Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.","2022-03-10"]
[11580,"30832407","Nutrients","10.3390/nu11030541","Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.","2022-03-10"]
[11599,"30824402","Nutr Res","10.1016/j.nutres.2018.12.003","Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.","2022-03-10"]
[11619,"30817593","Medicine (Baltimore)","10.1097/MD.0000000000014672","Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.","2022-03-10"]
[11638,"30809789","Semin Liver Dis","10.1055/s-0038-1676806","Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets.","2022-03-10"]
[11655,"30802917","Exp Clin Endocrinol Diabetes","10.1055/a-0848-8076","Progression of Albuminuria Among Patients with Type 1 Diabetes Mellitus: A Long Term Observational Follow-up Study.","2022-03-10"]
[11664,"30798028","Environ Pollut","10.1016/j.envpol.2019.01.112","MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts.","2022-03-10"]
[11696,"30788556","Abdom Radiol (NY)","10.1007/s00261-019-01931-6","Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).","2022-03-10"]
[11713,"30781472","Antioxidants (Basel)","10.3390/antiox8020044","Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.","2022-03-10"]
[11732,"30772951","J Cell Mol Med","10.1111/jcmm.14232","Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.","2022-03-10"]
[11752,"30766413","Fed Pract",null,"Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans.","2022-03-10"]
[11770,"30758165","J Sports Med Phys Fitness","10.23736/S0022-4707.19.09231-4","Aerobic capacity and exercise performance in nonalcoholic fatty liver disease.","2022-03-10"]
[11789,"30744560","BMC Gastroenterol","10.1186/s12876-019-0951-y","Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis.","2022-03-10"]
[11807,"30732129","Medicine (Baltimore)","10.1097/MD.0000000000014139","Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[11826,"30719457","J Immunol Res","10.1155/2019/3954890","The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD.","2022-03-10"]
[11844,"30710884","Nutrition","10.1016/j.nut.2018.10.016","No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women.","2022-03-10"]
[11861,"30705715","World J Hepatol","10.4254/wjh.v11.i1.1","Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.","2022-03-10"]
[11879,"30700500","Biochem Soc Trans","10.1042/BST20180335","Dissecting metabolism using zebrafish models of disease.","2022-03-10"]
[11897,"30689995","Eur J Pharmacol","10.1016/j.ejphar.2019.01.043","Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease.","2022-03-10"]
[11916,"30683312","Biochem Biophys Res Commun","10.1016/j.bbrc.2018.12.149","Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway.","2022-03-10"]
[11917,"30682878","Medicina (Kaunas)","10.3390/medicina55020026","Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[11936,"30674308","BMC Med","10.1186/s12916-019-1251-7","The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study.","2022-03-10"]
[11956,"30668889","J Gastroenterol Hepatol","10.1111/jgh.14608","Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.","2022-03-10"]
[11978,"30659956","Exp Gerontol","10.1016/j.exger.2019.01.014","Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPAR&#945; signaling pathway in cultured hepatocytes.","2022-03-10"]
[11997,"30653341","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00358.2018","Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.","2022-03-10"]
[12019,"30641737","Diabetes Metab Syndr","10.1016/j.dsx.2018.10.001","Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.","2022-03-10"]
[12039,"30628769","ACS Appl Mater Interfaces","10.1021/acsami.8b19717","Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[12054,"30621686","Lipids Health Dis","10.1186/s12944-018-0955-6","Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.","2022-03-10"]
[12074,"30614770","Metab Syndr Relat Disord","10.1089/met.2018.0050","Pubertal Status and Gonadal Functions in Obese Boys with Fatty Liver.","2022-03-10"]
[12092,"30605883","Redox Biol","10.1016/j.redox.2018.101092","Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.","2022-03-10"]
[12110,"30598254","Surg Obes Relat Dis","10.1016/j.soard.2018.10.035","Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders.","2022-03-10"]
[12128,"30590937","Vnitr Lek",null,"Transient elastography - role in the assessment of the liver disease development.","2022-03-10"]
[12145,"30582898","Biochem Pharmacol","10.1016/j.bcp.2018.12.018","Developments in bile salt based therapies: A critical overview.","2022-03-10"]
[12164,"30577089","Hepatol Res","10.1111/hepr.13304","Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus.","2022-03-10"]
[12181,"30573200","Arch Med Res","10.1016/j.arcmed.2018.11.006","Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models.","2022-03-10"]
[12200,"30564426","R Soc Open Sci","10.1098/rsos.181457","Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.","2022-03-10"]
[12221,"30557833","Biomed Pharmacother","10.1016/j.biopha.2018.12.039","Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol.","2022-03-10"]
[12240,"30551380","Biomed Pharmacother","10.1016/j.biopha.2018.10.196","Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.","2022-03-10"]
[12260,"30542827","Obes Surg","10.1007/s11695-018-03641-2","Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.","2022-03-10"]
[12277,"30537674","Biomed Pharmacother","10.1016/j.biopha.2018.12.003","Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.","2022-03-10"]
[12294,"30522122","Cell Physiol Biochem","10.1159/000495830","Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.","2022-03-10"]
[12314,"30502056","EBioMedicine","10.1016/j.ebiom.2018.11.020","Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.","2022-03-10"]
[12332,"30511198","Dig Dis Sci","10.1007/s10620-018-5395-7","Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.","2022-03-10"]
[12356,"30488259","Obes Surg","10.1007/s11695-018-3612-2","A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.","2022-03-10"]
[12374,"30482436","J Pharmacol Sci","10.1016/j.jphs.2018.09.012","Lipid-modulate activity of Cichorium glandulosum Boiss. et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model.","2022-03-10"]
[12394,"30472795","Mass Spectrom Rev","10.1002/mas.21583","Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.","2022-03-10"]
[12414,"30465824","Free Radic Biol Med","10.1016/j.freeradbiomed.2018.11.016","Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.","2022-03-10"]
[12433,"30457067","Proc Nutr Soc","10.1017/S0029665118002653","Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state.","2022-03-10"]
[12452,"30451739","Transplantation","10.1097/TP.0000000000002497","Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.","2022-03-10"]
[12472,"30440285","Annu Int Conf IEEE Eng Med Biol Soc","10.1109/EMBC.2018.8513011","Objective Liver Fibrosis Estimation from Shear Wave Elastography.","2022-03-10"]
[12495,"30423871","Int J Environ Res Public Health","10.3390/ijerph15112521","Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.","2022-03-10"]
[12515,"30412872","Sci Total Environ","10.1016/j.scitotenv.2018.10.387","Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease.","2022-03-10"]
[12533,"30405551","Front Microbiol","10.3389/fmicb.2018.02470","Endotoxemia by Porphyromonas gingivalis Injection Aggravates Non-alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice.","2022-03-10"]
[12551,"30394863","Metab Syndr Relat Disord","10.1089/met.2018.0072","Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers.","2022-03-10"]
[12569,"30387292","J Diabetes Investig","10.1111/jdi.12967","Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men.","2022-03-10"]
[12588,"30374329","Front Endocrinol (Lausanne)","10.3389/fendo.2018.00588","Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.","2022-03-10"]
[12606,"30366981","Mol Pharmacol","10.1124/mol.118.113217","Cilostazol Improves HFD-Induced Hepatic Steatosis by Upregulating Hepatic STAMP2 Expression through AMPK.","2022-03-10"]
[12625,"30360555","Nutrients","10.3390/nu10111571","Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence.","2022-03-10"]
[12642,"30353552","Aliment Pharmacol Ther","10.1111/apt.15015","The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.","2022-03-10"]
[12660,"30341231","Postgrad Med J","10.1136/postgradmedj-2018-135967","Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.","2022-03-10"]
[12677,"30333571","Sci Rep","10.1038/s41598-018-32853-w","Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver.","2022-03-10"]
[12696,"30323853","Nutr Metab (Lond)","10.1186/s12986-018-0304-9","Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer.","2022-03-10"]
[12715,"30317776","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2018.07.009","[Nutritional status and energy metabolism characteristics in patients with nonalcoholic fatty liver disease].","2022-03-10"]
[12736,"30310298","Diabetes Metab Syndr Obes","10.2147/DMSO.S175935","Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians.","2022-03-10"]
[12754,"30300671","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2018.10.010","Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.","2022-03-10"]
[12755,"30300289","Transplantation","10.1097/TP.0000000000002483","Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.","2022-03-10"]
[12772,"30294300","Front Endocrinol (Lausanne)","10.3389/fendo.2018.00548","Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Permanently Alters Blood-Liver Balance of Lipids in Male Mice.","2022-03-10"]
[12804,"30279702","Front Genet","10.3389/fgene.2018.00396","Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity.","2022-03-10"]
[12811,"30273090","J Med Food","10.1089/jmf.2017.4135","Aqueous Extract of Humulus japonicus Attenuates Hyperlipidemia and Fatty Liver in Obese Mice.","2022-03-10"]
[12829,"30265007","J Proteome Res","10.1021/acs.jproteome.8b00417","d2ome, Software for in Vivo Protein Turnover Analysis Using Heavy Water Labeling and LC-MS, Reveals Alterations of Hepatic Proteome Dynamics in a Mouse Model of NAFLD.","2022-03-10"]
[12849,"30257633","Med J Aust","10.5694/mja17.01067","The gut microbiota: cause and cure of gut diseases.","2022-03-10"]
[12868,"30249611","Br J Gen Pract","10.3399/bjgp18X699377","GPs' experiences and perceptions of early detection of liver disease: a qualitative study in primary care.","2022-03-10"]
[12886,"30241896","Cytokine","10.1016/j.cyto.2018.09.004","Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity.","2022-03-10"]
[12904,"30232020","Ultrasound Med Biol","10.1016/j.ultrasmedbio.2018.07.019","Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance.","2022-03-10"]
[12926,"30222981","Toxicol Appl Pharmacol","10.1016/j.taap.2018.09.015","Met-enkephalin improves metabolic syndrome in high fat diet challenged mice through promotion of adipose tissue browning.","2022-03-10"]
[12947,"30213555","Gastroenterology","10.1053/j.gastro.2018.09.010","Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.","2022-03-10"]
[12965,"30206277","Sci Rep","10.1038/s41598-018-31886-5","Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.","2022-03-10"]
[12983,"30197273","J Clin Lipidol","10.1016/j.jacl.2018.08.003","Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.","2022-03-10"]
[13003,"30186230","Front Endocrinol (Lausanne)","10.3389/fendo.2018.00455","Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis.","2022-03-10"]
[13020,"30178600","Diabetes Obes Metab","10.1111/dom.13520","Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.","2022-03-10"]
[13040,"30170220","Atherosclerosis","10.1016/j.atherosclerosis.2018.07.028","Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.","2022-03-10"]
[13065,"30154499","Sci Rep","10.1038/s41598-018-31389-3","The PPAR&#945; Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity.","2022-03-10"]
[13084,"30144360","J Gastroenterol Hepatol","10.1111/jgh.14448","Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.","2022-03-10"]
[13104,"30136293","Aliment Pharmacol Ther","10.1111/apt.14937","Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.","2022-03-10"]
[13124,"30128963","Curr Nutr Rep","10.1007/s13668-018-0235-0","Nutritional Ketosis for Weight Management and Reversal of Metabolic Syndrome.","2022-03-10"]
[13141,"30120404","Pediatr Res","10.1038/s41390-018-0132-7","In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children.","2022-03-10"]
[13160,"30109182","Acta Pharm Sin B","10.1016/j.apsb.2017.10.003","Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.","2022-03-10"]
[13182,"30097139","J Psychosom Res","10.1016/j.jpsychores.2018.07.004","Quality of life in patients with nonalcoholic fatty liver disease: A systematic review.","2022-03-10"]
[13199,"30089858","Lab Invest","10.1038/s41374-018-0112-x","Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis.","2022-03-10"]
[13217,"30077664","Surg Obes Relat Dis","10.1016/j.soard.2018.05.024","Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.","2022-03-10"]
[13236,"30070714","Hepatology","10.1002/hep.30125","Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition.","2022-03-10"]
[13256,"30061575","Nat Commun","10.1038/s41467-018-05383-2","Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis.","2022-03-10"]
[13274,"30056271","Redox Biol","10.1016/j.redox.2018.07.011","Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy.","2022-03-10"]
[13293,"30047462","Chin J Nat Med","10.1016/S1875-5364(18)30074-8","Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.","2022-03-10"]
[13311,"30037123","Nutrients","10.3390/nu10070943","Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk.","2022-03-10"]
[13329,"30028193","Br J Radiol","10.1259/bjr.20170587","Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis.","2022-03-10"]
[13348,"30019185","J Physiol Biochem","10.1007/s13105-018-0644-y","Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.","2022-03-10"]
[13366,"30014489","Hepatology","10.1002/hep.30161","Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.","2022-03-10"]
[13383,"30008738","PPAR Res","10.1155/2018/4292509","Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice.","2022-03-10"]
[13404,"29992975","Sci Rep","10.1038/s41598-018-28650-0","A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.","2022-03-10"]
[13421,"29986142","J Med Chem","10.1021/acs.jmedchem.8b00864","Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[13440,"29973631","Sci Rep","10.1038/s41598-018-28494-8","Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study.","2022-03-10"]
[13457,"29963467","Euroasian J Hepatogastroenterol","10.5005/jp-journals-10018-1263","Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka.","2022-03-10"]
[13474,"29956209","Adv Exp Med Biol","10.1007/978-981-10-8684-7_8","The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[13493,"29950116","Expert Opin Investig Drugs","10.1080/13543784.2018.1494153","MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis.","2022-03-10"]
[13512,"29940269","J Hepatol","10.1016/j.jhep.2018.06.008","Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.","2022-03-10"]
[13531,"29928260","Front Endocrinol (Lausanne)","10.3389/fendo.2018.00293","Liver Enlargement Predicts Obstructive Sleep Apnea-Hypopnea Syndrome in Morbidly Obese Women.","2022-03-10"]
[13549,"29916857","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001189","Serum lactate level accurately predicts mortality in critically ill patients with cirrhosis with acute kidney injury.","2022-03-10"]
[13565,"29907965","Hepatology","10.1002/hep.30113","The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice.","2022-03-10"]
[13568,"29904577","F1000Res","10.12688/f1000research.13515.1","Surgical treatment of obesity.","2022-03-10"]
[13585,"29894414","Transplantation","10.1097/TP.0000000000002319","Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.","2022-03-10"]
[13603,"29883530","Transpl Int","10.1111/tri.13288","Fat and liver transplantation: clinical implications.","2022-03-10"]
[13622,"29869810","Diabet Med","10.1111/dme.13697","Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.","2022-03-10"]
[13640,"29859544","Br J Nutr","10.1017/S0007114518000946","Do inositol supplements enhance phosphatidylinositol supply and thus support endoplasmic reticulum function?","2022-03-10"]
[13659,"29852170","Biochem Biophys Res Commun","10.1016/j.bbrc.2018.05.187","Suppression of NF-&#954;B activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.","2022-03-10"]
[13676,"29844879","Oncotarget","10.18632/oncotarget.23816","Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.","2022-03-10"]
[13693,"29803897","Clin Chim Acta","10.1016/j.cca.2018.05.046","Uric acid and cardiovascular disease.","2022-03-10"]
[13711,"29797393","Liver Int","10.1111/liv.13886","Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.","2022-03-10"]
[13729,"29787418","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001169","Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.","2022-03-10"]
[13746,"29778532","Biochem Biophys Res Commun","10.1016/j.bbrc.2018.05.078","Non-alcoholic fatty liver disease: Insights from sphingolipidomics.","2022-03-10"]
[13767,"29766801","Curr Pharm Biotechnol","10.2174/1389201019666180514170122","Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective.","2022-03-10"]
[13785,"29759071","Lipids Health Dis","10.1186/s12944-018-0762-0","Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.","2022-03-10"]
[13806,"29746920","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2018.04.024","Animal models of NAFLD from the pathologist's point of view.","2022-03-10"]
[13829,"29735977","Cell Mol Immunol","10.1038/s41423-018-0032-0","Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.","2022-03-10"]
[13847,"29729104","Liver Transpl","10.1002/lt.25189","The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.","2022-03-10"]
[13866,"29719629","Oncotarget","10.18632/oncotarget.23603","Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.","2022-03-10"]
[13883,"29710765","Nutrients","10.3390/nu10050547","A Vitamin E-Enriched Antioxidant Diet Interferes with the Acute Adaptation of the Liver to Physical Exercise in Mice.","2022-03-10"]
[13901,"29702089","Chem Biol Interact","10.1016/j.cbi.2018.04.023","Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.","2022-03-10"]
[13930,"29683981","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001141","Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.","2022-03-10"]
[13939,"29679552","Clin Biochem","10.1016/j.clinbiochem.2018.04.017","Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease.","2022-03-10"]
[13961,"29670908","Biomed Res Int","10.1155/2018/8071093","Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis.","2022-03-10"]
[13978,"29661431","Transplant Proc","10.1016/j.transproceed.2018.02.021","Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.","2022-03-10"]
[13996,"29653100","Chem Biol Interact","10.1016/j.cbi.2018.04.010","Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet.","2022-03-10"]
[14015,"29633352","J Gastroenterol Hepatol","10.1111/jgh.14156","Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[14033,"29624631","Cancer","10.1002/cncr.31373","Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.","2022-03-10"]
[14054,"29608451","J Clin Gastroenterol","10.1097/MCG.0000000000001026","Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments.","2022-03-10"]
[14078,"29600696","Minerva Gastroenterol Dietol","10.23736/S1121-421X.18.02490-X","Helicobacter pylori in metabolic related diseases.","2022-03-10"]
[14097,"29589386","Endocrinol Metab (Seoul)","10.3803/EnM.2018.33.1.33","Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[14116,"29575055","J Cell Biochem","10.1002/jcb.26776","MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.","2022-03-10"]
[14135,"29569260","Clin Exp Pharmacol Physiol","10.1111/1440-1681.12940","Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.","2022-03-10"]
[14152,"29562379","Acta Gastroenterol Belg",null,"The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[14172,"29552625","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2017.11.016","Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are&#160;Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).","2022-03-10"]
[14192,"29536744","Bratisl Lek Listy","10.4149/BLL_2018_030","The relationship between hepatocytes and small bowel after early and short food restriction: What the results show in morphometry.","2022-03-10"]
[14217,"29520889","Phytother Res","10.1002/ptr.6073","Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.","2022-03-10"]
[14238,"29510489","Int J Mol Sci","10.3390/ijms19030722","Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease.","2022-03-10"]
[14255,"29503733","BMJ Open Gastroenterol","10.1136/bmjgast-2017-000150","Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study.","2022-03-10"]
[14275,"29488482","Ter Arkh","10.17116/terarkh20178912204-210","[Optimization of therapy for hepatobiliary disorders in psoriatic patients].","2022-03-10"]
[14292,"29479832","Liver Int","10.1111/liv.13730","Osteoporosis in chronic liver disease.","2022-03-10"]
[14317,"29469051","Ann Hepatol","10.5604/01.3001.0010.8631","Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse.","2022-03-10"]
[14323,"29466466","PLoS One","10.1371/journal.pone.0193138","Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.","2022-03-10"]
[14356,"29450671","Inflammopharmacology","10.1007/s10787-018-0443-7","Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice.","2022-03-10"]
[14377,"29438460","Adv Nutr","10.1093/advances/nmx007","Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.","2022-03-10"]
[14395,"29428667","Biomed Pharmacother","10.1016/j.biopha.2018.01.144","Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice.","2022-03-10"]
[14412,"29419789","Nutrients","10.3390/nu10020187","Aged Oolong Tea Reduces High-Fat Diet-Induced Fat Accumulation and Dyslipidemia by Regulating the AMPK/ACC Signaling Pathway.","2022-03-10"]
[14413,"29419350","Ultrastruct Pathol","10.1080/01913123.2017.1422581","Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet.","2022-03-10"]
[14432,"29409538","BMC Res Notes","10.1186/s13104-018-3212-1","Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.","2022-03-10"]
[14452,"29404465","Hepatol Commun","10.1002/hep4.1055","Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation.","2022-03-10"]
[14469,"29398867","World J Gastroenterol","10.3748/wjg.v24.i4.461","Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.","2022-03-10"]
[14486,"29387723","Biomed Res Int","10.1155/2017/6297651","The Common Mechanisms of Sarcopenia and NAFLD.","2022-03-10"]
[14504,"29378152","Can J Physiol Pharmacol","10.1139/cjpp-2017-0559","Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats.","2022-03-10"]
[14525,"29367725","Sci Rep","10.1038/s41598-018-19973-z","Omentectomy Prevents Metabolic Syndrome By Reducing Appetite and Body Weight In A Diet-Induced Obesity Rat Model.","2022-03-10"]
[14547,"29359454","J Ultrasound Med","10.1002/jum.14537","Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[14566,"29351115","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001075","Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.","2022-03-10"]
[14583,"29341046","Horm Metab Res","10.1055/s-0043-124970","Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children.","2022-03-10"]
[14601,"29329924","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2017.10.027","Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[14618,"29321674","Sci Rep","10.1038/s41598-017-18854-1","Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population.","2022-03-10"]
[14639,"29312569","Oncotarget","10.18632/oncotarget.22163","Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXR&#945; signaling pathway.","2022-03-10"]
[14659,"29304731","BMC Gastroenterol","10.1186/s12876-017-0736-0","Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.","2022-03-10"]
[14678,"29290651","World J Gastroenterol","10.3748/wjg.v23.i46.8140","miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.","2022-03-10"]
[14697,"29286155","Mol Med Rep","10.3892/mmr.2017.8326","Mesenchymal stem cells reverse high&#8209;fat diet&#8209;induced non&#8209;alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice.","2022-03-10"]
[14716,"29274380","Free Radic Biol Med","10.1016/j.freeradbiomed.2017.12.019","The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.","2022-03-10"]
[14734,"29266667","Aging Cell","10.1111/acel.12696","Plasticity of lifelong calorie-restricted C57BL/6J mice in adapting to a medium-fat diet intervention at old age.","2022-03-10"]
[14756,"29253525","Pharmacol Res","10.1016/j.phrs.2017.12.013","Crosstalk mechanisms in hepatoprotection: Thyroid hormone-docosahexaenoic acid (DHA) and DHA-extra virgin olive oil combined protocols.","2022-03-10"]
[14778,"29238323","Front Endocrinol (Lausanne)","10.3389/fendo.2017.00335","Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.","2022-03-10"]
[14796,"29227477","Nat Med","10.1038/nm.4453","The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.","2022-03-10"]
[14816,"29222051","Biochem Biophys Res Commun","10.1016/j.bbrc.2017.12.003","Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced obese mice.","2022-03-10"]
[14834,"29212576","Gene Expr","10.3727/105221617X15124844266408","The Effects of Physical Exercise on Fatty Liver Disease.","2022-03-10"]
[14856,"29202557","Korean J Intern Med","10.3904/kjim.2017.343","Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.","2022-03-10"]
[14874,"29197393","Lipids Health Dis","10.1186/s12944-017-0613-4","Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.","2022-03-10"]
[14893,"29188065","BMJ Open Diabetes Res Care","10.1136/bmjdrc-2017-000393","High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-control study.","2022-03-10"]
[14914,"29175651","Atherosclerosis","10.1016/j.atherosclerosis.2017.11.012","Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis.","2022-03-10"]
[14939,"29165568","Am J Clin Pathol","10.1093/ajcp/aqx104","Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[14957,"29156529","Biomed Pharmacother","10.1016/j.biopha.2017.10.035","Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.","2022-03-10"]
[14976,"29148806","J Med Chem","10.1021/acs.jmedchem.7b00907","Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).","2022-03-10"]
[14993,"29133343","Diabetes Care","10.2337/dc17-1349","Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.","2022-03-10"]
[15012,"29128057","Clin Liver Dis","10.1016/j.cld.2017.08.014","Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.","2022-03-10"]
[15031,"29122967","Clin Sci (Lond)","10.1042/CS20171039","Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency.","2022-03-10"]
[15048,"29118995","Open Heart","10.1136/openhrt-2017-000631","Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis.","2022-03-10"]
[15067,"29111276","Diabetes Res Clin Pract","10.1016/j.diabres.2017.10.019","The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.","2022-03-10"]
[15075,"29108123","Hepatology","10.1002/hep.29639","Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.","2022-03-10"]
[15106,"29091299","Hepatology","10.1002/hep.29633","Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.","2022-03-10"]
[15123,"29085206","World J Gastroenterol","10.3748/wjg.v23.i36.6571","Nonalcoholic fatty liver disease: Evolving paradigms.","2022-03-10"]
[15141,"29077210","Hepatology","10.1002/hep.29616","Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.","2022-03-10"]
[15160,"29067086","Pak J Med Sci","10.12669/pjms.334.12315","The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs.","2022-03-10"]
[15181,"29059699","Hepatol Res","10.1111/hepr.12992","Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.","2022-03-10"]
[15199,"29055914","Ann Hepatol","10.5604/01.3001.0010.5272","Evidence-Based Medicine and the Problem of Healthy Volunteers.","2022-03-10"]
[15220,"29038352","Physiol Rep","10.14814/phy2.13386","Differential relationships of hepatic and epicardial fat to body composition in HIV.","2022-03-10"]
[15238,"29028281","Liver Int","10.1111/liv.13612","Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.","2022-03-10"]
[15239,"29028128","Hepatology","10.1002/hep.29596","Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.","2022-03-10"]
[15257,"29022011","Heliyon","10.1016/j.heliyon.2017.e00416","Placental extract ameliorates non-alcoholic steatohepatitis (NASH) by exerting protective effects on endothelial cells.","2022-03-10"]
[15279,"28989095","J Hepatol","10.1016/j.jhep.2017.09.016","Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.","2022-03-10"]
[15297,"28980219","Curr Environ Health Rep","10.1007/s40572-017-0166-8","Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease.","2022-03-10"]
[15314,"28970532","Sci Rep","10.1038/s41598-017-13058-z","Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation.","2022-03-10"]
[15333,"28964324","Metabolism","10.1016/j.metabol.2017.06.007","Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.","2022-03-10"]
[15351,"28952917","Exp Clin Transplant","10.6002/ect.2016.0340","Accuracy of Noninvasive Fibrosis Scores in Predicting the Presence of Fibrosis in Patients after Liver Transplantation.","2022-03-10"]
[15369,"28942246","Free Radic Biol Med","10.1016/j.freeradbiomed.2017.09.016","Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.","2022-03-10"]
[15388,"28935188","Dig Liver Dis","10.1016/j.dld.2017.08.022","Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.","2022-03-10"]
[15406,"28927249","Minerva Gastroenterol Dietol","10.23736/S1121-421X.17.02376-5","Gut microbiota, obesity and metabolic disorders.","2022-03-10"]
[15424,"28919478","Biochim Biophys Acta Mol Cell Biol Lipids","10.1016/j.bbalip.2017.09.007","Atorvastatin reduces lipid accumulation in the liver by activating protein kinase A-mediated phosphorylation of perilipin 5.","2022-03-10"]
[15442,"28905102","Arch Dermatol Res","10.1007/s00403-017-1775-7","Digestive system in psoriasis: an update.","2022-03-10"]
[15465,"28894517","Middle East J Dig Dis","10.15171/mejdd.2017.66","Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial.","2022-03-10"]
[15479,"28883861","Arch Med Sci","10.5114/aoms.2017.68972","Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women.","2022-03-10"]
[15498,"28875318","Eur J Nutr","10.1007/s00394-017-1524-x","Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.","2022-03-10"]
[15517,"28866089","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2017.08.001","The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.","2022-03-10"]
[15539,"28853202","Liver Int","10.1111/liv.13562","Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.","2022-03-10"]
[15558,"28844958","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2017.08.017","Growth arrest and DNA damage-inducible 45&#945; protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.","2022-03-10"]
[15579,"28834687","Appl Physiol Nutr Metab","10.1139/apnm-2017-0317","Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet.","2022-03-10"]
[15596,"28823367","Hepatobiliary Pancreat Dis Int","10.1016/S1499-3872(17)60019-5","Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[15615,"28809727","Ann Hepatol","10.5604/01.3001.0010.2713","Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.","2022-03-10"]
[15635,"28797077","PLoS One","10.1371/journal.pone.0181052","Gender difference in NASH susceptibility: Roles of hepatocyte Ikk&#946; and Sult1e1.","2022-03-10"]
[15654,"28781785","Mol Clin Oncol","10.3892/mco.2017.1314","Effect of age on the development of chemotherapy-associated liver injury in colorectal cancer liver metastasis.","2022-03-10"]
[15677,"28770225","Biomed Res Int","10.1155/2017/8234507","PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-&#947;/CD36 Pathway.","2022-03-10"]
[15696,"28754826","J Lipid Res","10.1194/jlr.M078980","Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver.","2022-03-10"]
[15715,"28747982","Lab Anim Res","10.5625/lar.2017.33.2.157","Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources.","2022-03-10"]
[15735,"28737569","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000001614","Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[15756,"28726335","J Gastroenterol Hepatol","10.1111/jgh.13903","Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.","2022-03-10"]
[15776,"28714900","Int J Mol Sci","10.3390/ijms18071534","A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[15803,"28702206","BMC Obes","10.1186/s40608-017-0163-3","Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetes.","2022-03-10"]
[15820,"28694246","Eur J Endocrinol","10.1530/EJE-16-1063","MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.","2022-03-10"]
[15845,"28685623","Expert Opin Pharmacother","10.1080/14656566.2017.1351946","Cardiovascular disease prevention strategies for type 2 diabetes mellitus.","2022-03-10"]
[15862,"28677333","Aliment Pharmacol Ther","10.1111/apt.14210","Review article: new treatments in non-alcoholic fatty liver disease.","2022-03-10"]
[15884,"28673574","Med Hypotheses","10.1016/j.mehy.2017.05.013","LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge.","2022-03-10"]
[15904,"28659437","Sci Transl Med","10.1126/scitranslmed.aal3694","Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-&#946;.","2022-03-10"]
[15925,"28648927","J Ethnopharmacol","10.1016/j.jep.2017.06.030","Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.","2022-03-10"]
[15945,"28641570","Endocr Metab Immune Disord Drug Targets","10.2174/1871530317666170613123958","1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity.","2022-03-10"]
[15963,"28636830","Appl Physiol Nutr Metab","10.1139/apnm-2016-0635","Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBP&#946; signalling in high-fat-diet-treated mice.","2022-03-10"]
[15981,"28628039","J Clin Invest","10.1172/JCI95008","ChREBP refines the hepatic response to fructose to protect the liver from injury.","2022-03-10"]
[16004,"28616057","J Res Med Sci","10.4103/jrms.JRMS_788_16","Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[16022,"28606220","Nutr Res Rev","10.1017/S0954422417000087","Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer.","2022-03-10"]
[16041,"28596677","World J Gastroenterol","10.3748/wjg.v23.i19.3407","Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.","2022-03-10"]
[16062,"28587208","Mar Drugs","10.3390/md15060163","Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.","2022-03-10"]
[16079,"28580850","Orv Hetil","10.1556/650.2017.30775","[Advances in the pathogenesis of non alcoholic fatty liver disease].","2022-03-10"]
[16098,"28573064","World J Gastrointest Pathophysiol","10.4291/wjgp.v8.i2.11","Nonalcoholic fatty liver disease: Diagnostic biomarkers.","2022-03-10"]
[16099,"28572039","Dig Liver Dis","10.1016/j.dld.2017.05.002","AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[16117,"31682383","J Tradit Chin Med",null,"Colon hydrotherapy plus Traditional Chinese Medicine to treat non-alcoholic fatty liver disease: a pilot study.","2022-03-10"]
[16136,"28544608","Obes Rev","10.1111/obr.12556","Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance?","2022-03-10"]
[16153,"28535787","BMC Infect Dis","10.1186/s12879-017-2462-1","Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.","2022-03-10"]
[16170,"28526812","Oncotarget","10.18632/oncotarget.17598","Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.","2022-03-10"]
[16191,"28511161","Wiad Lek",null,"[The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity].","2022-03-10"]
[16208,"28506365","Gastroenterol Clin North Am","10.1016/j.gtc.2017.01.004","Drug-induced Liver Injury: The Hepatic Pathologist's Approach.","2022-03-10"]
[16229,"28497760","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(16)30241-2","The intestinal microbiome and paediatric liver disease.","2022-03-10"]
[16267,"28478385","J Biol Chem","10.1074/jbc.M117.784322","Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.","2022-03-10"]
[16272,"28473851","Int J Endocrinol","10.1155/2017/5753039","Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.","2022-03-10"]
[16291,"28470401","Abdom Radiol (NY)","10.1007/s00261-017-1166-8","Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease.","2022-03-10"]
[16312,"28464369","Aliment Pharmacol Ther","10.1111/apt.14112","Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.","2022-03-10"]
[16331,"28455679","Curr Obes Rep","10.1007/s13679-017-0262-y","Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over.","2022-03-10"]
[16349,"28443702","J Am Coll Nutr","10.1080/07315724.2016.1267597","Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.","2022-03-10"]
[16366,"28436198","Mol Nutr Food Res","10.1002/mnfr.201700016","Effects of selenium on apoptosis and abnormal amino acid metabolism induced by excess fatty acid in isolated rat hepatocytes.","2022-03-10"]
[16386,"28425401","Ann Hepatol","10.5604/16652681.1235474","MRE in NAFLD: Promising but Further Validation is Required.","2022-03-10"]
[16403,"28415887","Free Radic Res","10.1080/10715762.2017.1320554","Amelioration of late-onset hepatic steatosis in IDH2-deficient mice.","2022-03-10"]
[16422,"28404072","Lancet Gastroenterol Hepatol","10.1016/S2468-1253(16)30018-8","Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.","2022-03-10"]
[16442,"28386616","Food Funct","10.1039/c7fo00090a","Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-&#945; and Nrf2 activation, and NF-&#954;B down-regulation.","2022-03-10"]
[16462,"28373874","Front Immunol","10.3389/fimmu.2017.00301","Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.","2022-03-10"]
[16481,"28363784","Chem Phys Lipids","10.1016/j.chemphyslip.2017.03.009","The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease.","2022-03-10"]
[16502,"28349964","Sci Rep","10.1038/srep45176","Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.","2022-03-10"]
[16519,"28344322","Acta Pharmacol Sin","10.1038/aps.2016.175","Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation.","2022-03-10"]
[16537,"28327588","Nat Commun","10.1038/ncomms14859","Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice.","2022-03-10"]
[16554,"28319060","Oncogene","10.1038/onc.2017.38","The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.","2022-03-10"]
[16574,"28298942","J Ultrasound","10.1007/s40477-016-0229-y","Liver acoustic radiation force impulse (ARFI) in childhood obesity: comparison and correlation with biochemical markers.","2022-03-10"]
[16593,"28294174","Eur J Clin Nutr","10.1038/ejcn.2017.9","Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.","2022-03-10"]
[16610,"28284571","Med Eng Phys","10.1016/j.medengphy.2017.02.014","Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease.","2022-03-10"]
[16617,"28281516","Ter Arkh","10.17116/terarkh201789252-58","[Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease].","2022-03-10"]
[16649,"28266614","Sci Rep","10.1038/srep43238","A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.","2022-03-10"]
[16666,"28256088","Diabetes Obes Metab","10.1111/dom.12929","Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database.","2022-03-10"]
[16685,"28244714","Asia Pac J Clin Nutr","10.6133/apjcn.092016.04","Serum uric acid levels in non-alcoholic steatosis patients: a meta-analysis.","2022-03-10"]
[16704,"28233737","Ann Hepatol","10.5604/16652681.1231550","Perspectives on NASH Histology: Cellular Ballooning.","2022-03-10"]
[16722,"28223446","Diabetes Care","10.2337/dc16-1787","Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.","2022-03-10"]
[16740,"28214524","Gastroenterology","10.1053/j.gastro.2017.01.055","Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[16758,"28202906","Sci Rep","10.1038/srep42801","BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.","2022-03-10"]
[16776,"28184213","Front Endocrinol (Lausanne)","10.3389/fendo.2017.00008","Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[16794,"28169509","Obesity (Silver Spring)","10.1002/oby.21767","Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study.","2022-03-10"]
[16816,"28155627","Curr Vasc Pharmacol","10.2174/1570161115666170202160948","Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity.","2022-03-10"]
[16834,"28139128","Vnitr Lek",null,"[Coffee as hepatoprotective factor].","2022-03-10"]
[16851,"28127194","World J Gastroenterol","10.3748/wjg.v23.i2.204","Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.","2022-03-10"]
[16872,"28116779","Mol Nutr Food Res","10.1002/mnfr.201600889","Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.","2022-03-10"]
[16890,"28109099","Nan Fang Yi Ke Da Xue Xue Bao",null,"[Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-&#954;B-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].","2022-03-10"]
[16908,"28099601","An Bras Dermatol","10.1590/abd1806-4841.20165080","Psoriasis comorbidities: complications and benefits of immunobiological treatment.","2022-03-10"]
[16909,"28099469","PLoS One","10.1371/journal.pone.0169952","The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.","2022-03-10"]
[16928,"28089429","Rev Gastroenterol Mex","10.1016/j.rgmx.2016.06.001","Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging.","2022-03-10"]
[16947,"28078997","Curr Med Chem","10.2174/0929867324666170112111948","Lipoprotein (a) and Cardiovascular Risk: The Show Must go on.","2022-03-10"]
[16972,"28068223","Cell Metab","10.1016/j.cmet.2016.09.016","Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.","2022-03-10"]
[17005,"28052624","Liver Int","10.1111/liv.13299","The epidemiology of non-alcoholic fatty liver disease.","2022-03-10"]
[17009,"28051792","Ann Hepatol","10.5604/16652681.1226814","Management strategies for liver fibrosis.","2022-03-10"]
[17029,"30276302","Brain Circ","10.4103/bc.bc_28_16","Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis.","2022-03-10"]
[17046,"28030540","PLoS One","10.1371/journal.pone.0167888","Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.","2022-03-10"]
[17066,"28012135","Lipids","10.1007/s11745-016-4222-1","Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[17084,"27999641","Caspian J Intern Med",null,"Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.","2022-03-10"]
[17102,"27991855","Turk J Gastroenterol","10.5152/tjg.2016.0357","Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.","2022-03-10"]
[17122,"27981274","Med Ultrason","10.11152/mu-868","Noninvasive quantitative estimation of hepatic steatosis by ultrasound: a comparison of the hepato-renal index and ultrasound attenuation index.","2022-03-10"]
[17140,"27966066","Obes Surg","10.1007/s11695-016-2482-8","Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[17158,"27941940","Nutr Diabetes","10.1038/nutd.2016.49","Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.","2022-03-10"]
[17177,"27929200","Thromb Haemost","10.1160/TH16-09-0716","Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.","2022-03-10"]
[17198,"27917557","Hepatol Res","10.1111/hepr.12837","Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus.","2022-03-10"]
[17217,"27908430","J Trace Elem Med Biol","10.1016/j.jtemb.2016.08.007","Evaluation of tissue metal and trace element content in a rat model of non-alcoholic fatty liver disease using ICP-DRC-MS.","2022-03-10"]
[17235,"27895587","Front Physiol","10.3389/fphys.2016.00498","Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.","2022-03-10"]
[17253,"27889576","Gastroenterology","10.1053/j.gastro.2016.11.020","Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.","2022-03-10"]
[17271,"27874078","Sci Rep","10.1038/srep37468","Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice.","2022-03-10"]
[17290,"27862096","Aliment Pharmacol Ther","10.1111/apt.13860","Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[17314,"27852946","Postgrad Med J","10.1136/postgradmedj-2016-134383","Non-alcoholic fatty liver disease and colorectal cancer.","2022-03-10"]
[17334,"27836992","J Lipid Res","10.1194/jlr.P067454","Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.","2022-03-10"]
[17353,"27827899","Nutrients","10.3390/nu8110697","Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding.","2022-03-10"]
[17378,"27816954","Clin Chem Lab Med","10.1515/cclm-2016-0762","Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkers.","2022-03-10"]
[17390,"27504850","J Clin Endocrinol Metab","10.1210/jc.2016-1320","Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis.","2022-03-10"]
[17417,"27794526","Lab Med","10.1093/labmed/lmw052","Association of UCP2 -866G>A Polymorphism With Nonalcoholic Fatty Liver Disease in Patients From North-West of Iran.","2022-03-10"]
[17436,"27569726","Gastroenterology","10.1053/j.gastro.2016.08.027","In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.","2022-03-10"]
[17455,"27780309","Pediatr Obes","10.1111/ijpo.12189","Incidental inflammatory adenoma with &#946;-catenin activation in the setting of paediatric NASH.","2022-03-10"]
[17474,"27732911","J Nutr Biochem","10.1016/j.jnutbio.2016.08.013","Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice.","2022-03-10"]
[17497,"27637015","Hepatology","10.1002/hep.28820","Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.","2022-03-10"]
[17519,"27759627","Medicine (Baltimore)","10.1097/MD.0000000000004947","Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials.","2022-03-10"]
[17538,"27094876","Obes Surg","10.1007/s11695-016-2176-2","Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.","2022-03-10"]
[17558,"27748192","Curr Pharm Des","10.2174/1381612822666161010115235","Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.","2022-03-10"]
[17584,"27733959","Cureus","10.7759/cureus.754","Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[17602,"27722159","Visc Med","10.1159/000446379","NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?","2022-03-10"]
[17623,"27710158","Postgrad Med","10.1080/00325481.2016.1243005","Hypertriglyceridemia: the importance of identifying patients at risk.","2022-03-10"]
[17641,"27693527","Life Sci","10.1016/j.lfs.2016.09.022","Effect of HFD/STZ on expression of genes involved in lipid, cholesterol and glucose metabolism in rats.","2022-03-10"]
[17659,"27680976","Front Med","10.1007/s11684-016-0468-5","miRNAs in non-alcoholic fatty liver disease.","2022-03-10"]
[17679,"27663794","BMC Cardiovasc Disord","10.1186/s12872-016-0358-4","The interaction effects of risk factors for hypertension in adults: a cross-sectional survey in Guilin, China.","2022-03-10"]
[17696,"27650757","BMJ Open","10.1136/bmjopen-2015-010507","Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging.","2022-03-10"]
[17714,"27639593","Transl Res","10.1016/j.trsl.2016.08.006","Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.","2022-03-10"]
[17734,"27631178","Arch Iran Med","0161909/AIM.006","Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.","2022-03-10"]
[17752,"27621009","J Surg Res","10.1016/j.jss.2015.12.013","The impact of postoperative adjuvant chemotherapy on the development of nonalcoholic fatty liver disease after pancreatoduodenectomy.","2022-03-10"]
[17770,"27609847","BMJ Open","10.1136/bmjopen-2016-011939","Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study.","2022-03-10"]
[17777,"27603810","Minerva Gastroenterol Dietol",null,"Glutathione in the treatment of liver diseases: insights from clinical practice.","2022-03-10"]
[17793,"27586548","Croat Med J","10.3325/cmj.2016.57.331","Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.","2022-03-10"]
[17813,"27564680","Ann Surg","10.1097/SLA.0000000000001968","Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy.","2022-03-10"]
[17831,"27548267","Dig Dis","10.1159/000447279","Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.","2022-03-10"]
[17849,"27535001","Sci Rep","10.1038/srep31829","Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport.","2022-03-10"]
[17868,"27513850","Radiology","10.1148/radiol.2016160308","Detection of Steatohepatitis in a Rat Model by Using Spectroscopic Shear-Wave US Elastography.","2022-03-10"]
[17889,"27494683","Int Immunopharmacol","10.1016/j.intimp.2016.07.028","High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats.","2022-03-10"]
[17908,"27484357","Int J Food Sci Nutr","10.1080/09637486.2016.1214239","Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.","2022-03-10"]
[17930,"27470889","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2016.05.009","[Influence of leptin receptor gene K109R polymorphism on the risk of nonalcoholic fatty liver disease and its interaction with PNPLA3 I148M polymorphism].","2022-03-10"]
[17949,"27458502","World J Hepatol","10.4254/wjh.v8.i20.827","Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.","2022-03-10"]
[17968,"27446562","Mol Clin Oncol","10.3892/mco.2016.924","Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse).","2022-03-10"]
[17989,"27432584","Exp Mol Pathol","10.1016/j.yexmp.2016.07.002","Upregulation of autophagy components in alcoholic hepatitis and nonalcoholic steatohepatitis.","2022-03-10"]
[18009,"27418954","Oxid Med Cell Longev","10.1155/2016/8173876","Euterpe edulis Extract but Not Oil Enhances Antioxidant Defenses and Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Rats.","2022-03-10"]
[18028,"27404689","Int J Cardiol","10.1016/j.ijcard.2016.06.180","Echocardiography and NAFLD (non-alcoholic fatty liver disease).","2022-03-10"]
[18049,"27383530","J Diabetes Investig","10.1111/jdi.12549","Analysis of risk factors and their interactions in type 2 diabetes mellitus: A cross-sectional survey in Guilin, China.","2022-03-10"]
[18068,"27373160","Cell Rep","10.1016/j.celrep.2016.06.019","Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease.","2022-03-10"]
[18088,"29201749","Euroasian J Hepatogastroenterol","10.5005/jp-journals-10018-1189","Nonalcoholic Fatty Liver Disease in South Asia.","2022-03-10"]
[18107,"27348270","Liver Transpl","10.1002/lt.24507","Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.","2022-03-10"]
[18126,"27339419","Arch Toxicol","10.1007/s00204-016-1761-4","Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue.","2022-03-10"]
[18145,"27322467","EBioMedicine","10.1016/j.ebiom.2016.04.002","Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.","2022-03-10"]
[18166,"27310963","Medicine (Baltimore)","10.1097/MD.0000000000003843","The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.","2022-03-10"]
[18187,"27301913","Hepatology","10.1002/hep.28677","Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.","2022-03-10"]
[18205,"27287838","Orv Hetil","10.1556/650.2016.30425","[Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].","2022-03-10"]
[18225,"27275102","World J Gastroenterol","10.3748/wjg.v22.i21.5096","Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.","2022-03-10"]
[18252,"27262844","Dig Dis Sci","10.1007/s10620-016-4213-3","Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[18270,"27252817","Middle East J Dig Dis","10.15171/mejdd.2016.15","An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[18290,"27237960","Microbes Infect","10.1016/j.micinf.2016.05.004","Lipid droplets affect elimination of Porphyromonas gingivalis in HepG2 cells by altering the autophagy-lysosome system.","2022-03-10"]
[18309,"27221093","Diabetologia","10.1007/s00125-016-3991-7","A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.","2022-03-10"]
[18327,"27207512","Diabetes","10.2337/db16-0162","Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.","2022-03-10"]
[18345,"27190693","World J Gastrointest Pathophysiol","10.4291/wjgp.v7.i2.211","Insulin resistance in development and progression of nonalcoholic fatty liver disease.","2022-03-10"]
[18364,"27181051","Sci Rep","10.1038/srep25747","Ces3/TGH Deficiency Attenuates Steatohepatitis.","2022-03-10"]
[18384,"27171561","PLoS One","10.1371/journal.pone.0155234","Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings.","2022-03-10"]
[18401,"27157992","Am J Pathol","10.1016/j.ajpath.2016.03.003","Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in Hepatocytes.","2022-03-10"]
[18423,"27145114","Mol Nutr Food Res","10.1002/mnfr.201500689","Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.","2022-03-10"]
[18443,"30133212","Zhong Yao Cai",null,"[Protection of Fufang Zhenzhu Tiaozhi Formula on NAFLD in Mice by Regulating ERS].","2022-03-10"]
[18460,"27117865","Lipids","10.1007/s11745-016-4155-8","Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.","2022-03-10"]
[18478,"27103143","BMC Genomics","10.1186/s12864-016-2617-2","Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice.","2022-03-10"]
[18498,"27090939","Biochim Biophys Acta","10.1016/j.bbalip.2016.04.005","Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.","2022-03-10"]
[18515,"27077736","PLoS One","10.1371/journal.pone.0153497","Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[18534,"27063723","Anal Sci","10.2116/analsci.32.473","Imaging Mass Spectrometry Reveals a Decrease of Cardiolipin in the Kidney of NASH Model Mice.","2022-03-10"]
[18553,"27061197","Aliment Pharmacol Ther","10.1111/apt.13620","Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.","2022-03-10"]
[18566,"27054361","Obes Facts","10.1159/000443692","Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study.","2022-03-10"]
[18597,"27040510","Biochim Biophys Acta","10.1016/j.bbalip.2016.03.026","Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.","2022-03-10"]
[18617,"27030186","Ter Arkh","10.17116/terarkh201688264-70","[Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome].","2022-03-10"]
[18618,"27030185","Ter Arkh","10.17116/terarkh201688258-63","[Evaluation of the efficiency of hepatoprotective monotherapy using succinic acid and methionine for nonalcoholic fatty liver disease at the stage of steatohepatitis].","2022-03-10"]
[18638,"27019761","Scientifica (Cairo)","10.1155/2016/5029414","A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[18661,"27006654","Gastroenterol Res Pract","10.1155/2016/7109270","A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD.","2022-03-10"]
[18680,"27001282","Nutr Res","10.1016/j.nutres.2015.12.007","Opuntia ficus-indica seed attenuates hepatic steatosis and promotes M2 macrophage polarization in high-fat diet-fed mice.","2022-03-10"]
[18699,"26993825","Dig Dis Sci","10.1007/s10620-016-4125-2","Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","2022-03-10"]
[18721,"26983472","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2016.02.002","[New advances in diagnosis of nonalcoholic fatty liver disease].","2022-03-10"]
[18738,"26977755","Am J Gastroenterol","10.1038/ajg.2016.43","Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study.","2022-03-10"]
[18756,"26969270","BMC Res Notes","10.1186/s13104-016-1946-1","Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.","2022-03-10"]
[18776,"26949499","Iran J Basic Med Sci",null,"Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study.","2022-03-10"]
[18794,"26937136","World J Gastroenterol","10.3748/wjg.v22.i8.2483","Glycosyltransferases and non-alcoholic fatty liver disease.","2022-03-10"]
[18813,"26924542","J Autoimmun","10.1016/j.jaut.2016.02.007","Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.","2022-03-10"]
[18835,"26911638","Neurology","10.1212/WNL.0000000000002498","Nonalcoholic fatty liver disease is associated with cognitive function in adults.","2022-03-10"]
[18853,"26901384","Liver Int","10.1111/liv.13097","Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.","2022-03-10"]
[18872,"26892109","BMC Gastroenterol","10.1186/s12876-016-0431-6","Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.","2022-03-10"]
[18891,"26882978","Biochem Biophys Res Commun","10.1016/j.bbrc.2016.02.047","Depletion of Rab32 decreases intracellular lipid accumulation and induces lipolysis through enhancing ATGL expression in hepatocytes.","2022-03-10"]
[18909,"26874076","Gastroenterology","10.1053/j.gastro.2016.01.038","Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-&#945; and&#160;-&#948;, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.","2022-03-10"]
[18928,"26866817","Hepatol Res","10.1111/hepr.12671","Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials.","2022-03-10"]
[18950,"26855179","Biochim Biophys Acta","10.1016/j.bbagrm.2016.01.006","Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.","2022-03-10"]
[18965,"26845607","Ann Hepatol","10.5604/16652681.1193726","&#160;Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?","2022-03-10"]
[18983,"26832365","Lipids Health Dis","10.1186/s12944-016-0190-y","Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.","2022-03-10"]
[19002,"26825357","Curr Opin Organ Transplant","10.1097/MOT.0000000000000283","Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.","2022-03-10"]
[19021,"26815314","Liver Int","10.1111/liv.13076","Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.","2022-03-10"]
[19039,"26807847","PLoS One","10.1371/journal.pone.0147469","Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.","2022-03-10"]
[19057,"26794269","Nat Rev Drug Discov","10.1038/nrd.2015.3","Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.","2022-03-10"]
[19079,"26775764","Nat Rev Endocrinol","10.1038/nrendo.2015.226","The Framingham Heart Study--67 years of discovery in metabolic disease.","2022-03-10"]
[19098,"26770272","Therap Adv Gastroenterol","10.1177/1756283X15593700","Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis.","2022-03-10"]
[19116,"26754585","Endocrinol Metab (Seoul)","10.3803/EnM.2016.31.1.86","The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[19136,"26733747","Clujul Med","10.15386/cjmed-595","Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship.","2022-03-10"]
[19155,"26725058","Dig Dis Sci","10.1007/s10620-015-4025-x","Function of Autophagy in Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[19173,"29889453","Eksp Klin Gastroenterol",null,"THE INFLUENCE OF PLACENTAL DRUG LAENNEC ON MOTOR FUNCTION OF THE BILIARY TRACT IN PATIENTS WITH FATTY DEGENERATION OF LIVER.","2022-03-10"]
[19190,"28332698","Mol Med","10.2119/molmed.2016.00203","Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.","2022-03-10"]
[19207,"26703125","Dig Dis Sci","10.1007/s10620-015-3983-3","Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.","2022-03-10"]
[19226,"26690419","Int J Mol Sci","10.3390/ijms161226190","Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases.","2022-03-10"]
[19244,"26675585","BBA Clin","10.1016/j.bbacli.2014.09.001","Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.","2022-03-10"]
[19263,"26667191","J Gastroenterol Hepatol","10.1111/jgh.13264","Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.","2022-03-10"]
[19280,"26657326","Gastroenterology","10.1053/j.gastro.2015.11.043","Circadian Clock Control of Liver Metabolic Functions.","2022-03-10"]
[19299,"26639394","J Hepatol","10.1016/j.jhep.2015.11.022","Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism.","2022-03-10"]
[19320,"26630411","Int J Sport Nutr Exerc Metab","10.1123/ijsnem.2014-0256","Waist-to-Hip Ratio is Related to Body Fat Content and Distribution Regardless of the Waist Circumference Measurement Protocol in Nonalcoholic Fatty Liver Disease Patients.","2022-03-10"]
[19339,"26621219","Sci Rep","10.1038/srep17528","Inhibition of NF-&#954;B by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis.","2022-03-10"]
[19360,"26608256","Lancet","10.1016/S0140-6736(15)00803-X","Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.","2022-03-10"]
[19380,"26599351","Hepatology","10.1002/hep.28368","Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.","2022-03-10"]
[19400,"26591766","Wei Sheng Yan Jiu",null,"[Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].","2022-03-10"]
[19420,"26576787","J Med Ultrason (2001)","10.1007/s10396-015-0615-7","Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients.","2022-03-10"]
[19442,"26567194","Adv Nutr","10.3945/an.115.009423","Potential for dietary &#969;-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.","2022-03-10"]
[19462,"26556368","Nutrients","10.3390/nu7115454","Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.","2022-03-10"]
[19463,"26555669","Mol Nutr Food Res","10.1002/mnfr.201500445","Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland.","2022-03-10"]
[19482,"26530296","BMC Res Notes","10.1186/s13104-015-1645-3","Coffee consumption and NAFLD: a community based study on 1223 subjects.","2022-03-10"]
[19502,"26518313","Lipids","10.1007/s11745-015-4084-y","Tyrosol Attenuates High Fat Diet-Induced Hepatic Oxidative Stress: Potential Involvement of Cystathionine &#946;-Synthase and Cystathionine &#947;-Lyase.","2022-03-10"]
[19527,"26509555","Liver Int","10.1111/liv.12994","Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study.","2022-03-10"]
[19545,"26496770","Acta Diabetol","10.1007/s00592-015-0816-y","Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.","2022-03-10"]
[19565,"26482965","Diabetes Metab Syndr","10.1016/j.dsx.2015.09.005","Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.","2022-03-10"]
[19583,"26473416","Annu Rev Med","10.1146/annurev-med-090514-013832","Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.","2022-03-10"]
[19600,"26463276","Gastroenterol Rep (Oxf)","10.1093/gastro/gov047","Perceptions of non-alcoholic fatty liver disease - an Asian community-based study.","2022-03-10"]
[19621,"26450572","BMC Pediatr","10.1186/s12887-015-0465-x","A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study.","2022-03-10"]
[19642,"26441288","Aten Primaria","10.1016/j.aprim.2015.06.006","[Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care].","2022-03-10"]
[19661,"26430807","J Gastroenterol Hepatol","10.1111/jgh.13183","Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.","2022-03-10"]
[19681,"26416722","Arch Biochem Biophys","10.1016/j.abb.2015.09.018","MicroRNAs in obesity-associated disorders.","2022-03-10"]
[19700,"26405687","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2015.01.001","Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.","2022-03-10"]
[19731,"26386476","Ultrasound Med Biol","10.1016/j.ultrasmedbio.2015.08.008","Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.","2022-03-10"]
[19740,"26380042","World J Hepatol","10.4254/wjh.v7.i19.2184","Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?","2022-03-10"]
[19759,"26374819","Laeknabladid","10.17992/lbl.2015.09.40","[Importance of waist circumference measurements when following children with obesity: Serious abnormalities in blood values of Iceandic children with obesity].","2022-03-10"]
[19779,"26355465","Inflamm Bowel Dis","10.1097/MIB.0000000000000569","PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.","2022-03-10"]
[19798,"26343077","Med Ultrason","10.11152/mu.2013.2066.173.cas","Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.","2022-03-10"]
[19816,"26330104","Sci Rep","10.1038/srep13729","Effect of miR-34a in regulating steatosis by targeting PPAR&#945; expression in nonalcoholic fatty liver disease.","2022-03-10"]
[19835,"26316434","J Clin Res Pediatr Endocrinol","10.4274/jcrpe.1749","Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[19852,"26305052","Biochem Cell Biol","10.1139/bcb-2014-0136","Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.","2022-03-10"]
[19875,"26290633","World J Gastroenterol","10.3748/wjg.v21.i30.9067","Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.","2022-03-10"]
[19893,"26280342","FP Essent",null,"Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[19913,"26271188","Int J Obes (Lond)","10.1038/ijo.2015.151","Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.","2022-03-10"]
[19930,"26258810","Eur J Cancer Prev","10.1097/CEJ.0000000000000172","Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis.","2022-03-10"]
[19947,"26250514","Obesity (Silver Spring)","10.1002/oby.21170","Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice.","2022-03-10"]
[19970,"26233911","Adv Pharmacol","10.1016/bs.apha.2015.04.002","Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.","2022-03-10"]
[19988,"26223319","Free Radic Res","10.3109/10715762.2015.1078461","Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.","2022-03-10"]
[20006,"26212089","J Gastroenterol Hepatol","10.1111/jgh.13058","Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[20026,"26200917","Chem Phys Lipids","10.1016/j.chemphyslip.2015.07.005","In vivo proton magnetic resonance spectroscopy of liver metabolites in non-alcoholic fatty liver disease in rats: T2 relaxation times in methylene protons.","2022-03-10"]
[20043,"26193757","Int J Urol","10.1111/iju.12877","Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.","2022-03-10"]
[20062,"26185381","World J Gastroenterol","10.3748/wjg.v21.i26.8096","Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.","2022-03-10"]
[20083,"26168700","J Nutr Biochem","10.1016/j.jnutbio.2015.05.011","Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.","2022-03-10"]
[20101,"26155039","J Clin Exp Hepatol","10.1016/j.jceh.2015.04.002","Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.","2022-03-10"]
[20112,"26147768","Hepatol Res","10.1111/hepr.12552","Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus.","2022-03-10"]
[20140,"26133037","J Med Food","10.1089/jmf.2014.3259","Beneficial Effects of Red Yeast Rice on High-Fat Diet-Induced Obesity, Hyperlipidemia, and Fatty Liver in Mice.","2022-03-10"]
[20164,"26114995","Liver Int","10.1111/liv.12902","Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.","2022-03-10"]
[20182,"26102086","PLoS One","10.1371/journal.pone.0131269","Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis.","2022-03-10"]
[20203,"26085908","World J Hepatol","10.4254/wjh.v7.i11.1484","\"Weighing the risk\": Obesity and outcomes following liver transplantation.","2022-03-10"]
[20227,"26077675","J Transl Med","10.1186/s12967-015-0552-7","Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.","2022-03-10"]
[20244,"26066299","Prostaglandins Leukot Essent Fatty Acids","10.1016/j.plefa.2015.04.010","Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation.","2022-03-10"]
[20262,"26057287","JAMA","10.1001/jama.2015.5370","Nonalcoholic fatty liver disease: a systematic review.","2022-03-10"]
[20280,"26047766","Clin Nutr","10.1016/j.clnu.2015.05.001","Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.","2022-03-10"]
[20298,"26040357","Nutr Hosp","10.3305/nh.2015.31.6.8908","Predictive factors of non-alcoholic steatohepatitis: relationship with metabolic syndrome.","2022-03-10"]
[20300,"26039829","Arq Gastroenterol","10.1590/S0004-28032015000200008","Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.","2022-03-10"]
[20321,"28210688","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2015.05.006","Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.","2022-03-10"]
[20343,"26020401","Medicine (Baltimore)","10.1097/MD.0000000000000907","Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study.","2022-03-10"]
[20362,"26016715","Diabetes","10.2337/db14-1947","Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis.","2022-03-10"]
[20381,"26001595","Transl Res","10.1016/j.trsl.2015.04.014","High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.","2022-03-10"]
[20401,"25991038","Hepatology","10.1002/hep.27844","The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[20419,"25977117","Liver Int","10.1111/liv.12872","Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.","2022-03-10"]
[20437,"25966055","Genet Mol Res","10.4238/2015.April.10.1","Role of APN and TNF-&#945; in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.","2022-03-10"]
[20457,"25948763","Acta Med Indones",null,"Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-&#945; as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).","2022-03-10"]
[20477,"25937862","World J Hepatol","10.4254/wjh.v7.i6.846","Non-alcoholic fatty liver disease: The diagnosis and management.","2022-03-10"]
[20495,"25922141","Eur J Pediatr","10.1007/s00431-015-2551-3","Childhood obesity and its physical and psychological co-morbidities: a systematic review of Australian children and adolescents.","2022-03-10"]
[20516,"25914296","Hepatology","10.1002/hep.27869","Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.","2022-03-10"]
[20536,"25905490","PLoS One","10.1371/journal.pone.0122406","Higher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong.","2022-03-10"]
[20559,"25887357","Diabetes Care","10.2337/dc14-1239","Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.","2022-03-10"]
[20576,"25875942","PLoS One","10.1371/journal.pone.0123787","LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).","2022-03-10"]
[20593,"25866601","World J Hepatol","10.4254/wjh.v7.i4.638","Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.","2022-03-10"]
[20616,"25849950","Nutrients","10.3390/nu7042440","Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease.","2022-03-10"]
[20636,"25843191","Saudi J Gastroenterol","10.4103/1319-3767.153812","Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis.","2022-03-10"]
[20654,"25829790","Pharmacognosy Res","10.4103/0974-8490.151459","Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study.","2022-03-10"]
[20672,"25815106","Oxid Med Cell Longev","10.1155/2015/172493","P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis.","2022-03-10"]
[20696,"25794572","Curr Treat Options Gastroenterol","10.1007/s11938-015-0053-z","New medical treatment strategies for nonalcoholic steatohepatitis.","2022-03-10"]
[20715,"25784075","Dig Dis Sci","10.1007/s10620-015-3627-7","Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (&#946;-Cell) Function.","2022-03-10"]
[20733,"25771388","J Pediatr","10.1016/j.jpeds.2015.01.056","Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.","2022-03-10"]
[20753,"25755550","J Clin Exp Hepatol","10.1016/j.jceh.2013.05.008","Nutrition in the management of cirrhosis and its neurological complications.","2022-03-10"]
[20773,"25743002","Intern Med","10.2169/internalmedicine.54.2685","Background of the FIB-4 index in Japanese non-alcoholic fatty liver disease.","2022-03-10"]
[20791,"25732561","Drugs R D","10.1007/s40268-015-0084-x","Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical study.","2022-03-10"]
[20812,"25716573","J Diabetes Complications","10.1016/j.jdiacomp.2014.12.017","Excess intake of fat and sugar potentiates epinephrine-induced hyperglycemia in male rats.","2022-03-10"]
[20830,"25708290","J Gastroenterol","10.1007/s00535-015-1050-7","Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.","2022-03-10"]
[20847,"25690422","Nutrients","10.3390/nu7021352","Low-normal thyroid function and novel cardiometabolic biomarkers.","2022-03-10"]
[20871,"25672270","Int J Mol Med","10.3892/ijmm.2015.2092","MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis.","2022-03-10"]
[20882,"25666645","Nat Rev Gastroenterol Hepatol","10.1038/nrgastro.2015.23","NAFLD. Accurate quantification of hepatic fat--is it important?","2022-03-10"]
[20910,"25648511","Mar Drugs","10.3390/md13020788","Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats.","2022-03-10"]
[20932,"25632750","Zhongguo Zhong Xi Yi Jie He Za Zhi",null,"[Effect of Shugan Jianpi Recipe on LXR&#945;/FAS signaling pathway mediated hepatocyte fatty deposits in NAFLD rats].","2022-03-10"]
[20953,"25619540","Curr Diabetes Rev","10.2174/1573399811666150115110747","Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma?","2022-03-10"]
[20978,"25606030","Case Rep Gastroenterol","10.1159/000369968","A 25-year-old woman with type 2 diabetes and liver disease.","2022-03-10"]
[20999,"25591123","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000000715","Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.","2022-03-10"]
[21018,"25574593","Diabetes Technol Ther","10.1089/dia.2014.0214","Relationship between &#946;-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.","2022-03-10"]
[21040,"25561963","J Tehran Heart Cent",null,"Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review.","2022-03-10"]
[21063,"27508191","J Hepatocell Carcinoma","10.2147/JHC.S44521","A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma.","2022-03-10"]
[21081,"25544877","World J Hepatol","10.4254/wjh.v6.i12.901","Vitamin D deficiency in chronic liver disease.","2022-03-10"]
[21099,"25536648","Ann Hepatol",null,"Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD.","2022-03-10"]
[21116,"25531861","Endocr Res","10.3109/07435800.2014.987399","Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.","2022-03-10"]
[21137,"25522307","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000000662","GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.","2022-03-10"]
[21154,"25514908","Rev Recent Clin Trials","10.2174/1574887109666141216102231","The role of liver biopsy to assess non-alcoholic fatty liver disease.","2022-03-10"]
[21173,"25501226","Genet Mol Res","10.4238/2014.December.4.9","Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis.","2022-03-10"]
[21174,"25500885","J Clin Invest","10.1172/JCI76738","Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.","2022-03-10"]
[21191,"25491010","Eur J Intern Med","10.1016/j.ejim.2014.11.007","The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[21213,"25477264","J Hepatol","10.1016/j.jhep.2014.11.034","Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.","2022-03-10"]
[21231,"25468788","Med Hypotheses","10.1016/j.mehy.2014.10.020","Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C.","2022-03-10"]
[21250,"25456097","Metabolism","10.1016/j.metabol.2014.10.012","Leptin in nonalcoholic fatty liver disease: a narrative review.","2022-03-10"]
[21270,"25445395","J Hepatol","10.1016/j.jhep.2014.11.030","Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.","2022-03-10"]
[21295,"25427907","Adv Exp Med Biol","10.1007/978-3-319-09614-8_10","Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma.","2022-03-10"]
[21308,"25415231","Horm Metab Res","10.1055/s-0034-1395531","Leptin improves fatty liver independently of insulin sensitization and appetite suppression in hepatocyte-specific Pten-deficient mice with insulin hypersensitivity.","2022-03-10"]
[21327,"25404123","Drugs R D","10.1007/s40268-014-0068-2","In vivo efficacy study of milk thistle extract (ETHIS-094&#8482;) in STAM&#8482; model of nonalcoholic steatohepatitis.","2022-03-10"]
[21344,"25386164","Front Endocrinol (Lausanne)","10.3389/fendo.2014.00164","Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.","2022-03-10"]
[21365,"25371775","Oxid Med Cell Longev","10.1155/2014/637027","Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.","2022-03-10"]
[21386,"25356033","World J Gastroenterol","10.3748/wjg.v20.i40.14706","ADV36 adipogenic adenovirus in human liver disease.","2022-03-10"]
[21403,"25347470","J Clin Invest","10.1172/JCI76388","Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.","2022-03-10"]
[21421,"25331524","Hepatology","10.1002/hep.27575","Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development.","2022-03-10"]
[21438,"25317840","Food Funct","10.1039/c4fo00549j","Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease.","2022-03-10"]
[21457,"25307311","Mini Rev Med Chem",null,"Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.","2022-03-10"]
[21475,"25295245","Biomed Res Int","10.1155/2014/120179","Autophagy and non-alcoholic fatty liver disease.","2022-03-10"]
[21493,"25281430","Diabetes","10.2337/db14-0444","WISP1 is a novel adipokine linked to inflammation in obesity.","2022-03-10"]
[21511,"25266069","J Diabetes","10.1111/1753-0407.12221","Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.","2022-03-10"]
[21530,"25251446","Pediatr Obes","10.1111/ijpo.265","Sonographically measured suprailiac adipose tissue is a useful predictor of non-alcoholic fatty liver disease in obese children and adolescents.","2022-03-10"]
[21549,"25238938","Pathol Res Pract","10.1016/j.prp.2014.08.007","Histopathological aspects of liver under variable food restriction: has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?","2022-03-10"]
[21569,"25220580","Sleep Med Rev","10.1016/j.smrv.2014.07.004","Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.","2022-03-10"]
[21589,"25203709","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2014.06.010","[Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].","2022-03-10"]
[21610,"25189458","World J Urol","10.1007/s00345-014-1392-4","Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.","2022-03-10"]
[21628,"25170559","Digestion","10.1159/000365415","Can serum pin1 level be regarded as an indicative marker of nonalcoholic steatohepatitis and fibrotic stages?","2022-03-10"]
[21646,"25155259","Aliment Pharmacol Ther","10.1111/apt.12923","Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.","2022-03-10"]
[21666,"25138021","J Pharmacol Exp Ther","10.1124/jpet.114.218545","Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.","2022-03-10"]
[21685,"25121514","PLoS One","10.1371/journal.pone.0104558","The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease.","2022-03-10"]
[21705,"25105443","Ann Transplant","10.12659/AOT.890664","Thiazolidinedione therapy versus lifestyle recommendation in the treatment of post-liver transplant graft steatosis.","2022-03-10"]
[21724,"25090711","Zhong Yao Cai",null,"[Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].","2022-03-10"]
[21741,"25080921","Toxicol Sci","10.1093/toxsci/kfu156","Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.","2022-03-10"]
[21762,"25063410","J Ultrasound Med","10.7863/ultra.33.8.1447","Focal fatty sparing usually does not arise in preexisting nonalcoholic diffuse homogeneous fatty liver.","2022-03-10"]
[21780,"25048953","J Hepatol","10.1016/j.jhep.2014.07.008","Cyclophilin inhibition as potential therapy for liver diseases.","2022-03-10"]
[21798,"25038727","Metabolism","10.1016/j.metabol.2014.06.009","Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter?","2022-03-10"]
[21817,"25024607","World J Gastroenterol","10.3748/wjg.v20.i26.8525","High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.","2022-03-10"]
[21834,"25015398","Abdom Imaging","10.1007/s00261-014-0175-0","Cross-sectional and longitudinal evaluation of  liver volume and total liver fat burden in adults  with nonalcoholic steatohepatitis.","2022-03-10"]
[21854,"24998389","Sci Rep","10.1038/srep05587","Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model.","2022-03-10"]
[21874,"24987758","J Magn Reson Imaging","10.1002/jmri.24321","Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.","2022-03-10"]
[21893,"24976277","Saudi J Gastroenterol","10.4103/1319-3767.132983","Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis.","2022-03-10"]
[21912,"24966608","World J Gastroenterol","10.3748/wjg.v20.i23.7381","Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.","2022-03-10"]
[21931,"24957697","Scand J Gastroenterol","10.3109/00365521.2013.836754","Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[21949,"24944601","Exp Ther Med","10.3892/etm.2014.1698","Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells.","2022-03-10"]
[21967,"24927058","Expert Rev Mol Diagn","10.1586/14737159.2014.928205","Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease.","2022-03-10"]
[21988,"24910023","J Gastroenterol Hepatol","10.1111/jgh.12643","Clinical association between non-alcoholic fatty liver disease and the development of hypertension.","2022-03-10"]
[21990,"24906975","J Endocrinol Invest","10.1007/s40618-014-0101-x","Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women.","2022-03-10"]
[22009,"24894597","J Dig Dis","10.1111/1751-2980.12164","Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region.","2022-03-10"]
[22027,"24868320","World J Hepatol","10.4254/wjh.v6.i5.263","Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.","2022-03-10"]
[22064,"24844310","Eat Weight Disord","10.1007/s40519-014-0129-0","Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?","2022-03-10"]
[22067,"24843703","J Diabetes Investig","10.1111/jdi.12107","Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver disease.","2022-03-10"]
[22085,"24829735","Int J Prev Med",null,"Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs.","2022-03-10"]
[22104,"24818764","Gastroenterology","10.1053/j.gastro.2014.04.046","No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.","2022-03-10"]
[22122,"24799988","World J Hepatol","10.4254/wjh.v6.i4.199","Insulin sensitizers for the treatment of non-alcoholic fatty liver disease.","2022-03-10"]
[22142,"24793347","J Clin Lipidol","10.1016/j.jacl.2014.02.007","Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.","2022-03-10"]
[22161,"30736156","Expert Rev Endocrinol Metab","10.1586/17446651.2014.900438","Insulin-like growth factors (IGF-I and -II): new actors in the development of non-alcoholic fatty liver disease.","2022-03-10"]
[22180,"24764677","World J Gastroenterol","10.3748/wjg.v20.i15.4382","Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.","2022-03-10"]
[22199,"24753132","Hepatology","10.1002/hep.27173","Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.","2022-03-10"]
[22217,"24743702","PLoS One","10.1371/journal.pone.0095604","Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease.","2022-03-10"]
[22237,"24731940","Int J Biochem Cell Biol","10.1016/j.biocel.2014.04.002","Regulation of microRNAs and their role in liver development, regeneration and disease.","2022-03-10"]
[22255,"24716226","J Gastroenterol Hepatol","10.1111/jgh.12437","Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.","2022-03-10"]
[22274,"24698021","Hepatol Res","10.1111/hepr.12338","Impact of non-alcoholic fatty liver disease on liver volume in humans.","2022-03-10"]
[22296,"24685236","J Acad Nutr Diet","10.1016/j.jand.2014.01.017","Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth.","2022-03-10"]
[22313,"24671009","Curr Opin Gastroenterol","10.1097/MOG.0000000000000059","Current status of fibrosis markers.","2022-03-10"]
[22330,"24656139","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2014.01.013","Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.","2022-03-10"]
[22348,"24647824","Eur Radiol","10.1007/s00330-014-3141-x","Application of localized &#179;&#185;P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[22368,"24634829","Mol Metab","10.1016/j.molmet.2013.12.009","Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.","2022-03-10"]
[22386,"24627311","Drug Saf","10.1007/s40264-014-0147-x","Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition.","2022-03-10"]
[22403,"24611991","J Gastroenterol Hepatol","10.1111/jgh.12541","Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity.","2022-03-10"]
[22426,"24587653","World J Gastroenterol","10.3748/wjg.v20.i7.1756","Dietary habits and behaviors associated with nonalcoholic fatty liver disease.","2022-03-10"]
[22440,"24576046","Radiology","10.1148/radiol.14131890","Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.","2022-03-10"]
[22459,"24552858","Ann Hepatol",null,"The prevalence of nonalcoholic fatty liver disease in the Americas.","2022-03-10"]
[22478,"24528633","J Dig Dis","10.1111/1751-2980.12113","The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[22495,"24517411","Metab Syndr Relat Disord","10.1089/met.2013.0129","Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice.","2022-03-10"]
[22518,"24496399","Food Funct","10.1039/c3fo60551e","The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.","2022-03-10"]
[22538,"24481324","Endocr Relat Cancer","10.1530/ERC-14-0036","Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence.","2022-03-10"]
[22558,"24463897","Arq Bras Cir Dig","10.1590/s0102-67202013000600009","Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity.","2022-03-10"]
[22579,"24445237","Biol Chem","10.1515/hsz-2013-0271","Citrate--new functions for an old metabolite.","2022-03-10"]
[22599,"24426199","Indian J Clin Biochem","10.1007/s12291-012-0236-5","Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression.","2022-03-10"]
[22617,"24407920","Diabetologia","10.1007/s00125-013-3149-9","The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.","2022-03-10"]
[22642,"24388885","J Physiol Pharmacol",null,"Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[22661,"24377455","Nutrition","10.1016/j.nut.2013.07.023","Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease.","2022-03-10"]
[22678,"26528002","Clujul Med","10.15386/cjmed-277","From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?","2022-03-10"]
[22696,"25798442","Front Med (Lausanne)","10.3389/fmed.2014.00004","Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver Disease.","2022-03-10"]
[22714,"24362075","J Hepatol","10.1016/j.jhep.2013.12.012","Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.","2022-03-10"]
[22733,"24349054","PLoS One","10.1371/journal.pone.0081312","No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.","2022-03-10"]
[22752,"24329852","J Viral Hepat","10.1111/jvh.12172","Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?","2022-03-10"]
[22771,"24320032","Curr Pharm Des","10.2174/1381612819666131206111352","The metabolic syndrome and chronic liver disease.","2022-03-10"]
[22790,"24303090","World J Hepatol","10.4254/wjh.v5.i11.621","Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome.","2022-03-10"]
[22810,"26202295","Hepatol Int","10.1007/s12072-013-9477-5","Lean NASH: distinctiveness and clinical implication.","2022-03-10"]
[22812,"26202293","Hepatol Int","10.1007/s12072-013-9455-y","Hard clinical outcomes in patients with NAFLD.","2022-03-10"]
[22829,"24277052","J Gastroenterol","10.1007/s00535-013-0911-1","Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.","2022-03-10"]
[22847,"24274865","Clin Liver Dis","10.1016/j.cld.2013.09.002","Obesity and NAFLD: the role of bacteria and microbiota.","2022-03-10"]
[22865,"24267865","Liver Int","10.1111/liv.12379","Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.","2022-03-10"]
[22883,"24256086","Am J Respir Crit Care Med","10.1164/rccm.201307-1339OC","Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.","2022-03-10"]
[22901,"24222948","World J Gastroenterol","10.3748/wjg.v19.i41.7055","Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.","2022-03-10"]
[22920,"24210820","Cell Rep","10.1016/j.celrep.2013.10.007","SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.","2022-03-10"]
[22939,"24190226","Int J Mol Med","10.3892/ijmm.2013.1544","Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats.","2022-03-10"]
[22962,"24172912","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000000015","Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[22980,"24140091","Metabolism","10.1016/j.metabol.2013.09.013","Irisin in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[23000,"24123276","Hepatology","10.1002/hep.26761","Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.","2022-03-10"]
[23020,"24113768","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00225.2013","Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.","2022-03-10"]
[23037,"24084730","Int J Mol Sci","10.3390/ijms141019867","Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis.","2022-03-10"]
[23054,"24074715","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2013.07.015","[Non-canonical Wnt signaling contributes to development of non-alcoholic steatohepatitis in a rat model of type 2 diabetes mellitus].","2022-03-10"]
[23073,"24065295","Int J Mol Med","10.3892/ijmm.2013.1503","Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study.","2022-03-10"]
[23091,"24047346","Ultrastruct Pathol","10.3109/01913123.2013.799625","What's in a name?-\"Lipolysosome\": ultrastructural features of a lipid-containing organelle.","2022-03-10"]
[23109,"24035445","Metabolism","10.1016/j.metabol.2013.08.003","Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels.","2022-03-10"]
[23127,"24019886","PLoS One","10.1371/journal.pone.0072928","Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.","2022-03-10"]
[23144,"24006666","Zhen Ci Yan Jiu",null,"[Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats].","2022-03-10"]
[23164,"25755505","J Clin Exp Hepatol","10.1016/j.jceh.2013.09.001","MicroRNAs in Liver Disease: Bench to Bedside.","2022-03-10"]
[23178,"23982157","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00401.2013","Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice.","2022-03-10"]
[23201,"23964925","Genet Test Mol Biomarkers","10.1089/gtmb.2013.0309","Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis.","2022-03-10"]
[23222,"23942585","Eur J Nutr","10.1007/s00394-013-0573-z","Dietary walnut oil modulates liver steatosis in the obese Zucker rat.","2022-03-10"]
[23240,"23931760","Cell Metab","10.1016/j.cmet.2013.07.004","DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.","2022-03-10"]
[23259,"23921844","Eur J Gastroenterol Hepatol","10.1097/MEG.0b013e3283650650","Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy.","2022-03-10"]
[23277,"23905917","J Allergy Clin Immunol","10.1016/j.jaci.2013.06.022","Innate sensors of pathogen and stress: linking inflammation to obesity.","2022-03-10"]
[23294,"23891824","Gene","10.1016/j.gene.2013.06.091","Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.","2022-03-10"]
[23316,"23855293","J Gastroenterol Hepatol","10.1111/jgh.12031","Retinoids and their target genes in liver functions and diseases.","2022-03-10"]
[23333,"23864802","Korean J Intern Med","10.3904/kjim.2013.28.4.439","Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease.","2022-03-10"]
[23353,"23848366","Expert Opin Emerg Drugs","10.1517/14728214.2013.811232","Emerging drugs for non-alcoholic steatohepatitis.","2022-03-10"]
[23373,"23835912","Clin Obstet Gynecol","10.1097/GRF.0b013e3182a09760","Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the\"first hit\".","2022-03-10"]
[23390,"23824212","Diabetologia","10.1007/s00125-013-2981-2","Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids.","2022-03-10"]
[23410,"23805238","PLoS One","10.1371/journal.pone.0066570","High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats.","2022-03-10"]
[23427,"23793849","Curr Hypertens Rep","10.1007/s11906-013-0364-1","Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review.","2022-03-10"]
[23445,"23775317","Dig Dis Sci","10.1007/s10620-013-2743-5","Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).","2022-03-10"]
[23467,"23754536","Mol Med Rep","10.3892/mmr.2013.1512","Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-&#945; activation.","2022-03-10"]
[23485,"23738963","Liver Int","10.1111/liv.12220","MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population.","2022-03-10"]
[23504,"26201791","Hepatol Int","10.1007/s12072-012-9412-1","Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components.","2022-03-10"]
[23522,"23711137","Am J Chin Med","10.1142/S0192415X13500353","Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.","2022-03-10"]
[23541,"23697659","Antioxid Redox Signal","10.1089/ars.2012.5157","A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia.","2022-03-10"]
[23549,"23691267","Oxid Med Cell Longev","10.1155/2013/781050","Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease.","2022-03-10"]
[23578,"23661906","Mediators Inflamm","10.1155/2013/684237","Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD.","2022-03-10"]
[23597,"23643483","Toxicol Lett","10.1016/j.toxlet.2013.04.019","Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.","2022-03-10"]
[23617,"23624251","J Hepatol","10.1016/j.jhep.2013.04.016","Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.","2022-03-10"]
[23635,"23609339","Ultrasound Q","10.1097/RUQ.0b013e318291580e","Sonographic evaluation for predicting the presence and severity of coronary artery disease.","2022-03-10"]
[23636,"23607402","Hepatol Res","10.1111/hepr.12140","Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis.","2022-03-10"]
[23653,"23596266","Asia Pac J Public Health","10.1177/1010539513483830","The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital.","2022-03-10"]
[23672,"23578506","Zhonghua Yi Xue Za Zhi",null,"[Liver disease spectrum in hospitalized type 2 diabetes and related risk factors analysis of non-alcoholic fatty liver disease].","2022-03-10"]
[23693,"23560695","J Diabetes","10.1111/1753-0407.12056","Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology.","2022-03-10"]
[23710,"23547829","Nutr J","10.1186/1475-2891-12-37","Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD).","2022-03-10"]
[23728,"23529597","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","10.1007/s00103-012-1639-4","[Non-alcoholic fatty liver disease in obese children and adolescents].","2022-03-10"]
[23746,"23512965","Obesity (Silver Spring)","10.1002/oby.20440","Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression.","2022-03-10"]
[23766,"23503837","J Gastroenterol","10.1007/s00535-013-0776-3","Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis.","2022-03-10"]
[23785,"23482433","Korean J Pediatr","10.3345/kjp.2013.56.2.45","Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease.","2022-03-10"]
[23804,"23461136","Adv Clin Chem","10.1016/b978-0-12-405211-6.00006-1","Toll-like receptors in liver disease.","2022-03-10"]
[23821,"23447451","Hepatology","10.1002/hep.26342","Desmosterol in human nonalcoholic steatohepatitis.","2022-03-10"]
[23841,"23432982","Arab J Gastroenterol","10.1016/j.ajg.2012.06.010","Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration.","2022-03-10"]
[23858,"23424927","Rev Prat",null,"[Treatment of nonalcoholic steatohepatitis].","2022-03-10"]
[23877,"23406705","Pediatr Exerc Sci","10.1123/pes.25.1.3","Cardiorespiratory fitness, but not central obesity or C-reactive protein, is related to liver function in obese children.","2022-03-10"]
[23897,"23397532","Semin Liver Dis","10.1055/s-0032-1329905","A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease.","2022-03-10"]
[23915,"23390894","Atherosclerosis","10.1016/j.atherosclerosis.2013.01.002","The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.","2022-03-10"]
[23941,"23369196","Clin Exp Pharmacol Physiol","10.1111/1440-1681.12063","Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men.","2022-03-10"]
[23956,"23352496","J Diabetes Complications","10.1016/j.jdiacomp.2012.12.005","Potential of incretin-based therapies for non-alcoholic fatty liver disease.","2022-03-10"]
[23976,"23331460","Basic Clin Pharmacol Toxicol","10.1111/bcpt.12049","Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis.","2022-03-10"]
[23996,"23318274","Biochim Biophys Acta","10.1016/j.bbalip.2012.12.014","The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR&#945;; and repressed by C/EBP&#945;: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.","2022-03-10"]
[24014,"23301938","J Gastroenterol Hepatol","10.1111/jgh.12112","Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.","2022-03-10"]
[24034,"23293232","Georgian Med News",null,"[Relationship gene polymorphism adipor1 with cardiovascular risk in patients with nonalcoholic fatty liver disease].","2022-03-10"]
[24052,"23278163","Aliment Pharmacol Ther","10.1111/apt.12186","Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.","2022-03-10"]
[24069,"23268961","Biomed Res","10.2220/biomedres.33.373","Protective effects of the herbal medicine goshajinkigan in a rat model of non-alcoholic fatty liver disease.","2022-03-10"]
[24095,"23233555","Hematology Am Soc Hematol Educ Program","10.1182/asheducation-2012.1.13","Gaucher disease and other storage disorders.","2022-03-10"]
[24116,"23214350","Acta Gastroenterol Latinoam",null,"[Transient elastography: noninvasive assessment of liver fibrosis. Report of 1,000 cases in Argentina].","2022-03-10"]
[24135,"25755455","J Clin Exp Hepatol","10.1016/j.jceh.2012.10.010","A Randomized Controlled Trial Comparing Efficacy of&#160;Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.","2022-03-10"]
[24154,"23174781","Hepatology","10.1002/hep.26167","Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway.","2022-03-10"]
[24173,"23152415","Clin Chem Lab Med","10.1515/cclm-2012-0584","High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.","2022-03-10"]
[24191,"23136827","Biomarkers","10.3109/1354750X.2012.738249","Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases.","2022-03-10"]
[24212,"23113697","Fundam Clin Pharmacol","10.1111/fcp.12009","Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery.","2022-03-10"]
[24230,"23075870","Dig Dis","10.1159/000341127","Nonalcoholic fatty liver disease: what the pathologist can tell the clinician.","2022-03-10"]
[24248,"23077931","Rev Med Chir Soc Med Nat Iasi",null,"The central role of the non alcoholic fatty liver disease in metabolic syndrome.","2022-03-10"]
[24267,"23063693","Biochimie","10.1016/j.biochi.2012.09.028","A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPAR&#945;.","2022-03-10"]
[24288,"23036645","Metabolism","10.1016/j.metabol.2012.08.013","Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.","2022-03-10"]
[24306,"23022226","Biochem Pharmacol","10.1016/j.bcp.2012.09.019","High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload.","2022-03-10"]
[24319,"23000435","J Hepatol","10.1016/j.jhep.2012.09.011","Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.","2022-03-10"]
[24346,"22980664","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi",null,"[Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].","2022-03-10"]
[24365,"22964849","Lab Invest","10.1038/labinvest.2012.128","Stimulation of fat accumulation in hepatocytes by PGE&#8322;-dependent repression of hepatic lipolysis, &#946;-oxidation and VLDL-synthesis.","2022-03-10"]
[24384,"22950794","Nucleic Acid Ther","10.1089/nat.2012.0381","Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation.","2022-03-10"]
[24404,"22933183","J Gastroenterol","10.1007/s00535-012-0650-8","Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.","2022-03-10"]
[24421,"22914580","AIDS","10.1097/QAD.0b013e32835804f9","Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.","2022-03-10"]
[24439,"22892494","Intern Med","10.2169/internalmedicine.51.7578","Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis.","2022-03-10"]
[24459,"22876027","World J Gastroenterol","10.3748/wjg.v18.i29.3782","Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.","2022-03-10"]
[24478,"22855443","Dongwuxue Yanjiu","10.3724/SP.J.1141.2012.04367","[Effects of resistin on hepatic fibrosis: possible mechanisms in non-alcoholic fatty liver disease in in vitro and in vivo].","2022-03-10"]
[24479,"22854109","Metabolism","10.1016/j.metabol.2012.06.008","High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.","2022-03-10"]
[24497,"22837800","Int J Clin Exp Med",null,"Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding.","2022-03-10"]
[24517,"22820754","Tohoku J Exp Med","10.1620/tjem.227.253","The C-681G polymorphism of the PPAR-&#947; gene is associated with susceptibility to non-alcoholic fatty liver disease.","2022-03-10"]
[24536,"22792295","PLoS One","10.1371/journal.pone.0040376","The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.","2022-03-10"]
[24554,"22753133","Hepatology","10.1002/hep.25930","Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.","2022-03-10"]
[24572,"22738690","J Cardiol","10.1016/j.jjcc.2012.05.003","The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease.","2022-03-10"]
[24590,"22718512","Mol Biol Rep","10.1007/s11033-012-1836-0","Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.","2022-03-10"]
[24609,"22694047","Clin Transplant","10.1111/j.1399-0012.2012.01669.x","Complications associated with liver transplantation in the obese recipient.","2022-03-10"]
[24630,"22673296","Endocr J","10.1507/endocrj.ej12-0081","A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI.","2022-03-10"]
[24650,"22648540","Histol Histopathol","10.14670/HH-27.835","Farnesoid X Receptor (FXR) from normal to malignant state.","2022-03-10"]
[24670,"22626039","Ophthalmic Genet","10.3109/13816810.2012.689411","Mutational analysis of SDCCAG8 in Bardet-Biedl syndrome patients with renal involvement and absent polydactyly.","2022-03-10"]
[24690,"22596186","Curr Opin Cardiol","10.1097/HCO.0b013e328354829c","Nonalcoholic fatty liver disease and vascular risk.","2022-03-10"]
[24718,"22567185","World J Hepatol","10.4254/wjh.v4.i4.129","G6PT-H6PDH-11&#946;HSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.","2022-03-10"]
[24729,"22554256","Aliment Pharmacol Ther","10.1111/j.1365-2036.2012.05121.x","Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.","2022-03-10"]
[24747,"22541252","Gastroenterol Hepatol","10.1016/j.gastrohep.2012.02.005","[Influence of non-alcoholic fatty liver disease on cardiovascular disease].","2022-03-10"]
[24767,"22521357","J Hepatol","10.1016/j.jhep.2012.03.024","Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).","2022-03-10"]
[24786,"22496902","PLoS One","10.1371/journal.pone.0035143","Effect of dietary advanced glycation end products on mouse liver.","2022-03-10"]
[24807,"22469726","Hepatogastroenterology","10.5754/hge11255","The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.","2022-03-10"]
[24826,"22460459","J Physiol Pharmacol",null,"The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study.","2022-03-10"]
[24844,"22435761","Liver Int","10.1111/j.1478-3231.2012.02781.x","Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.","2022-03-10"]
[24865,"22419057","Dig Dis Sci","10.1007/s10620-012-2118-3","Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.","2022-03-10"]
[24884,"22395410","Pflugers Arch","10.1007/s00424-012-1078-y","TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice.","2022-03-10"]
[24903,"22375551","J Biomed Sci","10.1186/1423-0127-19-26","Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress.","2022-03-10"]
[24923,"22356310","J Dig Dis","10.1111/j.1751-2980.2011.00571.x","Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study.","2022-03-10"]
[24942,"22331365","J Gastroenterol","10.1007/s00535-012-0534-y","Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.","2022-03-10"]
[24959,"22311412","Chin J Integr Med","10.1007/s11655-012-0993-2","Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.","2022-03-10"]
[24979,"22285877","Magn Reson Imaging","10.1016/j.mri.2011.12.013","Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging.","2022-03-10"]
[24999,"22259190","J Nutr","10.3945/jn.111.150052","Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice.","2022-03-10"]
[25018,"22242926","Metab Syndr Relat Disord","10.1089/met.2011.0113","Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation.","2022-03-10"]
[25040,"22221818","Liver Int","10.1111/j.1478-3231.2011.02730.x","The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.","2022-03-10"]
[25060,"24713803","Ann Gastroenterol",null,"Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic.","2022-03-10"]
[25079,"22184802","MMW Fortschr Med",null,"[Omega-3 fatty acids as an option in the treatment of NAFLD].","2022-03-10"]
[25101,"22170794","Eur J Endocrinol","10.1530/EJE-11-0864","Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.","2022-03-10"]
[25118,"22155853","Hepatogastroenterology","10.5754/hge11689","Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin.","2022-03-10"]
[25145,"22140316","Vasc Health Risk Manag","10.2147/VHRM.S26011","Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease.","2022-03-10"]
[25163,"24843533","J Diabetes Investig","10.1111/j.2040-1124.2011.00134.x","Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.","2022-03-10"]
[25181,"22110265","World J Gastroenterol","10.3748/wjg.v17.i39.4396","Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis.","2022-03-10"]
[25200,"22097893","Liver Int","10.1111/j.1478-3231.2011.02639.x","Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[25221,"22082482","Curr Mol Med","10.2174/156652412798376161","The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.","2022-03-10"]
[25240,"22059109","World J Hepatol","10.4254/wjh.v3.i10.265","Role of ezetimibe in non-alcoholic fatty liver disease.","2022-03-10"]
[25260,"22034200","J Magn Reson Imaging","10.1002/jmri.22748","Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques.","2022-03-10"]
[25277,"22014765","Diabetes Res Clin Pract","10.1016/j.diabres.2011.09.016","Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C.","2022-03-10"]
[25295,"21987619","World J Gastroenterol","10.3748/wjg.v17.i33.3776","Spleen: A new role for an old player?","2022-03-10"]
[25316,"21963507","Biol Pharm Bull","10.1248/bpb.34.1628","meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells.","2022-03-10"]
[25317,"21962038","BMC Public Health","10.1186/1471-2458-11-754","Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.","2022-03-10"]
[25336,"21949781","PLoS One","10.1371/journal.pone.0024895","Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study.","2022-03-10"]
[25357,"21931690","PLoS One","10.1371/journal.pone.0024363","Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis.","2022-03-10"]
[25376,"21910083","Adv Exp Med Biol","10.1007/978-1-4614-0650-1_5","Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.","2022-03-10"]
[25395,"21894008","Dig Dis","10.1159/000329800","Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.","2022-03-10"]
[25415,"25755327","J Clin Exp Hepatol","10.1016/S0973-6883(11)60136-9","Nuclear Factor High-mobility Group Box1 Mediating the Activation of Toll-like Receptor 4 Signaling in Hepatocytes in the Early Stage of Non-alcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[25435,"21846782","Gut","10.1136/gutjnl-2011-300342","Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.","2022-03-10"]
[25453,"21817060","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00150.2011","Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.","2022-03-10"]
[25488,"21773586","Food Funct","10.1039/c0fo00069h","The impact of choline availability on muscle lipid metabolism.","2022-03-10"]
[25493,"21769986","J Magn Reson Imaging","10.1002/jmri.22701","Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.","2022-03-10"]
[25518,"21748770","Hepatology","10.1002/hep.24558","Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.","2022-03-10"]
[25541,"21734385","Dig Dis","10.1159/000323886","ASH and NASH.","2022-03-10"]
[25563,"21708823","Gut","10.1136/gut.2011.242073","Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.","2022-03-10"]
[25586,"21688282","Hepatology","10.1002/hep.24491","The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.","2022-03-10"]
[25605,"21659620","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00050.2011","Role of integrins in fibrosing liver diseases.","2022-03-10"]
[25623,"21633525","World J Gastroenterol","10.3748/wjg.v17.i17.2172","Mallory-Denk Bodies in chronic hepatitis.","2022-03-10"]
[25644,"21602702","J Clin Gastroenterol","10.1097/MCG.0b013e31821377e4","Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.","2022-03-10"]
[25661,"21569072","Clin Endocrinol (Oxf)","10.1111/j.1365-2265.2011.04093.x","Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome.","2022-03-10"]
[25680,"21557024","Hepatol Int","10.1007/s12072-011-9277-8","Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.","2022-03-10"]
[25702,"21521338","Clin Endocrinol (Oxf)","10.1111/j.1365-2265.2011.04070.x","Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes.","2022-03-10"]
[25723,"21504366","Antioxid Redox Signal","10.1089/ars.2010.3834","Nrf2 inhibits LXR&#945;-dependent hepatic lipogenesis by competing with FXR for acetylase binding.","2022-03-10"]
[25743,"21488074","Hepatology","10.1002/hep.24349","Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish.","2022-03-10"]
[25762,"21476916","Expert Rev Gastroenterol Hepatol","10.1586/egh.11.16","Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?","2022-03-10"]
[25785,"21459158","Clin Gastroenterol Hepatol","10.1016/j.cgh.2011.03.027","Factors that affect risk for hepatocellular carcinoma and effects of surveillance.","2022-03-10"]
[25805,"21440669","Clin Gastroenterol Hepatol","10.1016/j.cgh.2011.03.020","Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.","2022-03-10"]
[25825,"21425426","Diabetes Metab Res Rev","10.1002/dmrr.1198","Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.","2022-03-10"]
[25844,"21401898","J Dig Dis","10.1111/j.1751-2980.2011.00487.x","Relationship between nonalcoholic fatty liver disease and metabolic syndrome.","2022-03-10"]
[25864,"21381068","Hepatology","10.1002/hep.24283","Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.","2022-03-10"]
[25884,"21354232","J Hepatol","10.1016/j.jhep.2011.01.048","Lack of interleukin-1&#945; or interleukin-1&#946; inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.","2022-03-10"]
[25897,"21346097","J Nutr","10.3945/jn.110.135210","PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.","2022-03-10"]
[25925,"21320636","Int Immunopharmacol","10.1016/j.intimp.2011.01.036","Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.","2022-03-10"]
[25945,"21281435","Liver Int","10.1111/j.1478-3231.2010.02444.x","Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.","2022-03-10"]
[25966,"21255792","J Comp Pathol","10.1016/j.jcpa.2010.11.011","Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats.","2022-03-10"]
[25984,"21238518","J Hepatol","10.1016/j.jhep.2010.12.017","C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.","2022-03-10"]
[26005,"21216282","Biochim Biophys Acta","10.1016/j.bbadis.2011.01.003","Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.","2022-03-10"]
[26024,"22568272","Rom J Intern Med",null,"Depression and anxiety in nonalcoholic steatohepatitis: is there any association?","2022-03-10"]
[26042,"21173431","Carcinogenesis","10.1093/carcin/bgq277","Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis.","2022-03-10"]
[26063,"21147154","Prev Med","10.1016/j.ypmed.2010.11.021","Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.","2022-03-10"]
[26082,"21134109","Liver Int","10.1111/j.1478-3231.2010.02375.x","Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.","2022-03-10"]
[26102,"21097793","Arch Dis Child","10.1136/adc.2010.190975","Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.","2022-03-10"]
[26120,"21068129","Gut","10.1136/gut.2010.221382","Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.","2022-03-10"]
[26137,"21042023","Digestion","10.1159/000318741","Obesity affects the liver - the link between adipocytes and hepatocytes.","2022-03-10"]
[26159,"20976843","World J Gastroenterol","10.3748/wjg.v16.i40.5065","Hepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease.","2022-03-10"]
[26178,"20950125","Int J Pediatr Obes","10.3109/17477161003792580","Vascular function in obese children with non-alcoholic fatty liver disease.","2022-03-10"]
[26195,"20931285","Dig Dis Sci","10.1007/s10620-010-1417-9","Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.","2022-03-10"]
[26196,"20929443","Clin Sci (Lond)","10.1042/CS20100387","Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.","2022-03-10"]
[26216,"20880062","Hepatol Res","10.1111/j.1872-034X.2010.00719.x","Iron state in association with retinoid metabolism in non-alcoholic fatty liver disease.","2022-03-10"]
[26236,"20849600","World J Surg Oncol","10.1186/1477-7819-8-83","Human vascular adhesion prote&#305;n-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.","2022-03-10"]
[26256,"20827318","Int J Clin Exp Med",null,"Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.","2022-03-10"]
[26278,"20798875","J Obes","10.1155/2010/741521","Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease.","2022-03-10"]
[26297,"20687985","Acta Med Port",null,"[Association of gamma glutamyltransferase, metabolic syndrome and cardiovascular risk].","2022-03-10"]
[26315,"20658466","Hepatology","10.1002/hep.23789","Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.","2022-03-10"]
[26334,"20634799","Am J Hypertens","10.1038/ajh.2010.144","Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study.","2022-03-10"]
[26353,"20604719","Scand J Clin Lab Invest","10.3109/00365513.2010.500675","Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[26370,"20578268","Hepatology","10.1002/hep.23623","A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.","2022-03-10"]
[26389,"20546964","J Hepatol","10.1016/j.jhep.2010.02.034","The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.","2022-03-10"]
[26407,"20506389","J Cell Biochem","10.1002/jcb.22696","ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers.","2022-03-10"]
[26425,"20477484","Biomark Med","10.2217/bmm.09.36","Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?","2022-03-10"]
[26443,"20460915","Dig Dis","10.1159/000282091","Bile acids as regulators of hepatic lipid and glucose metabolism.","2022-03-10"]
[26461,"20451522","Gastroenterology","10.1053/j.gastro.2010.04.054","Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.","2022-03-10"]
[26480,"20413174","J Hepatol","10.1016/j.jhep.2009.12.042","Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice.","2022-03-10"]
[26497,"20392616","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2010.01.003","Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[26517,"20370677","Curr Pharm Des","10.2174/138161210791208875","Insulin resistance in nonalcoholic fatty liver disease.","2022-03-10"]
[26535,"20305757","Hepatol Int","10.1007/s12072-009-9160-z","Fatty liver disease in children: eat now pay later.","2022-03-10"]
[26553,"20216561","Eur J Clin Nutr","10.1038/ejcn.2010.35","Dietary and physical activity patterns in children with fatty liver.","2022-03-10"]
[26571,"20189787","Prostaglandins Leukot Essent Fatty Acids","10.1016/j.plefa.2010.02.012","Fatty liver: role of inflammation and fatty acid nutrition.","2022-03-10"]
[26590,"20145609","Am J Gastroenterol","10.1038/ajg.2010.18","Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.","2022-03-10"]
[26609,"20096896","Metabolism","10.1016/j.metabol.2009.12.012","Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.","2022-03-10"]
[26628,"20066503","Obes Surg","10.1007/s11695-009-0051-0","Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.","2022-03-10"]
[26646,"21525763","Dig Dis","10.1159/000324286","Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.","2022-03-10"]
[26661,"20030578","Scand J Gastroenterol","10.3109/00365520903384742","Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome.","2022-03-10"]
[26682,"19958640","Zhonghua Gan Zang Bing Za Zhi",null,"[Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].","2022-03-10"]
[26699,"19936233","PLoS One","10.1371/journal.pone.0007929","IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.","2022-03-10"]
[26718,"19908945","J Immunotoxicol","10.1080/15476910903241704","Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.","2022-03-10"]
[26736,"19877230","Liver Transpl","10.1002/lt.21812","Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: a single-center experience in mainland China.","2022-03-10"]
[26756,"19799688","J Gastroenterol Hepatol","10.1111/j.1440-1746.2009.06080.x","The liver and the waistline: Fifty years of growth.","2022-03-10"]
[26775,"19811343","Scand J Gastroenterol","10.1080/00365520902845268","Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.","2022-03-10"]
[26794,"19773396","J Clin Endocrinol Metab","10.1210/jc.2009-1125","Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance.","2022-03-10"]
[26812,"19733470","J Nutr Biochem","10.1016/j.jnutbio.2009.06.007","Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.","2022-03-10"]
[26832,"19690397","Gerontology","10.1159/000235677","Non-alcoholic fatty liver disease in older people.","2022-03-10"]
[26849,"19664838","J Hepatol","10.1016/j.jhep.2009.06.008","Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.","2022-03-10"]
[26867,"19622617","J Clin Endocrinol Metab","10.1210/jc.2009-0870","Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.","2022-03-10"]
[26886,"19584965","Drugs Today (Barc)","10.1358/dot.2009.45.5.1370460","Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders?","2022-03-10"]
[26908,"19556219","Arch Dis Child","10.1136/adc.2009.159566","A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease.","2022-03-10"]
[26927,"19533014","J Gastroenterol","10.1007/s00535-009-0091-1","Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.","2022-03-10"]
[26944,"19491838","Am J Gastroenterol","10.1038/ajg.2009.238","The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.","2022-03-10"]
[26961,"19459046","Dig Dis Sci","10.1007/s10620-009-0815-3","Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats.","2022-03-10"]
[26980,"19418409","Z Gastroenterol","10.1055/s-0028-1109146","Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.","2022-03-10"]
[26998,"19371271","Pediatr Int","10.1111/j.1442-200X.2008.02647.x","Ghrelin and leptin modulate immunity and liver function in overweight children.","2022-03-10"]
[26999,"19370784","World J Gastroenterol","10.3748/wjg.15.1863","Non-alcoholic steatohepatitis with normal aminotransferase values.","2022-03-10"]
[27032,"19302184","Liver Int","10.1111/j.1478-3231.2009.01988.x","Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.","2022-03-10"]
[27042,"19285022","Biochem Biophys Res Commun","10.1016/j.bbrc.2009.01.150","The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis.","2022-03-10"]
[27061,"19242728","Pediatr Nephrol","10.1007/s00467-009-1134-9","Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.","2022-03-10"]
[27078,"19221528","Ann Hepatol",null,"Hepatogenous diabetes. Current views of an ancient problem.","2022-03-10"]
[27096,"19194305","Eur J Gastroenterol Hepatol","10.1097/MEG.0b013e328328f3ec","Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.","2022-03-10"]
[27114,"19147984","J Clin Invest","10.1172/JCI32661","Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates.","2022-03-10"]
[27132,"20948730","F1000 Med Rep","10.3410/M1-50","Is there an effective therapy available for non-alcoholic fatty liver disease?","2022-03-10"]
[27152,"19074370","J Lipid Res","10.1194/jlr.R800089-JLR200","Nonalcoholic fatty liver disease.","2022-03-10"]
[27169,"19053946","Clin Sci (Lond)","10.1042/CS20080621","Magic angle spinning magnetic resonance: a novel method opening up translational research into NAFLD?","2022-03-10"]
[27186,"19016656","Clin Sci (Lond)","10.1042/CS20070311","Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.","2022-03-10"]
[27205,"18989145","Eur J Gastroenterol Hepatol","10.1097/MEG.0b013e3282fc9743","Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.","2022-03-10"]
[27223,"18956291","Semin Liver Dis","10.1055/s-0028-1091979","Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.","2022-03-10"]
[27242,"18854760","J Hypertens","10.1097/HJH.0b013e32830dfe4b","Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients.","2022-03-10"]
[27259,"18821470","Curr Opin Investig Drugs",null,"The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease.","2022-03-10"]
[27277,"18769764","Biol Res","/S0716-97602008000100008","Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.","2022-03-10"]
[27296,"18710430","Liver Int","10.1111/j.1478-3231.2008.01853.x","Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.","2022-03-10"]
[27313,"18664346","Zhong Xi Yi Jie He Xue Bao","10.3736/jcim20080805","[Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].","2022-03-10"]
[27330,"18637145","Hepatol Res","10.1111/j.1872-034X.2008.00399.x","Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis.","2022-03-10"]
[27350,"18594178","Korean J Lab Med","10.3343/kjlm.2008.28.3.244","[Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups].","2022-03-10"]
[27368,"18524776","J Biol Chem","10.1074/jbc.M803510200","Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.","2022-03-10"]
[27390,"18488193","Arch Toxicol","10.1007/s00204-008-0312-z","Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.","2022-03-10"]
[27405,"18461519","Z Gastroenterol","10.1055/s-2008-1027151","[Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC)].","2022-03-10"]
[27422,"18417046","Curr Gastroenterol Rep","10.1007/s11894-008-0012-0","Nonalcoholic fatty liver disease as a component of the metabolic syndrome.","2022-03-10"]
[27441,"18376369","Ann Hepatol",null,"Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[27463,"18335793","Natl Med J India",null,"Spectrum of histological features in non-alcoholic fatty liver disease.","2022-03-10"]
[27481,"18308829","Gut","10.1136/gut.2007.147496","Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.","2022-03-10"]
[27499,"18264740","Obes Surg","10.1007/s11695-007-9361-2","Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity.","2022-03-10"]
[27516,"18218340","Trends Mol Med","10.1016/j.molmed.2007.12.003","Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.","2022-03-10"]
[27535,"18173779","Paediatr Perinat Epidemiol","10.1111/j.1365-3016.2007.00876.x","The associations between birthweight and adult markers of liver damage and function.","2022-03-10"]
[27554,"18075282","J Endocrinol Invest","10.1007/BF03349221","Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis.","2022-03-10"]
[27571,"18035683","Verh Dtsch Ges Pathol",null,"[Alcoholic and non-alcoholic steatohepatitis].","2022-03-10"]
[27589,"17976158","Liver Int","10.1111/j.1478-3231.2007.01614.x","Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.","2022-03-10"]
[27606,"17917083","Med Oncol","10.1007/s12032-007-0034-8","A case-control study of non-alcoholic fatty liver disease in breast cancer.","2022-03-10"]
[27628,"17879403","World J Gastroenterol","10.3748/wjg.v13.i40.5336","Liver biopsy in a district general hospital: changes over two decades.","2022-03-10"]
[27645,"17767466","Aliment Pharmacol Ther","10.1111/j.1365-2036.2007.03425.x","Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.","2022-03-10"]
[27662,"17567459","J Gastroenterol Hepatol","10.1111/j.1440-1746.2006.04640.x","Role of mitochondria in non-alcoholic fatty liver disease.","2022-03-10"]
[27681,"17683488","J Gastroenterol Hepatol","10.1111/j.1440-1746.2007.05070.x","Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease.","2022-03-10"]
[27700,"17628189","Vitam Horm","10.1016/S0083-6729(07)76021-1","Vitamin E in chronic liver diseases and liver fibrosis.","2022-03-10"]
[27718,"17565630","J Gastroenterol Hepatol","10.1111/j.1440-1746.2007.05001.x","Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.","2022-03-10"]
[27737,"17544971","Clin Liver Dis","10.1016/j.cld.2007.02.014","Role of radiologic modalities in the management of non-alcoholic steatohepatitis.","2022-03-10"]
[27755,"17512085","J Hepatol","10.1016/j.jhep.2007.04.002","Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.","2022-03-10"]
[27775,"17476088","Indian J Pediatr","10.1007/s12098-007-0068-0","Non-alcoholic fatty liver disease and childhood obesity.","2022-03-10"]
[27795,"17414142","J Pediatr Gastroenterol Nutr","10.1097/MPG.0b013e31803815d9","Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.","2022-03-10"]
[27815,"17376039","J Gastroenterol Hepatol","10.1111/j.1440-1746.2006.04758.x","Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients.","2022-03-10"]
[27817,"17373869","An Med Interna","10.4321/s0212-71992007000100010","[Utility of analytical parameters in the diagnosis of liver disease].","2022-03-10"]
[27836,"17311616","Liver Int","10.1111/j.1478-3231.2006.01401.x","Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.","2022-03-10"]
[27856,"17241384","Liver Int","10.1111/j.1478-3231.2006.01396.x","Prevalence and clinical associations of posttransplant fatty liver disease.","2022-03-10"]
[27874,"17181567","Eur J Clin Invest","10.1111/j.1365-2362.2007.01745.x","Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.","2022-03-10"]
[27891,"17096066","J Gastroenterol","10.1007/s00535-006-1883-1","Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.","2022-03-10"]
[27912,"17033514","J Pediatr Gastroenterol Nutr","10.1097/01.mpg.0000239995.58388.56","Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.","2022-03-10"]
[27930,"16970837","Curr HIV/AIDS Rep","10.1007/BF02696654","Nonalcoholic fatty liver disease and HIV infection.","2022-03-10"]
[27947,"16928437","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2006.04.002","Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.","2022-03-10"]
[27968,"16845716","J Zhejiang Univ Sci B","10.1631/jzus.2006.B0627","Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.","2022-03-10"]
[27987,"16792871","Zhonghua Gan Zang Bing Za Zhi",null,"[A clinical and pathological study of nonalcoholic fatty liver disease].","2022-03-10"]
[28005,"16762625","Gastroenterology","10.1053/j.gastro.2006.03.019","Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.","2022-03-10"]
[28027,"16689200","J Chin Med Assoc","10.1016/S1726-4901(09)70201-1","Nonalcoholic fatty liver disease manifesting esophageal variceal bleeding.","2022-03-10"]
[28045,"16609997","World J Gastroenterol","10.3748/wjg.v12.i12.1905","Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats.","2022-03-10"]
[28065,"16540762","J Clin Gastroenterol","10.1097/01.mcg.0000168645.86658.22","Pathophysiology of nonalcoholic steatohepatitis.","2022-03-10"]
[28084,"16489632","World J Gastroenterol","10.3748/wjg.v12.i3.345","Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?","2022-03-10"]
[28103,"16416209","Dig Dis Sci","10.1007/s10620-006-3082-6","Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease.","2022-03-10"]
[28120,"16374859","Hepatology","10.1002/hep.21006","Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.","2022-03-10"]
[28150,"16259794","Ann Clin Biochem","10.1258/000456305774538210","Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?","2022-03-10"]
[28162,"16242203","Diabetes Res Clin Pract","10.1016/j.diabres.2005.09.007","Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease.","2022-03-10"]
[28180,"16225469","Aliment Pharmacol Ther","10.1111/j.1365-2036.2005.02592.x","Review article: the metabolic syndrome and non-alcoholic fatty liver disease.","2022-03-10"]
[28197,"16177552","Korean J Hepatol",null,"[A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].","2022-03-10"]
[28216,"16108837","Diabet Med","10.1111/j.1464-5491.2005.01748.x","Recent concepts in non-alcoholic fatty liver disease.","2022-03-10"]
[28237,"15991291","World J Gastroenterol","10.3748/wjg.v11.i25.3905","Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.","2022-03-10"]
[28256,"15942443","J Clin Gastroenterol","10.1097/01.mcg.0000165671.25272.0f","Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.","2022-03-10"]
[28274,"15841464","Hepatology","10.1002/hep.20689","Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town.","2022-03-10"]
[28292,"15767815","Am J Med Sci","10.1097/00000441-200503000-00001","Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).","2022-03-10"]
[28310,"15716798","Curr Opin Clin Nutr Metab Care","10.1097/00075197-200503000-00013","Fatty liver in the intensive care unit.","2022-03-10"]
[28328,"15641471","Gac Med Mex",null,"[The metabolic syndrome: a concept in evolution].","2022-03-10"]
[28347,"15561640","Best Pract Res Clin Gastroenterol","10.1016/j.bpg.2004.06.021","Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.","2022-03-10"]
[28366,"15454290","Free Radic Biol Med","10.1016/j.freeradbiomed.2004.06.033","Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.","2022-03-10"]
[28383,"15331061","Clin Liver Dis","10.1016/j.cld.2004.04.004","The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.","2022-03-10"]
[28401,"15209628","J Gastroenterol Hepatol","10.1111/j.1440-1746.2004.03349.x","Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.","2022-03-10"]
[28421,"15084161","Am J Transplant","10.1111/j.1600-6143.2004.00432.x","Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.","2022-03-10"]
[28440,"14739055","Diabetes Res Clin Pract","10.1016/j.diabres.2003.09.007","Non-alcoholic steatohepatitis in patients cared in metabolic units.","2022-03-10"]
[28458,"14598660","Ryumachi",null,"[Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].","2022-03-10"]
[28476,"12774006","Hepatology","10.1053/jhep.2003.50229","Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.","2022-03-10"]
[28497,"12516196","Clin Liver Dis","10.1016/s1089-3261(02)00060-0","The liver in obesity and type 2 diabetes mellitus.","2022-03-10"]
[28515,"12406438","Best Pract Res Clin Gastroenterol","10.1053/bega.2002.0333","Pathogenesis of steatohepatitis.","2022-03-10"]
[28519,"12296456","Nutr Rev","10.1301/002966402320387224","Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.","2022-03-10"]
[28552,"11475019","Ned Tijdschr Geneeskd",null,"[Abdominal obesity: metabolic complications and consequences for the liver].","2022-03-10"]
[28571,"10418175","Zhonghua Yi Xue Za Zhi (Taipei)",null,"Interleukin-8 and alcoholic liver disease.","2022-03-10"]
[28590,"8219405","Baillieres Clin Gastroenterol","10.1016/0950-3528(93)90007-f","Investigation of alcoholic liver disease.","2022-03-10"]
[28617,"35226608","IEEE Trans Neural Netw Learn Syst","10.1109/TNNLS.2022.3151250","Recursive Reasoning With Reduced Complexity and Intermittency for Nonequilibrium Learning in Stochastic Games.","2022-03-10"]
[28641,"35203369","Cells","10.3390/cells11040720","Selective PPAR&#945; Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis.","2022-03-10"]
[28644,"35194060","Sci Rep","10.1038/s41598-022-06542-8","Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.","2022-03-10"]
[28685,"35134275","Hepatol Commun","10.1002/hep4.1910","Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019.","2022-03-10"]
[28717,"35101153","Inflamm Regen","10.1186/s41232-021-00191-6","A novel prostaglandin I2 agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice.","2022-03-10"]
[28745,"35072486","J Med Chem","10.1021/acs.jmedchem.1c01673","5-C-Branched Deoxynojirimycin: Strategy for Designing a 1-Deoxynojirimycin-Based Pharmacological Chaperone with a Nanomolar Affinity for Pompe Disease.","2022-03-10"]
[28778,"35020147","Environ Sci Pollut Res Int","10.1007/s11356-021-18457-4","Using HYDRUS-2D model to simulate the water flow and nitrogen transport in a paddy field with traditional flooded irrigation.","2022-03-10"]
[28825,"34934833","Heliyon","10.1016/j.heliyon.2021.e08509","Streamflow and sediment yield estimation, and area prioritization for better conservation planning in the Dawe River watershed of the Wabi Shebelle River Basin, Ethiopia.","2022-03-10"]
[28871,"34883935","Sensors (Basel)","10.3390/s21237931","Research on Efficient Reinforcement Learning for Adaptive Frequency-Agility Radar.","2022-03-10"]
[28917,"34818366","PLoS One","10.1371/journal.pone.0260231","An improved predator-prey particle swarm optimization algorithm for Nash equilibrium solution.","2022-03-10"]
[28954,"34781614","J Assoc Physicians India",null,"Association of Sarcopenia with Health Related Quality of Life in Cirrhotics.","2022-03-10"]
[28984,"34740336","BMC Public Health","10.1186/s12889-021-12022-x","The significant places of African American adults and their perceived influence on cardiovascular disease risk behaviors.","2022-03-10"]
[29034,"34670284","Dtsch Med Wochenschr","10.1055/a-1226-3047","[Hepatocellular Carcinoma].","2022-03-10"]
[29083,"34606522","JMIRx Med","10.2196/29638","Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study.","2022-03-10"]
[29148,"34506952","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2021.08.019","Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway.","2022-03-10"]
[29186,"34437077","IEEE Trans Neural Netw Learn Syst","10.1109/TNNLS.2021.3105227","Training Generative Adversarial Networks via Stochastic Nash Games.","2022-03-10"]
[29230,"34384949","Water Res","10.1016/j.watres.2021.117483","Cyanobacteria cell prediction using interpretable deep learning model with observed, numerical, and sensing data assemblage.","2022-03-10"]
[29275,"34316375","Gastroenterol Rep (Oxf)","10.1093/gastro/goaa057","Bariatric surgery proves long-term benefit in patients with cirrhosis.","2022-03-10"]
[29319,"34260795","Hepatol Res","10.1111/hepr.13695","Efficacy and safety of apararenone (MT-3995) in patients with nonalcoholic steatohepatitis: A randomized controlled study.","2022-03-10"]
[29367,"34176099","Drug Deliv Transl Res","10.1007/s13346-021-01018-0","Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.","2022-03-10"]
[29417,"34098274","Sci Total Environ","10.1016/j.scitotenv.2021.148139","Modeling water quantity and quality for a typical agricultural plain basin of northern China by a coupled model.","2022-03-10"]
[29467,"34025027","J Clin Biochem Nutr","10.3164/jcbn.20-136","Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic.","2022-03-10"]
[29513,"33961581","IEEE Trans Cybern","10.1109/TCYB.2021.3071746","Nash Equilibrium Seeking for Graphic Games With Dynamic Event-Triggered Mechanism.","2022-03-10"]
[29551,"33895877","Eur Spine J","10.1007/s00586-021-06839-8","Assessment of pedicle size in patients with scoliosis using EOS 2D imaging: a validity and reliability study.","2022-03-10"]
[29589,"33826548","Am J Surg Pathol","10.1097/PAS.0000000000001714","Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.","2022-03-10"]
[29634,"33759096","Environ Sci Pollut Res Int","10.1007/s11356-021-13503-7","Spatial modelling of soil salinity: deep or shallow learning models?","2022-03-10"]
[29672,"33710965","IEEE Trans Cybern","10.1109/TCYB.2021.3052832","Q-Learning for Feedback Nash Strategy of Finite-Horizon Nonzero-Sum Difference Games.","2022-03-10"]
[29737,"33601552","Phys Rev E","10.1103/PhysRevE.103.012304","Maximizing cooperation in the prisoner's dilemma evolutionary game via optimal control.","2022-03-10"]
[29793,"33513817","Entropy (Basel)","10.3390/e23020154","Tripartite Dynamic Zero-Sum Quantum Games.","2022-03-10"]
[29838,"33423330","Transpl Int","10.1111/tri.13814","Disease-specific waitlist outcomes in liver transplantation - a retrospective study.","2022-03-10"]
[29877,"33351765","IEEE Trans Neural Netw Learn Syst","10.1109/TNNLS.2020.3042331","Multiplayer Stackelberg-Nash Game for Nonlinear System via Value Iteration-Based Integral Reinforcement Learning.","2022-03-10"]
[29926,"33263584","Water Sci Technol","10.2166/wst.2020.472","Study of pollution transport through the river confluences by derivation of an analytical model.","2022-03-10"]
[29961,"33198998","Sci Total Environ","10.1016/j.scitotenv.2020.143433","Assessing the impacts of diversified crop rotation systems on yields and nitrous oxide emissions in Canada using the DNDC model.","2022-03-10"]
[30000,"33142670","Sensors (Basel)","10.3390/s20216216","Multiple Power Allocation Game Schemes for Spectrum Coexistence Model Between Multistatic MIMO Radar Sensors and MU Communication.","2022-03-10"]
[30060,"33040211","Environ Monit Assess","10.1007/s10661-020-08659-7","Monthly evapotranspiration estimation using optimal climatic parameters: efficacy of hybrid support vector regression integrated with whale optimization algorithm.","2022-03-10"]
[30109,"32968496","R Soc Open Sci","10.1098/rsos.191957","Predicting hydrologic responses to climate changes in highly glacierized and mountainous region Upper Indus Basin.","2022-03-10"]
[30139,"32910724","Plant Dis","10.1094/PDIS-04-20-0816-RE","Molecular Characterization of an Emerging Root-Knot Nematode Meloidogyne enterolobii in North Carolina, USA.","2022-03-10"]
[30219,"32793866","Mayo Clin Proc Innov Qual Outcomes","10.1016/j.mayocpiqo.2020.04.003","Hepatitis C Testing and Liver Fibrosis Predictors in the Birth Cohort of a Primary Care Practice.","2022-03-10"]
[30266,"32721288","J Environ Manage","10.1016/j.jenvman.2020.110792","Modeling seasonal water yield for landscape management: Applications in Peru and Myanmar.","2022-03-10"]
[30316,"32655230","J Clin Exp Hepatol","10.1016/j.jceh.2019.11.008","Non-Wilson's Disease-Associated Hypoceruloplasminemia.","2022-03-10"]
[30381,"32531896","Int J Environ Res Public Health","10.3390/ijerph17114132","Data-Driven Modeling and the Influence of Objective Function Selection on Model Performance in Limited Data Regions.","2022-03-10"]
[30436,"32448510","Biochem Biophys Res Commun","10.1016/j.bbrc.2020.05.072","Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicity.","2022-03-10"]
[30480,"32377219","Nutr Metab (Lond)","10.1186/s12986-020-00454-y","Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.","2022-03-10"]
[30510,"32312957","Cell Death Dis","10.1038/s41419-020-2460-x","Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases.","2022-03-10"]
[30567,"32201944","Cancer","10.1002/cncr.32789","Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.","2022-03-10"]
[30606,"32121273","Int J Mol Sci","10.3390/ijms21051651","Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis-A Novel Form of Non-Apoptotic Cell Death?","2022-03-10"]
[30654,"32039401","JHEP Rep","10.1016/j.jhepr.2019.11.004","Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.","2022-03-10"]
[30655,"32039387","JHEP Rep","10.1016/j.jhepr.2019.09.005","The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity.","2022-03-10"]
[30708,"31927430","Sci Total Environ","10.1016/j.scitotenv.2019.136157","Validation and uncertainty analysis of a stormwater biofilter treatment model for faecal microorganisms.","2022-03-10"]
[30766,"31824216","Proc Math Phys Eng Sci","10.1098/rspa.2019.0355","The stabilization of equilibria in evolutionary game dynamics through mutation: mutation limits in evolutionary games.","2022-03-10"]
[30810,"31747961","Stem Cell Res Ther","10.1186/s13287-019-1474-8","Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.","2022-03-10"]
[30855,"31661503","PLoS One","10.1371/journal.pone.0224153","Carbon emission reduction and profit distribution mechanism of construction supply chain with fairness concern and cap-and-trade.","2022-03-10"]
[30909,"31573701","Risk Anal","10.1111/risa.13411","A Game Theory Approach for Assessment of Risk and Deployment of Police Patrols in Response to Criminal Activity in San Francisco.","2022-03-10"]
[30978,"31444409","Sci Rep","10.1038/s41598-019-48813-x","+50 Years of Terrestrial Hydroclimatic Variability in Africa's Transboundary Waters.","2022-03-10"]
[31018,"31388630","Hepatol Commun","10.1002/hep4.1383","Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.","2022-03-10"]
[31076,"31267760","Australas Psychiatry","10.1177/1039856219859284","Career medical officers in psychiatry and addiction in NSW: description, role and educational needs.","2022-03-10"]
[31132,"31186641","J Cancer Epidemiol","10.1155/2019/8534372","Segmental Distribution of Hepatocellular Carcinoma Correlates with Microvascular Invasion in Liver Explants Undergoing Transplantation.","2022-03-10"]
[31207,"31035357","Int J Environ Res Public Health","10.3390/ijerph16091503","Effectiveness Analysis of Systematic Combined Sewer Overflow Control Schemes in the Sponge City Pilot Area of Beijing.","2022-03-10"]
[31244,"30967480","Mol Cancer Res","10.1158/1541-7786.MCR-18-1045","Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.","2022-03-10"]
[31299,"30860824","Environ Sci Technol","10.1021/acs.est.8b06777","Modeling Spatial and Temporal Variation in Natural Background Specific Conductivity.","2022-03-10"]
[31341,"30760956","Proc Math Phys Eng Sci","10.1098/rspa.2018.0490","Sparse low-rank separated representation models for learning from data.","2022-03-10"]
[31387,"30671951","New Phytol","10.1111/nph.15703","Unfair trade underground revealed by integrating data with Nash bargaining models.","2022-03-10"]
[31427,"30592793","Int J Clin Pract","10.1111/ijcp.13309","Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long-term outcomes after liver transplantation.","2022-03-10"]
[31485,"30471196","Pest Manag Sci","10.1002/ps.5276","Inverse analysis to estimate site-specific parameters of a mathematical model for simulating pesticide dissipations in paddy test systems.","2022-03-10"]
[31533,"30357453","J Math Biol","10.1007/s00285-018-1300-4","Fixation probabilities for the Moran process in evolutionary games with two strategies: graph shapes and large population asymptotics.","2022-03-10"]
[31570,"30273165","IEEE Trans Cybern","10.1109/TCYB.2018.2868715","Data-Based Optimal Control of Multiagent Systems: A Reinforcement Learning Design Approach.","2022-03-10"]
[31619,"30186272","Front Microbiol","10.3389/fmicb.2018.01967","Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels.","2022-03-10"]
[31667,"30080444","FASEB J","10.1096/fj.201800400R","Interaction between plasma homocysteine and the MTHFR c.677C > T polymorphism is associated with site-specific changes in DNA methylation in humans.","2022-03-10"]
[31700,"30010609","IEEE Trans Cybern","10.1109/TCYB.2018.2851620","Joint Pricing and Decision-Making for Heterogeneous User Demand in Cognitive Radio Networks.","2022-03-10"]
[31728,"29973237","J Exp Clin Cancer Res","10.1186/s13046-018-0781-8","Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.","2022-03-10"]
[31778,"29886405","Water Res","10.1016/j.watres.2018.05.038","Predicting long term removal of heavy metals from porous pavements for stormwater treatment.","2022-03-10"]
[31821,"29753082","Clin Gastroenterol Hepatol","10.1016/j.cgh.2018.04.062","Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.","2022-03-10"]
[31859,"29686329","Sci Rep","10.1038/s41598-018-24819-9","Mathematical model of ammonium nitrogen transport with overland flow on a slope after polyacrylamide application.","2022-03-10"]
[31917,"29566109","JAMA Oncol","10.1001/jamaoncol.2018.0071","Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.","2022-03-10"]
[31960,"29465440","Curr Opin Organ Transplant","10.1097/MOT.0000000000000513","Obesity management in the liver transplant recipient: the role of bariatric surgery.","2022-03-10"]
[32014,"29332298","J Math Biol","10.1007/s00285-018-1207-0","The ESS and replicator equation in matrix games under time constraints.","2022-03-10"]
[32064,"29271075","Clin Pharmacol Ther","10.1002/cpt.997","Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.","2022-03-10"]
[32093,"29203594","N C Med J","10.18043/ncm.78.6.357","Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties.","2022-03-10"]
[32145,"29116096","Sci Rep","10.1038/s41598-017-14557-9","AQP3 is regulated by PPAR&#947; and JNK in hepatic stellate cells carrying PNPLA3 I148M.","2022-03-10"]
[32184,"29035235","IEEE Trans Cybern","10.1109/TCYB.2017.2754919","Asymmetric Game: A Silver Bullet to Weighted Vertex Cover of Networks.","2022-03-10"]
[32244,"28882507","Biosystems","10.1016/j.biosystems.2017.08.001","Stochastic noncooperative and cooperative evolutionary game strategies of a population of biological networks under natural selection.","2022-03-10"]
[32297,"28768902","JCI Insight","10.1172/jci.insight.94488","Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.","2022-03-10"]
[32333,"28701506","J R Soc Interface","10.1098/rsif.2017.0095","Modelling the host-pathogen interactions of macrophages and Candida albicans using Game Theory and dynamic optimization.","2022-03-10"]
[32381,"28601689","Seizure","10.1016/j.seizure.2017.05.002","Epilepsy management in older people: Lessons from National Audit of Seizure management in Hospitals (NASH).","2022-03-10"]
[32422,"28486701","Epidemiol Rev","10.1093/epirev/mxw003","Cancer in Transgender People: Evidence and Methodological Considerations.","2022-03-10"]
[32472,"28364810","Clin Liver Dis","10.1016/j.cld.2016.12.001","Liver Transplantation and Bariatric Surgery: Best Approach.","2022-03-10"]
[32518,"28223491","Proc Natl Acad Sci U S A","10.1073/pnas.1700349114","Oogenesis and reproductive investment of Atlantic herring are functions of not only present but long-ago environmental influences as well.","2022-03-10"]
[32580,"28068134","Am Psychol","10.1037/a0040382","Psychologists in patient-centered medical homes (PCMHs): Roles, evidence, opportunities, and challenges.","2022-03-10"]
[32631,"30379467","Masui",null,"[Desflurane Anesthesia and Intraoperative Motor Evoked Potential Monitoring of a Patient with Cervical Cavernous Hemangioma Complicated with Liver Cirrhosis].","2022-03-10"]
[32677,"27740615","Cancer Gene Ther","10.1038/cgt.2016.41","Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.","2022-03-10"]
[32725,"27677330","Sci Rep","10.1038/srep34102","The Evolution of Generosity in the Ultimatum Game.","2022-03-10"]
[32730,"27662861","Environ Sci Pollut Res Int","10.1007/s11356-016-7707-9","Vetiver plantlets in aerated system degrade phenol in illegally dumped industrial wastewater by phytochemical and rhizomicrobial degradation.","2022-03-10"]
[32774,"27513953","PLoS One","10.1371/journal.pone.0160775","Postpartum Loss to HIV Care and HIV Viral Suppression among Previously Diagnosed HIV-Infected Women with a Live Birth in New York State.","2022-03-10"]
[32825,"27344122","Sci Total Environ","10.1016/j.scitotenv.2016.06.094","A mathematical model for the transfer of soil solutes to runoff under water scouring.","2022-03-10"]
[32875,"27187978","IEEE Trans Cybern","10.1109/TCYB.2016.2557802","A Framework of Camera Source Identification Bayesian Game.","2022-03-10"]
[32928,"27079362","Surgery","10.1016/j.surg.2016.02.029","Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer.","2022-03-10"]
[32978,"26937962","PLoS One","10.1371/journal.pone.0149843","Genetic Association and Gene-Gene Interaction Reveal Genetic Variations in ADH1B, GSTM1 and MnSOD Independently Confer Risk to Alcoholic Liver Diseases in India.","2022-03-10"]
[33027,"26843403","Environ Sci Technol","10.1021/acs.est.5b04725","Identification of Biochemical Pathways Associated with Lead Tolerance and Detoxification in Chrysopogon zizanioides L. Nash (Vetiver) by Metabolic Profiling.","2022-03-10"]
[33143,"26605241","Adv Biomed Res","10.4103/2277-9175.166149","Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial.","2022-03-10"]
[33180,"26529794","IEEE Trans Cybern","10.1109/TCYB.2015.2488680","Experience Replay for Optimal Control of Nonzero-Sum Game Systems With Unknown Dynamics.","2022-03-10"]
[33238,"26393617","Sensors (Basel)","10.3390/s150924230","Cell Selection Game for Densely-Deployed Sensor and Mobile Devices In 5G Networks Integrating Heterogeneous Cells and the Internet of Things.","2022-03-10"]
[33309,"26258522","PLoS One","10.1371/journal.pone.0135137","A novel utility function for energy-efficient power control game in cognitive radio networks.","2022-03-10"]
[33360,"26138277","Nat Commun","10.1038/ncomms8651","Navigable networks as Nash equilibria of navigation games.","2022-03-10"]
[33403,"26055838","J Am Acad Audiol","10.3766/jaaa.14098","Differences in Perception of Musical Stimuli among Acoustic, Electric, and Combined Modality Listeners.","2022-03-10"]
[33459,"25956647","J Hazard Mater","10.1016/j.jhazmat.2015.04.061","Cement kiln dust (CKD)-filter sand permeable reactive barrier for the removal of Cu(II) and Zn(II) from simulated acidic groundwater.","2022-03-10"]
[33515,"25830098","Mol Metab","10.1016/j.molmet.2015.01.009","The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis.","2022-03-10"]
[33550,"25741394","Open Respir Med J","10.2174/1874306401509010015","Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community.","2022-03-10"]
[33607,"25603241","J Environ Qual","10.2134/jeq2014.01.0023","Performance of Weibull and Linear Semi-logarithmic Models in Simulating Inactivation in Waters.","2022-03-10"]
[33648,"25516092","J Int AIDS Soc","10.7448/IAS.17.1.19045","Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.","2022-03-10"]
[33718,"25322849","HPB (Oxford)","10.1111/hpb.12340","Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis.","2022-03-10"]
[33771,"25183224","J Am Soc Mass Spectrom","10.1007/s13361-014-0967-z","Top-down and bottom-up identification of proteins by liquid extraction surface analysis mass spectrometry of healthy and diseased human liver tissue.","2022-03-10"]
[33806,"25120581","Scoliosis","10.1186/1748-7161-9-11","The radiographic method for evaluation of axial vertebral rotation - presentation of the new method.","2022-03-10"]
[33868,"24987431","Evid Based Complement Alternat Med","10.1155/2014/648308","Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects.","2022-03-10"]
[33941,"24813992","Biochem Biophys Res Commun","10.1016/j.bbrc.2014.04.159","Therapeutic potential of flurbiprofen against obesity in mice.","2022-03-10"]
[34006,"24650697","Nitric Oxide","10.1016/j.niox.2014.03.163","H2S during circulatory shock: some unresolved questions.","2022-03-10"]
[34056,"24548175","J Org Chem","10.1021/jo402872p","Thioacetic acid/NaSH-mediated synthesis of N-protected amino thioacids and their utility in peptide synthesis.","2022-03-10"]
[34131,"24361823","J Back Musculoskelet Rehabil","10.3233/BMR-130452","Effects of novel corrective spinal technique on adolescent idiopathic scoliosis as assessed by radiographic imaging.","2022-03-10"]
[34187,"24189085","BMJ Open","10.1136/bmjopen-2013-003995","Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial.","2022-03-10"]
[34254,"23948302","J Autoimmun","10.1016/j.jaut.2013.07.008","STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by&#160;the protein kinase inhibitor sorafenib.","2022-03-10"]
[34298,"23824403","Dig Dis Sci","10.1007/s10620-013-2747-1","Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats.","2022-03-10"]
[34333,"26838973","Surg Pathol Clin","10.1016/j.path.2013.03.002","Nonalcoholic Steatohepatitis: Diagnostic Challenges.","2022-03-10"]
[34379,"23612901","Eur Spine J","10.1007/s00586-013-2786-5","Can decompression surgery relieve low back pain in patients with lumbar spinal stenosis combined with degenerative lumbar scoliosis?","2022-03-10"]
[34445,"23441191","PLoS One","10.1371/journal.pone.0056416","Cyclic game dynamics driven by iterated reasoning.","2022-03-10"]
[34509,"23281043","Hepatology","10.1002/hep.26207","Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice.","2022-03-10"]
[34579,"23152743","PLoS One","10.1371/journal.pone.0048366","Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.","2022-03-10"]
[34637,"23007134","Lab Invest","10.1038/labinvest.2012.121","Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.","2022-03-10"]
[34702,"22834991","Hepatol Res","10.1111/j.1872-034X.2012.01062.x","Altered expression and function of hepatic natural killer T cells in obese and diabetic KK-A(y)  mice.","2022-03-10"]
[34770,"22648882","Int J STD AIDS","10.1258/ijsa.2011.011274","The contribution of antenatal care to the coverage and correlates of HIV testing among adults in Zimbabwe 2005-06.","2022-03-10"]
[34831,"22487102","Hepatol Res","10.1111/j.1872-034X.2012.00986.x","Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.","2022-03-10"]
[34884,"22294490","Phytother Res","10.1002/ptr.4602","Hepatoprotective effects of pycnogenol in a rat model of non-alcoholic steatohepatitis.","2022-03-10"]
[34957,"22153941","Bioorg Med Chem Lett","10.1016/j.bmcl.2011.11.034","Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.","2022-03-10"]
[35004,"21998641","PLoS One","10.1371/journal.pone.0025190","Clustering in large networks does not promote upstream reciprocity.","2022-03-10"]
[35052,"21865331","Am J Clin Nutr","10.3945/ajcn.111.015610","Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.","2022-03-10"]
[35112,"21711427","Hepatol Res","10.1111/j.1872-034X.2011.00814.x","Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase.","2022-03-10"]
[35178,"21520194","Hepatology","10.1002/hep.24370","A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.","2022-03-10"]
[35227,"21373270","J Clin Biochem Nutr","10.3164/jcbn.09-122GFR","Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model.","2022-03-10"]
[35231,"21348864","Biochem J","10.1042/BJ20101920","A composite biochemical system for bacterial nitrate and nitrite assimilation as exemplified by Paracoccus denitrificans.","2022-03-10"]
[35289,"25013596","Int J Organ Transplant Med",null,"Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection.","2022-03-10"]
[35352,"21038418","Hepatology","10.1002/hep.24001","Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","2022-03-10"]
[35397,"20835270","Acta Pharmacol Sin","10.1038/aps.2010.110","Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression.","2022-03-10"]
[35435,"20683947","Hepatology","10.1002/hep.23727","High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial.","2022-03-10"]
[35480,"20561512","Chem Biol Interact","10.1016/j.cbi.2010.06.006","Hepatocyte or serum albumin protein carbonylation by oxidized fructose metabolites: Glyceraldehyde or glycolaldehyde as endogenous toxins?","2022-03-10"]
[35529,"21949477","Hepat Med","10.2147/HMER.S8902","Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.","2022-03-10"]
[35564,"20355833","ACS Appl Mater Interfaces","10.1021/am900425v","Janus nanostructures based on Au-TiO2 heterodimers and their photocatalytic activity in the oxidation of methanol.","2022-03-10"]
[35626,"20082768","Anal Chim Acta","10.1016/j.aca.2009.11.001","Modeling the performance of \"up-flow anaerobic sludge blanket\" reactor based wastewater treatment plant using linear and nonlinear approaches--a case study.","2022-03-10"]
[35663,"19968100","Huan Jing Ke Xue",null,"[Nonpoint source pollution model, AnnAGNPS, assessment for a mixed forested watershed in Three Gorges Reservoir area].","2022-03-10"]
[35710,"19856102","Dig Dis Sci","10.1007/s10620-009-1020-0","Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats.","2022-03-10"]
[35765,"19748164","Clin Nutr","10.1016/j.clnu.2009.08.014","Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats.","2022-03-10"]
[35812,"19638084","J Gastroenterol Hepatol","10.1111/j.1440-1746.2009.05865.x","Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients.","2022-03-10"]
[35864,"19540686","Gastroenterol Clin Biol","10.1016/j.gcb.2009.05.001","[Nonalcoholic fatty liver disease: 30 years research changed NASH].","2022-03-10"]
[35907,"19444873","Hepatology","10.1002/hep.22970","Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.","2022-03-10"]
[35942,"19375276","Neural Netw","10.1016/j.neunet.2009.03.010","Valuation of uncertain and delayed rewards in primate prefrontal cortex.","2022-03-10"]
[35979,"19281869","Clin Gastroenterol Hepatol","10.1016/j.cgh.2009.02.025","Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.","2022-03-10"]
[36014,"19203941","Tree Physiol","10.1093/treephys/tpn019","Seasonal changes in depth of water uptake for encroaching trees Juniperus virginiana and Pinus ponderosa and two dominant C4 grasses in a semiarid grassland.","2022-03-10"]
[36077,"19053005","Z Gastroenterol","10.1055/s-2008-1027411","Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH).","2022-03-10"]
[36127,"18973872","Am J Obstet Gynecol","10.1016/j.ajog.2008.07.008","Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis.","2022-03-10"]
[36179,"18806095","J Nutr","10.1093/jn/138.10.1872","N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.","2022-03-10"]
[36228,"18689562","J Am Coll Nutr","10.1080/07315724.2008.10719703","Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment.","2022-03-10"]
[36272,"18563978","Rev Esp Enferm Dig","10.4321/s1130-01082008000400004","[Gene expression in obese patients with non-alcoholic steatohepatitis].","2022-03-10"]
[36314,"18473397","Psychooncology","10.1002/pon.1341","Exercise and relaxation intervention for breast cancer survivors: feasibility, acceptability and effects.","2022-03-10"]
[36404,"18277895","J Clin Gastroenterol","10.1097/MCG.0b013e31815591aa","Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis.","2022-03-10"]
[36464,"18090988","Eur J Gastroenterol Hepatol","10.1097/MEG.0b013e3282efa4f2","Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases.","2022-03-10"]
[36534,"17929294","Hepatology","10.1002/hep.21874","Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.","2022-03-10"]
[36583,"17681180","Gastroenterology","10.1053/j.gastro.2007.05.019","Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.","2022-03-10"]
[36620,"17599864","Endocr Pract","10.4158/EP.13.3.300","The multifaceted associations of hepatobiliary disease and diabetes.","2022-03-10"]
[36674,"17477913","Clin Biochem","10.1016/j.clinbiochem.2007.02.006","Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis.","2022-03-10"]
[36717,"17394061","Dig Dis Sci","10.1007/s10620-007-9810-8","Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).","2022-03-10"]
[36754,"17331167","Alcohol Clin Exp Res","10.1111/j.1530-0277.2006.00287.x","Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis.","2022-03-10"]
[36799,"17244458","Zhonghua Gan Zang Bing Za Zhi",null,"[The role of apoptosis and the related genes in non-alcoholic steatohepatitis].","2022-03-10"]
[36850,"17101320","Gastroenterology","10.1053/j.gastro.2006.08.036","Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.","2022-03-10"]
[36899,"16971174","Hepatol Res","10.1016/j.hepres.2006.08.003","Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study.","2022-03-10"]
[36962,"16838687","Water Sci Technol","10.2166/wst.2006.295","Application of WetSpa model for assessing land use impacts on floods in the Margecany-Hornad watershed, Slovakia.","2022-03-10"]
[36995,"16768113","Nihon Rinsho",null,"[Adipokine interrelationship with the liver].","2022-03-10"]
[37058,"16554999","Surg Today","10.1007/s00595-005-3167-4","Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases.","2022-03-10"]
[37104,"16469221","Obes Surg","10.1381/096089206775565122","Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.","2022-03-10"]
[37144,"16385236","Alcohol Clin Exp Res","10.1097/01.alc.0000191777.36629.33","Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.","2022-03-10"]
[37209,"16256868","J Am Coll Cardiol","10.1016/j.jacc.2005.06.073","Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease.","2022-03-10"]
[37246,"16191492","Endocr Pract","10.4158/EP.11.5.319","Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings.","2022-03-10"]
[37314,"15980672","Korean J Hepatol",null,"[Antioxidant status in nonalcoholic steatohepatitis].","2022-03-10"]
[37322,"15959406","Ann Endocrinol (Paris)",null,"[Nonalcoholic steatohepatitis].","2022-03-10"]
[37379,"15820484","Clin Chim Acta","10.1016/j.cccn.2004.12.022","Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis.","2022-03-10"]
[37436,"15690087","J Clin Invest","10.1172/JCI22710","SOCS2 negatively regulates growth hormone action in vitro and in vivo.","2022-03-10"]
[37499,"15554595","Neth J Med",null,"Nonalcoholic steatohepatitis.","2022-03-10"]
[37563,"15352910","Aliment Pharmacol Ther","10.1111/j.1365-2036.2004.02153.x","A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients.","2022-03-10"]
[37608,"15292897","Am J Infect Control","10.1016/j.ajic.2003.12.003","Reducing percutaneous injuries at an academic health center: a 5-year review.","2022-03-10"]
[37675,"15142652","Med Hypotheses","10.1016/j.mehy.2003.12.041","Aerobic exercise: a potential therapeutic intervention for patients with liver disease.","2022-03-10"]
[37727,"15024100","Proc Natl Acad Sci U S A","10.1073/pnas.0308738101","The Nash equilibrium: a perspective.","2022-03-10"]
[37781,"14679419","Can J Gastroenterol","10.1155/2003/857869","Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.","2022-03-10"]
[37843,"14499785","Am J Gastroenterol","10.1111/j.1572-0241.2003.07659.x","The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.","2022-03-10"]
[37897,"12830008","Hepatology","10.1053/jhep.2003.50290","Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis.","2022-03-10"]
[37963,"12663234","J Hepatol","10.1016/s0168-8278(03)00027-8","Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[38027,"12469151","Oncol Rep",null,"Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.","2022-03-10"]
[38084,"12194005","Int J Biometeorol","10.1007/s00484-002-0125-3","Aerial short-range dispersion of volatilized pesticides from an area source.","2022-03-10"]
[38164,"12009054","Psychol Sci","10.1111/1467-9280.00454","Effects of financial incentives on the breakdown of mutual trust.","2022-03-10"]
[38226,"11851839","J Gastroenterol Hepatol","10.1046/j.1440-1746.2001.02644.x","Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.","2022-03-10"]
[38294,"11668021","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.2001.281.5.G1135","Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.","2022-03-10"]
[38385,"11381176","Biorheology",null,"Dependence of adhesive behavior of neutrophils on local fluid dynamics in a region with recirculating flow.","2022-03-10"]
[38444,"30832038","Plant Dis","10.1094/PDIS.2001.85.3.256","Isolation and Identification of Fusarium solani f. sp. glycines from Soil on Modified Nash and Snyder's Medium.","2022-03-10"]
[38552,"10964418","Anal Biochem","10.1006/abio.2000.4709","High-performance liquid chromatography determination of N- and O-demethylase activities of chemicals in human liver microsomes: application of postcolumn fluorescence derivatization using Nash reagent.","2022-03-10"]
[38688,"10553416","Gan To Kagaku Ryoho",null,"[Early detection and prevention of cancers in various therapeutic areas. Discussion].","2022-03-10"]
[38746,"10408063","Z Orthop Ihre Grenzgeb","10.1055/s-2008-1039354","[Primary correction of scoliosis with the Wilmington corset].","2022-03-10"]
[38864,"9735263","J Theor Biol","10.1006/jtbi.1998.0705","War of Attrition with Individual Differences on RHP.","2022-03-10"]
[38981,"9367489","Chest","10.1378/chest.112.5.1432","Nonsurgical therapy for pulmonary hydatid cyst disease.","2022-03-10"]
[39155,"8798671","J Biol Chem","10.1074/jbc.271.39.24257","DNA ligase IV from HeLa cell nuclei.","2022-03-10"]
[39317,"7659518","Nucleic Acids Res",null,"In vivo interaction of the Escherichia coli integration host factor with its specific binding sites.","2022-03-10"]
[39610,"8270266","Immunol Cell Biol","10.1038/icb.1993.43","Recombinant cytokines as immunological adjuvants.","2022-03-10"]
[39842,"1602256","J Mal Vasc",null,"[Erythrocyte aggregation and clinical course stages of venous insufficiency of the legs].","2022-03-10"]
[39983,"2124853","Nurs Stand",null,"Oncology: the role of the Macmillan nurse.","2022-03-10"]
[40097,"1968061","J Biol Chem",null,"An alternatively processed mRNA specific for gamma-glutamyl transpeptidase in human tissues.","2022-03-10"]
[40380,"3124648","Am J Trop Med Hyg","10.4269/ajtmh.1988.38.86","Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study.","2022-03-10"]
[40729,"6748040","J Med Microbiol","10.1099/00222615-18-1-47","Vaginal carriage and neonatal acquisition of Clostridium difficile.","2022-03-10"]
[40931,"7091454","Am J Public Health","10.2105/ajph.72.7.662","Traditional and emerging forms of dental practice: another view.","2022-03-10"]
[41166,"10308047","Employee Relat Law J",null,"The Labor Reform Act of 1977: a detailed analysis.","2022-03-10"]
[41753,"34492999","Ecology","10.2307/1933738","Phenological Variation within Seven Transplanted Grassland Community Fractions from Texas and New Mexico.","2022-03-10"]
[42219,"35183767","Clin Gastroenterol Hepatol","10.1016/j.cgh.2022.02.029","Bridging the gap: Screening for non-alcoholic fatty liver disease in the primary care population.","2022-03-10"]
[42236,"35127953","J Diabetes Res","10.1155/2022/8429847","Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.","2022-03-10"]
[42253,"35089675","Pol Arch Intern Med","10.20452/pamw.16188","Are mobile applications a solution for the assessment of fatty acid intake? Authors' reply.","2022-03-10"]
[42271,"35034629","BMC Gastroenterol","10.1186/s12876-022-02098-z","Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis.","2022-03-10"]
[42289,"34964947","J Microbiol","10.1007/s12275-022-1614-1","The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism.","2022-03-10"]
[42306,"34915503","J Innate Immun","10.1159/000521305","Immunometabolism: Where Immunology and Metabolism Meet.","2022-03-10"]
[42318,"34886776","Curr Vasc Pharmacol","10.2174/1570161119666211209161023","Cilofexor for the Treatment of Nonalcoholic Steatohepatitis","2022-03-10"]
[42342,"34813941","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.11.023","Symptom Classes in Decompensated Liver Disease.","2022-03-10"]
[42360,"34766515","Physiol Genomics","10.1152/physiolgenomics.00066.2021","Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways.","2022-03-10"]
[42377,"34738233","J Clin Pharmacol","10.1002/jcph.1996","Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic Impairment.","2022-03-10"]
[42394,"34675485","Drug Des Devel Ther","10.2147/DDDT.S341223","Saroglitazar - A Potential Therapeutic Option in Treating NASH? [Letter].","2022-03-10"]
[42395,"34675006","Diabetes","10.2337/db21-0240","Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication.","2022-03-10"]
[42412,"34603218","Front Endocrinol (Lausanne)","10.3389/fendo.2021.760558","Editorial: The Brain - Gut - Microbiome Network in Metabolic Regulation and Dysregulation.","2022-03-10"]
[42430,"34542351","Crit Rev Food Sci Nutr","10.1080/10408398.2021.1977910","Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity?","2022-03-10"]
[42447,"34509644","Clin Gastroenterol Hepatol","10.1016/j.cgh.2021.09.006","Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women.","2022-03-10"]
[42465,"34461208","J Hepatol","10.1016/j.jhep.2021.08.017","Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline.","2022-03-10"]
[42483,"34414117","Liver Cancer","10.1159/000517841","Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?","2022-03-10"]
[42500,"34362163","J Clin Med","10.3390/jcm10153380","Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy.","2022-03-10"]
[42517,"34309877","Hepatology","10.1002/hep.32072","Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications.","2022-03-10"]
[42536,"34228993","J Hepatol","10.1016/j.jhep.2021.06.032","Multiple investigations for a very common disorder: Finding the right balance in NAFLD.","2022-03-10"]
[42554,"34170539","Aliment Pharmacol Ther","10.1111/apt.16462","Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.","2022-03-10"]
[42572,"34139785","Semin Liver Dis","10.1055/s-0041-1731016","Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine.","2022-03-10"]
[42589,"34097226","Int J Comput Assist Radiol Surg","10.1007/s11548-021-02414-0","Liver disease classification from ultrasound using multi-scale CNN.","2022-03-10"]
[42606,"34035780","Gastroenterol Hepatol (N Y)",null,"Lean Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[42624,"33983128","Interact J Med Res","10.2196/27784","Relevance of Anthropometric Measurements in a Multiethnic Obesity Cohort: Observational Study.","2022-03-10"]
[42641,"33925340","Molecules","10.3390/molecules26092539","The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.","2022-03-10"]
[42660,"33864034","Nat Rev Cancer","10.1038/s41568-021-00362-0","T cell drivers in NASH-HCC.","2022-03-10"]
[42685,"33784425","J Leukoc Biol","10.1002/JLB.3MR0121-277R","HMGB1: An overview of its roles in the pathogenesis of liver disease.","2022-03-10"]
[42696,"33739235","Crit Rev Clin Lab Sci","10.1080/10408363.2020.1857681","Potential value and impact of data mining and machine learning in clinical diagnostics.","2022-03-10"]
[42714,"33666272","Hepatology","10.1002/hep.31790","Macrophage Heterogeneity in NASH: More Than Just Nomenclature.","2022-03-10"]
[42732,"33612688","Intern Med","10.2169/internalmedicine.6906-20","Potential Effect of a Selective Peroxisome Proliferator-activated Receptor Alpha Modulator on Metabolic Dysfunction-associated Fatty Liver Disease.","2022-03-10"]
[42749,"33586126","Am J Clin Dermatol","10.1007/s40257-021-00590-y","Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.","2022-03-10"]
[42767,"33529671","J Hepatol","10.1016/j.jhep.2021.01.034","Reply to: \"NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease\" and \"Two sides of NNMT in alcoholic and non-alcoholic fatty liver development\".","2022-03-10"]
[42784,"33485519","Am J Kidney Dis","10.1053/j.ajkd.2020.06.022","Clinical Approach to a Patient With an Acid-Base Disturbance.","2022-03-10"]
[42802,"33441256","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2020.101611","Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease?","2022-03-10"]
[42819,"33353459","Thyroid","10.1089/thy.2020.0651","Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta.","2022-03-10"]
[42836,"33337742","Clin Obstet Gynecol","10.1097/GRF.0000000000000593","Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health.","2022-03-10"]
[42854,"33280222","Liver Int","10.1111/liv.14750","Re: Fouad Y, et al. The NAFLD-MAFLD debate: Eminence versus evidence. Liver Int.&#160;2020 Nov 21.&#160;doi: 10.1111/liv.14739.","2022-03-10"]
[42871,"33248097","Clin Gastroenterol Hepatol","10.1016/j.cgh.2020.04.044","Reply.","2022-03-10"]
[42888,"33190748","Clin Gastroenterol Hepatol","10.1016/j.cgh.2020.07.063","Use of FibroScan-AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US Veterans.","2022-03-10"]
[42906,"33145629","J Med Ultrason (2001)","10.1007/s10396-020-01060-4","On the occasion of publication of the feature on diagnosis and assessment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis using ultrasound elastography.","2022-03-10"]
[42923,"33085985","Aliment Pharmacol Ther","10.1111/apt.16110","Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally.","2022-03-10"]
[42941,"33023724","Clin Investig Arterioscler","10.1016/j.arteri.2020.09.001","Control del riesgo cardiovascular, la enfermedad metab&#243;lica y la esteatosis hep&#225;tica a trav&#233;s del empoderamiento de la salud: una propuesta de futuro.","2022-03-10"]
[42959,"32958329","J Hepatol","10.1016/j.jhep.2020.06.043","From pregnant women to infants: Non-alcoholic fatty liver disease is a poor inheritance.","2022-03-10"]
[42976,"32906011","Pathol Res Pract","10.1016/j.prp.2020.153191","Correlation between M30 immunochemistry and histological activity in steatohepatitis: One piece of a complex puzzle.","2022-03-10"]
[42994,"32869840","Clin Infect Dis","10.1093/cid/ciaa1303","Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.","2022-03-10"]
[43011,"32819754","J Hepatol","10.1016/j.jhep.2020.06.016","MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?","2022-03-10"]
[43031,"32759301","Gut","10.1136/gutjnl-2020-321964","NAFLD between genes and environment: what drives fibrogenesis?","2022-03-10"]
[43047,"32697967","EBioMedicine","10.1016/j.ebiom.2020.102888","Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease.","2022-03-10"]
[43064,"32647638","Liver Cancer","10.1159/000506947","Reply to the Letter to the Editor: \"Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma\".","2022-03-10"]
[43084,"32609746","PLoS One","10.1371/journal.pone.0235729","Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.","2022-03-10"]
[43101,"32562889","Clin Gastroenterol Hepatol","10.1016/j.cgh.2020.06.022","Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.","2022-03-10"]
[43118,"32514153","Nat Rev Gastroenterol Hepatol","10.1038/s41575-020-0315-7","NAFLD - sounding the alarm on a silent epidemic.","2022-03-10"]
[43136,"32461575","Nat Rev Gastroenterol Hepatol","10.1038/s41575-020-0316-6","From NAFLD to MAFLD: when pathophysiology succeeds.","2022-03-10"]
[43153,"32419825","Evid Based Complement Alternat Med","10.1155/2020/7826874","Mogroside V Protects against Hepatic Steatosis in Mice on a High-Fat Diet and LO2 Cells Treated with Free Fatty Acids via AMPK Activation.","2022-03-10"]
[43154,"32416974","J Hepatol","10.1016/j.jhep.2020.03.020","Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward.","2022-03-10"]
[43171,"32378399","J Obes Metab Syndr","10.7570/jomes20010","Current Long-Term Pharmacotherapies for the Management of Obesity.","2022-03-10"]
[43188,"32349649","Curr Pharm Des","10.2174/138161282610200424091752","NAFLD in the 20's. From Epidemiology to Pathogenesis and Management of Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[43206,"32284341","Cancer Epidemiol Biomarkers Prev","10.1158/1055-9965.EPI-20-0051","Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health Study.","2022-03-10"]
[43223,"32255299","Clin Lab","10.7754/Clin.Lab.2019.190922","Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease.","2022-03-10"]
[43240,"32205228","Food Chem Toxicol","10.1016/j.fct.2020.111242","Blood BTEXS and heavy metal levels are associated with liver injury and systemic inflammation in Gulf states residents.","2022-03-10"]
[43258,"32132415","Curr Opin Lipidol","10.1097/MOL.0000000000000666","Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease.","2022-03-10"]
[43276,"32087105","Am J Med","10.1016/j.amjmed.2020.01.026","A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis.","2022-03-10"]
[43296,"32037049","Am J Surg","10.1016/j.amjsurg.2019.11.001","Discussion on: Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis.","2022-03-10"]
[43313,"32006524","Transl Res","10.1016/j.trsl.2020.01.001","Role of placental fibrinogen-like protein 1 in gestational diabetes.","2022-03-10"]
[43330,"31979841","J Assoc Physicians India",null,"Insulin Resistance, Dyslipidaemia and Glycemic Abnormalities in Nondiabetic NAFLD (Non Alcoholic Fatty Liver Disease).","2022-03-10"]
[43348,"31930974","Metabolism","10.1016/j.metabol.2020.154144","Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns.","2022-03-10"]
[43375,"31887441","Clin Gastroenterol Hepatol","10.1016/j.cgh.2019.12.018","Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine?","2022-03-10"]
[43384,"31860245","Am J Manag Care",null,"NASH and liver cancer: the new cancer headline.","2022-03-10"]
[43401,"31823334","Probiotics Antimicrob Proteins","10.1007/s12602-019-09594-x","Therapeutic and Nutritional Effects of Synbiotic Yogurts in Children and Adults: a Clinical Review.","2022-03-10"]
[43418,"31765518","J Diabetes Investig","10.1111/jdi.13190","Are the polyol pathway and hyperuricemia partners in the development of non-alcoholic fatty liver disease in diabetes?","2022-03-10"]
[43436,"31715175","Metabolism","10.1016/j.metabol.2019.154009","Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons.","2022-03-10"]
[43453,"31677320","Liver Int","10.1111/liv.14288","Cognitive impairment in patients with nonalcoholic fatty liver disease with liver fibrosis.","2022-03-10"]
[43472,"31625368","Clin Lab","10.7754/Clin.Lab.2019.190331","Is Urinary Transferrin an Independent Risk Factor for Nonalcoholic Fatty Liver Disease?","2022-03-10"]
[43490,"31590050","Colloids Surf B Biointerfaces","10.1016/j.colsurfb.2019.110528","Fe3O4@OA@Poloxamer nanoparticles lower triglyceride in hepatocytes through liposuction effect and nano-enzyme effect.","2022-03-10"]
[43507,"31566589","Pol Arch Intern Med","10.20452/pamw.14999","Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply.","2022-03-10"]
[43525,"31520590","Gastrointest Endosc","10.1016/j.gie.2019.09.006","Endoscopic abdominal exploration in the acute abdomen: No&#160;longer a contraindication?","2022-03-10"]
[43542,"31464781","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001506","Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease.","2022-03-10"]
[43559,"31411836","Rev Med Suisse",null,null,"2022-03-10"]
[43577,"31360687","J Cancer Prev","10.15430/JCP.2019.24.2.72","Therapeutic Effects of Amino Acids in Liver Diseases: Current Studies and Future Perspectives.","2022-03-10"]
[43594,"31325127","J Gen Intern Med","10.1007/s11606-019-05163-8","Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes.","2022-03-10"]
[43614,"31288553","Angiology","10.1177/0003319719862458","NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?","2022-03-10"]
[43631,"31245423","Hepatobiliary Surg Nutr","10.21037/hbsn.2019.01.13","Alcohol consumption in non-alcoholic fatty liver disease-harmful or beneficial?","2022-03-10"]
[43648,"31213365","J Hepatol","10.1016/j.jhep.2019.03.016","Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers.","2022-03-10"]
[43667,"31149958","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000001412","The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[43684,"31104878","Clin Nutr","10.1016/j.clnu.2019.04.026","Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance?","2022-03-10"]
[43702,"31081583","Liver Int","10.1111/liv.14134","Statins and non-alcoholic fatty liver disease.","2022-03-10"]
[43720,"31029550","Bioorg Med Chem","10.1016/j.bmc.2019.04.029","Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists.","2022-03-10"]
[43726,"31018107","Annu Rev Nutr","10.1146/annurev-nutr-082018-124344","Bile Acids as Metabolic Regulators and Nutrient Sensors.","2022-03-10"]
[43756,"30949926","Curr Treat Options Gastroenterol","10.1007/s11938-019-00228-3","Contemporary Epidemiology of Cirrhosis.","2022-03-10"]
[43773,"30912096","Semin Liver Dis","10.1055/s-0039-1681032","Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis.","2022-03-10"]
[43790,"30879091","Cell Mol Life Sci","10.1007/s00018-019-03053-0","Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.","2022-03-10"]
[43808,"30831595","Ann Intern Med","10.7326/A18-0015","Web Exclusive. Annals On Call - Nonalcoholic Fatty Liver Disease: A Spectrum of Disorders.","2022-03-10"]
[43825,"30778234","Nat Biotechnol","10.1038/s41587-019-0047-9","The new liver epidemic.","2022-03-10"]
[43843,"30721959","Adv Nutr","10.1093/advances/nmy063","Mechanisms of Action of Probiotics.","2022-03-10"]
[43861,"30666860","J Biol Regul Homeost Agents",null,"Mechanism of high-fat diet-induced non-alcoholic fatty liver disease..","2022-03-10"]
[43878,"30615211","Hepatology","10.1002/hep.30494","Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.","2022-03-10"]
[43896,"30541093","Am J Clin Nutr","10.1093/ajcn/nqy204","A 12-wk whole-grain wheat intervention protects against hepatic fat: the Graandioos study, a randomized trial in overweight subjects.","2022-03-10"]
[43913,"30473472","Hepatobiliary Pancreat Dis Int","10.1016/j.hbpd.2018.10.004","Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma.","2022-03-10"]
[43930,"30429068","Dig Liver Dis","10.1016/j.dld.2018.10.009","Not all NAFLD patients are the same: We need to find a personalized therapeutic approach.","2022-03-10"]
[43931,"30425817","Gastroenterol Hepatol Bed Bench",null,"Recent advances in non-alcoholic fatty liver disease.","2022-03-10"]
[43948,"30372586","Am J Transplant","10.1111/ajt.15152","Transplantation of HCV-infected organs into uninfected recipients: Advance with caution.","2022-03-10"]
[43966,"30308191","Gastroenterology","10.1053/j.gastro.2018.10.013","Acetyl-Coenzyme A carboxylase inhibition Delivers, as Anticipated, for Patients With Nonalcoholic Steatohepatitis.","2022-03-10"]
[43983,"30227919","J Hepatol","10.1016/j.jhep.2018.05.016","NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis.","2022-03-10"]
[44000,"30175408","Hepatology","10.1002/hep.30245","Advice Regarding Alcohol Use by Individuals With Nonalcoholic Fatty Liver Disease: Primum non nocere.","2022-03-10"]
[44018,"30143186","Lancet Diabetes Endocrinol","10.1016/S2213-8587(18)30201-8","Non-alcoholic fatty liver disease concerns with glucokinase activators - Authors' reply.","2022-03-10"]
[44035,"30077626","Gastroenterology","10.1053/j.gastro.2018.07.040","Managing Patients With Nonalcoholic Fatty Liver Disease: Is It Really Only About Fibrosis?","2022-03-10"]
[44052,"30033687","Hepatology","10.1002/hep.30186","Of Mice and Men and Nonalcoholic Steatohepatitis.","2022-03-10"]
[44070,"29963466","Euroasian J Hepatogastroenterol","10.5005/jp-journals-10018-1262","Liver Disease in Singapore.","2022-03-10"]
[44089,"29792896","J Hepatol","10.1016/j.jhep.2018.05.012","Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis.","2022-03-10"]
[44107,"29743802","J Clin Exp Hepatol","10.1016/j.jceh.2017.09.006","Upper Gastrointestinal Bleed Due to Invasive Hepatocellular Carcinoma and Hepato-Gastric Fistula.","2022-03-10"]
[44124,"29672330","Am J Ther","10.1097/MJT.0000000000000741","Tacrolimus-Associated Jaundice.","2022-03-10"]
[44141,"29604219","Hepatology","10.1002/hep.29909","Plasma Bile Acid Concentrations in Humans: Suggestions for Presentation in Tabular Form.","2022-03-10"]
[44159,"29549040","Gastroenterology","10.1053/j.gastro.2018.03.026","Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.","2022-03-10"]
[44176,"29507905","Hepatol Commun","10.1002/hep4.1139","Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice.","2022-03-10"]
[44194,"29465311","FASEB J","10.1096/fj.201701004RR","p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression.","2022-03-10"]
[44211,"29376040","Can J Gastroenterol Hepatol","10.1155/2017/4083272","Comment on \"Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp\".","2022-03-10"]
[44228,"29315298","Nat Med","10.1038/nm.4468","Lipid metabolic reprogramming in hepatic ischemia-reperfusion injury.","2022-03-10"]
[44247,"29253541","Clin Gastroenterol Hepatol","10.1016/j.cgh.2017.12.023","Reply.","2022-03-10"]
[44264,"29201778","Euroasian J Hepatogastroenterol","10.5005/jp-journals-10018-1217","Liver Disease in Sri Lanka.","2022-03-10"]
[44281,"29168809","Nature","10.1038/d41586-017-05868-y","Childhood obesity: A growing concern.","2022-03-10"]
[44299,"29101980","J Am Coll Radiol","10.1016/j.jacr.2017.08.045","ACR Appropriateness Criteria&#174; Chronic Liver&#160;Disease.","2022-03-10"]
[44317,"29055391","Med Hypotheses","10.1016/j.mehy.2017.09.008","A quick overview to the early phase clinical trials of Simtuzumab&#174;: Are we loosing the most promising anti-fibrotic product?","2022-03-10"]
[44335,"28960107","Am J Respir Cell Mol Biol","10.1165/rcmb.2017-0204ED","Putting It Together: Sleep Apnea, the Integrated Stress Response, and Metabolic Dysfunction.","2022-03-10"]
[44352,"28867686","Endocr J","10.1507/endocrj.EJ17-0245","Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.","2022-03-10"]
[44369,"28804516","Therap Adv Gastroenterol","10.1177/1756283X17705775","The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.","2022-03-10"]
[44387,"28741294","Hepatology","10.1002/hep.29393","Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect.","2022-03-10"]
[44405,"28697852","J Pediatr Surg","10.1016/j.jpedsurg.2017.06.021","A multidisciplinary approach to laparoscopic sleeve gastrectomy among multiethnic adolescents in the United States.","2022-03-10"]
[44422,"28676712","Nat Rev Gastroenterol Hepatol","10.1038/nrgastro.2017.95","NAFLD: Increased familial risk of fibrosis in NAFLD.","2022-03-10"]
[44437,"28631945","Curr Med Res Opin","10.1080/03007995.2017.1333955","Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study. Curr Med Res Opin 2017;33:797-801.","2022-03-10"]
[44458,"31089501","J Obes Metab Syndr","10.7570/jomes.2017.26.2.86","The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease.","2022-03-10"]
[44476,"28506114","J Am Coll Nutr","10.1080/07315724.2016.1262802","The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients.","2022-03-10"]
[44493,"28471888","Transplantation","10.1097/TP.0000000000001807","Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?","2022-03-10"]
[44510,"28433112","Handb Clin Neurol","10.1016/B978-0-444-63625-6.00007-0","Wilson disease - liver pathology.","2022-03-10"]
[44528,"28356593","Nat Rev Drug Discov","10.1038/nrd.2017.60","Liver disease: Conscious uncoupling in NASH.","2022-03-10"]
[44545,"28286195","Clin Gastroenterol Hepatol","10.1016/j.cgh.2017.02.031","Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis.","2022-03-10"]
[44563,"28195343","Hepatology","10.1002/hep.29106","Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.","2022-03-10"]
[44580,"28105255","World J Hepatol","10.4254/wjh.v9.i1.18","PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis.","2022-03-10"]
[44597,"28061944","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2016.08.007","Comments on \"Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk\".","2022-03-10"]
[44615,"27942586","JCI Insight","10.1172/jci.insight.88689","IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.","2022-03-10"]
[44632,"27861140","J Pediatr Endocrinol Metab","10.1515/jpem-2016-0415","Non-alcoholic fatty liver disease in children and adolescents.","2022-03-10"]
[44650,"27807313","Hong Kong Med J",null,"Effect of combined use of Fructus Schisandrae and statin on high-fat-diet-induced metabolic syndrome in rats.","2022-03-10"]
[44668,"27480050","Hepatology","10.1002/hep.28746","Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis.","2022-03-10"]
[44685,"27740531","Ann Hepatol","10.5604/16652681.1222117","&#160;Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease.","2022-03-10"]
[44686,"27738886","Endocrine","10.1007/s12020-016-1144-x","Circulating periostin in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[44703,"27679492","Gut","10.1136/gutjnl-2016-312891","Non-alcoholic fatty liver disease as driving force in coronary heart disease?","2022-03-10"]
[44720,"30169948","Nihon Naika Gakkai Zasshi",null,"[113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Non-alcoholic Fatty Liver Diseases and Non-alcoholic Steatohepatitis: Current Concepts","2022-03-10"]
[44738,"27484935","Aliment Pharmacol Ther","10.1111/apt.13716","Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress.","2022-03-10"]
[44756,"27423933","Endocrinol Nutr","10.1016/j.endonu.2016.06.001","Nonalcoholic steatohepatitis and diabetes.","2022-03-10"]
[44778,"27339672","Crit Care Clin","10.1016/j.ccc.2016.02.001","Acute-on-chronic and Decompensated Chronic Liver Failure: Definitions, Epidemiology, and Prognostication.","2022-03-10"]
[44792,"27291253","Future Cardiol","10.2217/fca-2016-0033","Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis.","2022-03-10"]
[44809,"27243019","Inflamm Intest Dis","10.1159/000443196","Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?","2022-03-10"]
[44827,"28868447","GE Port J Gastroenterol","10.1016/j.jpge.2016.03.004","A Bugs Battle on Behalf of the Liver.","2022-03-10"]
[44844,"27097220","PLoS One","10.1371/journal.pone.0152877","Spaceflight Activates Lipotoxic Pathways in Mouse Liver.","2022-03-10"]
[44861,"27045003","Hepatology","10.1002/hep.28586","Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation?","2022-03-10"]
[44879,"26997005","Indian J Med Res","10.4103/0971-5916.178574","Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.","2022-03-10"]
[44896,"26926530","Hepatology","10.1002/hep.28524","The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.","2022-03-10"]
[44915,"26826669","Gastroenterology","10.1053/j.gastro.2016.01.025","Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?","2022-03-10"]
[44932,"26728014","J Nucl Cardiol","10.1007/s12350-015-0380-4","Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?","2022-03-10"]
[44949,"26638929","Aliment Pharmacol Ther","10.1111/apt.13421","Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease.","2022-03-10"]
[44967,"26585566","Endocrine","10.1007/s12020-015-0803-7","Periostin on the road to nonalcoholic fatty liver disease.","2022-03-10"]
[44985,"26517408","Hepatology","10.1002/hep.28317","Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant.","2022-03-10"]
[45002,"26456845","J Hepatol","10.1016/j.jhep.2015.09.021","Statins and non-alcoholic steatohepatitis.","2022-03-10"]
[45020,"26426833","Eur J Gastroenterol Hepatol","10.1097/MEG.0000000000000469","Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark.","2022-03-10"]
[45037,"26352206","Biochim Biophys Acta","10.1016/j.bbamcr.2015.09.003","Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulation.","2022-03-10"]
[45055,"26278559","Aliment Pharmacol Ther","10.1111/apt.13312","Editorial: novel association between serum Pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.","2022-03-10"]
[45072,"26169861","Lancet","10.1016/S0140-6736(15)61200-4","Trials of obeticholic acid for non-alcoholic steatohepatitis - Authors' reply.","2022-03-10"]
[45089,"26108684","Mol Nutr Food Res","10.1002/mnfr.201400809","Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling.","2022-03-10"]
[45107,"26061228","J Med Food","10.1089/jmf.2014.3307","Ethanol Extract of Persimmon Tree Leaves Improves Blood Circulation and Lipid Metabolism in Rats Fed a High-Fat Diet.","2022-03-10"]
[45123,"26014325","J Ultrasound Med","10.7863/ultra.34.6.1051","Improved method for calculating hepatic steatosis using the hepatorenal index.","2022-03-10"]
[45143,"25933501","Nutrition","10.1016/j.nut.2014.08.007","Vitamin E therapy for NAFLD/NASH.","2022-03-10"]
[45165,"25846391","Aliment Pharmacol Ther","10.1111/apt.13158","Letter: HIV-associated NAFLD--more questions than answers? Authors' reply.","2022-03-10"]
[45182,"25797508","Dtsch Arztebl Int","10.3238/arztebl.2015.0143b","Mediterranean diet.","2022-03-10"]
[45200,"25687425","J Hepatol","10.1016/j.jhep.2015.01.040","The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese.","2022-03-10"]
[45217,"28210672","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2015.01.007","The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?","2022-03-10"]
[45234,"25578638","World J Urol","10.1007/s00345-015-1483-x","Comment on \"Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study\".","2022-03-10"]
[45252,"25546414","Hepatology","10.1002/hep.27670","Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease.","2022-03-10"]
[45269,"25469034","World J Gastroenterol","10.3748/wjg.v20.i44.16649","Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?","2022-03-10"]
[45287,"25373858","J Pediatr Gastroenterol Nutr","10.1097/MPG.0000000000000618","On the origin of pediatric nonalcoholic Fatty liver disease.","2022-03-10"]
[45304,"25278702","World J Gastroenterol","10.3748/wjg.v20.i36.13079","Role of Nrf2 in chronic liver disease.","2022-03-10"]
[45321,"25196882","Am J Gastroenterol","10.1038/ajg.2014.207","NAFLD is underrecognized in the primary care setting: UK experience.","2022-03-10"]
[45339,"25117963","J Acquir Immune Defic Syndr","10.1097/QAI.0000000000000260","Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.","2022-03-10"]
[45356,"25033062","Annu Rev Nutr","10.1146/annurev-nutr-071813-105729","The emerging role of microRNAs and nutrition in modulating health and disease.","2022-03-10"]
[45373,"24927523","Proc Natl Acad Sci U S A","10.1073/pnas.1323785111","TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.","2022-03-10"]
[45391,"24849166","Aliment Pharmacol Ther","10.1111/apt.12785","Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply.","2022-03-10"]
[45409,"24755648","J Lipid Res","10.1194/jlr.M045500","The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.","2022-03-10"]
[45427,"24680647","Trends Immunol","10.1016/j.it.2014.02.008","The immunomodulating role of exercise in metabolic disease.","2022-03-10"]
[45444,"24516926","Zhonghua Gan Zang Bing Za Zhi",null,"[Current status of gut microbiota and metagenome with nonalcoholic fatty liver disease].","2022-03-10"]
[45461,"24445036","J Nutr Biochem","10.1016/j.jnutbio.2013.09.011","Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model.","2022-03-10"]
[45462,"24444807","Nutr Metab Cardiovasc Dis","10.1016/j.numecd.2013.04.012","Nonalcoholic fatty liver disease is a potential risk factor for cardiovascular diseases.","2022-03-10"]
[45492,"24327587","J Prim Care Community Health","10.1177/2150131913495739","Temporal trends in the diagnosis and management of childhood obesity/overweight in primary care.","2022-03-10"]
[45498,"24290839","Metabolism","10.1016/j.metabol.2013.10.010","Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.","2022-03-10"]
[45515,"24195213","Zhongguo Zhen Jiu",null,"[Electroacupuncture at Jiaji (extra points) for 30 cases of nonalcoholic fatty liver disease].","2022-03-10"]
[45532,"24099290","Methods Cell Biol","10.1016/B978-0-12-408051-5.00007-3","Analysis of lipid droplets in hepatocytes.","2022-03-10"]
[45550,"23970447","Hum Exp Toxicol","10.1177/0960327113485253","Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice.","2022-03-10"]
[45567,"23853344","Orv Hetil","10.1556/OH.2013.29672","[Editor's commentary].","2022-03-10"]
[45584,"23772495","Nihon Naika Gakkai Zasshi","10.2169/naika.102.836","[Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].","2022-03-10"]
[45602,"23710178","Int J Endocrinol","10.1155/2013/972962","Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice.","2022-03-10"]
[45619,"23627455","Arch Pathol Lab Med","10.5858/arpa.2012-0050-OA","Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis.","2022-03-10"]
[45637,"23508615","Angiology","10.1177/0003319713481101","Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.","2022-03-10"]
[45654,"23440555","J Gastroenterol","10.1007/s00535-013-0768-3","Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease.","2022-03-10"]
[45671,"23333451","J Hepatol","10.1016/j.jhep.2012.12.026","Bariatric surgery for curing NASH in the morbidly obese?","2022-03-10"]
[45689,"23269715","J Ultrasound Med","10.7863/jum.2013.32.1.105","Evaluation of carotid artery stiffness in obese children using ultrasound radiofrequency data technology.","2022-03-10"]
[45706,"23175343","Postepy Hig Med Dosw (Online)","10.5604/17322693.1019650","[Role of sphingolipids in digestive system].","2022-03-10"]
[45723,"23070526","Sleep Breath","10.1007/s11325-012-0772-5","Obstructive sleep apnea and dyslipidemia: importance of the liver axis.","2022-03-10"]
[45741,"31186860","Clin Liver Dis (Hoboken)","10.1002/cld.81","Nonalcoholic fatty liver disease: Definitions, risk factors, and workup.","2022-03-10"]
[45758,"22917635","Dig Liver Dis","10.1016/j.dld.2012.07.009","Comment on \"atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-&#945;-lowering property\".","2022-03-10"]
[45776,"22811431","Physiol Rev","10.1152/physrev.00022.2011","Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.","2022-03-10"]
[45793,"22701473","Exp Diabetes Res","10.1155/2012/958169","Molecular intricacies and the role of ER stress in diabetes.","2022-03-10"]
[45810,"22641309","Am J Gastroenterol","10.1038/ajg.2012.128","The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","2022-03-10"]
[45835,"22467903","J Int Assoc Physicians AIDS Care (Chic)","10.1177/1545109711427606","Low prevalence of chronic hypertransaminasemia in a cohort of HIV-infected patients with no coinfections.","2022-03-10"]
[45846,"22423369","Zhonghua Gan Zang Bing Za Zhi",null,"[Clinical observation of Qianggan capsule in the treatment of non-alcoholic of non-alcoholic fatty liver fibrosis].","2022-03-10"]
[45864,"22311368","Dig Dis Sci","10.1007/s10620-012-2066-y","Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.","2022-03-10"]
[45881,"22219592","World J Gastroenterol","10.3748/wjg.v17.i48.5240","Impact of liver diseases on the development of type 2 diabetes mellitus.","2022-03-10"]
[45898,"22153811","Transl Res","10.1016/j.trsl.2011.10.011","Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease.","2022-03-10"]
[45916,"22095841","Hepatology","10.1002/hep.24783","Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.","2022-03-10"]
[45933,"21972445","Zhonghua Gan Zang Bing Za Zhi",null,"[The joint pathway of metabolism and inflammation in nonalcoholic fatty liver disease].","2022-03-10"]
[45950,"21898494","Hepatology","10.1002/hep.24642","Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?","2022-03-10"]
[45968,"21788578","Diabetes","10.2337/db11-0231","The metabolically benign and malignant fatty liver.","2022-03-10"]
[45985,"23776795","Int J Appl Basic Med Res","10.4103/2229-516X.91164","Eyeing non-alcoholic fatty liver disease: The noninvasive way.","2022-03-10"]
[46003,"21640324","Am J Med","10.1016/j.amjmed.2011.02.016","Hyperinsulinemia in nonalcoholic fatty liver disease in nondiabetic adults.","2022-03-10"]
[46020,"21521305","Clin Endocrinol (Oxf)","10.1111/j.1365-2265.2011.04036.x","Setpoints and susceptibility: do small differences in thyroid function really matter?","2022-03-10"]
[46037,"21472743","Hepatology","10.1002/hep.24134","Two solutions in search of a problem.","2022-03-10"]
[46055,"21384408","Hepatology","10.1002/hep.24279","The contribution of endoplasmic reticulum stress to liver diseases.","2022-03-10"]
[46072,"21276207","J Dig Dis","10.1111/j.1751-2980.2010.00476.x","Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166).","2022-03-10"]
[46090,"21157581","Can J Gastroenterol","10.1155/2010/153986","Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.","2022-03-10"]
[46107,"21055694","Clin Liver Dis","10.1016/j.cld.2010.07.007","Advances in hepatobiliary pathology: update for 2010.","2022-03-10"]
[46124,"20888438","Mitochondrion","10.1016/j.mito.2010.09.009","Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease.","2022-03-10"]
[46142,"20798858","J Obes","10.1155/2010/831901","Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents.","2022-03-10"]
[46159,"20660030","J Clin Endocrinol Metab","10.1210/jc.2010-0520","Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease?","2022-03-10"]
[46176,"20567582","Gastroenterol Hepatol (N Y)",null,"The treatment of hepatic encephalopathy in the cirrhotic patient.","2022-03-10"]
[46180,"20521114","Dig Dis Sci","10.1007/s10620-010-1269-3","Omega-3 fatty acids: a promising alternative treatment approach for patients with nonalcoholic fatty liver disease.","2022-03-10"]
[46212,"20347746","J Am Coll Surg","10.1016/j.jamcollsurg.2010.01.020","Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.","2022-03-10"]
[46213,"20335584","N Engl J Med","10.1056/NEJMoa0907295","Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.","2022-03-10"]
[46230,"20159747","Orv Hetil","10.1556/OH.2010.28816","[Patomechanisms of hepatic steatosis].","2022-03-10"]
[46247,"20041401","Hepatology","10.1002/hep.23438","Molecular signatures of nonalcoholic fatty liver disease: the present and future.","2022-03-10"]
[46265,"19937689","Hepatology","10.1002/hep.23345","Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.","2022-03-10"]
[46282,"19788599","J Gastroenterol Hepatol","10.1111/j.1440-1746.2009.06087.x","Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt?","2022-03-10"]
[46299,"19702897","J Gastroenterol Hepatol","10.1111/j.1440-1746.2009.05977.x","Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease.","2022-03-10"]
[46317,"19560790","Med Clin (Barc)","10.1016/j.medcli.2008.10.015","[Advances in nonalcoholic fatty liver disease].","2022-03-10"]
[46334,"19472314","Hepatology","10.1002/hep.22980","Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.","2022-03-10"]
[46352,"19368628","J Gastroenterol Hepatol","10.1111/j.1440-1746.2009.05806.x","Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?","2022-03-10"]
[46369,"19262374","Curr Opin Endocrinol Diabetes Obes","10.1097/MED.0b013e3283293015","Nonalcoholic fatty liver disease in type 2 diabetes mellitus.","2022-03-10"]
[46386,"19131468","Diabetes Care","10.2337/dc08-1917","Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents.","2022-03-10"]
[46404,"19032859","Zhonghua Gan Zang Bing Za Zhi",null,"[Evaluation of animal models of nonalcoholic fatty liver disease].","2022-03-10"]
[46421,"18792129","Hepatology","10.1002/hep.22372","Does the hormone of eternal youth protect against nonalcoholic steatohepatitis?","2022-03-10"]
[46439,"18666225","Hepatology","10.1002/hep.22399","Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.","2022-03-10"]
[46456,"18510615","Am J Gastroenterol","10.1111/j.1572-0241.2007.01783.x","In search of an ideal biomarker for nonalcoholic fatty liver disease.","2022-03-10"]
[46473,"18393323","Hepatology","10.1002/hep.22246","Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?","2022-03-10"]
[46491,"18301087","Curr Opin Clin Nutr Metab Care","10.1097/MCO.0b013e3282f44bf4","Nonalcoholic fatty liver disease: emerging mechanisms and consequences.","2022-03-10"]
[46508,"18187076","Am J Med","10.1016/j.amjmed.2007.08.041","Carotid artery intima-media thickness in nonalcoholic fatty liver disease.","2022-03-10"]
[46519,"18046726","Hepatology","10.1002/hep.21998","Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers.","2022-03-10"]
[46544,"17726184","Diabetes Care","10.2337/dc07-0982","Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.","2022-03-10"]
[46561,"17578885","Am J Physiol Endocrinol Metab","10.1152/ajpendo.00194.2007","Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity.","2022-03-10"]
[46579,"17489796","Am J Gastroenterol","10.1111/j.1572-0241.2007.01180_10.x","Nutrition and nonalcoholic fatty liver disease? Still in search of evidence!","2022-03-10"]
[46596,"17388108","Hellenic J Cardiol",null,"Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.","2022-03-10"]
[46613,"17295173","Semin Liver Dis","10.1055/s-2006-960167","Applying genomics to the study of complex disease.","2022-03-10"]
[46631,"17099371","Eur J Gastroenterol Hepatol","10.1097/01.meg.0000243872.86949.95","Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy.","2022-03-10"]
[46648,"16912127","J Clin Endocrinol Metab","10.1210/jc.2006-1010","Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.","2022-03-10"]
[46666,"16762000","Liver Int","10.1111/j.1478-3231.2006.01255.x","Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.","2022-03-10"]
[46683,"16555318","Liver Transpl","10.1002/lt.20738","Nonalcoholic fatty liver disease and liver transplantation.","2022-03-10"]
[46700,"16423615","J Pediatr","10.1016/j.jpeds.2005.07.036","Direct diagnosis of Wilson disease by molecular genetics.","2022-03-10"]
[46718,"16245220","Turk J Gastroenterol",null,"Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.","2022-03-10"]
[46735,"16085912","Clin Diagn Lab Immunol","10.1128/CDLI.12.8.941-948.2005","Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.","2022-03-10"]
[46752,"15913829","J Hepatol","10.1016/j.jhep.2005.04.004","Signalling links in the liver: knitting SOCS with fat and inflammation.","2022-03-10"]
[46770,"15727688","Zhonghua Gan Zang Bing Za Zhi",null,"[Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease].","2022-03-10"]
[46787,"15571010","Dig Liver Dis","10.1016/j.dld.2004.07.009","Coeliac disease and non-alcoholic fatty liver disease.","2022-03-10"]
[46805,"15208756","Clin Pediatr (Phila)","10.1177/000992280404300512","Non-alcoholic fatty liver disease in a toddler.","2022-03-10"]
[46822,"14653214","Rinsho Byori",null,"[Laboratory data for assessment of nutrition in liver disease--with special reference to alcoholic hepatitis and nonalcoholic steatohepatitis (NASH)].","2022-03-10"]
[46839,"12828075","Hepatogastroenterology",null,"Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.","2022-03-10"]
[46857,"12512048","Gastroenterology","10.1053/gast.2003.50032","Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.","2022-03-10"]
[46862,"12404244","Gastroenterology","10.1053/gast.2002.36569","American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.","2022-03-10"]
[46892,"11296693","Semin Liver Dis","10.1055/s-2001-12926","Clinical features and natural history of nonalcoholic steatosis syndromes.","2022-03-10"]
[46912,"34525389","J Nutr Biochem","10.1016/j.jnutbio.2021.108852","A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD+ metabolism upon alcohol withdrawal.","2022-03-10"]
[46933,"33713857","Biochem Biophys Res Commun","10.1016/j.bbrc.2021.02.123","Mesencephalic astrocyte-derived neurotrophic factor alleviates alcohol induced hepatic steatosis via activating Stat3-mediated autophagy.","2022-03-10"]
[46952,"32790342","ACS Nano","10.1021/acsnano.0c00539","Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes.","2022-03-10"]
[46972,"31711913","Ann Hepatol","10.1016/j.aohep.2019.09.007","Calling a stage-based treatment model for chronic liver diseases in China mainland.","2022-03-10"]
[46992,"31063562","JAMA","10.1001/jama.2019.2276","Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016.","2022-03-10"]
[46993,"31034614","Alcohol Clin Exp Res","10.1111/acer.14069","AIN-93 Diet as an Alternative Model to Lieber-DeCarli Diet for Alcoholic Cardiomyopathy.","2022-03-10"]
[47011,"30115921","Nat Rev Dis Primers","10.1038/s41572-018-0014-7","Alcoholic liver disease.","2022-03-10"]
[47029,"29095436","Cell Death Dis","10.1038/cddis.2017.543","RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers.","2022-03-10"]
[47047,"28042659","Alcohol Clin Exp Res","10.1111/acer.13270","Does Genetic Loss of Immunoglobulin A Have No Impact on Alcoholic Liver Disease?","2022-03-10"]
[47066,"27080262","Br J Nutr","10.1017/S0007114516001197","Decreased hepatic iron in response to alcohol may contribute to alcohol-induced suppression of hepcidin.","2022-03-10"]
[47085,"26497211","Oncotarget","10.18632/oncotarget.6203","Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.","2022-03-10"]
[47107,"25879823","BMC Fam Pract","10.1186/s12875-015-0247-4","Primary health care utilization for alcohol-attributed diseases in British Columbia Canada 2001-2011.","2022-03-10"]
[47124,"25557254","J Pathol","10.1002/path.4494","22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR&#945;.","2022-03-10"]
[47142,"25104501","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00185.2014","An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice.","2022-03-10"]
[47160,"24713392","Am J Pathol","10.1016/j.ajpath.2014.02.014","M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease.","2022-03-10"]
[47178,"24117505","Alcohol Clin Exp Res","10.1111/acer.12271","Rab GTPases associate with isolated lipid droplets (LDs) and show altered content after ethanol administration: potential role in alcohol-impaired LD metabolism.","2022-03-10"]
[47195,"23408358","Hepatology","10.1002/hep.26321","Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.","2022-03-10"]
[47212,"22684045","Gastroenterology","10.1053/j.gastro.2012.05.048","&#946;-Catenin regulates hepatic mitochondrial function and energy balance in mice.","2022-03-10"]
[47230,"22169690","Zhonghua Yu Fang Yi Xue Za Zhi",null,"[The effects of NF-E2-related factor-2 prompter polymorphism on alcoholic liver disease with Vibrio vulnificus sepsis].","2022-03-10"]
[47249,"21423135","Lab Invest","10.1038/labinvest.2011.44","Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.","2022-03-10"]
[47265,"20042322","Phytomedicine","10.1016/j.phymed.2009.10.021","Osthol regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine.","2022-03-10"]
[47283,"19208340","Gastroenterology","10.1053/j.gastro.2009.01.007","Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1.","2022-03-10"]
[47300,"18481025","Arch Pharm Res","10.1007/s12272-001-1209-2","Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease.","2022-03-10"]
[47318,"17255218","Gut","10.1136/gut.2006.111302","Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.","2022-03-10"]
[47335,"16227360","Gut","10.1136/gut.2004.056929","Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.","2022-03-10"]
[47352,"14647036","J Lab Clin Med","10.1016/S0022-2143(03)00138-0","Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice.","2022-03-10"]
[47370,"11343243","Hepatology","10.1053/jhep.2001.24236","Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.","2022-03-10"]
[47387,"9665313","Alcohol","10.1016/s0741-8329(97)00170-5","Stimulation of monocyte interleukin-8 by lipid peroxidation products: a mechanism for alcohol-induced liver injury.","2022-03-10"]
[47405,"9113278","Alcohol Clin Exp Res",null,"Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon.","2022-03-10"]
[47422,"8566398","Biochem Soc Trans","10.1042/bst023497s","Mitochondrial beta-oxidation in human alcoholic liver disease.","2022-03-10"]
[47439,"8119681","Hepatology","10.1002/hep.1840190306","\"Inapparent\" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease.","2022-03-10"]
[47457,"7511380","Alcohol Alcohol Suppl","10.1093/alcalc/28.supplement_1a.37","Serum vitronectin receptor in alcoholic liver disease: correlation with fibronectin receptor and morphological features.","2022-03-10"]
[47474,"1845555","Alcohol Alcohol Suppl",null,"Effects of liver disease on red blood cell acetaldehyde in alcoholics and non-alcoholics.","2022-03-10"]
[47491,"2668943","Mod Pathol",null,"Morphometry of liver parenchyma in needle biopsy specimens from patients with alcoholic liver disease: preliminary variables for the diagnosis and prognosis of cirrhosis.","2022-03-10"]
[47509,"3162222","Gut","10.1136/gut.29.2.146","Histocompatibility antigens in patients with alcoholic liver disease in Scotland and northeastern England: failure to show an association.","2022-03-10"]
[47526,"3518564","Ann Intern Med","10.7326/0003-4819-104-6-826","Drug-induced hepatotoxicity.","2022-03-10"]
[47544,"3992174","Scand J Gastroenterol","10.3109/00365528509089652","Plasma disappearance of 14C-glycocholic acid as a test of liver dysfunction. Relation to liver histology.","2022-03-10"]
[47561,"6610087","Liver","10.1111/j.1600-0676.1984.tb00915.x","Cellular cytotoxicity against autologous hepatocytes in alcoholic liver disease.","2022-03-10"]
[47578,"6416854","Eur J Clin Invest","10.1111/j.1365-2362.1983.tb00120.x","Hormone and metabolite profiles in alcoholic liver disease.","2022-03-10"]
[47592,"6602264","Liver","10.1111/j.1600-0676.1983.tb00844.x","Lymphocyte cytotoxicity to autologous hepatocytes in alcoholic liver disease.","2022-03-10"]
[47616,"35053615","Cancers (Basel)","10.3390/cancers14020454","CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma.","2022-03-10"]
[47635,"34535664","Nat Commun","10.1038/s41467-021-25468-9","A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.","2022-03-10"]
[47655,"34167979","BMJ Case Rep","10.1136/bcr-2021-242368","Successful treatment of recurrent hepatic encephalopathy with revision of transjugular intrahepatic portasystemic shunt and embolisation of splenorenal shunt.","2022-03-10"]
[47674,"33860126","Hepatol Commun","10.1002/hep4.1661","Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.","2022-03-10"]
[47693,"33572780","Cancers (Basel)","10.3390/cancers13030514","MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.","2022-03-10"]
[47710,"33163830","Hepatol Commun","10.1002/hep4.1601","Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis.","2022-03-10"]
[47728,"32830851","J Clin Endocrinol Metab","10.1210/clinem/dgaa558","Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion.","2022-03-10"]
[47748,"32563759","J Surg Res","10.1016/j.jss.2020.05.030","Neuropraxia: An Underappreciated Morbidity of Liver Transplantation.","2022-03-10"]
[47765,"32289375","Gastroenterology","10.1053/j.gastro.2020.03.075","Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.","2022-03-10"]
[47766,"32270989","Am J Manag Care","10.37765/ajmc.2020.42839","Outcomes of liver transplantation by insurance types in the United States.","2022-03-10"]
[47784,"31974614","Mol Med Rep","10.3892/mmr.2019.10894","Protein kinase&#160;C promotes choline transporter&#8209;like protein&#160;1 function via improved cell surface expression in immortalized human hepatic cells.","2022-03-10"]
[47804,"31571775","J Clin Exp Hepatol","10.1016/j.jceh.2019.01.005","Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients.","2022-03-10"]
[47824,"31301451","Clin Gastroenterol Hepatol","10.1016/j.cgh.2019.07.006","Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.","2022-03-10"]
[47843,"31040890","World J Gastrointest Endosc","10.4253/wjge.v11.i4.292","Rare cause of dysphagia after esophageal variceal banding: A case report.","2022-03-10"]
[47861,"30702608","Medicine (Baltimore)","10.1097/MD.0000000000014312","Cone beam versus conventional computed tomography angiography volume measurement in partial splenic embolization.","2022-03-10"]
[47879,"30194503","Glycoconj J","10.1007/s10719-018-9838-3","Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.","2022-03-10"]
[47896,"29870275","Diabetes Technol Ther","10.1089/dia.2018.0103","The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs.","2022-03-10"]
[47914,"29410095","Biochem Biophys Res Commun","10.1016/j.bbrc.2018.01.191","Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice.","2022-03-10"]
[47933,"28879603","World J Surg","10.1007/s00268-017-4194-1","Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.","2022-03-10"]
[47951,"28503559","Hepatobiliary Surg Nutr","10.21037/hbsn.2017.01.07","Cell-free DNA methylation as liquid biopsy for the assessment of fibrosis in patients with nonalcoholic steatohepatitis: a gap between innovation and implementation.","2022-03-10"]
[47980,"27443844","Mol Cell Biochem","10.1007/s11010-016-2768-0","A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling.","2022-03-10"]
[47989,"27166937","Cell Metab","10.1016/j.cmet.2016.04.018","Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis.","2022-03-10"]
[48008,"28799575","Adv Radiat Oncol","10.1016/j.adro.2015.12.003","Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma.","2022-03-10"]
[48025,"26132522","Future Med Chem","10.4155/fmc.15.54","Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application.","2022-03-10"]
[48047,"28210679","Cell Mol Gastroenterol Hepatol","10.1016/j.jcmgh.2015.02.001","Necroptosis in Nonalcoholic Steatohepatitis.","2022-03-10"]
[48065,"27278026","J Med Ultrason (2001)","10.1007/s10396-014-0542-z","Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy.","2022-03-10"]
[48083,"24602085","Ann N Y Acad Sci","10.1111/nyas.12385","Gastrointestinal morbidity in obesity.","2022-03-10"]
[48100,"23630312","Radiology","10.1148/radiol.13122208","Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.","2022-03-10"]
[48118,"24159567","Liver Cancer","10.1159/000339016","Epidemiology and surveillance of hepatocellular carcinoma.","2022-03-10"]
[48135,"21961086","J Gastrointestin Liver Dis",null,"What has the optimistic bias got to do with the need to differentiate fatty liver from nonalcoholic steatohepatitis?","2022-03-10"]
[48153,"21168706","Transplant Proc","10.1016/j.transproceed.2010.07.010","The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery.","2022-03-10"]
[48170,"20812358","Hepatology","10.1002/hep.23716","Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.","2022-03-10"]
[48187,"20329442","J Assoc Physicians India",null,"Cryptogenic cirrhosis: a vanishing entity.","2022-03-10"]
[48205,"19808779","Endocrinology","10.1210/en.2009-0517","Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1.","2022-03-10"]
[48222,"19398926","J Clin Gastroenterol","10.1097/MCG.0b013e3181945956","Body mass index and serum aminotransferase levels in Korean men and women.","2022-03-10"]
[48240,"18982250","Intern Emerg Med","10.1007/s11739-008-0199-y","Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?","2022-03-10"]
[48257,"18316359","Diabetes","10.2337/db07-0714","Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.","2022-03-10"]
[48274,"17828789","Hepatology","10.1002/hep.21885","Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.","2022-03-10"]
[48292,"17241893","Gastroenterology","10.1053/j.gastro.2006.11.048","Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?","2022-03-10"]
[48309,"16958000","Dig Dis Sci","10.1007/s10620-006-9126-0","Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?","2022-03-10"]
[48327,"16407588","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00413.2005","Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.","2022-03-10"]
[48345,"15835633","Ned Tijdschr Geneeskd",null,"[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].","2022-03-10"]
[48362,"15208516","MedGenMed",null,"Clinical importance of gamma glutamyltransferase in the Ankara-Pursaklar region of Turkey.","2022-03-10"]
[48380,"12924667","Dig Dis Sci","10.1023/a:1024752915488","Nonalcoholic steatohepatitis-related cirrhosis with subacute liver failure: an autopsy case.","2022-03-10"]
[48397,"12544284","Curr Opin Pediatr","10.1097/00008480-200302000-00021","Case report: nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes.","2022-03-10"]
[48414,"12058881","Intern Med","10.2169/internalmedicine.41.345","Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen.","2022-03-10"]
[48432,"11124851","Hepatology","10.1053/jhep.2001.0330311","The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.","2022-03-10"]
[48449,"10453959","J Hepatol","10.1016/s0168-8278(99)80243-8","A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis.","2022-03-10"]
[48466,"9273835","Ann Intern Med","10.7326/0003-4819-127-5-199709010-00015","Nonalcoholic steatohepatitis.","2022-03-10"]
[48484,"2777026","Gastroenterology","10.1016/0016-5085(89)91513-8","Steatohepatitis associated with limb lipodystrophy.","2022-03-10"]
[48501,"35258349","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00011.2022","Bile Acid Detergency: Permeability, Inflammation and Effects of Sulfation.","2022-03-10"]
[48521,"34956750","Cureus","10.7759/cureus.19615","The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional Study.","2022-03-10"]
[48538,"34493776","Sci Rep","10.1038/s41598-021-96648-2","Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis.","2022-03-10"]
[48557,"34141166","Toxicol Res (Camb)","10.1093/toxres/tfab042","A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects.","2022-03-10"]
[48558,"34137731","Endocr Connect","10.1530/EC-21-0130","How glucagon-like peptide 1 receptor agonists work.","2022-03-10"]
[48577,"33746085","J Hepatol","10.1016/j.jhep.2021.02.033","A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.","2022-03-10"]
[48595,"33408109","BMJ Case Rep","10.1136/bcr-2020-238378","Recurrent haematochezia in an 85-year-old man with hepatocellular carcinoma.","2022-03-10"]
[48612,"33113429","Biomed Pharmacother","10.1016/j.biopha.2020.110889","Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.","2022-03-10"]
[48630,"32655813","Am J Transl Res",null,"Gr-1highLy6G+Myeloid-derived suppressor cells and their role in a murine model of non-alcoholic steatohepatitis.","2022-03-10"]
[48650,"32371195","J Hepatol","10.1016/j.jhep.2020.04.033","Danger signals in liver injury and restoration of homeostasis.","2022-03-10"]
[48683,"31551291","Heart","10.1136/heartjnl-2019-315534","Characteristics of subjects with alcoholic cardiomyopathy and sudden cardiac death.","2022-03-10"]
[48687,"31489312","Hepatobiliary Surg Nutr","10.21037/hbsn.2019.03.13","Molecular pathways between obesity, non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC).","2022-03-10"]
[48688,"31479734","Biochim Biophys Acta Mol Cell Biol Lipids","10.1016/j.bbalip.2019.158518","Low profile high value target: The role of OxLDL in cancer.","2022-03-10"]
[48689,"33625442","Rev Med Chil","10.4067/s0034-98872019000901099","[Surgical complications in cirrhotic patients. Analysis of 102 cases].","2022-03-10"]
[48690,"31413924","Oncoimmunology","10.1080/2162402X.2019.1615818","Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma.","2022-03-10"]
[48691,"31405111","Medicina (Kaunas)","10.3390/medicina55080459","Targeting Microbiota: What Do We Know about It at Present?","2022-03-10"]
[48692,"31401465","Eur J Med Chem","10.1016/j.ejmech.2019.07.040","Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.","2022-03-10"]
[48693,"31401190","Biochimie","10.1016/j.biochi.2019.08.001","Apolipoprotein A-I improves hepatic autophagy through the AMPK pathway.","2022-03-10"]
[48694,"31392858","S Afr J Surg",null,"Adult liver transplant for hepatocellular carcinoma at Wits Donald Gordon Medical Centre in Johannesburg, South Africa.","2022-03-10"]
[48695,"31376210","FEBS Open Bio","10.1002/2211-5463.12712","A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.","2022-03-10"]
[48696,"31368881","Endocr Metab Immune Disord Drug Targets","10.2174/1871530319666190801142637","Key Relevance of Epigenetic Programming of Adiponectin Gene in Pathogenesis of Metabolic Disorders.","2022-03-10"]
[48697,"31237018","J Gastroenterol Hepatol","10.1111/jgh.14763","Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.","2022-03-10"]
[48698,"31234428","Medicina (Kaunas)","10.3390/medicina55060296","Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.","2022-03-10"]
[48699,"31210948","United European Gastroenterol J","10.1177/2050640619841254","Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.","2022-03-10"]
[48700,"31207018","Liver Int","10.1111/liv.14175","Adipopenia correlates with higher portal pressure in patients with cirrhosis.","2022-03-10"]
[48701,"31171906","Int J Med Sci","10.7150/ijms.30097","MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA.","2022-03-10"]
[48702,"31128214","Cancer Lett","10.1016/j.canlet.2019.05.023","Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.","2022-03-10"]
[48703,"31119644","Drugs","10.1007/s40265-019-01126-9","Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities.","2022-03-10"]
[48704,"31089967","Obes Surg","10.1007/s11695-019-03897-2","Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.","2022-03-10"]
[48706,"31069999","J Hepatobiliary Pancreat Sci","10.1002/jhbp.632","Current status of hepatopulmonary syndrome in liver transplantation in Japan: a Japanese multicenter analysis.","2022-03-10"]
[48707,"31069227","Front Med (Lausanne)","10.3389/fmed.2019.00082","Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.","2022-03-10"]
[48708,"31058022","Cureus","10.7759/cureus.4139","Thin Patient, Fatty Liver.","2022-03-10"]
[48709,"31053546","Ann Hepatol","10.1016/j.aohep.2019.04.005","Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).","2022-03-10"]
[48710,"31000363","J Hepatol","10.1016/j.jhep.2019.01.036","Clinical utility of genomic analysis in adults with idiopathic liver disease.","2022-03-10"]
[48711,"30983976","Front Cell Neurosci","10.3389/fncel.2019.00124","Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.","2022-03-10"]
[48712,"30957910","Aliment Pharmacol Ther","10.1111/apt.15255","Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients.","2022-03-10"]
[48713,"30917505","Int J Mol Sci","10.3390/ijms20061503","Role of SIRT-3, p-mTOR and HIF-1&#945; in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.","2022-03-10"]
[48714,"30883752","J Pathol","10.1002/path.5265","Bile ductular reactions in the liver: similarities are only skin deep.","2022-03-10"]
[48715,"30853493","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2018.11.009","Severe takotsubo cardiomyopathy following orthotopic liver transplantation: A case series.","2022-03-10"]
[48716,"30852708","Mar Biotechnol (NY)","10.1007/s10126-019-09889-8","Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer.","2022-03-10"]
[48717,"30817309","Rev Neurosci","10.1515/revneuro-2018-0073","The effects of dietary methionine restriction on the function and metabolic reprogramming in the liver and brain - implications for longevity.","2022-03-10"]
[48718,"30748014","Alcohol Clin Exp Res","10.1111/acer.13982","The Chemical Chaperone 4-Phenylbutyric Acid Prevents Alcohol-Induced Liver Injury in Obese KK-Ay Mice.","2022-03-10"]
[48719,"30747989","Klin Mikrobiol Infekc Lek",null,"[Acute decompensation (AD) of advanced chronic liver disease (ACLD) and hepatitis E virus (HEV) infection as the trigger].","2022-03-10"]
[48721,"30706151","Curr Gastroenterol Rep","10.1007/s11894-019-0675-8","The Role of EUS in Liver Biopsy.","2022-03-10"]
[48722,"30691442","BMC Pediatr","10.1186/s12887-019-1395-9","Bariatric surgery in adolescents:&#160;a prospective randomized controlled trial comparing laparoscopic gastric banding to combined lifestyle interventions in adolescents with severe obesity&#160;(BASIC trial).","2022-03-10"]
[48723,"30658726","J Hepatol","10.1016/j.jhep.2018.10.023","Inflammatory pathways in alcoholic steatohepatitis.","2022-03-10"]
[48724,"30652433","J Med Imaging Radiat Oncol","10.1111/1754-9485.12856","Outcome and safety of targeted liver biopsies for indeterminate lesions in patients with chronic liver disease: A single centre experience.","2022-03-10"]
[48725,"30602573","Clin Sci (Lond)","10.1042/CS20180873","Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis.","2022-03-10"]
[48726,"30562963","Cancers (Basel)","10.3390/cancers10120520","Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1&#945; that Acts as a Dominant Tumor Repressor.","2022-03-10"]
[48727,"30513996","Int J Mol Sci","10.3390/ijms19123857","Genetic and Epigenetic Modifiers of Alcoholic Liver Disease.","2022-03-10"]
[48728,"30483228","Front Microbiol","10.3389/fmicb.2018.02682","Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function.","2022-03-10"]
[48730,"30448775","Gut","10.1136/gutjnl-2018-317232","Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.","2022-03-10"]
[48731,"30379089","Mod Rheumatol","10.1080/14397595.2018.1542962","Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate.","2022-03-10"]
[48732,"30353976","ChemMedChem","10.1002/cmdc.201800549","Selective Optimization of Pranlukast to Farnesoid&#8197;X Receptor Modulators.","2022-03-10"]
[48733,"30338039","Oncotarget","10.18632/oncotarget.26119","Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon.","2022-03-10"]
[48734,"30324146","Clin Exp Hepatol","10.5114/ceh.2018.78125","Cellulitis in liver cirrhosis - a series of 25 cases from southern India.","2022-03-10"]
[48735,"30319645","Front Immunol","10.3389/fimmu.2018.02201","Inflammasome: A Double-Edged Sword in Liver Diseases.","2022-03-10"]
[48736,"30305645","Sci Rep","10.1038/s41598-018-32875-4","Hesperidin and capsaicin, but not the combination, prevent hepatic steatosis and other metabolic syndrome-related alterations in western diet-fed rats.","2022-03-10"]
[48737,"30279623","J Clin Biochem Nutr","10.3164/jcbn.17-125","Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model.","2022-03-10"]
[48738,"30267745","Toxicol Appl Pharmacol","10.1016/j.taap.2018.09.037","Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.","2022-03-10"]
[48739,"30254647","Front Immunol","10.3389/fimmu.2018.02082","Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut.","2022-03-10"]
[48740,"30214760","Clin Case Rep","10.1002/ccr3.1706","A case of non-alcoholic steatohepatitis complicated with severe acute pancreatitis induced by decreased lipoprotein lipase and hepatic triglyceride lipase activity levels in a young Japanese woman.","2022-03-10"]
[48741,"30165058","Toxicol Appl Pharmacol","10.1016/j.taap.2018.08.019","Nrf2 in alcoholic liver disease.","2022-03-10"]
[48742,"30144956","J Hepatol","10.1016/j.jhep.2018.06.024","EASL Clinical Practice Guidelines on nutrition in chronic liver disease.","2022-03-10"]
[48743,"30026040","Bioorg Med Chem","10.1016/j.bmc.2018.07.017","Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonists.","2022-03-10"]
[48744,"29966389","Nutrients","10.3390/nu10070855","Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective.","2022-03-10"]
[48745,"29935912","Diabetes Res Clin Pract","10.1016/j.diabres.2018.06.014","Corrigendum to \"An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis\" [Diab. Res. Clin. Pract. 135 (2018) 102-110].","2022-03-10"]
[48746,"29926478","Br J Clin Pharmacol","10.1111/bcp.13688","MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study.","2022-03-10"]
[48747,"29915227","Cell Death Dis","10.1038/s41419-018-0752-1","MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.","2022-03-10"]
[48748,"29892294","Front Immunol","10.3389/fimmu.2018.01155","The Interleukin-20 Cytokine Family in Liver Disease.","2022-03-10"]
[48750,"29774155","United European Gastroenterol J","10.1177/2050640617732886","Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?","2022-03-10"]
[48751,"29751356","Clin Exp Pharmacol Physiol","10.1111/1440-1681.12963","Exploring novel pharmacotherapeutic applications and repurposing potential of sodium glucose CoTransporter 2 inhibitors.","2022-03-10"]
[48752,"29723585","Food Chem Toxicol","10.1016/j.fct.2018.04.062","Platycodon grandiflorum-derived saponin enhances exercise function, skeletal muscle protein synthesis, and mitochondrial function.","2022-03-10"]
[48753,"29700216","Biosci Rep","10.1042/BSR20180466","In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with 111In-radiolabelled leucocytes.","2022-03-10"]
[48754,"29687200","Probiotics Antimicrob Proteins","10.1007/s12602-018-9419-6","Are Probiotics Effective in Targeting Alcoholic Liver Diseases?","2022-03-10"]
[48755,"29611411","Yonsei Med J","10.3349/ymj.2018.59.3.461","Erratum to \"Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis\" by Park BH, et al. (Yonsei Med J 2017;58:756-762.).","2022-03-10"]
[48756,"29597210","Pharmacology","10.1159/000487892","Euodia daniellii Hemsl. (Bee-Bee Tree) Oil Attenuates Palmitate-Induced Lipid Accumulation and Apoptosis in Hepatocytes.","2022-03-10"]
[48757,"29564203","Curr Transplant Rep","10.1007/s40472-018-0175-z","Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List.","2022-03-10"]
[48758,"29519261","Ned Tijdschr Geneeskd",null,"[EndoBarrier as a treatment for obesity and diabetes].","2022-03-10"]
[48759,"29518452","J Hepatol","10.1016/j.jhep.2018.02.018","Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.","2022-03-10"]
[48760,"29488575","Rev Med Chil","10.4067/S0034-98872017001001336","[Fundal variceal bleeding treated with balloon occluded endoscopic inyection sclerotherapy. Report of two cases].","2022-03-10"]
[48761,"29483449","Gan To Kagaku Ryoho",null,"[A Case of the Locally Advanced Breast Cancer with Serious Comorbidities Obtained a Good Local Control].","2022-03-10"]
[48762,"29452403","Int Immunol","10.1093/intimm/dxy016","Mechanisms controlling nucleic acid-sensing Toll-like receptors.","2022-03-10"]
[48763,"29404365","Ann Transl Med","10.21037/atm.2017.11.39","Acute right ventricular failure after orthotopic liver transplantation.","2022-03-10"]
[48764,"29379119","Nat Immunol","10.1038/s41590-018-0044-z","The immunology of hepatocellular carcinoma.","2022-03-10"]
[48765,"29369503","NMR Biomed","10.1002/nbm.3891","Magnetic resonance elastography of liver and spleen: Methods and applications.","2022-03-10"]
[48766,"29341392","Liver Int","10.1111/liv.13696","Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.","2022-03-10"]
[48767,"29312947","Front Nutr","10.3389/fnut.2017.00063","Taheebo Polyphenols Attenuate Free Fatty Acid-Induced Inflammation in Murine and Human Macrophage Cell Lines As Inhibitor of Cyclooxygenase-2.","2022-03-10"]
[48768,"29312861","World J Transplant","10.5500/wjt.v7.i6.324","Elderly donor graft for liver transplantation: Never too late.","2022-03-10"]
[48769,"29312290","Front Immunol","10.3389/fimmu.2017.01728","Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease.","2022-03-10"]
[48770,"29293679","PLoS One","10.1371/journal.pone.0190595","Functional role of ADAMTS5 in adiposity and metabolic health.","2022-03-10"]
[48771,"29287792","Food Chem Toxicol","10.1016/j.fct.2017.12.045","Platycodon grandiflorum-derived saponin attenuates the eccentric exercise-induced muscle damage.","2022-03-10"]
[48772,"29246445","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2017.12.013","Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.","2022-03-10"]
[48773,"29234193","J Clin Exp Hepatol","10.1016/j.jceh.2017.03.012","Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.","2022-03-10"]
[48774,"29175240","J Hepatol","10.1016/j.jhep.2017.11.021","Reply to: \"Energy drinks and adolescents - A hepatic health hazard?\"","2022-03-10"]
[48775,"29159825","Hepatology","10.1002/hep.29676","Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.","2022-03-10"]
[48776,"29121925","BMC Med","10.1186/s12916-017-0966-6","Advances and challenges in cirrhosis and portal hypertension.","2022-03-10"]
[48777,"29108122","Hepatology","10.1002/hep.29645","Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients.","2022-03-10"]
[48778,"28990365","J Cell Mol Med","10.1111/jcmm.13359","Endocannabinoid-related compounds in gastrointestinal diseases.","2022-03-10"]
[48779,"28989700","Toxicol Res (Camb)","10.1039/C7TX00020K","Toxicological Implications of Mitochondrial Localization of CYP2E1.","2022-03-10"]
[48780,"28988570","Alcohol Res",null,"Alcoholic Liver Disease: Pathogenesis and Current Management.","2022-03-10"]
[48781,"28987386","Cancer Lett","10.1016/j.canlet.2017.09.049","Autophagy in the \"inflammation-carcinogenesis\" pathway of liver and HCC immunotherapy.","2022-03-10"]
[48782,"28967501","Ultrasound Med Biol","10.1016/j.ultrasmedbio.2017.08.934","Intra-Individual Comparison between 2-D Shear Wave Elastography (GE System) and Virtual Touch Tissue Quantification (Siemens System) in Grading Liver Fibrosis.","2022-03-10"]
[48783,"28895299","J Diabetes Investig","10.1111/jdi.12745","Case of lipoatrophic diabetes induced by juvenile dermatomyositis.","2022-03-10"]
[48784,"28809732","Ann Hepatol","10.5604/01.3001.0010.2787","Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients.","2022-03-10"]
[48785,"28770495","Curr Infect Dis Rep","10.1007/s11908-017-0586-5","Fecal Microbiota Transplantation: Beyond Clostridium difficile.","2022-03-10"]
[48786,"28723981","Arq Gastroenterol","10.1590/S0004-2803.201700000-31","INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES.","2022-03-10"]
[48788,"28715695","Eur J Cancer","10.1016/j.ejca.2017.06.003","New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.","2022-03-10"]
[48789,"28711599","Biochim Biophys Acta Mol Basis Dis","10.1016/j.bbadis.2017.07.003","Arachidonic acid sex-dependently affects obesity through linking gut microbiota-driven inflammation to hypothalamus-adipose-liver axis.","2022-03-10"]
[48790,"28624101","Best Pract Res Clin Gastroenterol","10.1016/j.bpg.2017.04.005","Reversal of liver fibrosis: From fiction to reality.","2022-03-10"]
[48791,"28596043","Lancet","10.1016/S0140-6736(17)31279-5","Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.","2022-03-10"]
[48792,"28561276","Liver Int","10.1111/liv.13485","Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.","2022-03-10"]
[48793,"28550049","Gut","10.1136/gutjnl-2016-313432","Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease.","2022-03-10"]
[48794,"28474176","Abdom Radiol (NY)","10.1007/s00261-017-1171-y","Hepatic venous pressure gradient correlates with advanced hepatic fibrosis: a retrospective review.","2022-03-10"]
[48795,"28462238","ACG Case Rep J","10.14309/crj.2017.61","Peritumoral Hyperplasia in Hepatic Sclerosed Hemangioma.","2022-03-10"]
[48796,"28432575","Curr Treat Options Gastroenterol","10.1007/s11938-017-0135-1","Liver Transplantation: the Role of Metabolic Syndrome.","2022-03-10"]
[48797,"28396038","Atherosclerosis","10.1016/j.atherosclerosis.2017.03.038","Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.","2022-03-10"]
[48798,"28392436","J Immunol Methods","10.1016/j.jim.2017.03.023","An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy.","2022-03-10"]
[48799,"28357101","Mol Clin Oncol","10.3892/mco.2016.1109","Laparoscopic hepatectomy in a morbidly obese patient with liver cirrhosis: A case report.","2022-03-10"]
[48800,"28281236","Obes Surg","10.1007/s11695-017-2634-5","Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?","2022-03-10"]
[48801,"28131467","Semin Diagn Pathol","10.1053/j.semdp.2016.12.007","Hepatocellular adenoma: Classification, variants and clinical relevance.","2022-03-10"]
[48802,"28123707","Biomed Rep","10.3892/br.2016.808","Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis.","2022-03-10"]
[48803,"28063617","J Hepatol","10.1016/j.jhep.2016.12.006","Corrigendum to \"Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2\".","2022-03-10"]
[48804,"28050235","World J Hepatol","10.4254/wjh.v8.i35.1547","Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M.","2022-03-10"]
[48805,"30802391","Klin Lab Diagn","10.18821/0869-2084-2017-62-8-462-467","[The chronic hepatitis under pulmonary, extra-pulmonary and abdominal tuberculosis.]","2022-03-10"]
[48806,"27995467","Clin J Gastroenterol","10.1007/s12328-016-0703-2","A case of gastrojejunocolic fistula with steatohepatitis.","2022-03-10"]
[48807,"27960085","Cancer Cell","10.1016/j.ccell.2016.11.004","Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.","2022-03-10"]
[48808,"27932147","Transplant Proc","10.1016/j.transproceed.2016.04.003","Case Report Demonstrating the Safe and Effective Means of Expanding the Donor Pool With Livers Recovered From Brain-Dead Donors After Ethylene Glycol Toxicity.","2022-03-10"]
[48810,"27267907","Alcohol Alcohol","10.1093/alcalc/agw032","Alcohol Use after Liver Transplantation is Independent of Liver Disease Etiology.","2022-03-10"]
[48811,"27775791","Eur Rev Med Pharmacol Sci",null,"Association between irisin and major chronic diseases: a review.","2022-03-10"]
[48812,"27774805","Orv Hetil","10.1556/650.2016.30567","[Fructose and fructose intolerance].","2022-03-10"]
[48813,"27660175","J Hepatol","10.1016/j.jhep.2016.07.002","The inflammasome in liver disease.","2022-03-10"]
[48814,"27734263","Med Oncol","10.1007/s12032-016-0845-6","Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.","2022-03-10"]
[48815,"27728806","Cancer Cell","10.1016/j.ccell.2016.09.004","p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.","2022-03-10"]
[48816,"27714681","Hepatol Int","10.1007/s12072-016-9760-3","Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.","2022-03-10"]
[48817,"27709831","J Cell Mol Med","10.1111/jcmm.13002","GATA binding protein 3 is correlated with leptin regulation of PPAR&#947;1 in hepatic stellate cells.","2022-03-10"]
[48818,"27701715","Exp Clin Endocrinol Diabetes","10.1055/s-0042-112367","Hypothyroidism Induces a Moderate Steatohepatitis Accompanied by Liver Regeneration, Mast Cells Infiltration, and Changes in the Expression of the Farnesoid X Receptor.","2022-03-10"]
[48819,"27639537","Lancet Diabetes Endocrinol","10.1016/S2213-8587(16)30155-3","Clinical relevance of the bile acid receptor TGR5 in metabolism.","2022-03-10"]
[48820,"27627077","Vnitr Lek",null,"[Treatment of liver cirrhosis - actually possibility of ambulant internist].","2022-03-10"]
[48821,"27618008","Int J Mol Sci","10.3390/ijms17091495","Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations.","2022-03-10"]
[48822,"27574547","World J Hepatol","10.4254/wjh.v8.i22.933","Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model.","2022-03-10"]
[48823,"27540438","J Clin Med Res","10.14740/jocmr2625w","Ultrasound Elastography Used for Preventive Non-Invasive Screening in Early Detection of Liver Fibrosis.","2022-03-10"]
[48824,"27498701","Sci Rep","10.1038/srep31026","Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury.","2022-03-10"]
[48825,"27493866","J Cachexia Sarcopenia Muscle","10.1002/jcsm.12039","Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.","2022-03-10"]
[48826,"27467521","PLoS One","10.1371/journal.pone.0159375","Crucial Role of Elovl6 in Chondrocyte Growth and Differentiation during Growth Plate Development in Mice.","2022-03-10"]
[48828,"27439970","Clin Sci (Lond)","10.1042/CS20160400","NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling.","2022-03-10"]
[48829,"27386263","Springerplus","10.1186/s40064-016-2512-y","Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis.","2022-03-10"]
[48830,"27339464","Mol Imaging Biol","10.1007/s11307-016-0976-3","Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis.","2022-03-10"]
[48831,"27158749","Nat Rev Dis Primers","10.1038/nrdp.2016.18","Hepatocellular carcinoma.","2022-03-10"]
[48832,"27148681","Minerva Med",null,"Treatment of alcohol use disorder patients affected by liver cirrhosis and/or hepatocellular carcinoma awaiting liver transplantation.","2022-03-10"]
[48833,"27105314","J Clin Virol","10.1016/j.jcv.2016.04.003","Sexually-transmitted seronegative HCV infection in an HIV-positive post-liver transplant recipient. Case report and review of the literature.","2022-03-10"]
[48834,"27060105","Biochem J","10.1042/BJ20151182","Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity.","2022-03-10"]
[48835,"27059470","Surg Case Rep","10.1186/s40792-016-0159-0","Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report.","2022-03-10"]
[48836,"27003699","Obes Surg","10.1007/s11695-016-2083-6","The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss.","2022-03-10"]
[48837,"26997580","Obes Rev","10.1111/obr.12385","Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders.","2022-03-10"]
[48839,"26855815","World J Gastrointest Pharmacol Ther","10.4292/wjgpt.v7.i1.91","Clinical applications, limitations and future role of transient elastography in the management of liver disease.","2022-03-10"]
[48840,"26824277","Future Med Chem","10.4155/fmc.15.178","SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound.","2022-03-10"]
[48841,"26808690","PLoS One","10.1371/journal.pone.0147864","Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.","2022-03-10"]
[48842,"26797127","J Biol Chem","10.1074/jbc.M115.710582","Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.","2022-03-10"]
[48843,"26773358","Environ Toxicol Pharmacol","10.1016/j.etap.2015.12.018","Protective effects of carnosine alone and together with alpha-tocopherol on lipopolysaccharide (LPS) plus ethanol-induced liver injury.","2022-03-10"]
[48844,"26763484","Liver Int","10.1111/liv.13064","Chronic hepatitis C virus infection, a new cardiovascular risk factor?","2022-03-10"]
[48845,"26755860","World J Gastroenterol","10.3748/wjg.v22.i1.50","Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?","2022-03-10"]
[48846,"26755858","World J Gastroenterol","10.3748/wjg.v22.i1.24","Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.","2022-03-10"]
[48847,"26738395","Br J Biomed Sci","10.1080/09674845.2015.11665745","Pentraxin-3 and nitric oxide as indicators of disease severity in alcoholic cirrhosis.","2022-03-10"]
[48848,"26701066","Toxicol Appl Pharmacol","10.1016/j.taap.2015.12.001","Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity.","2022-03-10"]
[48849,"26681055","Genet Mol Res","10.4238/2015.December.16.8","Angiotensin-converting enzyme gene polymorphism (insertion/deletion) and liver fibrosis in Turkish patients from the western Black Sea region, Turkey.","2022-03-10"]
[48850,"26680665","Physiol Res","10.33549/physiolres.933196","Fasting and nonfasting triglycerides in cardiovascular and other diseases.","2022-03-10"]
[48851,"26651978","Curr Drug Metab","10.2174/1389200217666151210125105","Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection.","2022-03-10"]
[48852,"26609559","Redox Biol","10.1016/j.redox.2015.11.001","Curcumin inhibits activation of TRPM2 channels in rat hepatocytes.","2022-03-10"]
[48853,"26603491","Semin Immunol","10.1016/j.smim.2015.10.006","Interactions between adipose tissue and the immune system in health and malnutrition.","2022-03-10"]
[48854,"26585107","Cesk Patol",null,"[Recurrence of primary diseases after liver transplantation].","2022-03-10"]
[48855,"26540078","Biomolecules","10.3390/biom5042978","Update on Alcoholic Hepatitis.","2022-03-10"]
[48856,"26540040","Int J Mol Sci","10.3390/ijms161125942","The Role of Oxidative Stress and Antioxidants in Liver Diseases.","2022-03-10"]
[48857,"26448681","Mediators Inflamm","10.1155/2015/491641","C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease.","2022-03-10"]
[48858,"26443688","Liver Int","10.1111/liv.12978","Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.","2022-03-10"]
[48859,"26416085","Hepatol Int","10.1007/s12072-015-9666-5","Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B?","2022-03-10"]
[48860,"26355776","Hepatol Res","10.1111/hepr.12591","Three-dimensional computed tomography of portopulmonary venous anastomoses in patients with esophageal varices before treatment.","2022-03-10"]
[48861,"26336926","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00041.2015","The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.","2022-03-10"]
[48862,"26263921","Clin Transplant","10.1111/ctr.12602","A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.","2022-03-10"]
[48863,"26252713","PLoS One","10.1371/journal.pone.0134302","Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.","2022-03-10"]
[48864,"26220739","Clin Chim Acta","10.1016/j.cca.2015.07.021","Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.","2022-03-10"]
[48865,"26189984","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2015.05.016","Notch signaling and M1 macrophage activation in obesity-alcohol synergism.","2022-03-10"]
[48866,"26189980","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2015.05.005","Liver fibrosis: Common mechanisms and antifibrotic therapies.","2022-03-10"]
[48867,"26097999","Lab Invest","10.1038/labinvest.2015.67","The role of iNOS in cholesterol-induced liver fibrosis.","2022-03-10"]
[48868,"26093942","Surg Oncol","10.1016/j.suronc.2015.06.010","Management of colon cancer in patients with cirrhosis: A review.","2022-03-10"]
[48869,"26047667","Arch Toxicol","10.1007/s00204-015-1543-4","Experimental models of liver fibrosis.","2022-03-10"]
[48870,"26019805","Iran J Basic Med Sci",null,"Modulation of IKK&#946;/NF-&#954;B and TGF-&#946;1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice.","2022-03-10"]
[48871,"25954479","World J Hepatol","10.4254/wjh.v7.i7.968","Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?","2022-03-10"]
[48872,"25954093","World J Gastroenterol","10.3748/wjg.v21.i17.5191","Role of vitamins in gastrointestinal diseases.","2022-03-10"]
[48873,"25941109","Alcohol Clin Exp Res","10.1111/acer.12728","Severe Vitamin D Deficiency May be an Additional Cofactor for the Occurrence of Alcoholic Steatohepatitis.","2022-03-10"]
[48879,"25879290","Immunol Rev","10.1111/imr.12279","Hepatitis regulation by the inflammasome signaling pathway.","2022-03-10"]
[48880,"25800177","Pancreatology","10.1016/j.pan.2015.03.003","Metabolic reprogramming and cell fate regulation in alcoholic liver disease.","2022-03-10"]
[48881,"25798621","J Clin Invest","10.1172/JCI76468","NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.","2022-03-10"]
[48882,"25762432","NMR Biomed","10.1002/nbm.3272","Clinical applications at ultrahigh field (7&#8201;&#8201;T). Where does it make the difference?","2022-03-10"]
[48883,"25746479","Toxicol Lett","10.1016/j.toxlet.2015.03.002","Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease.","2022-03-10"]
[48884,"25673576","Br J Anaesth","10.1093/bja/aeu556","Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes.","2022-03-10"]
[48885,"25603848","Korean J Gastroenterol","10.4166/kjg.2015.65.1.4","[Diagnostic and therapeutic strategies for severe alcoholic hepatitis].","2022-03-10"]
[48886,"25557648","Clin Transplant","10.1111/ctr.12506","Liver transplantation arrests and reverses muscle wasting.","2022-03-10"]
[48887,"25540733","World J Transplant","10.5500/wjt.v4.i4.229","Female gender in the setting of liver transplantation.","2022-03-10"]
[48888,"25531568","Lab Invest","10.1038/labinvest.2014.151","TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.","2022-03-10"]
[48889,"25509693","J Med Assoc Thai",null,"Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study.","2022-03-10"]
[48890,"25467255","Rev Soc Bras Med Trop","10.1590/0037-8682-0145-2014","Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Esp&#237;rito Santo.","2022-03-10"]
[48891,"25463480","Biochim Biophys Acta","10.1016/j.bbalip.2014.11.006","Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice.","2022-03-10"]
[48892,"25454538","Alcohol","10.1016/j.alcohol.2014.08.012","Abnormal ultrastructure of intestinal epithelial barrier in mice with alcoholic steatohepatitis.","2022-03-10"]
[48893,"25401051","Curr Pathobiol Rep","10.1007/s40139-014-0057-8","Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies.","2022-03-10"]
[48894,"25379674","PLoS One","10.1371/journal.pone.0112667","Photoacoustic tomography of human hepatic malignancies using intraoperative indocyanine green fluorescence imaging.","2022-03-10"]
[48895,"25356026","World J Gastroenterol","10.3748/wjg.v20.i40.14626","Non-invasive diagnosis of alcoholic liver disease.","2022-03-10"]
[48896,"25323790","Cell Physiol Biochem","10.1159/000366348","Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2&#945;.","2022-03-10"]
[48897,"25263269","Aliment Pharmacol Ther","10.1111/apt.12974","Review article: the management of cirrhosis in women.","2022-03-10"]
[48898,"25251280","Hepatology","10.1002/hep.27489","Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.","2022-03-10"]
[48899,"25230385","Rozhl Chir",null,"Bariatric metabolic surgery.","2022-03-10"]
[48900,"25126389","World J Diabetes","10.4239/wjd.v5.i4.415","Pancreatic steatosis: Is it related to either obesity or diabetes mellitus?","2022-03-10"]
[48901,"25103596","Acta Clin Belg","10.1179/2295333714Y.0000000062","The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.","2022-03-10"]
[48902,"25086218","Biochim Biophys Acta","10.1016/j.bbalip.2014.07.017","Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver.","2022-03-10"]
[48903,"25052257","Hepatol Res","10.1111/hepr.12250","Is the measurement of serum cytokeratin-18 useful for diagnosis or screening non-alcoholic steatohepatitis?","2022-03-10"]
[48904,"25040315","Aliment Pharmacol Ther","10.1111/apt.12881","The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US.","2022-03-10"]
[48905,"24896361","Front Biosci (Landmark Ed)","10.2741/4292","MicroRNA in hepatic fibrosis and cirrhosis.","2022-03-10"]
[48906,"24838495","Dig Dis Sci","10.1007/s10620-014-3179-2","Statin use in patients with cirrhosis: a retrospective cohort study.","2022-03-10"]
[48907,"24824124","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2014.03.013","[TLR4 contributes to intestinal hyperpermeability in alcoholic liver disease].","2022-03-10"]
[48908,"24814604","Am J Pathol","10.1016/j.ajpath.2014.03.005","Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.","2022-03-10"]
[48910,"24804175","Liver Cancer","10.1159/000343856","Hepatic iron overload and hepatocellular carcinoma.","2022-03-10"]
[48911,"24796378","Hepatol Res","10.1111/hepr.12352","Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice.","2022-03-10"]
[48912,"24769730","Cell Death Differ","10.1038/cdd.2014.49","Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.","2022-03-10"]
[48913,"24747242","Sci Total Environ","10.1016/j.scitotenv.2014.03.075","Obesity-mediated association between exposure to brominated trihalomethanes and type II diabetes mellitus: an exploratory analysis.","2022-03-10"]
[48914,"24710571","Arch Toxicol","10.1007/s00204-014-1234-6","LC-MS-based metabolomics: an update.","2022-03-10"]
[48915,"24622872","Z Gastroenterol","10.1055/s-0033-1356138","[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases].","2022-03-10"]
[48916,"24592262","Front Immunol","10.3389/fimmu.2014.00039","TWEAK and LT&#946; Signaling during Chronic Liver Disease.","2022-03-10"]
[48917,"24580680","Hepatol Res","10.1111/hepr.12113","Third-generation inhibitor for the renin-angiotensin system: Can it strongly protect against progression of hepatic fibrosis in non-alcoholic steatohepatitis?","2022-03-10"]
[48918,"24498546","Oncoimmunology","10.4161/onci.26468","Role of lymphocytes in liver cancer.","2022-03-10"]
[48919,"24489787","PLoS One","10.1371/journal.pone.0086795","Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.","2022-03-10"]
[48920,"24438608","Chin Med J (Engl)",null,"Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.","2022-03-10"]
[48921,"24400890","J Cell Mol Med","10.1111/jcmm.12223","The functional role of microRNAs in alcoholic liver injury.","2022-03-10"]
[48922,"24397312","Ups J Med Sci","10.3109/03009734.2013.872736","Endothelial dysfunction in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[48923,"24393274","Liver Int","10.1111/liv.12457","Endoplasmic reticulum stress and angiogenesis: is there an interaction between them?","2022-03-10"]
[48924,"24379606","World J Gastroenterol","10.3748/wjg.v19.i47.8831","Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.","2022-03-10"]
[48925,"24247485","Nutr Diabetes","10.1038/nutd.2013.36","Very low calorie ketogenic weight reduction diet in patients with cirrhosis: a case series.","2022-03-10"]
[48926,"24236751","Ups J Med Sci","10.3109/03009734.2013.852275","Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis.","2022-03-10"]
[48927,"24224451","Pol Merkur Lekarski",null,"[The diagnostic value of non-invasive biochemical biomarkers in alcohol abuse].","2022-03-10"]
[48928,"24217957","Alcohol Alcohol","10.1093/alcalc/agt167","Notch1-nuclear factor &#954;B involves in oxidative stress-induced alcoholic steatohepatitis.","2022-03-10"]
[48929,"24187450","World J Gastroenterol","10.3748/wjg.v19.i40.6744","Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.","2022-03-10"]
[48930,"24179616","World J Hepatol","10.4254/wjh.v5.i10.568","Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis.","2022-03-10"]
[48931,"24119080","Acta Physiol (Oxf)","10.1111/apha.12171","Lipotoxicity and the role of maternal nutrition.","2022-03-10"]
[48932,"24090942","Best Pract Res Clin Gastroenterol","10.1016/j.bpg.2013.06.014","Liver abnormalities and endocrine diseases.","2022-03-10"]
[48933,"24068196","Int J Mol Med","10.3892/ijmm.2013.1508","Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.","2022-03-10"]
[48934,"24032513","Mini Rev Med Chem",null,"Triglyceride Metabolism and Hepatic Diseases.","2022-03-10"]
[48935,"23937266","Hepatol Res","10.1111/hepr.12219","Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody.","2022-03-10"]
[48936,"23871536","Alcohol","10.1016/j.alcohol.2013.05.004","Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis.","2022-03-10"]
[48937,"23850687","Biochem Biophys Res Commun","10.1016/j.bbrc.2013.06.117","Saturated fatty acid palmitate induces extracellular release of histone H3: a possible mechanistic basis for high-fat diet-induced inflammation and thrombosis.","2022-03-10"]
[48938,"23848072","Nutr Hosp","10.3305/nh.2013.28.3.6602","[Probiotics in liver diseases].","2022-03-10"]
[48939,"23805355","World J Hepatol","10.4254/wjh.v5.i6.311","Non-viral factors contributing to hepatocellular carcinoma.","2022-03-10"]
[48940,"23768554","Best Pract Res Clin Gastroenterol","10.1016/j.bpg.2013.03.007","Diabetes, obesity and gut microbiota.","2022-03-10"]
[48941,"23723127","Catheter Cardiovasc Interv","10.1002/ccd.25043","Safety of transradial cardiac catheterization in patients with end-stage liver disease.","2022-03-10"]
[48942,"23700549","Adipocyte","10.4161/adip.21837","Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice.","2022-03-10"]
[48943,"23663886","Zhonghua Gan Zang Bing Za Zhi","10.3760/cma.j.issn.1007-3418.2013.02.013","[Activation of Fas/FasL and its downstream signaling pathway promotes development of alcoholic steatohepatitis and liver fibrosis in mice].","2022-03-10"]
[48944,"23646229","World J Hepatol","10.4254/wjh.v5.i2.46","Lymphocyte subsets in alcoholic liver disease.","2022-03-10"]
[48945,"23607715","Hepatol Res","10.1111/hepr.12072","Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients.","2022-03-10"]
[48946,"23560159","Gut Liver","10.5009/gnl.2013.7.2.221","Lipoic Acid prevents the changes of intracellular lipid partitioning by free Fatty Acid.","2022-03-10"]
[48947,"23515103","Clin Chem Lab Med","10.1515/cclm-2012-0849","Gender medicine: a task for the third millennium.","2022-03-10"]
[48948,"23467319","Case Rep Gastroenterol","10.1159/000347154","Rapid recovery from acute liver failure secondary to pancreatoduodenectomy-related non-alcoholic steatohepatitis.","2022-03-10"]
[48949,"23454483","Gene","10.1016/j.gene.2013.02.004","Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes.","2022-03-10"]
[48950,"23406785","Digestion","10.1159/000346080","A combination of &#945;-fetoprotein and des-&#947;-carboxy prothrombin is superior in detection of hepatocellular carcinoma.","2022-03-10"]
[48951,"23388073","Lipids Health Dis","10.1186/1476-511X-12-11","Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.","2022-03-10"]
[48952,"23341981","PLoS One","10.1371/journal.pone.0053719","Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.","2022-03-10"]
[48953,"23340308","Br J Nutr","10.1017/S0007114512005806","Coumarin: an alternative candidate for the treatment of non-alcoholic steatohepatitis?","2022-03-10"]
[48954,"23301878","Hepatol Res","10.1111/hepr.12042","Chymase inhibitor ameliorates hepatic steatosis and fibrosis on established non-alcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet.","2022-03-10"]
[48955,"23266490","J Hepatol","10.1016/j.jhep.2012.12.017","Therapeutic strategies in inflammasome mediated diseases of the liver.","2022-03-10"]
[48956,"23252785","Aliment Pharmacol Ther","10.1111/apt.12156","Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis--authors' reply.","2022-03-10"]
[48957,"23252784","Aliment Pharmacol Ther","10.1111/apt.12142","Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis.","2022-03-10"]
[48958,"23184344","Eur J Nutr","10.1007/s00394-012-0467-5","Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells.","2022-03-10"]
[48959,"23180946","World J Gastroenterol","10.3748/wjg.v18.i43.6255","Celiac disease markers in patients with liver diseases: a single center large scale screening study.","2022-03-10"]
[48960,"23161303","Turk J Gastroenterol",null,"Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.","2022-03-10"]
[48961,"23106368","J Gastroenterol Hepatol","10.1111/j.1440-1746.2012.07255.x","Pro-oxidants or anti-oxidant defenses? Which one to blame in non-alcoholic steatohepatitis pathogenesis?","2022-03-10"]
[48962,"23094853","Hepatol Res","10.1111/j.1872-034X.2012.01052.x","Is rosuvastatin effective for non-alcoholic steatohepatitis with dyslipidemia?","2022-03-10"]
[48963,"23057725","Hepatol Res","10.1111/j.1872-034X.2012.01101.x","Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model.","2022-03-10"]
[48964,"23027617","Carcinogenesis","10.1093/carcin/bgs303","Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.","2022-03-10"]
[48965,"22959954","Prostaglandins Leukot Essent Fatty Acids","10.1016/j.plefa.2012.08.004","Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans.","2022-03-10"]
[48966,"22959770","Biochem Biophys Res Commun","10.1016/j.bbrc.2012.08.104","Expression and function of the atypical cadherin FAT1 in chronic liver disease.","2022-03-10"]
[48967,"22908868","J Gastroenterol Hepatol","10.1111/j.1440-1746.2012.07196.x","Beyond obesity: is cholesterol-induced liver injury the cause of non-alcoholic steatohepatitis?","2022-03-10"]
[48968,"22885387","J Hepatol","10.1016/j.jhep.2012.06.040","Modest alcohol consumption and non-alcoholic steatohepatitis.","2022-03-10"]
[48969,"22873368","Curr Cancer Drug Targets","10.2174/156800912803988011","mTor as a potential target for the prevention and treatment of hepatocellular carcinoma.","2022-03-10"]
[48970,"22819910","Hepatogastroenterology","10.5754/hge10778","Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.","2022-03-10"]
[48971,"22801434","Panminerva Med",null,"Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.","2022-03-10"]
[48972,"22721876","Nutrition","10.1016/j.nut.2012.02.013","Caffeine attenuates metabolic syndrome in diet-induced obese rats.","2022-03-10"]
[48973,"22661952","Front Physiol","10.3389/fphys.2012.00138","Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.","2022-03-10"]
[48974,"22637703","Gut","10.1136/gutjnl-2011-301146","Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.","2022-03-10"]
[48975,"22543705","Acta Pharmacol Sin","10.1038/aps.2012.19","Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats.","2022-03-10"]
[48976,"22495049","Hinyokika Kiyo",null,"[A case of malignant peritoneal mesothelioma presenting with bilateral swelling of spermatic cord].","2022-03-10"]
[48977,"22489261","World J Hepatol","10.4254/wjh.v4.i3.91","Human immunodeficiency virus infection and the liver.","2022-03-10"]
[48978,"22452372","Br J Pharmacol","10.1111/j.1476-5381.2012.01959.x","Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus - insights into its mechanisms of action.","2022-03-10"]
[48979,"22449800","Lab Invest","10.1038/labinvest.2012.53","Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro.","2022-03-10"]
[48980,"22419002","Minerva Gastroenterol Dietol",null,"Advanced HCC: emerging molecular therapies.","2022-03-10"]
[48981,"22412843","PLoS One","10.1371/journal.pone.0031823","Prolyl isomerase Pin1 regulates mouse embryonic fibroblast differentiation into adipose cells.","2022-03-10"]
[48982,"22406735","J Hepatol","10.1016/j.jhep.2012.02.013","Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial.","2022-03-10"]
[48983,"22352842","Br J Pharmacol","10.1111/j.1476-5381.2012.01910.x","Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPAR&#947; activity and attenuating oxidative stress.","2022-03-10"]
[48984,"22337830","J Alzheimers Dis","10.3233/JAD-2012-111727","Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.","2022-03-10"]
[48985,"22278845","J Physiol Biochem","10.1007/s13105-012-0145-3","Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats.","2022-03-10"]
[48986,"22271627","Liver Transpl","10.1002/lt.23391","Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy.","2022-03-10"]
[48987,"22267590","Gut","10.1136/gutjnl-2011-300717","MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.","2022-03-10"]
[48988,"22241822","Jpn J Clin Oncol","10.1093/jjco/hyr198","Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.","2022-03-10"]
[48989,"22237790","Minerva Anestesiol",null,"Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.","2022-03-10"]
[48990,"22214245","Fibrogenesis Tissue Repair","10.1186/1755-1536-5-1","Genomics and proteomics in liver fibrosis and cirrhosis.","2022-03-10"]
[48991,"22182059","Scand J Gastroenterol","10.3109/00365521.2011.644319","Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis.","2022-03-10"]
[48992,"22165611","MMW Fortschr Med","10.1007/BF03367684","[Naturopathy consultation. Fatty liver and non-alcoholic steatohepatitis].","2022-03-10"]
[48993,"22124143","J Physiol","10.1113/jphysiol.2011.219691","Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.","2022-03-10"]
[48994,"22087248","PLoS One","10.1371/journal.pone.0027087","The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.","2022-03-10"]
[48995,"22032676","Hepatol Res","10.1111/j.1872-034X.2011.00882.x","Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis patients with dyslipidemia.","2022-03-10"]
[48996,"21995448","Microb Cell Fact","10.1186/1475-2859-10-S1-S10","Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.","2022-03-10"]
[48997,"21999649","Paediatr Drugs","10.2165/11591610-000000000-00000","Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.","2022-03-10"]
[48998,"21974938","Clin Res Hepatol Gastroenterol","10.1016/j.clinre.2011.08.011","Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis.","2022-03-10"]
[48999,"21951423","Hepatol Res","10.1111/j.1872-034X.2011.00888.x","Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice.","2022-03-10"]
[49000,"21951092","Dig Endosc","10.1111/j.1443-1661.2011.01128.x","Non-alcoholic steatohepatitis mimicking liver metastasis in obesity surgery.","2022-03-10"]
[49001,"21763667","J Hepatol","10.1016/j.jhep.2011.04.031","Caspase-cleaved keratin 18 as a biomarker for non-alcoholic steatohepatitis (NASH) - the need for correct terminology.","2022-03-10"]
[49002,"21734800","World J Gastroenterol","10.3748/wjg.v17.i24.2890","Probiotics in hepatology.","2022-03-10"]
[49003,"21682827","Hepatol Res","10.1111/j.1872-034X.2011.00818.x","Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.","2022-03-10"]
[49004,"21612060","Vnitr Lek",null,"[Diabetes mellitus and the liver cirrhosis].","2022-03-10"]
[49005,"21604434","Cesk Patol",null,"[Prague Hepatology Meeting 2010--hepatopathology news].","2022-03-10"]
[49006,"21545524","J Gastroenterol Hepatol","10.1111/j.1440-1746.2011.06756.x","Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances.","2022-03-10"]
[49007,"21504529","Transpl Infect Dis","10.1111/j.1399-3062.2011.00639.x","Incidental hepatic schistosomiasis in a liver transplant recipient.","2022-03-10"]
[49008,"21479756","J Nucl Cardiol","10.1007/s12350-010-9332-1","Left ventricular dyssynchrony in patients with end-stage liver disease.","2022-03-10"]
[49009,"21466434","Curr Pharm Biotechnol","10.2174/138920112798868818","Silymarin in the prevention and treatment of liver diseases and primary liver cancer.","2022-03-10"]
[49010,"21463341","Alcohol Clin Exp Res","10.1111/j.1530-0277.2011.01487.x","Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.","2022-03-10"]
[49011,"21463335","Alcohol Clin Exp Res","10.1111/j.1530-0277.2011.01466.x","Role of intestinal circadian genes in alcohol-induced gut leakiness.","2022-03-10"]
[49012,"21338451","Hepatol Res","10.1111/j.1872-034X.2011.00776.x","Evolution of hepatic fibrosis research.","2022-03-10"]
[49013,"21329534","Ned Tijdschr Geneeskd",null,"[Diabetes mellitus and cirrhosis of the liver: a prognostically unfavourable combination].","2022-03-10"]
[49014,"21329483","Scand J Urol Nephrol","10.3109/00365599.2011.552435","Management of diuretic treatment: a challenge in the obese patient.","2022-03-10"]
[49015,"21281429","Liver Int","10.1111/j.1478-3231.2010.02434.x","Recurrence of non-viral liver disease after orthotopic liver transplantation.","2022-03-10"]
[49016,"21256123","Chem Biol Interact","10.1016/j.cbi.2011.01.013","Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.","2022-03-10"]
[49017,"21195127","Mol Cell Endocrinol","10.1016/j.mce.2010.12.028","Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.","2022-03-10"]
[49018,"21156189","J Hepatol","10.1016/j.jhep.2010.11.025","Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.","2022-03-10"]
[49019,"21150335","Oxid Med Cell Longev","10.4161/oxim.3.5.13069","Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).","2022-03-10"]
[49020,"21145871","J Hepatol","10.1016/j.jhep.2010.11.011","Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma.","2022-03-10"]
[49021,"21131943","Am J Gastroenterol","10.1038/ajg.2010.363","Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series.","2022-03-10"]
[49022,"21112115","J Hepatol","10.1016/j.jhep.2010.07.054","Insulin resistance and oxidative stress: two therapeutic targets in non-alcoholic steatohepatitis.","2022-03-10"]
[49023,"21103235","Case Rep Gastroenterol","10.1159/000292093","Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis.","2022-03-10"]
[49024,"21088486","Cell Cycle","10.4161/cc.9.22.14048","Metformin against TGF&#946;-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.","2022-03-10"]
[49025,"20979658","Lipids Health Dis","10.1186/1476-511X-9-124","Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.","2022-03-10"]
[49026,"20977462","Br J Pharmacol","10.1111/j.1476-5381.2010.00956.x","Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase.","2022-03-10"]
[49027,"20969493","Scand J Gastroenterol","10.3109/00365521.2010.525717","Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.","2022-03-10"]
[49028,"20953861","Diabetologia","10.1007/s00125-010-1932-4","Targeting energy expenditure via fuel switching and beyond.","2022-03-10"]
[49029,"20953207","Acta Pharmacol Sin","10.1038/aps.2010.142","Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.","2022-03-10"]
[49030,"20887591","Hepatol Res","10.1111/j.1872-034X.2010.00692.x","Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.","2022-03-10"]
[49031,"20716942","Oxid Med Cell Longev","10.4161/oxim.3.3.12288","Acetaldehyde adducts in alcoholic liver disease.","2022-03-10"]
[49032,"20706677","Gastroenterol Res Pract","10.1155/2010/192543","Toll-like receptor signaling and liver fibrosis.","2022-03-10"]
[49033,"20704547","Curr Drug Targets","10.2174/1389450111009011541","Heme oxygenase-1 and iron in liver inflammation: a complex alliance.","2022-03-10"]
[49034,"20658448","Diagn Interv Radiol","10.4261/1305-3825.DIR.2810-09.1","Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis.","2022-03-10"]
[49035,"20594211","J Gastroenterol Hepatol","10.1111/j.1440-1746.2010.06279.x","Molecular basis for a functional role of cytochrome P450 2E1 in non-alcoholic steatohepatitis.","2022-03-10"]
[49036,"20570793","Orv Hetil","10.1556/OH.2010.28913","[Role of environmental factors in the etiology of hepatocellular carcinoma].","2022-03-10"]
[49037,"20512524","Mol Cell Biochem","10.1007/s11010-010-0498-2","Differential response of two models of genetically modified mice fed with high fat and cholesterol diets: relationship to the study of non-alcoholic steatohepatitis.","2022-03-10"]
[49038,"20460903","Dig Dis","10.1159/000299799","Apoptosis in immune-mediated liver diseases.","2022-03-10"]
[49039,"20458850","Acta Gastroenterol Belg",null,"Rapidly evolving liver decompensation with some remarkable features 14 years after biliopancreatic derivation: a case report and literature review.","2022-03-10"]
[49040,"20455447","Lik Sprava",null,"[Correction of microcirculation disorder in the liver of patients with non-alcoholic steatohepatitis].","2022-03-10"]
[49041,"20394202","Vnitr Lek",null,"[Non-alcoholic steatosis and steatohepatitis].","2022-03-10"]
[49042,"20383479","Internist (Berl)","10.1007/s00108-009-2564-y","[Hormonal and metabolic functions of the small intestine].","2022-03-10"]
[49043,"20337979","Pediatr Int","10.1111/j.1442-200X.2010.03127.x","Itraconazole for invasive fungal infection with pediatric malignancies.","2022-03-10"]
[49044,"20192918","Cell Biol Int","10.1042/CBI20090130","Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.","2022-03-10"]
[49045,"20186755","Proteomics","10.1002/pmic.200900757","Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications.","2022-03-10"]
[49046,"20175957","Clin Neuropathol","10.5414/npp29084","Amiodarone-induced liver cirrhosis and parkinsonism: a case report.","2022-03-10"]
[49047,"20072945","Curr Opin Mol Ther",null,"Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.","2022-03-10"]
[49048,"20064513","Gastroenterology","10.1053/j.gastro.2009.12.055","Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.","2022-03-10"]
[49049,"20037312","Gan To Kagaku Ryoho",null,"[Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].","2022-03-10"]
[49050,"19957713","Lik Sprava",null,"[Capabilities of complex therapy of chronic biliary pancreatitis with concomitant obesity using multinutrient functional complexes \"Grinization\"].","2022-03-10"]
[49051,"19957376","Hepatology","10.1002/hep.23382","Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse.","2022-03-10"]
[49052,"19942167","Best Pract Res Clin Gastroenterol","10.1016/j.bpg.2009.10.005","Liver disorders in the elderly.","2022-03-10"]
[49053,"19930687","BMC Gastroenterol","10.1186/1471-230X-9-89","What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?","2022-03-10"]
[49054,"19906067","Cancer Sci","10.1111/j.1349-7006.2009.01402.x","Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.","2022-03-10"]
[49055,"19840249","Liver Int","10.1111/j.1478-3231.2009.02136.x","Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.","2022-03-10"]
[49056,"19803220","Rev Med Suisse",null,"[Portal hypertension and HIV infection].","2022-03-10"]
[49057,"19796036","Hepatol Res","10.1111/j.1872-034X.2009.00596.x","Adiponectin as a therapeutic target of non-alcoholic steatohepatitis.","2022-03-10"]
[49058,"19785490","Rev Esp Enferm Dig","10.4321/s1130-01082009000800001","Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)?","2022-03-10"]
[49059,"19680465","Cytojournal","10.4103/1742-6413.54919","Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study.","2022-03-10"]
[49060,"19646832","Gastroenterol Clin Biol","10.1016/j.gcb.2009.05.010","Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial.","2022-03-10"]
[49061,"19638343","J Biol Chem","10.1074/jbc.M109.022491","JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.","2022-03-10"]
[49062,"19629685","Dig Dis Sci","10.1007/s10620-009-0896-z","Non-alcoholic steatohepatitis over multiple generations.","2022-03-10"]
[49063,"19594758","Br J Pharmacol","10.1111/j.1476-5381.2009.00261.x","Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells.","2022-03-10"]
[49064,"19594730","Basic Clin Pharmacol Toxicol","10.1111/j.1742-7843.2009.00394.x","Progression of lipid peroxidation measured as thiobarbituric acid reactive substances, damage to DNA and histopathological changes in the liver of rats subjected to a methionine-choline-deficient diet.","2022-03-10"]
[49065,"19590654","HPB (Oxford)","10.1111/j.1477-2574.2009.00043.x","Simultaneous pancreatectomy and liver transplantation: a single-institution experience.","2022-03-10"]
[49066,"19538246","Diabet Med","10.1111/j.1464-5491.2009.02724.x","Insulin resistance and endothelial dysfunction in type 2 diabetic patients with non-alcoholic steatohepatitis.","2022-03-10"]
[49067,"19490419","Liver Int","10.1111/j.1478-3231.2009.02024.x","Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease.","2022-03-10"]
[49068,"19415399","J Gastrointest Surg","10.1007/s11605-009-0904-9","Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation.","2022-03-10"]
[49069,"24345559","Obes Res Clin Pract","10.1016/j.orcp.2008.11.002","Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans.","2022-03-10"]
[49070,"19255916","Crit Rev Clin Lab Sci","10.1080/10408360802610878","The paraoxonases: role in human diseases and methodological difficulties in measurement.","2022-03-10"]
[49071,"19250782","Gastroenterol Clin Biol","10.1016/j.gcb.2008.12.008","[Review of the association between obesity and gastroesophageal reflux and its complications].","2022-03-10"]
[49072,"19247452","PLoS One","10.1371/journal.pone.0004623","HIV induces TRAIL sensitivity in hepatocytes.","2022-03-10"]
[49073,"19174085","Gastroenterol Hepatol","10.1016/S0210-5705(08)75816-3","[Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators].","2022-03-10"]
[49074,"19143196","Ter Arkh",null,"[Porphirin metabolism in non-alcoholic steatohepatitis].","2022-03-10"]
[49075,"18947977","Nutrition","10.1016/j.nut.2008.07.023","Nutritional lipid-induced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes.","2022-03-10"]
[49076,"18925608","Hepatology","10.1002/hep.22515","Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism.","2022-03-10"]
[49077,"18832522","Gut","10.1136/gut.2008.157735","Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B.","2022-03-10"]
[49078,"18805482","Biochim Biophys Acta","10.1016/j.bbadis.2008.08.008","Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies.","2022-03-10"]
[49079,"18793162","Biochem Soc Trans","10.1042/BST0360920","NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?","2022-03-10"]
[49080,"18752754","Zhonghua Gan Zang Bing Za Zhi",null,"[Effect of rosiglitazone in non-alcoholic steatohepatitis associated liver fibrosis].","2022-03-10"]
[49081,"18670431","Nat Rev Drug Discov","10.1038/nrd2619","Targeting bile-acid signalling for metabolic diseases.","2022-03-10"]
[49082,"18626433","Ann Hepatol",null,"Impact of diabetes mellitus on outcome of HCC.","2022-03-10"]
[49083,"18537187","Hepatology","10.1002/hep.22317","Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.","2022-03-10"]
[49084,"18516003","Korean J Gastroenterol",null,"[Comparison of transient elastography and hepatic fibrosis assessed by histology in chronic liver disease].","2022-03-10"]
[49085,"18473847","Curr Pharm Des","10.2174/138161208784139701","Advanced glycation end products (AGEs) and their involvement in liver disease.","2022-03-10"]
[49086,"22967918","Endocrinol Nutr","10.1016/S1575-0922(08)70673-9","Hepatic involvement in a teenager with type 1 diabetes and poor metabolic control.","2022-03-10"]
[49087,"18443813","Histochem Cell Biol","10.1007/s00418-008-0431-x","Intermediate filament cytoskeleton of the liver in health and disease.","2022-03-10"]
[49088,"18410556","Aliment Pharmacol Ther","10.1111/j.1365-2036.2008.03711.x","Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index.","2022-03-10"]
[49089,"18408098","Gut","10.1136/gut.2007.141986","Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy.","2022-03-10"]
[49090,"18400637","Anadolu Kardiyol Derg",null,"[Global confusion on the diagnostic criteria for metabolic syndrome: what is the point that guidelines can not agree?].","2022-03-10"]
[49091,"18336675","J Gastroenterol Hepatol","10.1111/j.1440-1746.2007.05277.x","Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex.","2022-03-10"]
[49092,"18371159","Hepatol Res","10.1111/j.1872-034X.2008.00342.x","A possible rat model for non-alcoholic steatohepatitis: Histological findings in SHR/NDmcr-cp rats.","2022-03-10"]
[49093,"18329127","J Hepatol","10.1016/j.jhep.2008.01.026","Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.","2022-03-10"]
[49094,"18290780","Liver Int","10.1111/j.1478-3231.2008.01663.x","Previous practice of high-intensity sports as a risk factor for non-alcoholic steatohepatitis.","2022-03-10"]
[49095,"18022724","J Hepatol","10.1016/j.jhep.2007.10.004","Rosiglitazone: possible complications and treatment of non-alcoholic steatohepatitis (NASH).","2022-03-10"]
[49096,"17926479","Ter Arkh",null,"[Pathogenetic treatment of non-alcoholic steatohepatitis: arguments, efficacy, safety].","2022-03-10"]
[49097,"17919273","Aliment Pharmacol Ther","10.1111/j.1365-2036.2007.03538.x","Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.","2022-03-10"]
[49098,"17877468","Hepatol Res","10.1111/j.1872-034X.2007.00170.x","Hepatocellular carcinoma in Taiwan.","2022-03-10"]
[49099,"17845508","Basic Clin Pharmacol Toxicol","10.1111/j.1742-7843.2007.00116.x","Silymarin prevents palmitate-induced lipotoxicity in HepG2 cells: involvement of maintenance of Akt kinase activation.","2022-03-10"]
[49100,"17567477","J Gastroenterol Hepatol","10.1111/j.1440-1746.2006.04663.x","Blockade of renin-angiotensin system in antifibrotic therapy.","2022-03-10"]
[49101,"17644211","J Hepatol","10.1016/j.jhep.2007.04.019","Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.","2022-03-10"]
[49102,"17617114","Hepatol Res","10.1111/j.1872-034X.2007.00122.x","Does hepcidin expression have a role in iron-related hepatic injury in patients with non-alcoholic steatohepatitis?","2022-03-10"]
[49103,"17592564","J Gastrointestin Liver Dis",null,"Non-alcoholic steatohepatitis (NASH): approaching more tailored and effective therapies.","2022-03-10"]
[49104,"17587244","Pathol Int","10.1111/j.1440-1827.2007.02121.x","Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes.","2022-03-10"]
[49105,"17510198","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00038.2007","Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition.","2022-03-10"]
[49106,"17435339","Nihon Yakurigaku Zasshi","10.1254/fpj.129.271","[Candidate drugs for non-alcoholic steatohepatitis (NASH)].","2022-03-10"]
[49107,"17406752","Arq Gastroenterol","10.1590/s0004-28032006000400004","[Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].","2022-03-10"]
[49108,"17374528","Clin Chim Acta","10.1016/j.cca.2007.02.019","Non-invasive assessment of chronic liver and gastric diseases.","2022-03-10"]
[49109,"17340120","Arch Toxicol","10.1007/s00204-007-0192-7","Arsenite induced oxidative damage in mouse liver is associated with increased cytokeratin 18 expression.","2022-03-10"]
[49110,"17339254","Gut","10.1136/gut.2006.106021","Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis.","2022-03-10"]
[49111,"17339155","J Formos Med Assoc","10.1016/S0929-6646(09)60227-8","Pancreaticobiliary anomalies is the leading cause of childhood recurrent pancreatitis.","2022-03-10"]
[49112,"17327932","Scand J Gastroenterol","10.1080/00365520601058395","Pharmacological treatment of non-alcoholic steatohepatitis: the current evidence.","2022-03-10"]
[49113,"17298297","Expert Opin Ther Targets","10.1517/14728222.11.3.403","Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases.","2022-03-10"]
[49114,"17198075","J Clin Gastroenterol","10.1097/01.mcg.0000212651.05656.5b","Abnormal glucose tolerance and non-esterified fatty acids (NEFAs) as predictors of non-alcoholic steatohepatitis (NASH): which Ash that ignites the NASH.","2022-03-10"]
[49115,"19662192","Biomark Insights",null,"Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.","2022-03-10"]
[49116,"17074033","J Gastroenterol Hepatol","10.1111/j.1440-1746.2006.04282.x","Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.","2022-03-10"]
[49117,"17058987","Rev Gastroenterol Mex",null,"[Ghrelin: beyond hunger regulation].","2022-03-10"]
[49118,"16977879","Voen Med Zh",null,"[Non-alcoholic steatohepatitis].","2022-03-10"]
[49119,"16958675","J Gastroenterol Hepatol","10.1111/j.1440-1746.2006.04575.x","Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease.","2022-03-10"]
[49120,"16923576","Leuk Lymphoma","10.1080/10428190500521101","Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone.","2022-03-10"]
[49121,"16799623","Oncogene","10.1038/sj.onc.1209558","Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.","2022-03-10"]
[49122,"16796125","Bratisl Lek Listy",null,"Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver.","2022-03-10"]
[49123,"16732299","Int J Obes (Lond)","10.1038/sj.ijo.0803367","Childhood obesity: a pandemic of the twenty-first century.","2022-03-10"]
[49124,"16638709","Scand J Gastroenterol","10.1080/00365520500320060","Rosuvastatin: a safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH).","2022-03-10"]
[49125,"16622296","Endocrine","10.1385/ENDO:29:1:91","Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.","2022-03-10"]
[49126,"16610061","World J Gastroenterol","10.3748/wjg.v12.i13.2080","Cryptogenic cirrhosis in the region where obesity is not prevalent.","2022-03-10"]
[49127,"16555625","Trans Am Clin Climatol Assoc",null,"Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings.","2022-03-10"]
[49128,"16508291","Dig Dis","10.1159/000090174","Molecular mechanisms of alcohol-induced hepatic fibrosis.","2022-03-10"]
[49129,"16499213","Nihon Naika Gakkai Zasshi","10.2169/naika.95.82","[Non-alcoholic steatohepatitis (NASH). 6. Treatment of NASH].","2022-03-10"]
[49130,"16499212","Nihon Naika Gakkai Zasshi","10.2169/naika.95.76","[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 3) Pathological diagnosis].","2022-03-10"]
[49131,"16499211","Nihon Naika Gakkai Zasshi","10.2169/naika.95.70","[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 2) Non-alcoholic steatohepatitis (NASH) by ultrasonography].","2022-03-10"]
[49132,"16499210","Nihon Naika Gakkai Zasshi","10.2169/naika.95.66","[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 1) Blood chemical analysis].","2022-03-10"]
[49133,"16499209","Nihon Naika Gakkai Zasshi","10.2169/naika.95.57","[Non-alcoholic steatohepatitis (NASH). 4. Physiopathological explanation (a lesson from experimental models)].","2022-03-10"]
[49134,"16499208","Nihon Naika Gakkai Zasshi","10.2169/naika.95.51","[Non-alcoholic steatohepatitis. 3. Oxidative stress and NASH].","2022-03-10"]
[49135,"16499207","Nihon Naika Gakkai Zasshi","10.2169/naika.95.46","[Non-alcoholic steatohepatitis (NASH). 2. Insulin resistance and NASH].","2022-03-10"]
[49136,"16499206","Nihon Naika Gakkai Zasshi","10.2169/naika.95.39","[Non-alcoholic steatohepatitis (NASH). 1. General concept].","2022-03-10"]
[49137,"16497631","Scand J Gastroenterol","10.1080/00365520500347089","Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.","2022-03-10"]
[49138,"16482497","J Pathol","10.1002/path.1950","Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.","2022-03-10"]
[49139,"16477590","J Pathol","10.1002/path.1946","Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?","2022-03-10"]
[49140,"16465366","Int J Oncol",null,"Protein level of apolipoprotein E increased in human hepatocellular carcinoma.","2022-03-10"]
[49141,"16448457","Liver Int","10.1111/j.1478-3231.2005.01211.x","The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases.","2022-03-10"]
[49142,"16385228","Alcohol Clin Exp Res","10.1097/01.alc.0000191948.27106.85","Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD).","2022-03-10"]
[49143,"16340448","Alcohol Clin Exp Res","10.1097/01.alc.0000187595.19324.ca","-238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men.","2022-03-10"]
[49144,"16296871","Drugs","10.2165/00003495-200565170-00003","Pathophysiological basis for antioxidant therapy in chronic liver disease.","2022-03-10"]
[49145,"16289367","Med Hypotheses","10.1016/j.mehy.2005.09.040","Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.","2022-03-10"]
[49146,"16278903","Am J Med Genet A","10.1002/ajmg.a.31013","A patient with monosomy 1p36, atypical features and phenotypic similarities with Cantu syndrome.","2022-03-10"]
[49147,"16225471","Aliment Pharmacol Ther","10.1111/j.1365-2036.2005.02594.x","Review article: steatosis, the metabolic syndrome and cancer.","2022-03-10"]
[49148,"16223568","Med Hypotheses","10.1016/j.mehy.2005.09.003","Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: new treatment for global dangers.","2022-03-10"]
[49149,"16215887","Z Gastroenterol","10.1055/s-2001-919025","Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).","2022-03-10"]
[49150,"16208305","Minerva Endocrinol",null,"The metabolic syndrome and type 2 diabetes.","2022-03-10"]
[49151,"16190545","Przegl Epidemiol",null,"[Epidemic outbreak of acute hepatitis C--clinical course, histology and effectiveness of therapy].","2022-03-10"]
[49152,"16185298","Pathol Int","10.1111/j.1440-1827.2005.01886.x","Post-liver transplantation de novo hepatitis with overlap features.","2022-03-10"]
[49153,"16165706","Scand J Gastroenterol","10.1080/00365520500329038","Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology.","2022-03-10"]
[49154,"16137475","Gastroenterol Hepatol","10.1157/13077761","[Etiopathogenesis of non-alcoholic steatohepatitis].","2022-03-10"]
[49155,"16130444","Orv Hetil",null,"[Non-alcoholic steatosis/steatohepatitis].","2022-03-10"]
[49156,"16097995","Aliment Pharmacol Ther","10.1111/j.1365-2036.2005.02562.x","Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.","2022-03-10"]
[49157,"16054984","Alcohol","10.1016/j.alcohol.2005.03.011","Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer.","2022-03-10"]
[49158,"16020491","Gut","10.1136/gut.2005.069153","Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.","2022-03-10"]
[49159,"15841433","Genet Mol Res",null,"Hereditary hemochromatosis in a Brazilian university hospital in S&#227;o Paulo State (1990-2000).","2022-03-10"]
[49160,"15777569","J Hepatol","10.1016/j.jhep.2004.11.022","Evaluation and management of non-alcoholic steatohepatitis.","2022-03-10"]
[49161,"15761983","World J Gastroenterol","10.3748/wjg.v11.i9.1392","Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats.","2022-03-10"]
[49162,"15724606","Lik Sprava",null,"[Changes in indices of connective tissue in patients with alcoholic and non-alcoholic steatohepatitis and their correction with glutargin].","2022-03-10"]
[49163,"15724437","Mol Cell Biochem","10.1007/s11010-005-2997-0","Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis.","2022-03-10"]
[49164,"15716019","Hepatol Res","10.1016/j.hepres.2004.09.008","Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan.","2022-03-10"]
[49165,"15698360","Med J Aust","10.5694/j.1326-5377.2005.tb06618.x","3. Management and prevention of obesity and its complications in children and adolescents.","2022-03-10"]
[49166,"15683446","J Gastroenterol Hepatol","10.1111/j.1440-1746.2005.03724.x","Liver failure caused by non-alcoholic steatohepatitis in an obese young male.","2022-03-10"]
[49167,"15649101","Treat Endocrinol","10.2165/00024677-200504010-00006","Surgical management of obesity: a review of the evidence relating to the health benefits and risks.","2022-03-10"]
[49168,"15647199","Gut","10.1136/gut.2003.024935","Cytokines and the pathogenesis of non-alcoholic steatohepatitis.","2022-03-10"]
[49169,"15641470","Gac Med Mex",null,"[Obesity and steatohepatitis. Histologic aspects].","2022-03-10"]
[49170,"15629523","J Hepatol","10.1016/j.jhep.2004.07.032","Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient.","2022-03-10"]
[49171,"15582125","J Hepatol","10.1016/j.jhep.2004.08.010","Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.","2022-03-10"]
[49172,"15570866","Nihon Shokakibyo Gakkai Zasshi",null,"[Histopathology of non-alcoholic steatohepatitis (NASH)].","2022-03-10"]
[49173,"15566507","Liver Int","10.1111/j.1478-3231.2004.0970.x","Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study.","2022-03-10"]
[49174,"15504303","Zhonghua Gan Zang Bing Za Zhi",null,"[The role of enterogenous endotoxemia in the pathogenesis of non-alcoholic steatohepatitis].","2022-03-10"]
[49175,"15489566","Eur J Gastroenterol Hepatol","10.1097/00042737-200411000-00003","Mitochondrial injury in steatohepatitis.","2022-03-10"]
[49176,"15475485","Am J Physiol Gastrointest Liver Physiol","10.1152/ajpgi.00107.2004","Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein.","2022-03-10"]
[49177,"15464253","J Hepatol","10.1016/j.jhep.2004.05.008","Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.","2022-03-10"]
[49178,"15449765","Klin Med (Mosk)",null,"[Chronic alcoholic and non-alcoholic steatohepatitis].","2022-03-10"]
[49179,"15368443","Hepatology","10.1002/hep.20302","Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.","2022-03-10"]
[49180,"15222062","Orv Hetil",null,"[Deranged parameters of hepatic function in non-alcoholic steatohepatitis].","2022-03-10"]
[49181,"15180496","Curr Drug Metab","10.2174/1389200043335531","Cytochrome P450 and liver diseases.","2022-03-10"]
[49182,"15119118","Orv Hetil",null,"[Treatment of non-alcoholic steatohepatitis].","2022-03-10"]
[49183,"15115430","Med J Aust","10.5694/j.1326-5377.2004.tb06031.x","10: Management of obesity.","2022-03-10"]
[49184,"15094675","Gastroenterol Clin Biol","10.1016/s0399-8320(04)94916-0","[Improving insulin resistance: certain progress in the management of patients with non-alcoholic steatohepatitis...but the story continues].","2022-03-10"]
[49185,"15040152","Vnitr Lek",null,"[The metabolic syndrome].","2022-03-10"]
[49186,"14989001","Pathologica",null,"[Non-alcoholic steatohepatitis].","2022-03-10"]
[49187,"14987322","Aliment Pharmacol Ther","10.1111/j.1365-2036.2004.01888.x","Metformin in the treatment of patients with non-alcoholic steatohepatitis.","2022-03-10"]
[49188,"14631300","Gastroenterol Clin Biol",null,"[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].","2022-03-10"]
[49189,"14586252","Gastroenterol Clin Biol",null,"[A man with non alcoholic steatohepatitis].","2022-03-10"]
[49190,"14586251","Gastroenterol Clin Biol",null,"[Non-alcoholic steatohepatitis: therapeutic management].","2022-03-10"]
[49191,"14586250","Gastroenterol Clin Biol",null,"[Non-alcoholic steatohepatitis: natural history and diagnosis].","2022-03-10"]
[49192,"14585066","Expert Opin Drug Saf","10.1517/14740338.2.6.581","Hepatotoxicity of thiazolidinediones.","2022-03-10"]
[49193,"14520852","Ter Arkh",null,"[Clinicomorphological changes of liver in atherogenic dyslipidemia and after treatment with statins].","2022-03-10"]
[49194,"12974918","J Gastroenterol Hepatol","10.1046/j.1440-1746.2003.03156.x","N-acetylcysteine in the treatment of non-alcoholic steatohepatitis.","2022-03-10"]
[49195,"12962433","Indian J Gastroenterol",null,"Adult celiac disease in northern India.","2022-03-10"]
[49196,"12940291","Obes Surg","10.1381/096089203322190853","Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities.","2022-03-10"]
[49197,"12860288","Cancer Lett","10.1016/s0304-3835(03)00213-1","Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver.","2022-03-10"]
[49198,"12794720","J Med Virol","10.1002/jmv.10433","Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.","2022-03-10"]
[49199,"12747817","Med Clin (Barc)","10.1016/s0025-7753(03)73803-2","[Non-alcoholic steatohepatitis].","2022-03-10"]
[49200,"12740357","Gut","10.1136/gut.52.6.914","Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency.","2022-03-10"]